<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:video="http://www.google.com/schemas/sitemap-video/1.1">
  <url>
    <loc>https://www.trianglehealth.com/phase-1/15-gpc3-car-t-cells-nct06815432/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06815432.jpg</video:thumbnail_loc>
      <video:title>15.GPC3-CAR T cells trial for Glioblastoma Multiforme of Brain (NCT06815432): short film</video:title>
      <video:description>15.GPC3-CAR T cells trial for Glioblastoma Multiforme of Brain (NCT06815432). GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma. The body has different ways of fighting infection and disease.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06815432.mp4</video:content_loc>
      <video:publication_date>2026-10-18T18:44:59.499Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/15-gpc3-car-t-cells-nct06815432/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06815432.jpg</video:thumbnail_loc>
      <video:title>15.GPC3-CAR T cells trial for Glioblastoma Multiforme of Brain (NCT06815432): vídeo corto</video:title>
      <video:description>15.GPC3-CAR T cells trial for Glioblastoma Multiforme of Brain (NCT06815432). GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma. The body has different ways of fighting infection and disease.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06815432.mp4</video:content_loc>
      <video:publication_date>2026-10-18T18:44:59.499Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/177lu-psma-617-nct07223034/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07223034.jpg</video:thumbnail_loc>
      <video:title>177Lu-PSMA-617 trial for Glioma (NCT07223034): short film</video:title>
      <video:description>177Lu-PSMA-617 trial for Glioma (NCT07223034). 177Lu-PSMA-617 in People With Gliomas. The researchers are doing this study to find out whether the radiopharmaceutical therapy (RPT) 177Lu-PSMA-617 is a safe…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07223034.mp4</video:content_loc>
      <video:publication_date>2026-10-18T18:45:39.436Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/177lu-psma-617-nct07223034/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07223034.jpg</video:thumbnail_loc>
      <video:title>177Lu-PSMA-617 trial for Glioma (NCT07223034): vídeo corto</video:title>
      <video:description>177Lu-PSMA-617 trial for Glioma (NCT07223034). 177Lu-PSMA-617 in People With Gliomas. The researchers are doing this study to find out whether the radiopharmaceutical therapy (RPT) 177Lu-PSMA-617 is a safe…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07223034.mp4</video:content_loc>
      <video:publication_date>2026-10-18T18:45:39.436Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/177lu-rhpsma-10-1-nct06066437/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06066437.jpg</video:thumbnail_loc>
      <video:title>177Lu rhPSMA-10.1 trial for Prostate Cancer (NCT06066437): short film</video:title>
      <video:description>177Lu rhPSMA-10.1 trial for Prostate Cancer (NCT06066437). NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial. To learn if the proposed dose of 177Lu rhPSMA-10.1 is safe.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06066437.mp4</video:content_loc>
      <video:publication_date>2026-10-18T18:47:42.318Z</video:publication_date>
      <video:duration>66</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/177lu-rhpsma-10-1-nct06066437/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06066437.jpg</video:thumbnail_loc>
      <video:title>177Lu rhPSMA-10.1 trial for Prostate Cancer (NCT06066437): vídeo corto</video:title>
      <video:description>177Lu rhPSMA-10.1 trial for Prostate Cancer (NCT06066437). NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial. To learn if the proposed dose of 177Lu rhPSMA-10.1 is safe.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06066437.mp4</video:content_loc>
      <video:publication_date>2026-10-18T18:47:42.318Z</video:publication_date>
      <video:duration>66</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/18f-v-6-bp-nct05452005/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05452005.jpg</video:thumbnail_loc>
      <video:title>[18F]-αvβ6-BP trial for Metastatic Non-Small Cell Lung Cancer (NCT05452005): short film</video:title>
      <video:description>[18F]-αvβ6-BP trial for Metastatic Non-Small Cell Lung Cancer (NCT05452005). Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer. This study investigates…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05452005.mp4</video:content_loc>
      <video:publication_date>2026-10-19T00:32:10.364Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/18f-v-6-bp-nct05452005/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05452005.jpg</video:thumbnail_loc>
      <video:title>[18F]-αvβ6-BP trial for Metastatic Non-Small Cell Lung Cancer (NCT05452005): vídeo corto</video:title>
      <video:description>[18F]-αvβ6-BP trial for Metastatic Non-Small Cell Lung Cancer (NCT05452005). Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer. This study investigates…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05452005.mp4</video:content_loc>
      <video:publication_date>2026-10-19T00:32:10.364Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/2141-v11-nct07818018/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07818018.jpg</video:thumbnail_loc>
      <video:title>2141-V11 trial for Advanced Esophageal, Gastric or GEJ Cancer (NCT07818018): short film</video:title>
      <video:description>2141-V11 trial for Advanced Esophageal, Gastric or GEJ Cancer (NCT07818018). 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma. The purpose of this study is to find out whether adding the drug…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07818018.mp4</video:content_loc>
      <video:publication_date>2026-10-20T00:53:48.428Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/2141-v11-nct07818018/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07818018.jpg</video:thumbnail_loc>
      <video:title>2141-V11 trial for Advanced Esophageal, Gastric or GEJ Cancer (NCT07818018): vídeo corto</video:title>
      <video:description>2141-V11 trial for Advanced Esophageal, Gastric or GEJ Cancer (NCT07818018). 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma. The purpose of this study is to find out whether adding the drug…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07818018.mp4</video:content_loc>
      <video:publication_date>2026-10-20T00:53:48.428Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/8-12-day-production-of-car-t-cells-nct04186520/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04186520.jpg</video:thumbnail_loc>
      <video:title>8/12-Day Production of Car-T Cells trial for Non Hodgkin Lymphoma (NHL) (NCT04186520): short film</video:title>
      <video:description>8/12-Day Production of Car-T Cells trial for Non Hodgkin Lymphoma (NHL) (NCT04186520). CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies. This is a Phase I/II, interventional, single-arm, open-label, treatment study…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04186520.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:44:28.776Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/8-12-day-production-of-car-t-cells-nct04186520/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04186520.jpg</video:thumbnail_loc>
      <video:title>8/12-Day Production of Car-T Cells trial for Non Hodgkin Lymphoma (NHL) (NCT04186520): vídeo corto</video:title>
      <video:description>8/12-Day Production of Car-T Cells trial for Non Hodgkin Lymphoma (NHL) (NCT04186520). CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies. This is a Phase I/II, interventional, single-arm, open-label, treatment study…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04186520.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:44:28.776Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/abcd-nk-nct06158828/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06158828.jpg</video:thumbnail_loc>
      <video:title>ABCD-NK trial for Acute Myeloid Leukemia, Pediatric (NCT06158828): short film</video:title>
      <video:description>ABCD-NK trial for Acute Myeloid Leukemia, Pediatric (NCT06158828). Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML. This trial represents a single institution phase I/II…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06158828.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:04:39.701Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/abcd-nk-nct06158828/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06158828.jpg</video:thumbnail_loc>
      <video:title>ABCD-NK trial for Acute Myeloid Leukemia, Pediatric (NCT06158828): vídeo corto</video:title>
      <video:description>ABCD-NK trial for Acute Myeloid Leukemia, Pediatric (NCT06158828). Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML. This trial represents a single institution phase I/II…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06158828.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:04:39.701Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/abemaciclib-nct04923542/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04923542.jpg</video:thumbnail_loc>
      <video:title>Radiosurgery + Abemaciclib trial for HR+/HER2- Breast Cancer Brain… (NCT04923542): short film</video:title>
      <video:description>Radiosurgery + Abemaciclib trial for HR+/HER2- Breast Cancer Brain Metastases (NCT04923542). SR &amp; Abemaciclib With/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain Metastases. This is a single arm study of abemaciclib and endocrine…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04923542.mp4</video:content_loc>
      <video:publication_date>2026-10-19T14:37:11.013Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/abemaciclib-nct04923542/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04923542.jpg</video:thumbnail_loc>
      <video:title>Radiosurgery + Abemaciclib trial for HR+/HER2- Breast Cancer Brain… (NCT04923542): vídeo corto</video:title>
      <video:description>Radiosurgery + Abemaciclib trial for HR+/HER2- Breast Cancer Brain Metastases (NCT04923542). SR &amp; Abemaciclib With/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain Metastases. This is a single arm study of abemaciclib and endocrine…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04923542.mp4</video:content_loc>
      <video:publication_date>2026-10-19T14:37:11.013Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/acalabrutinib-nct05256641/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05256641.jpg</video:thumbnail_loc>
      <video:title>Acalabrutinib Maintenance trial for High-Risk Large B-Cell Lymphoma… (NCT05256641): short film</video:title>
      <video:description>Acalabrutinib Maintenance trial for High-Risk Large B-Cell Lymphoma After Cellular Therapy (NCT05256641). Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma. This phase Ib/II trial studies the side effects and efficacy of…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05256641.mp4</video:content_loc>
      <video:publication_date>2026-10-20T05:51:48.930Z</video:publication_date>
      <video:duration>64</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/acalabrutinib-nct05256641/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05256641.jpg</video:thumbnail_loc>
      <video:title>Acalabrutinib Maintenance trial for High-Risk Large B-Cell Lymphoma… (NCT05256641): vídeo corto</video:title>
      <video:description>Acalabrutinib Maintenance trial for High-Risk Large B-Cell Lymphoma After Cellular Therapy (NCT05256641). Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma. This phase Ib/II trial studies the side effects and efficacy of…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05256641.mp4</video:content_loc>
      <video:publication_date>2026-10-20T05:51:48.930Z</video:publication_date>
      <video:duration>64</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/ad-hcmv-flt3l-nct06914479/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06914479.jpg</video:thumbnail_loc>
      <video:title>Ad-hCMV-Flt3L trial for Recurrent Diffuse Hemispheric Glioma, H3… (NCT06914479): short film</video:title>
      <video:description>Ad-hCMV-Flt3L trial for Recurrent Diffuse Hemispheric Glioma, H3 G34-Mutant (NCT06914479). Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable,…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06914479.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:26:18.809Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/ad-hcmv-flt3l-nct06914479/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06914479.jpg</video:thumbnail_loc>
      <video:title>Ad-hCMV-Flt3L trial for Recurrent Diffuse Hemispheric Glioma, H3… (NCT06914479): vídeo corto</video:title>
      <video:description>Ad-hCMV-Flt3L trial for Recurrent Diffuse Hemispheric Glioma, H3 G34-Mutant (NCT06914479). Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable,…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06914479.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:26:18.809Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/ad5-ycd-muttksr39rep-adp-adenovirus-nct05686798/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05686798.jpg</video:thumbnail_loc>
      <video:title>Ad5-yCD/mutTKSR39rep-ADP adenovirus trial for Malignant Glioma of Brain (NCT05686798): short film</video:title>
      <video:description>Ad5-yCD/mutTKSR39rep-ADP adenovirus trial for Malignant Glioma of Brain (NCT05686798). Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma. The primary goal of this Phase I study is to determine the maximum…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05686798.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:18:10.958Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/ad5-ycd-muttksr39rep-adp-adenovirus-nct05686798/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05686798.jpg</video:thumbnail_loc>
      <video:title>Ad5-yCD/mutTKSR39rep-ADP adenovirus trial for Malignant Glioma of Brain (NCT05686798): vídeo corto</video:title>
      <video:description>Ad5-yCD/mutTKSR39rep-ADP adenovirus trial for Malignant Glioma of Brain (NCT05686798). Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma. The primary goal of this Phase I study is to determine the maximum…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05686798.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:18:10.958Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/adaptive-stereotactic-body-radiation-nct05880667/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05880667.jpg</video:thumbnail_loc>
      <video:title>Adaptive Stereotactic Body Radiation trial for Abdominopelvic Metastases (NCT05880667): short film</video:title>
      <video:description>Adaptive Stereotactic Body Radiation trial for Abdominopelvic Metastases (NCT05880667). Adaptive Radiation for Abdominopelvic Metastases. Single arm Phase I trial of adaptive stereotactic body radiation (SBRT) for abdominopelvic metastases.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05880667.mp4</video:content_loc>
      <video:publication_date>2026-10-19T01:21:41.880Z</video:publication_date>
      <video:duration>59</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/adaptive-stereotactic-body-radiation-nct05880667/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05880667.jpg</video:thumbnail_loc>
      <video:title>Adaptive Stereotactic Body Radiation trial for Abdominopelvic Metastases (NCT05880667): vídeo corto</video:title>
      <video:description>Adaptive Stereotactic Body Radiation trial for Abdominopelvic Metastases (NCT05880667). Adaptive Radiation for Abdominopelvic Metastases. Single arm Phase I trial of adaptive stereotactic body radiation (SBRT) for abdominopelvic metastases.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05880667.mp4</video:content_loc>
      <video:publication_date>2026-10-19T01:21:41.880Z</video:publication_date>
      <video:duration>59</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/adclec-syn1-car-t-cells-nct05748197/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05748197.jpg</video:thumbnail_loc>
      <video:title>ADCLEC.syn1 CAR T cells trial for Acute Myeloid Leukemia (NCT05748197): short film</video:title>
      <video:description>ADCLEC.syn1 CAR T cells trial for Acute Myeloid Leukemia (NCT05748197). ADCLEC.syn1 in People With Acute Myeloid Leukemia. The purpose of this study is to test the safety of ADCLEC.syn1 CAR T cells in people with relapsed or…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05748197.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:14:11.987Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/adclec-syn1-car-t-cells-nct05748197/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05748197.jpg</video:thumbnail_loc>
      <video:title>ADCLEC.syn1 CAR T cells trial for Acute Myeloid Leukemia (NCT05748197): vídeo corto</video:title>
      <video:description>ADCLEC.syn1 CAR T cells trial for Acute Myeloid Leukemia (NCT05748197). ADCLEC.syn1 in People With Acute Myeloid Leukemia. The purpose of this study is to test the safety of ADCLEC.syn1 CAR T cells in people with relapsed or…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05748197.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:14:11.987Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/adenosine-a2b-receptor-antagonist-pbf-1129-nct05234307/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05234307.jpg</video:thumbnail_loc>
      <video:title>Adenosine A2B Receptor… trial for Metastatic Lung Non-Small… (NCT05234307): short film</video:title>
      <video:description>Adenosine A2B Receptor Antagonist PBF-1129 trial for Metastatic Lung Non-Small Cell Carcinoma (NCT05234307). PBF-1129 and Nivolumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer. This phase I trial studies the side effects and best dose of…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05234307.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:14:26.908Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/adenosine-a2b-receptor-antagonist-pbf-1129-nct05234307/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05234307.jpg</video:thumbnail_loc>
      <video:title>Adenosine A2B Receptor… trial for Metastatic Lung Non-Small… (NCT05234307): vídeo corto</video:title>
      <video:description>Adenosine A2B Receptor Antagonist PBF-1129 trial for Metastatic Lung Non-Small Cell Carcinoma (NCT05234307). PBF-1129 and Nivolumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer. This phase I trial studies the side effects and best dose of…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05234307.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:14:26.908Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/adept-nct07346144/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07346144.jpg</video:thumbnail_loc>
      <video:title>ADePT trial for Glioblastoma (GBM) (NCT07346144): short film</video:title>
      <video:description>ADePT trial for Glioblastoma (GBM) (NCT07346144). An AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma. The goal of this clinical trial is to first define the Safety and Optimal…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07346144.mp4</video:content_loc>
      <video:publication_date>2026-09-12T15:34:10.300Z</video:publication_date>
      <video:duration>241</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/adept-nct07346144/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07346144.jpg</video:thumbnail_loc>
      <video:title>ADePT trial for Glioblastoma (GBM) (NCT07346144): vídeo corto</video:title>
      <video:description>ADePT trial for Glioblastoma (GBM) (NCT07346144). An AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma. The goal of this clinical trial is to first define the Safety and Optimal…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07346144.mp4</video:content_loc>
      <video:publication_date>2026-09-12T15:34:10.300Z</video:publication_date>
      <video:duration>241</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/adv-hsv-tk-gene-therapy-nct03596086/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03596086.jpg</video:thumbnail_loc>
      <video:title>ADV/HSV-tk (gene therapy) trial for Recurrent Glioblastoma or Grade III… (NCT03596086): short film</video:title>
      <video:description>ADV/HSV-tk (gene therapy) trial for Recurrent Glioblastoma or Grade III Astrocytoma (NCT03596086). HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM. Study to assess the safety and efficacy of HSV-tk (gene therapy), valacyclovir, radiotherapy…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03596086.mp4</video:content_loc>
      <video:publication_date>2026-10-19T00:38:25.320Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/adv-hsv-tk-gene-therapy-nct03596086/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03596086.jpg</video:thumbnail_loc>
      <video:title>ADV/HSV-tk (gene therapy) trial for Recurrent Glioblastoma or Grade III… (NCT03596086): vídeo corto</video:title>
      <video:description>ADV/HSV-tk (gene therapy) trial for Recurrent Glioblastoma or Grade III Astrocytoma (NCT03596086). HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM. Study to assess the safety and efficacy of HSV-tk (gene therapy), valacyclovir, radiotherapy…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03596086.mp4</video:content_loc>
      <video:publication_date>2026-10-19T00:38:25.320Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/allogeneic-anti-ny-eso-1-tcr-il-15-transduced-cord-blood-nct06066359/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06066359.jpg</video:thumbnail_loc>
      <video:title>NY-ESO-1 TCR/IL-15 Cord Blood NK… trial for Relapsed/Refractory Myeloma (NCT06066359): short film</video:title>
      <video:description>NY-ESO-1 TCR/IL-15 Cord Blood NK Cells trial for Relapsed/Refractory Myeloma (NCT06066359). Ph I/II Trial of Cord Blood-derived NK Cells With NY-ESO-1 TCR/IL-15 for R/R Myeloma. To find the recommended dose of NY-ESO-1 TCR/IL-15 NK cells that can be…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06066359.mp4</video:content_loc>
      <video:publication_date>2026-10-18T20:20:59.738Z</video:publication_date>
      <video:duration>71</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/allogeneic-anti-ny-eso-1-tcr-il-15-transduced-cord-blood-nct06066359/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06066359.jpg</video:thumbnail_loc>
      <video:title>NY-ESO-1 TCR/IL-15 Cord Blood NK… trial for Relapsed/Refractory Myeloma (NCT06066359): vídeo corto</video:title>
      <video:description>NY-ESO-1 TCR/IL-15 Cord Blood NK Cells trial for Relapsed/Refractory Myeloma (NCT06066359). Ph I/II Trial of Cord Blood-derived NK Cells With NY-ESO-1 TCR/IL-15 for R/R Myeloma. To find the recommended dose of NY-ESO-1 TCR/IL-15 NK cells that can be…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06066359.mp4</video:content_loc>
      <video:publication_date>2026-10-18T20:20:59.738Z</video:publication_date>
      <video:duration>71</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/anti-cd19-cd20-cd22-car-t-cells-nct05418088/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05418088.jpg</video:thumbnail_loc>
      <video:title>Anti-CD19/CD20/CD22 CAR T-Cells trial for Recurrent Acute Lymphoblastic… (NCT05418088): short film</video:title>
      <video:description>Anti-CD19/CD20/CD22 CAR T-Cells trial for Recurrent Acute Lymphoblastic Leukemia (NCT05418088). Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies. This phase I trial tests the…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05418088.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:03:37.569Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/anti-cd19-cd20-cd22-car-t-cells-nct05418088/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05418088.jpg</video:thumbnail_loc>
      <video:title>Anti-CD19/CD20/CD22 CAR T-Cells trial for Recurrent Acute Lymphoblastic… (NCT05418088): vídeo corto</video:title>
      <video:description>Anti-CD19/CD20/CD22 CAR T-Cells trial for Recurrent Acute Lymphoblastic Leukemia (NCT05418088). Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies. This phase I trial tests the…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05418088.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:03:37.569Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/anti-cd30-bispecific-antibody-armed-anti-cd3-activated-a-nct05544968/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05544968.jpg</video:thumbnail_loc>
      <video:title>CD30-Armed T Cells trial for Relapsed or Refractory Hodgkin Lymphoma and… (NCT05544968): short film</video:title>
      <video:description>CD30-Armed T Cells trial for Relapsed or Refractory Hodgkin Lymphoma and CD30+ Lymphomas (NCT05544968). Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies. This first-in-human trial will assess the safety,…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05544968.mp4</video:content_loc>
      <video:publication_date>2026-10-20T02:24:17.450Z</video:publication_date>
      <video:duration>67</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/anti-cd30-bispecific-antibody-armed-anti-cd3-activated-a-nct05544968/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05544968.jpg</video:thumbnail_loc>
      <video:title>CD30-Armed T Cells trial for Relapsed or Refractory Hodgkin Lymphoma… (NCT05544968): vídeo corto</video:title>
      <video:description>CD30-Armed T Cells trial for Relapsed or Refractory Hodgkin Lymphoma and CD30+ Lymphomas (NCT05544968). Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies. This first-in-human trial will assess the safety,…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05544968.mp4</video:content_loc>
      <video:publication_date>2026-10-20T02:24:17.450Z</video:publication_date>
      <video:duration>67</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/anti-garp-chimeric-antigen-receptor-t-cells-nct06964737/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06964737.jpg</video:thumbnail_loc>
      <video:title>Anti-GARP Chimeric Antigen… trial for Recurrent Malignant Glioma (NCT06964737): short film</video:title>
      <video:description>Anti-GARP Chimeric Antigen Receptor T Cel… trial for Recurrent Malignant Glioma (NCT06964737). Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas. This phase I trial tests the safety, side effects,…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06964737.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:14:47.450Z</video:publication_date>
      <video:duration>63</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/anti-garp-chimeric-antigen-receptor-t-cells-nct06964737/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06964737.jpg</video:thumbnail_loc>
      <video:title>Anti-GARP Chimeric Antigen… trial for Recurrent Malignant Glioma (NCT06964737): vídeo corto</video:title>
      <video:description>Anti-GARP Chimeric Antigen Receptor T Cel… trial for Recurrent Malignant Glioma (NCT06964737). Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas. This phase I trial tests the safety, side effects,…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06964737.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:14:47.450Z</video:publication_date>
      <video:duration>63</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/archer-nct05950139/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05950139.jpg</video:thumbnail_loc>
      <video:title>ARCHER trial for NSCLC Stage IV (NCT05950139): short film</video:title>
      <video:description>ARCHER trial for NSCLC Stage IV (NCT05950139). Peptide Vaccine To Prevent Acquired Resistance In Patients With Advanced ALK+ NSCLC. The purpose of this study is to evaluate the safety of a cancer peptide…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05950139.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:16:22.405Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/archer-nct05950139/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05950139.jpg</video:thumbnail_loc>
      <video:title>ARCHER trial for NSCLC Stage IV (NCT05950139): vídeo corto</video:title>
      <video:description>ARCHER trial for NSCLC Stage IV (NCT05950139). Peptide Vaccine To Prevent Acquired Resistance In Patients With Advanced ALK+ NSCLC. The purpose of this study is to evaluate the safety of a cancer peptide…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05950139.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:16:22.405Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/astatine-at-211-anti-cd45-monoclonal-antibody-bc8-b10-nct03670966/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03670966.jpg</video:thumbnail_loc>
      <video:title>211At-BC8-B10 Before Stem Cell… trial for High-Risk Acute Leukemia or… (NCT03670966): short film</video:title>
      <video:description>211At-BC8-B10 Before Stem Cell Transplant trial for High-Risk Acute Leukemia or Myelodysplastic Syndrome (NCT03670966). 211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome.…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03670966.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:54:56.345Z</video:publication_date>
      <video:duration>71</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/astatine-at-211-anti-cd45-monoclonal-antibody-bc8-b10-nct03670966/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03670966.jpg</video:thumbnail_loc>
      <video:title>211At-BC8-B10 Before Stem Cell… trial for High-Risk Acute Leukemia… (NCT03670966): vídeo corto</video:title>
      <video:description>211At-BC8-B10 Before Stem Cell Transplant trial for High-Risk Acute Leukemia or Myelodysplastic Syndrome (NCT03670966). 211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome.…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03670966.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:54:56.345Z</video:publication_date>
      <video:duration>71</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/astx727-nct03922555/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03922555.jpg</video:thumbnail_loc>
      <video:title>ASTX727 trial for Recurrent/Progressive Non-Enhancing IDH-Mutant Glioma (NCT03922555): short film</video:title>
      <video:description>ASTX727 trial for Recurrent/Progressive Non-Enhancing IDH-Mutant Glioma (NCT03922555). ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas. this research study is evaluating the highest dose of ASTX727 that can be administered…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03922555.mp4</video:content_loc>
      <video:publication_date>2026-10-19T14:27:47.951Z</video:publication_date>
      <video:duration>67</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/astx727-nct03922555/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03922555.jpg</video:thumbnail_loc>
      <video:title>ASTX727 trial for Recurrent/Progressive Non-Enhancing IDH-Mutant Glioma (NCT03922555): vídeo corto</video:title>
      <video:description>ASTX727 trial for Recurrent/Progressive Non-Enhancing IDH-Mutant Glioma (NCT03922555). ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas. this research study is evaluating the highest dose of ASTX727 that can be administered…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03922555.mp4</video:content_loc>
      <video:publication_date>2026-10-19T14:27:47.951Z</video:publication_date>
      <video:duration>67</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/atezolizumab-nct05096715/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05096715.jpg</video:thumbnail_loc>
      <video:title>Atezolizumab + Bevacizumab + SBRT trial for Unresectable Hepatocellular… (NCT05096715): short film</video:title>
      <video:description>Atezolizumab + Bevacizumab + SBRT trial for Unresectable Hepatocellular Carcinoma (NCT05096715). Atezolizumab+Bevacizumab+SBRT in Unresectable HCC. This research study is evaluating the safety and tolerability of the drugs atezolizumab and bevacizumab…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05096715.mp4</video:content_loc>
      <video:publication_date>2026-10-20T03:53:25.515Z</video:publication_date>
      <video:duration>63</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/atezolizumab-nct05096715/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05096715.jpg</video:thumbnail_loc>
      <video:title>Atezolizumab + Bevacizumab + SBRT trial for Unresectable Hepatocellular… (NCT05096715): vídeo corto</video:title>
      <video:description>Atezolizumab + Bevacizumab + SBRT trial for Unresectable Hepatocellular Carcinoma (NCT05096715). Atezolizumab+Bevacizumab+SBRT in Unresectable HCC. This research study is evaluating the safety and tolerability of the drugs atezolizumab and bevacizumab…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05096715.mp4</video:content_loc>
      <video:publication_date>2026-10-20T03:53:25.515Z</video:publication_date>
      <video:duration>63</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/atra-nct06536413/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06536413.jpg</video:thumbnail_loc>
      <video:title>ATRA trial for Relapsed/Refractory Multiple Myeloma (NCT06536413): short film</video:title>
      <video:description>ATRA trial for Relapsed/Refractory Multiple Myeloma (NCT06536413). ATRA and Carfilzomib in Plasma Cell Myeloma Patients. This is a Phase IB/II trial that will investigate the safety, tolerability and efficacy of combination…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06536413.mp4</video:content_loc>
      <video:publication_date>2026-10-19T02:30:56.587Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/atra-nct06536413/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06536413.jpg</video:thumbnail_loc>
      <video:title>ATRA trial for Relapsed/Refractory Multiple Myeloma (NCT06536413): vídeo corto</video:title>
      <video:description>ATRA trial for Relapsed/Refractory Multiple Myeloma (NCT06536413). ATRA and Carfilzomib in Plasma Cell Myeloma Patients. This is a Phase IB/II trial that will investigate the safety, tolerability and efficacy of combination…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06536413.mp4</video:content_loc>
      <video:publication_date>2026-10-19T02:30:56.587Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/autologous-anti-psca-car-4-1bb-tcrzeta-cd19t-expressing-nct05805371/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05805371.jpg</video:thumbnail_loc>
      <video:title>PSCA-Targeting CAR-T Cells trial for Castration-Resistant Prostate… (NCT05805371): short film</video:title>
      <video:description>PSCA-Targeting CAR-T Cells trial for Castration-Resistant Prostate Carcinoma (NCT05805371). PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer. This phase Ib…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05805371.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:03:43.423Z</video:publication_date>
      <video:duration>65</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/autologous-anti-psca-car-4-1bb-tcrzeta-cd19t-expressing-nct05805371/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05805371.jpg</video:thumbnail_loc>
      <video:title>PSCA-Targeting CAR-T Cells trial for Castration-Resistant Prostate… (NCT05805371): vídeo corto</video:title>
      <video:description>PSCA-Targeting CAR-T Cells trial for Castration-Resistant Prostate Carcinoma (NCT05805371). PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer. This phase Ib…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05805371.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:03:43.423Z</video:publication_date>
      <video:duration>65</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/avasopasem-nct07137871/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07137871.jpg</video:thumbnail_loc>
      <video:title>Avasopasem trial for Metastatic Hormone Receptor-Positive Breast Cancer (NCT07137871): short film</video:title>
      <video:description>Avasopasem trial for Metastatic Hormone Receptor-Positive Breast Cancer (NCT07137871). Avasopasem in Patients With Metastatic Hormone Receptor Positive Breast Cancer With Progression on a CDK 4/6 Inhibitor and Hormonal Therapy. This study aims…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07137871.mp4</video:content_loc>
      <video:publication_date>2026-10-19T16:34:39.210Z</video:publication_date>
      <video:duration>63</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/avasopasem-nct07137871/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07137871.jpg</video:thumbnail_loc>
      <video:title>Avasopasem trial for Metastatic Hormone Receptor-Positive Breast Cancer (NCT07137871): vídeo corto</video:title>
      <video:description>Avasopasem trial for Metastatic Hormone Receptor-Positive Breast Cancer (NCT07137871). Avasopasem in Patients With Metastatic Hormone Receptor Positive Breast Cancer With Progression on a CDK 4/6 Inhibitor and Hormonal Therapy. This study aims…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07137871.mp4</video:content_loc>
      <video:publication_date>2026-10-19T16:34:39.210Z</video:publication_date>
      <video:duration>63</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/axatilimab-nct06523556/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06523556.jpg</video:thumbnail_loc>
      <video:title>Axatilimab trial for Advanced Myeloproliferative Neoplasms, MDS/MPN… (NCT06523556): short film</video:title>
      <video:description>Axatilimab trial for Advanced Myeloproliferative Neoplasms, MDS/MPN and High-Risk CMML (NCT06523556). Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06523556.mp4</video:content_loc>
      <video:publication_date>2026-10-20T01:31:08.763Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/axatilimab-nct06523556/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06523556.jpg</video:thumbnail_loc>
      <video:title>Axatilimab trial for Advanced Myeloproliferative Neoplasms, MDS/MPN… (NCT06523556): vídeo corto</video:title>
      <video:description>Axatilimab trial for Advanced Myeloproliferative Neoplasms, MDS/MPN and High-Risk CMML (NCT06523556). Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06523556.mp4</video:content_loc>
      <video:publication_date>2026-10-20T01:31:08.763Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/b7-h3-cd28z-cart-nct07390539/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07390539.jpg</video:thumbnail_loc>
      <video:title>B7-H3.CD28Z.CART trial for Central Nervous System Neoplasms (NCT07390539): short film</video:title>
      <video:description>B7-H3.CD28Z.CART trial for Central Nervous System Neoplasms (NCT07390539). B7-H3.CD28Z.CART in CNS Neoplasms. The purpose of this research study is to test the safety and effectiveness of a cell therapy at different doses for…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07390539.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:48:02.130Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/b7-h3-cd28z-cart-nct07390539/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07390539.jpg</video:thumbnail_loc>
      <video:title>B7-H3.CD28Z.CART trial for Central Nervous System Neoplasms (NCT07390539): vídeo corto</video:title>
      <video:description>B7-H3.CD28Z.CART trial for Central Nervous System Neoplasms (NCT07390539). B7-H3.CD28Z.CART in CNS Neoplasms. The purpose of this research study is to test the safety and effectiveness of a cell therapy at different doses for…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07390539.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:48:02.130Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/bcma-tgf-car-t-cells-0-50-x-10-6-cells-kg-nct05976555/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05976555.jpg</video:thumbnail_loc>
      <video:title>Phase I Trial of BCMA-TGF-BETA CAR-T Cell… trial for Multiple Myeloma (NCT05976555): short film</video:title>
      <video:description>Phase I Trial of BCMA-TGF-BETA CAR-T Cell… trial for Multiple Myeloma (NCT05976555). BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma. This is a phase I, interventional, single-arm, open-label, dose-finding treatment study designed to…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05976555.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:53:56.312Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/bcma-tgf-car-t-cells-0-50-x-10-6-cells-kg-nct05976555/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05976555.jpg</video:thumbnail_loc>
      <video:title>Phase I Trial of BCMA-TGF-BETA CAR-T Cell… trial for Multiple Myeloma (NCT05976555): vídeo corto</video:title>
      <video:description>Phase I Trial of BCMA-TGF-BETA CAR-T Cell… trial for Multiple Myeloma (NCT05976555). BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma. This is a phase I, interventional, single-arm, open-label, dose-finding treatment study designed to…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05976555.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:53:56.312Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/bevacizumab-nct01269853/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT01269853.jpg</video:thumbnail_loc>
      <video:title>Bevacizumab trial for Glioblastoma Multiforme (NCT01269853): short film</video:title>
      <video:description>Bevacizumab trial for Glioblastoma Multiforme (NCT01269853). Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA. The high-grade malignant brain tumors,…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT01269853.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:21:47.182Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/bevacizumab-nct01269853/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT01269853.jpg</video:thumbnail_loc>
      <video:title>Bevacizumab trial for Glioblastoma Multiforme (NCT01269853): vídeo corto</video:title>
      <video:description>Bevacizumab trial for Glioblastoma Multiforme (NCT01269853). Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA. The high-grade malignant brain tumors,…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT01269853.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:21:47.182Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/brachytherapy-nct06543576/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06543576.jpg</video:thumbnail_loc>
      <video:title>External Beam Radiation and… trial for Stage IVB Cervical Cancer (NCT06543576): short film</video:title>
      <video:description>External Beam Radiation and Brachytherapy trial for Stage IVB Cervical Cancer (NCT06543576). External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer. This phase I/II trial…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06543576.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:36:35.000Z</video:publication_date>
      <video:duration>65</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/brachytherapy-nct06543576/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06543576.jpg</video:thumbnail_loc>
      <video:title>External Beam Radiation and… trial for Stage IVB Cervical Cancer (NCT06543576): vídeo corto</video:title>
      <video:description>External Beam Radiation and Brachytherapy trial for Stage IVB Cervical Cancer (NCT06543576). External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer. This phase I/II trial…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06543576.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:36:35.000Z</video:publication_date>
      <video:duration>65</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/brite-nct04903795/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04903795.jpg</video:thumbnail_loc>
      <video:title>BRiTE trial for Newly Diagnosed Glioblastoma (NCT04903795): short film</video:title>
      <video:description>BRiTE trial for Newly Diagnosed Glioblastoma (NCT04903795). BRiTE - Bispecific T Cell Engager for Patients With Glioblastoma. This Phase 1 study will assess the safety of a novel brain Bispecific T cell engager (BRiTE)…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04903795.mp4</video:content_loc>
      <video:publication_date>2026-10-28T03:40:05.741Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/brite-nct04903795/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04903795.jpg</video:thumbnail_loc>
      <video:title>BRiTE trial for Newly Diagnosed Glioblastoma (NCT04903795): vídeo corto</video:title>
      <video:description>BRiTE trial for Newly Diagnosed Glioblastoma (NCT04903795). BRiTE - Bispecific T Cell Engager for Patients With Glioblastoma. This Phase 1 study will assess the safety of a novel brain Bispecific T cell engager (BRiTE)…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04903795.mp4</video:content_loc>
      <video:publication_date>2026-10-28T03:40:05.741Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/c7r-gd2-cart-cells-iv-and-icv-infusion-nct04099797/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04099797.jpg</video:thumbnail_loc>
      <video:title>C7R-GD2.CART cells (IV and ICV… trial for Diffuse Intrinsic Pontine… (NCT04099797): short film</video:title>
      <video:description>C7R-GD2.CART cells (IV and ICV infusion) trial for Diffuse Intrinsic Pontine Glioma (NCT04099797). C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B). In this study, there are two treatment groups called Cohort 1 and Cohort 2.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04099797.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:26:10.154Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/c7r-gd2-cart-cells-iv-and-icv-infusion-nct04099797/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04099797.jpg</video:thumbnail_loc>
      <video:title>C7R-GD2.CART cells (IV and ICV… trial for Diffuse Intrinsic Pontine… (NCT04099797): vídeo corto</video:title>
      <video:description>C7R-GD2.CART cells (IV and ICV infusion) trial for Diffuse Intrinsic Pontine Glioma (NCT04099797). C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B). In this study, there are two treatment groups called Cohort 1 and Cohort 2.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04099797.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:26:10.154Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/car-70-il15-transduced-cb-nk-cells-nct05092451/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05092451.jpg</video:thumbnail_loc>
      <video:title>CAR.70/IL15-transduced CB-NK cells trial for B-Cell Lymphoma (NCT05092451): short film</video:title>
      <video:description>CAR.70/IL15-transduced CB-NK cells trial for B-Cell Lymphoma (NCT05092451). CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05092451.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:32:10.330Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/car-70-il15-transduced-cb-nk-cells-nct05092451/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05092451.jpg</video:thumbnail_loc>
      <video:title>CAR.70/IL15-transduced CB-NK cells trial for B-Cell Lymphoma (NCT05092451): vídeo corto</video:title>
      <video:description>CAR.70/IL15-transduced CB-NK cells trial for B-Cell Lymphoma (NCT05092451). CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05092451.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:32:10.330Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/car-t-cell-nct05003895/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05003895.jpg</video:thumbnail_loc>
      <video:title>CAR-T cell trial for Hepatocellular Carcinoma (NCT05003895): short film</video:title>
      <video:description>CAR-T cell trial for Hepatocellular Carcinoma (NCT05003895). GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies. Background: A new cancer treatment takes a person s own T cells,…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05003895.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:02:25.642Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/car-t-cell-nct05003895/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05003895.jpg</video:thumbnail_loc>
      <video:title>CAR-T cell trial for Hepatocellular Carcinoma (NCT05003895): vídeo corto</video:title>
      <video:description>CAR-T cell trial for Hepatocellular Carcinoma (NCT05003895). GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies. Background: A new cancer treatment takes a person s own T cells,…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05003895.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:02:25.642Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/car-t-cell-nct06768905/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06768905.jpg</video:thumbnail_loc>
      <video:title>Iomab-B Followed by CAR-T Cell Therapy trial for Non Hodgkin Lymphoma (NCT06768905): short film</video:title>
      <video:description>Iomab-B Followed by CAR-T Cell Therapy trial for Non Hodgkin Lymphoma (NCT06768905). IOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCL. This study is being done to determine the safety, efficacy and tolerability of a single 50 mCi dose…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06768905.mp4</video:content_loc>
      <video:publication_date>2026-10-18T19:51:51.422Z</video:publication_date>
      <video:duration>65</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/car-t-cell-nct06768905/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06768905.jpg</video:thumbnail_loc>
      <video:title>Iomab-B Followed by CAR-T Cell Therapy trial for Non Hodgkin Lymphoma (NCT06768905): vídeo corto</video:title>
      <video:description>Iomab-B Followed by CAR-T Cell Therapy trial for Non Hodgkin Lymphoma (NCT06768905). IOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCL. This study is being done to determine the safety, efficacy and tolerability of a single 50 mCi dose…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06768905.mp4</video:content_loc>
      <video:publication_date>2026-10-18T19:51:51.422Z</video:publication_date>
      <video:duration>65</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/care-t-cells-nct04715191/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04715191.jpg</video:thumbnail_loc>
      <video:title>CARE T cells trial for Liver Cancer (NCT04715191): short film</video:title>
      <video:description>CARE T cells trial for Liver Cancer (NCT04715191). Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors. Patients may be considered if…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04715191.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:00:56.585Z</video:publication_date>
      <video:duration>85</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/care-t-cells-nct04715191/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04715191.jpg</video:thumbnail_loc>
      <video:title>CARE T cells trial for Liver Cancer (NCT04715191): vídeo corto</video:title>
      <video:description>CARE T cells trial for Liver Cancer (NCT04715191). Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors. Patients may be considered if…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04715191.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:00:56.585Z</video:publication_date>
      <video:duration>85</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/carlotta01-nct05836896/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05836896.jpg</video:thumbnail_loc>
      <video:title>CARLOTTA01 trial for Neoplasms (NCT05836896): short film</video:title>
      <video:description>CARLOTTA01 trial for Neoplasms (NCT05836896). Safety and Maximum Tolerated Dose of High-affinity Autologous BCMA-targeting Chimeric Antigen Receptor (CAR) T-cells in Patients With Relapsed and Refractory…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05836896.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:47:57.323Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/carlotta01-nct05836896/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05836896.jpg</video:thumbnail_loc>
      <video:title>CARLOTTA01 trial for Neoplasms (NCT05836896): vídeo corto</video:title>
      <video:description>CARLOTTA01 trial for Neoplasms (NCT05836896). Safety and Maximum Tolerated Dose of High-affinity Autologous BCMA-targeting Chimeric Antigen Receptor (CAR) T-cells in Patients With Relapsed and Refractory…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05836896.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:47:57.323Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/cart-nct07319676/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07319676.jpg</video:thumbnail_loc>
      <video:title>CART trial for B-cell Lymphoma Refractory (NCT07319676): short film</video:title>
      <video:description>CART trial for B-cell Lymphoma Refractory (NCT07319676). Antigen Targeted T Cell Therapy for Relapsed/Refractory B Cell Lymphomas. This is a single center, open label, phase 1 lead in to determine Recommended Phase…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07319676.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:27:21.015Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/cart-nct07319676/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07319676.jpg</video:thumbnail_loc>
      <video:title>CART trial for B-cell Lymphoma Refractory (NCT07319676): vídeo corto</video:title>
      <video:description>CART trial for B-cell Lymphoma Refractory (NCT07319676). Antigen Targeted T Cell Therapy for Relapsed/Refractory B Cell Lymphomas. This is a single center, open label, phase 1 lead in to determine Recommended Phase…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07319676.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:27:21.015Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/carv3-team-e-t-cells-nct05660369/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05660369.jpg</video:thumbnail_loc>
      <video:title>CARv3-TEAM-E T cells trial for Glioblastoma (NCT05660369): short film</video:title>
      <video:description>CARv3-TEAM-E T cells trial for Glioblastoma (NCT05660369). CARv3-TEAM-E T Cells in Glioblastoma. The goal of this research study is to determine the best dose of CARv3-TEAM-E T Cells for treating participants with…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05660369.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:18:12.097Z</video:publication_date>
      <video:duration>65</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/carv3-team-e-t-cells-nct05660369/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05660369.jpg</video:thumbnail_loc>
      <video:title>CARv3-TEAM-E T cells trial for Glioblastoma (NCT05660369): vídeo corto</video:title>
      <video:description>CARv3-TEAM-E T cells trial for Glioblastoma (NCT05660369). CARv3-TEAM-E T Cells in Glioblastoma. The goal of this research study is to determine the best dose of CARv3-TEAM-E T Cells for treating participants with…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05660369.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:18:12.097Z</video:publication_date>
      <video:duration>65</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/cd123-car-t-nct04318678/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04318678.jpg</video:thumbnail_loc>
      <video:title>CD123-CAR T trial for AML/MDS (NCT04318678): short film</video:title>
      <video:description>CD123-CAR T trial for AML/MDS (NCT04318678). CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML). The CD123-CAR T-cell therapy is a new treatment that is being investigated for…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04318678.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:51:36.484Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/cd123-car-t-nct04318678/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04318678.jpg</video:thumbnail_loc>
      <video:title>CD123-CAR T trial for AML/MDS (NCT04318678): vídeo corto</video:title>
      <video:description>CD123-CAR T trial for AML/MDS (NCT04318678). CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML). The CD123-CAR T-cell therapy is a new treatment that is being investigated for…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04318678.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:51:36.484Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/cd19-car-t-cells-nct03676504/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03676504.jpg</video:thumbnail_loc>
      <video:title>CD19.CAR T Cells trial for Acute Lymphoblastic Leukemia, Adult (NCT03676504): short film</video:title>
      <video:description>CD19.CAR T Cells trial for Acute Lymphoblastic Leukemia, Adult (NCT03676504). Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR. Adult patients with r/r acute…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03676504.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:57:41.650Z</video:publication_date>
      <video:duration>91</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/cd19-car-t-cells-nct03676504/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03676504.jpg</video:thumbnail_loc>
      <video:title>CD19.CAR T Cells trial for Acute Lymphoblastic Leukemia, Adult (NCT03676504): vídeo corto</video:title>
      <video:description>CD19.CAR T Cells trial for Acute Lymphoblastic Leukemia, Adult (NCT03676504). Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR. Adult patients with r/r acute…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03676504.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:57:41.650Z</video:publication_date>
      <video:duration>91</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/cd19-cd22-car-transduced-t-cells-nct05442515/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05442515.jpg</video:thumbnail_loc>
      <video:title>CD19/CD22-CAR-transduced T cells trial for B-Non Hodgkin Lymphoma (NCT05442515): short film</video:title>
      <video:description>CD19/CD22-CAR-transduced T cells trial for B-Non Hodgkin Lymphoma (NCT05442515). CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies. Background: Acute…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05442515.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:41:12.518Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/cd19-cd22-car-transduced-t-cells-nct05442515/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05442515.jpg</video:thumbnail_loc>
      <video:title>CD19/CD22-CAR-transduced T cells trial for B-Non Hodgkin Lymphoma (NCT05442515): vídeo corto</video:title>
      <video:description>CD19/CD22-CAR-transduced T cells trial for B-Non Hodgkin Lymphoma (NCT05442515). CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies. Background: Acute…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05442515.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:41:12.518Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/cd19car-cd28-cd3zeta-egfrt-expressing-tn-mem-t-lymphocyt-nct05625594/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05625594.jpg</video:thumbnail_loc>
      <video:title>CD19-CAR T Cells for CNS Lymphoma trial for Central Nervous System… (NCT05625594): short film</video:title>
      <video:description>CD19-CAR T Cells for CNS Lymphoma trial for Central Nervous System Lymphoma (NCT05625594). Intracerebroventricular Administration of CD19-CAR T Cells (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/Mem T-lymphocytes) for the Treatment of Central Nervous…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05625594.mp4</video:content_loc>
      <video:publication_date>2026-10-18T18:51:05.646Z</video:publication_date>
      <video:duration>60</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/cd19car-cd28-cd3zeta-egfrt-expressing-tn-mem-t-lymphocyt-nct05625594/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05625594.jpg</video:thumbnail_loc>
      <video:title>CD19-CAR T Cells for CNS Lymphoma trial for Central Nervous System… (NCT05625594): vídeo corto</video:title>
      <video:description>CD19-CAR T Cells for CNS Lymphoma trial for Central Nervous System Lymphoma (NCT05625594). Intracerebroventricular Administration of CD19-CAR T Cells (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/Mem T-lymphocytes) for the Treatment of Central Nervous…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05625594.mp4</video:content_loc>
      <video:publication_date>2026-10-18T18:51:05.646Z</video:publication_date>
      <video:duration>60</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/cd19x22-car-t-cells-nct05098613/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05098613.jpg</video:thumbnail_loc>
      <video:title>CD19x22 CAR T Cells trial for Non-Hodgkin Lymphoma (NCT05098613): short film</video:title>
      <video:description>CD19x22 CAR T Cells trial for Non-Hodgkin Lymphoma (NCT05098613). Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients. This open-label, single arm phase 1 trial aims to…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05098613.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:38:05.923Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/cd19x22-car-t-cells-nct05098613/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05098613.jpg</video:thumbnail_loc>
      <video:title>CD19x22 CAR T Cells trial for Non-Hodgkin Lymphoma (NCT05098613): vídeo corto</video:title>
      <video:description>CD19x22 CAR T Cells trial for Non-Hodgkin Lymphoma (NCT05098613). Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients. This open-label, single arm phase 1 trial aims to…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05098613.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:38:05.923Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/cd19x22-car-t-nct06559189/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06559189.jpg</video:thumbnail_loc>
      <video:title>CD19x22 CAR T trial for B-cell Acute Lymphoblastic Leukemia (NCT06559189): short film</video:title>
      <video:description>CD19x22 CAR T trial for B-cell Acute Lymphoblastic Leukemia (NCT06559189). CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL. This study will evaluate the safety and tolerability of administering a novel…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06559189.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:19:38.258Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/cd19x22-car-t-nct06559189/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06559189.jpg</video:thumbnail_loc>
      <video:title>CD19x22 CAR T trial for B-cell Acute Lymphoblastic Leukemia (NCT06559189): vídeo corto</video:title>
      <video:description>CD19x22 CAR T trial for B-cell Acute Lymphoblastic Leukemia (NCT06559189). CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL. This study will evaluate the safety and tolerability of administering a novel…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06559189.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:19:38.258Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/cd22cart-cell-nct04815356/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04815356.jpg</video:thumbnail_loc>
      <video:title>CD22CART cell trial for Hairy Cell Leukemia (NCT04815356): short film</video:title>
      <video:description>CD22CART cell trial for Hairy Cell Leukemia (NCT04815356). Anti-CD22 Chimeric Receptor T Cells in Patients With Relapsed/Refractory Hairy Cell Leukemia and Variant. Background: CAR (Chimeric Antigen Receptor) T cell…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04815356.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:29:24.481Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/cd22cart-cell-nct04815356/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04815356.jpg</video:thumbnail_loc>
      <video:title>CD22CART cell trial for Hairy Cell Leukemia (NCT04815356): vídeo corto</video:title>
      <video:description>CD22CART cell trial for Hairy Cell Leukemia (NCT04815356). Anti-CD22 Chimeric Receptor T Cells in Patients With Relapsed/Refractory Hairy Cell Leukemia and Variant. Background: CAR (Chimeric Antigen Receptor) T cell…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04815356.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:29:24.481Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/cd371-specific-ysnvz-i-18-car-t-cells-nct06017258/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06017258.jpg</video:thumbnail_loc>
      <video:title>CD371-specific/YSNVz/I-18 CAR T… trial for Refractory Acute Myeloid… (NCT06017258): short film</video:title>
      <video:description>CD371-specific/YSNVz/I-18 CAR T cells trial for Refractory Acute Myeloid Leukemia (NCT06017258). CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia. The purpose of this study is to find out whether CD371-YSNVZ-IL18 CAR T cells are safe,…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06017258.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:55:09.528Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/cd371-specific-ysnvz-i-18-car-t-cells-nct06017258/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06017258.jpg</video:thumbnail_loc>
      <video:title>CD371-specific/YSNVz/I-18 CAR T… trial for Refractory Acute Myeloid… (NCT06017258): vídeo corto</video:title>
      <video:description>CD371-specific/YSNVz/I-18 CAR T cells trial for Refractory Acute Myeloid Leukemia (NCT06017258). CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia. The purpose of this study is to find out whether CD371-YSNVZ-IL18 CAR T cells are safe,…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06017258.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:55:09.528Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/cd79b-19-car-t-cells-nct06026319/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06026319.jpg</video:thumbnail_loc>
      <video:title>CD79b-19 CAR T cells trial for Non-hodgkin Lymphoma (NCT06026319): short film</video:title>
      <video:description>CD79b-19 CAR T cells trial for Non-hodgkin Lymphoma (NCT06026319). CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma. This research study involves the study of CD79b-19 CAR T cells for treating people with relapsed/refractory…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06026319.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:34:23.611Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/cd79b-19-car-t-cells-nct06026319/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06026319.jpg</video:thumbnail_loc>
      <video:title>CD79b-19 CAR T cells trial for Non-hodgkin Lymphoma (NCT06026319): vídeo corto</video:title>
      <video:description>CD79b-19 CAR T cells trial for Non-hodgkin Lymphoma (NCT06026319). CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma. This research study involves the study of CD79b-19 CAR T cells for treating people with relapsed/refractory…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06026319.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:34:23.611Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/cdx-1140-nct05029999/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05029999.jpg</video:thumbnail_loc>
      <video:title>CDX-1140 + CDX-301 + PLD trial for Metastatic HER2-Negative Breast Cancer (NCT05029999): short film</video:title>
      <video:description>CDX-1140 + CDX-301 + PLD trial for Metastatic HER2-Negative Breast Cancer (NCT05029999). CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer. This research study is being done to find out if the immunotherapy drugs called…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05029999.mp4</video:content_loc>
      <video:publication_date>2026-10-19T14:46:47.250Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/cdx-1140-nct05029999/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05029999.jpg</video:thumbnail_loc>
      <video:title>CDX-1140 + CDX-301 + PLD trial for Metastatic HER2-Negative Breast Cancer (NCT05029999): vídeo corto</video:title>
      <video:description>CDX-1140 + CDX-301 + PLD trial for Metastatic HER2-Negative Breast Cancer (NCT05029999). CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer. This research study is being done to find out if the immunotherapy drugs called…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05029999.mp4</video:content_loc>
      <video:publication_date>2026-10-19T14:46:47.250Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/chimeric-antigen-receptor-t-cell-therapy-nct06815029/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06815029.jpg</video:thumbnail_loc>
      <video:title>Chimeric Antigen Receptor T-Cell Therapy trial for Recurrent Glioblastoma (NCT06815029): short film</video:title>
      <video:description>Chimeric Antigen Receptor T-Cell Therapy trial for Recurrent Glioblastoma (NCT06815029). Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06815029.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:09:19.890Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/chimeric-antigen-receptor-t-cell-therapy-nct06815029/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06815029.jpg</video:thumbnail_loc>
      <video:title>Chimeric Antigen Receptor T-Cell Therapy trial for Recurrent Glioblastoma (NCT06815029): vídeo corto</video:title>
      <video:description>Chimeric Antigen Receptor T-Cell Therapy trial for Recurrent Glioblastoma (NCT06815029). Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06815029.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:09:19.890Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/chimeric-antigen-receptor-t-cells-nct05225363/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05225363.jpg</video:thumbnail_loc>
      <video:title>Chimeric Antigen Receptor T-cells trial for Platinum-Resistant Ovarian… (NCT05225363): short film</video:title>
      <video:description>Chimeric Antigen Receptor T-cells trial for Platinum-Resistant Ovarian Carcinoma (NCT05225363). Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer. This phase I trial tests the…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05225363.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:16:36.738Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/chimeric-antigen-receptor-t-cells-nct05225363/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05225363.jpg</video:thumbnail_loc>
      <video:title>Chimeric Antigen Receptor T-cells trial for Platinum-Resistant Ovarian… (NCT05225363): vídeo corto</video:title>
      <video:description>Chimeric Antigen Receptor T-cells trial for Platinum-Resistant Ovarian Carcinoma (NCT05225363). Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer. This phase I trial tests the…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05225363.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:16:36.738Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/ciml-nk-cells-nct05580601/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05580601.jpg</video:thumbnail_loc>
      <video:title>CIML-NK Cells trial for Relapsed/Refractory Acute Myeloid Leukemia (NCT05580601): short film</video:title>
      <video:description>CIML-NK Cells trial for Relapsed/Refractory Acute Myeloid Leukemia (NCT05580601). Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed &amp; Refractory Acute Myeloid Leukemia (AML). The objective of this study is to…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05580601.mp4</video:content_loc>
      <video:publication_date>2026-10-19T00:44:37.918Z</video:publication_date>
      <video:duration>67</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/ciml-nk-cells-nct05580601/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05580601.jpg</video:thumbnail_loc>
      <video:title>CIML-NK Cells trial for Relapsed/Refractory Acute Myeloid Leukemia (NCT05580601): vídeo corto</video:title>
      <video:description>CIML-NK Cells trial for Relapsed/Refractory Acute Myeloid Leukemia (NCT05580601). Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed &amp; Refractory Acute Myeloid Leukemia (AML). The objective of this study is to…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05580601.mp4</video:content_loc>
      <video:publication_date>2026-10-19T00:44:37.918Z</video:publication_date>
      <video:duration>67</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/ciml-nk-nct04024761/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04024761.jpg</video:thumbnail_loc>
      <video:title>CIML NK trial for Acute Myeloid Leukemia (NCT04024761): short film</video:title>
      <video:description>CIML NK trial for Acute Myeloid Leukemia (NCT04024761). CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation. This research study is studying cytokine induced memory-like…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04024761.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:26:00.391Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/ciml-nk-nct04024761/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04024761.jpg</video:thumbnail_loc>
      <video:title>CIML NK trial for Acute Myeloid Leukemia (NCT04024761): vídeo corto</video:title>
      <video:description>CIML NK trial for Acute Myeloid Leukemia (NCT04024761). CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation. This research study is studying cytokine induced memory-like…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04024761.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:26:00.391Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/cladribine-nct04375631/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04375631.jpg</video:thumbnail_loc>
      <video:title>CLAG-M/FLAG-Ida + TBI trial for Relapsed or Refractory AML, MDS or CMML (NCT04375631): short film</video:title>
      <video:description>CLAG-M/FLAG-Ida + TBI trial for Relapsed or Refractory AML, MDS or CMML (NCT04375631). CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04375631.mp4</video:content_loc>
      <video:publication_date>2026-10-20T01:15:48.988Z</video:publication_date>
      <video:duration>66</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/cladribine-nct04375631/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04375631.jpg</video:thumbnail_loc>
      <video:title>CLAG-M/FLAG-Ida + TBI trial for Relapsed or Refractory AML, MDS or CMML (NCT04375631): vídeo corto</video:title>
      <video:description>CLAG-M/FLAG-Ida + TBI trial for Relapsed or Refractory AML, MDS or CMML (NCT04375631). CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04375631.mp4</video:content_loc>
      <video:publication_date>2026-10-20T01:15:48.988Z</video:publication_date>
      <video:duration>66</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/cladribine-nct04797767/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04797767.jpg</video:thumbnail_loc>
      <video:title>Venetoclax Plus CLAG-M trial for Acute Myeloid Leukemia and High-Grade… (NCT04797767): short film</video:title>
      <video:description>Venetoclax Plus CLAG-M trial for Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms (NCT04797767). Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms. This phase I/II trial finds the best dose, side effects…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04797767.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:13:31.199Z</video:publication_date>
      <video:duration>65</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/cladribine-nct04797767/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04797767.jpg</video:thumbnail_loc>
      <video:title>Venetoclax Plus CLAG-M trial for Acute Myeloid Leukemia and High-Grade… (NCT04797767): vídeo corto</video:title>
      <video:description>Venetoclax Plus CLAG-M trial for Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms (NCT04797767). Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms. This phase I/II trial finds the best dose, side effects…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04797767.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:13:31.199Z</video:publication_date>
      <video:duration>65</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/combination-treatment-cxrpt-of-external-beam-radiation-x-nct04892303/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04892303.jpg</video:thumbnail_loc>
      <video:title>Radiation + Radioactive Iodine trial for Recurrent Differentiated… (NCT04892303): short film</video:title>
      <video:description>Radiation + Radioactive Iodine trial for Recurrent Differentiated Thyroid Cancer (NCT04892303). Combination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid Cancer. The goal of this study is to evaluate combined radioactive…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04892303.mp4</video:content_loc>
      <video:publication_date>2026-10-19T11:56:04.344Z</video:publication_date>
      <video:duration>60</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/combination-treatment-cxrpt-of-external-beam-radiation-x-nct04892303/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04892303.jpg</video:thumbnail_loc>
      <video:title>Radiation + Radioactive Iodine trial for Recurrent Differentiated… (NCT04892303): vídeo corto</video:title>
      <video:description>Radiation + Radioactive Iodine trial for Recurrent Differentiated Thyroid Cancer (NCT04892303). Combination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid Cancer. The goal of this study is to evaluate combined radioactive…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04892303.mp4</video:content_loc>
      <video:publication_date>2026-10-19T11:56:04.344Z</video:publication_date>
      <video:duration>60</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/cord-blood-derived-expanded-allogeneic-natural-killer-ce-nct04991870/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04991870.jpg</video:thumbnail_loc>
      <video:title>Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM trial for Recurrent Gliosarcoma (NCT04991870): short film</video:title>
      <video:description>Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM trial for Recurrent Gliosarcoma (NCT04991870). Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM. This phase I trial is to find out the best dose, possible benefits and/or side effects of engineered natural killer…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04991870.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:30:40.833Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/cord-blood-derived-expanded-allogeneic-natural-killer-ce-nct04991870/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04991870.jpg</video:thumbnail_loc>
      <video:title>Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM trial for Recurrent Gliosarcoma (NCT04991870): vídeo corto</video:title>
      <video:description>Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM trial for Recurrent Gliosarcoma (NCT04991870). Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM. This phase I trial is to find out the best dose, possible benefits and/or side effects of engineered natural killer…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04991870.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:30:40.833Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/crd3874-si-nct07661095/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07661095.jpg</video:thumbnail_loc>
      <video:title>CRD3874-SI trial for Relapsed or Refractory Acute Myeloid Leukemia (NCT07661095): short film</video:title>
      <video:description>CRD3874-SI trial for Relapsed or Refractory Acute Myeloid Leukemia (NCT07661095). CRD3874-SI in People With Leukemia. The purpose of this study is to find out whether CRD3874-SI is a safe treatment for participants with acute myeloid…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07661095.mp4</video:content_loc>
      <video:publication_date>2026-10-20T04:39:57.037Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/crd3874-si-nct07661095/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07661095.jpg</video:thumbnail_loc>
      <video:title>CRD3874-SI trial for Relapsed or Refractory Acute Myeloid Leukemia (NCT07661095): vídeo corto</video:title>
      <video:description>CRD3874-SI trial for Relapsed or Refractory Acute Myeloid Leukemia (NCT07661095). CRD3874-SI in People With Leukemia. The purpose of this study is to find out whether CRD3874-SI is a safe treatment for participants with acute myeloid…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07661095.mp4</video:content_loc>
      <video:publication_date>2026-10-20T04:39:57.037Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/cscc-nct05377905/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05377905.jpg</video:thumbnail_loc>
      <video:title>MNA-D trial for Cutaneous Squamous Cell Carcinoma (NCT05377905): short film</video:title>
      <video:description>MNA-D trial for Cutaneous Squamous Cell Carcinoma (NCT05377905). Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC). The purpose of this study is to test a new method of experimental treatment for…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05377905.mp4</video:content_loc>
      <video:publication_date>2026-10-19T16:20:02.316Z</video:publication_date>
      <video:duration>55</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/cscc-nct05377905/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05377905.jpg</video:thumbnail_loc>
      <video:title>MNA-D trial for Cutaneous Squamous Cell Carcinoma (NCT05377905): vídeo corto</video:title>
      <video:description>MNA-D trial for Cutaneous Squamous Cell Carcinoma (NCT05377905). Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC). The purpose of this study is to test a new method of experimental treatment for…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05377905.mp4</video:content_loc>
      <video:publication_date>2026-10-19T16:20:02.316Z</video:publication_date>
      <video:duration>55</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/cue-102-nct06917885/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06917885.jpg</video:thumbnail_loc>
      <video:title>CUE-102 trial for Recurrent Glioblastoma (NCT06917885): short film</video:title>
      <video:description>CUE-102 trial for Recurrent Glioblastoma (NCT06917885). CUE-102 in Recurrent Glioblastoma. The goal of this study is to evaluate the safety of the experimental drug, CUE-102, and establish the recommended dose of…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06917885.mp4</video:content_loc>
      <video:publication_date>2026-10-20T01:00:30.896Z</video:publication_date>
      <video:duration>66</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/cue-102-nct06917885/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06917885.jpg</video:thumbnail_loc>
      <video:title>CUE-102 trial for Recurrent Glioblastoma (NCT06917885): vídeo corto</video:title>
      <video:description>CUE-102 trial for Recurrent Glioblastoma (NCT06917885). CUE-102 in Recurrent Glioblastoma. The goal of this study is to evaluate the safety of the experimental drug, CUE-102, and establish the recommended dose of…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06917885.mp4</video:content_loc>
      <video:publication_date>2026-10-20T01:00:30.896Z</video:publication_date>
      <video:duration>66</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/cyclosporine-nct03128034/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03128034.jpg</video:thumbnail_loc>
      <video:title>Cyclosporine trial for Acute Lymphoblastic Leukemia (NCT03128034): short film</video:title>
      <video:description>Cyclosporine trial for Acute Lymphoblastic Leukemia (NCT03128034). 211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03128034.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:22:44.004Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/cyclosporine-nct03128034/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03128034.jpg</video:thumbnail_loc>
      <video:title>Cyclosporine trial for Acute Lymphoblastic Leukemia (NCT03128034): vídeo corto</video:title>
      <video:description>Cyclosporine trial for Acute Lymphoblastic Leukemia (NCT03128034). 211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03128034.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:22:44.004Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/cytokine-induced-memory-like-natural-killer-cells-nct06138587/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06138587.jpg</video:thumbnail_loc>
      <video:title>Preemptive CIML NK Cell Therapy trial for Acute Myeloid Leukemia (NCT06138587): short film</video:title>
      <video:description>Preemptive CIML NK Cell Therapy trial for Acute Myeloid Leukemia (NCT06138587). Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation. The purpose of this research study is to test the safety and efficacy of…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06138587.mp4</video:content_loc>
      <video:publication_date>2026-10-18T19:07:27.932Z</video:publication_date>
      <video:duration>63</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/cytokine-induced-memory-like-natural-killer-cells-nct06138587/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06138587.jpg</video:thumbnail_loc>
      <video:title>Preemptive CIML NK Cell Therapy trial for Acute Myeloid Leukemia (NCT06138587): vídeo corto</video:title>
      <video:description>Preemptive CIML NK Cell Therapy trial for Acute Myeloid Leukemia (NCT06138587). Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation. The purpose of this research study is to test the safety and efficacy of…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06138587.mp4</video:content_loc>
      <video:publication_date>2026-10-18T19:07:27.932Z</video:publication_date>
      <video:duration>63</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/cytokine-induced-memory-like-natural-killer-cells-nct06152809/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06152809.jpg</video:thumbnail_loc>
      <video:title>CIML NK cells for AML trial for Acute Myeloid Leukemia (NCT06152809): short film</video:title>
      <video:description>CIML NK cells for AML trial for Acute Myeloid Leukemia (NCT06152809). CIML NK Cells With Venetoclax for AML. The purpose of this research study is to test the safety and to explore the effectiveness of infusing cytokine- induced…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06152809.mp4</video:content_loc>
      <video:publication_date>2026-10-18T18:52:08.328Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/cytokine-induced-memory-like-natural-killer-cells-nct06152809/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06152809.jpg</video:thumbnail_loc>
      <video:title>CIML NK cells for AML trial for Acute Myeloid Leukemia (NCT06152809): vídeo corto</video:title>
      <video:description>CIML NK cells for AML trial for Acute Myeloid Leukemia (NCT06152809). CIML NK Cells With Venetoclax for AML. The purpose of this research study is to test the safety and to explore the effectiveness of infusing cytokine- induced…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06152809.mp4</video:content_loc>
      <video:publication_date>2026-10-18T18:52:08.328Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/cytokine-induced-memory-like-natural-killer-cells-nct06321484/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06321484.jpg</video:thumbnail_loc>
      <video:title>CIML NK cells for ovarian cancer trial for Platinum-resistant Ovarian… (NCT06321484): short film</video:title>
      <video:description>CIML NK cells for ovarian cancer trial for Platinum-resistant Ovarian Cancer (NCT06321484). Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer. The goal of this research study is to evaluate the…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06321484.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:18:12.439Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/cytokine-induced-memory-like-natural-killer-cells-nct06321484/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06321484.jpg</video:thumbnail_loc>
      <video:title>CIML NK cells for ovarian cancer trial for Platinum-resistant Ovarian… (NCT06321484): vídeo corto</video:title>
      <video:description>CIML NK cells for ovarian cancer trial for Platinum-resistant Ovarian Cancer (NCT06321484). Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer. The goal of this research study is to evaluate the…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06321484.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:18:12.439Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/danvatirsen-nct05986240/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05986240.jpg</video:thumbnail_loc>
      <video:title>Danvatirsen trial for Relapsed/Refractory Acute Myeloid Leukemia and… (NCT05986240): short film</video:title>
      <video:description>Danvatirsen trial for Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome (NCT05986240). Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS &amp; AML. This is a Phase 1 study investigating the safety and…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05986240.mp4</video:content_loc>
      <video:publication_date>2026-10-19T01:28:14.263Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/danvatirsen-nct05986240/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05986240.jpg</video:thumbnail_loc>
      <video:title>Danvatirsen trial for Relapsed/Refractory Acute Myeloid Leukemia and… (NCT05986240): vídeo corto</video:title>
      <video:description>Danvatirsen trial for Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome (NCT05986240). Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS &amp; AML. This is a Phase 1 study investigating the safety and…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05986240.mp4</video:content_loc>
      <video:publication_date>2026-10-19T01:28:14.263Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/db107-rrv-nct06504381/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06504381.jpg</video:thumbnail_loc>
      <video:title>DB107-RRV trial for High Grade Glioma (NCT06504381): short film</video:title>
      <video:description>DB107-RRV trial for High Grade Glioma (NCT06504381). DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma. This is a multicenter, open-label study of DB107-RRV…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06504381.mp4</video:content_loc>
      <video:publication_date>2026-10-19T00:21:10.556Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/db107-rrv-nct06504381/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06504381.jpg</video:thumbnail_loc>
      <video:title>DB107-RRV trial for High Grade Glioma (NCT06504381): vídeo corto</video:title>
      <video:description>DB107-RRV trial for High Grade Glioma (NCT06504381). DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma. This is a multicenter, open-label study of DB107-RRV…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06504381.mp4</video:content_loc>
      <video:publication_date>2026-10-19T00:21:10.556Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/dc-aml-fusion-vaccine-nct07374029/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07374029.jpg</video:thumbnail_loc>
      <video:title>DC/AML Fusion Vaccine trial for Acute Myeloid Leukemia (NCT07374029): short film</video:title>
      <video:description>DC/AML Fusion Vaccine trial for Acute Myeloid Leukemia (NCT07374029). Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML. The goal of this research study is to test if the combination of a…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07374029.mp4</video:content_loc>
      <video:publication_date>2026-10-18T23:50:25.080Z</video:publication_date>
      <video:duration>63</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/dc-aml-fusion-vaccine-nct07374029/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07374029.jpg</video:thumbnail_loc>
      <video:title>DC/AML Fusion Vaccine trial for Acute Myeloid Leukemia (NCT07374029): vídeo corto</video:title>
      <video:description>DC/AML Fusion Vaccine trial for Acute Myeloid Leukemia (NCT07374029). Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML. The goal of this research study is to test if the combination of a…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07374029.mp4</video:content_loc>
      <video:publication_date>2026-10-18T23:50:25.080Z</video:publication_date>
      <video:duration>63</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/dc-mm-fusion-vaccine-nct07377435/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07377435.jpg</video:thumbnail_loc>
      <video:title>DC/MM Fusion Vaccine trial for Multiple Myeloma (NCT07377435): short film</video:title>
      <video:description>DC/MM Fusion Vaccine trial for Multiple Myeloma (NCT07377435). DC/MM Fusion Vaccine With BCMA CAR-T in R/R MM. This study is to evaluate the safety and effectiveness of dendritic cell DC/MM fusion vaccine in combination…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07377435.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:05:11.975Z</video:publication_date>
      <video:duration>71</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/dc-mm-fusion-vaccine-nct07377435/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07377435.jpg</video:thumbnail_loc>
      <video:title>DC/MM Fusion Vaccine trial for Multiple Myeloma (NCT07377435): vídeo corto</video:title>
      <video:description>DC/MM Fusion Vaccine trial for Multiple Myeloma (NCT07377435). DC/MM Fusion Vaccine With BCMA CAR-T in R/R MM. This study is to evaluate the safety and effectiveness of dendritic cell DC/MM fusion vaccine in combination…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07377435.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:05:11.975Z</video:publication_date>
      <video:duration>71</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/decipher-nct05504707/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05504707.jpg</video:thumbnail_loc>
      <video:title>DecipHER trial for Triple Negative Breast Cancer (NCT05504707): short film</video:title>
      <video:description>DecipHER trial for Triple Negative Breast Cancer (NCT05504707). DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer. The purpose of the study is to find out if an investigational vaccine called…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05504707.mp4</video:content_loc>
      <video:publication_date>2026-10-18T18:50:15.187Z</video:publication_date>
      <video:duration>68</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/decipher-nct05504707/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05504707.jpg</video:thumbnail_loc>
      <video:title>DecipHER trial for Triple Negative Breast Cancer (NCT05504707): vídeo corto</video:title>
      <video:description>DecipHER trial for Triple Negative Breast Cancer (NCT05504707). DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer. The purpose of the study is to find out if an investigational vaccine called…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05504707.mp4</video:content_loc>
      <video:publication_date>2026-10-18T18:50:15.187Z</video:publication_date>
      <video:duration>68</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/dnajb1-prkaca-peptide-vaccine-nct04248569/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04248569.jpg</video:thumbnail_loc>
      <video:title>DNAJB1-PRKACA peptide vaccine trial for Fibrolamellar Hepatocellular… (NCT04248569): short film</video:title>
      <video:description>DNAJB1-PRKACA peptide vaccine trial for Fibrolamellar Hepatocellular Carcinoma (FLC) (NCT04248569). DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma. The primary…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04248569.mp4</video:content_loc>
      <video:publication_date>2026-09-12T15:26:30.203Z</video:publication_date>
      <video:duration>233</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/dnajb1-prkaca-peptide-vaccine-nct04248569/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04248569.jpg</video:thumbnail_loc>
      <video:title>DNAJB1-PRKACA peptide vaccine trial for Fibrolamellar Hepatocellular… (NCT04248569): vídeo corto</video:title>
      <video:description>DNAJB1-PRKACA peptide vaccine trial for Fibrolamellar Hepatocellular Carcinoma (FLC) (NCT04248569). DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma. The primary…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04248569.mp4</video:content_loc>
      <video:publication_date>2026-09-12T15:26:30.203Z</video:publication_date>
      <video:duration>233</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/dt2216-nct06964009/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06964009.jpg</video:thumbnail_loc>
      <video:title>DT2216 trial for Platinum-Resistant Ovarian Cancer (NCT06964009): short film</video:title>
      <video:description>DT2216 trial for Platinum-Resistant Ovarian Cancer (NCT06964009). DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer. The purpose of this research study is determining the highest dose of the study drug DT2216 in…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06964009.mp4</video:content_loc>
      <video:publication_date>2026-10-19T01:34:09.298Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/dt2216-nct06964009/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06964009.jpg</video:thumbnail_loc>
      <video:title>DT2216 trial for Platinum-Resistant Ovarian Cancer (NCT06964009): vídeo corto</video:title>
      <video:description>DT2216 trial for Platinum-Resistant Ovarian Cancer (NCT06964009). DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer. The purpose of this research study is determining the highest dose of the study drug DT2216 in…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06964009.mp4</video:content_loc>
      <video:publication_date>2026-10-19T01:34:09.298Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/dupilumab-nct06088771/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06088771.jpg</video:thumbnail_loc>
      <video:title>Dupilumab trial for Non-Small Cell Lung Cancer (NCT06088771): short film</video:title>
      <video:description>Dupilumab trial for Non-Small Cell Lung Cancer (NCT06088771). Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC. This is a phase 1/2 study of combined treatment with dupilumab…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06088771.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:25:56.284Z</video:publication_date>
      <video:duration>65</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/dupilumab-nct06088771/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06088771.jpg</video:thumbnail_loc>
      <video:title>Dupilumab trial for Non-Small Cell Lung Cancer (NCT06088771): vídeo corto</video:title>
      <video:description>Dupilumab trial for Non-Small Cell Lung Cancer (NCT06088771). Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC. This is a phase 1/2 study of combined treatment with dupilumab…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06088771.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:25:56.284Z</video:publication_date>
      <video:duration>65</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/durable-nct05987644/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05987644.jpg</video:thumbnail_loc>
      <video:title>Alectinib ± Radiosurgery trial for ALK-Positive Lung Cancer With Brain… (NCT05987644): short film</video:title>
      <video:description>Alectinib ± Radiosurgery trial for ALK-Positive Lung Cancer With Brain Metastases (NCT05987644). Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05987644.mp4</video:content_loc>
      <video:publication_date>2026-10-20T02:31:09.578Z</video:publication_date>
      <video:duration>67</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/durable-nct05987644/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05987644.jpg</video:thumbnail_loc>
      <video:title>Alectinib ± Radiosurgery trial for ALK-Positive Lung Cancer With Brain… (NCT05987644): vídeo corto</video:title>
      <video:description>Alectinib ± Radiosurgery trial for ALK-Positive Lung Cancer With Brain Metastases (NCT05987644). Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05987644.mp4</video:content_loc>
      <video:publication_date>2026-10-20T02:31:09.578Z</video:publication_date>
      <video:duration>67</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/durvalumab-nct03011814/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03011814.jpg</video:thumbnail_loc>
      <video:title>Durvalumab trial for Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma (NCT03011814): short film</video:title>
      <video:description>Durvalumab trial for Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma (NCT03011814). Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma. This randomized phase I/II…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03011814.mp4</video:content_loc>
      <video:publication_date>2026-10-18T19:34:34.687Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/durvalumab-nct03011814/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03011814.jpg</video:thumbnail_loc>
      <video:title>Durvalumab trial for Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma (NCT03011814): vídeo corto</video:title>
      <video:description>Durvalumab trial for Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma (NCT03011814). Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma. This randomized phase I/II…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03011814.mp4</video:content_loc>
      <video:publication_date>2026-10-18T19:34:34.687Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/durvalumab-tremelimumab-nct05932199/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05932199.jpg</video:thumbnail_loc>
      <video:title>Durvalumab + Tremelimumab trial for Resectable Pleural Mesothelioma (NCT05932199): short film</video:title>
      <video:description>Durvalumab + Tremelimumab trial for Resectable Pleural Mesothelioma (NCT05932199). Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma. Objectives: The investigators will test whether combination of…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05932199.mp4</video:content_loc>
      <video:publication_date>2026-10-20T01:23:27.851Z</video:publication_date>
      <video:duration>64</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/durvalumab-tremelimumab-nct05932199/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05932199.jpg</video:thumbnail_loc>
      <video:title>Durvalumab + Tremelimumab trial for Resectable Pleural Mesothelioma (NCT05932199): vídeo corto</video:title>
      <video:description>Durvalumab + Tremelimumab trial for Resectable Pleural Mesothelioma (NCT05932199). Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma. Objectives: The investigators will test whether combination of…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05932199.mp4</video:content_loc>
      <video:publication_date>2026-10-20T01:23:27.851Z</video:publication_date>
      <video:duration>64</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/eagd-t-cell-nct03533816/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03533816.jpg</video:thumbnail_loc>
      <video:title>EAGD T-cell trial for Acute Myeloid Leukemia (NCT03533816): short film</video:title>
      <video:description>EAGD T-cell trial for Acute Myeloid Leukemia (NCT03533816). Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide. Gamma delta T-cells are…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03533816.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:21:45.403Z</video:publication_date>
      <video:duration>71</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/eagd-t-cell-nct03533816/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03533816.jpg</video:thumbnail_loc>
      <video:title>EAGD T-cell trial for Acute Myeloid Leukemia (NCT03533816): vídeo corto</video:title>
      <video:description>EAGD T-cell trial for Acute Myeloid Leukemia (NCT03533816). Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide. Gamma delta T-cells are…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03533816.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:21:45.403Z</video:publication_date>
      <video:duration>71</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/egfr-inhibitor-eras-801-nct07089641/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07089641.jpg</video:thumbnail_loc>
      <video:title>ERAS-801 trial for EGFR-Altered IDH-Wildtype Glioblastoma or Gliosarcoma (NCT07089641): short film</video:title>
      <video:description>ERAS-801 trial for EGFR-Altered IDH-Wildtype Glioblastoma or Gliosarcoma (NCT07089641). ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07089641.mp4</video:content_loc>
      <video:publication_date>2026-10-19T12:17:24.377Z</video:publication_date>
      <video:duration>67</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/egfr-inhibitor-eras-801-nct07089641/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07089641.jpg</video:thumbnail_loc>
      <video:title>ERAS-801 trial for EGFR-Altered IDH-Wildtype Glioblastoma or Gliosarcoma (NCT07089641): vídeo corto</video:title>
      <video:description>ERAS-801 trial for EGFR-Altered IDH-Wildtype Glioblastoma or Gliosarcoma (NCT07089641). ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07089641.mp4</video:content_loc>
      <video:publication_date>2026-10-19T12:17:24.377Z</video:publication_date>
      <video:duration>67</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/eli-002-7p-nct07671339/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07671339.jpg</video:thumbnail_loc>
      <video:title>ELI-002 7P trial for KRAS-Mutant Pancreatic Cancer (NCT07671339): short film</video:title>
      <video:description>ELI-002 7P trial for KRAS-Mutant Pancreatic Cancer (NCT07671339). ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer. The researchers are doing this study to find out whether ELI-002 7P in combination…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07671339.mp4</video:content_loc>
      <video:publication_date>2026-10-20T02:58:15.255Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/eli-002-7p-nct07671339/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07671339.jpg</video:thumbnail_loc>
      <video:title>ELI-002 7P trial for KRAS-Mutant Pancreatic Cancer (NCT07671339): vídeo corto</video:title>
      <video:description>ELI-002 7P trial for KRAS-Mutant Pancreatic Cancer (NCT07671339). ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer. The researchers are doing this study to find out whether ELI-002 7P in combination…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07671339.mp4</video:content_loc>
      <video:publication_date>2026-10-20T02:58:15.255Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/emapalumab-nct06996119/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06996119.jpg</video:thumbnail_loc>
      <video:title>Emapalumab trial for AML or MDS Undergoing Reduced-Intensity Transplant (NCT06996119): short film</video:title>
      <video:description>Emapalumab trial for AML or MDS Undergoing Reduced-Intensity Transplant (NCT06996119). Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06996119.mp4</video:content_loc>
      <video:publication_date>2026-10-20T01:55:22.743Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/emapalumab-nct06996119/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06996119.jpg</video:thumbnail_loc>
      <video:title>Emapalumab trial for AML or MDS Undergoing Reduced-Intensity Transplant (NCT06996119): vídeo corto</video:title>
      <video:description>Emapalumab trial for AML or MDS Undergoing Reduced-Intensity Transplant (NCT06996119). Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06996119.mp4</video:content_loc>
      <video:publication_date>2026-10-20T01:55:22.743Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/emavusertib-nct07107750/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07107750.jpg</video:thumbnail_loc>
      <video:title>Emavusertib + Chemoimmunotherapy trial for Untreated Advanced Biliary… (NCT07107750): short film</video:title>
      <video:description>Emavusertib + Chemoimmunotherapy trial for Untreated Advanced Biliary Tract Cancer (NCT07107750). Emavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab in Patients With Untreated Advanced or Metastatic Biliary Tract Cancer. Based…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07107750.mp4</video:content_loc>
      <video:publication_date>2026-10-20T00:45:55.581Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/emavusertib-nct07107750/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07107750.jpg</video:thumbnail_loc>
      <video:title>Emavusertib + Chemoimmunotherapy trial for Untreated Advanced Biliary… (NCT07107750): vídeo corto</video:title>
      <video:description>Emavusertib + Chemoimmunotherapy trial for Untreated Advanced Biliary Tract Cancer (NCT07107750). Emavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab in Patients With Untreated Advanced or Metastatic Biliary Tract Cancer. Based…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07107750.mp4</video:content_loc>
      <video:publication_date>2026-10-20T00:45:55.581Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/enfortumab-vedotin-nct04878029/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04878029.jpg</video:thumbnail_loc>
      <video:title>Cabozantinib + Enfortumab Vedotin trial for Locally Advanced or… (NCT04878029): short film</video:title>
      <video:description>Cabozantinib + Enfortumab Vedotin trial for Locally Advanced or Metastatic Urothelial Cancer (NCT04878029). Cabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer. This phase I/Ib trial seeks to find out the best…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04878029.mp4</video:content_loc>
      <video:publication_date>2026-10-20T05:58:21.716Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/enfortumab-vedotin-nct04878029/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04878029.jpg</video:thumbnail_loc>
      <video:title>Cabozantinib + Enfortumab Vedotin trial for Locally Advanced or… (NCT04878029): vídeo corto</video:title>
      <video:description>Cabozantinib + Enfortumab Vedotin trial for Locally Advanced or Metastatic Urothelial Cancer (NCT04878029). Cabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer. This phase I/Ib trial seeks to find out the best…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04878029.mp4</video:content_loc>
      <video:publication_date>2026-10-20T05:58:21.716Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/epcoritamab-nct06536049/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06536049.jpg</video:thumbnail_loc>
      <video:title>Epcoritamab + Ibrutinib trial for Relapsed or Refractory Aggressive… (NCT06536049): short film</video:title>
      <video:description>Epcoritamab + Ibrutinib trial for Relapsed or Refractory Aggressive B-Cell Lymphoma (NCT06536049). Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma. This phase Ib/II trial evaluates the safety,…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06536049.mp4</video:content_loc>
      <video:publication_date>2026-10-20T01:43:27.652Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/epcoritamab-nct06536049/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06536049.jpg</video:thumbnail_loc>
      <video:title>Epcoritamab + Ibrutinib trial for Relapsed or Refractory Aggressive… (NCT06536049): vídeo corto</video:title>
      <video:description>Epcoritamab + Ibrutinib trial for Relapsed or Refractory Aggressive B-Cell Lymphoma (NCT06536049). Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma. This phase Ib/II trial evaluates the safety,…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06536049.mp4</video:content_loc>
      <video:publication_date>2026-10-20T01:43:27.652Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/epcoritamab-nct06672705/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06672705.jpg</video:thumbnail_loc>
      <video:title>Epcoritamab trial for Relapsed or Refractory Post-Transplant… (NCT06672705): short film</video:title>
      <video:description>Epcoritamab trial for Relapsed or Refractory Post-Transplant Lymphoproliferative Disorder (NCT06672705). Epcoritamab for the Treatment of Relapsed or Refractory Post Transplant Lymphoproliferative Disorders. This phase Ib trial tests the safety and effectiveness…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06672705.mp4</video:content_loc>
      <video:publication_date>2026-10-20T05:39:08.970Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/epcoritamab-nct06672705/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06672705.jpg</video:thumbnail_loc>
      <video:title>Epcoritamab trial for Relapsed or Refractory Post-Transplant… (NCT06672705): vídeo corto</video:title>
      <video:description>Epcoritamab trial for Relapsed or Refractory Post-Transplant Lymphoproliferative Disorder (NCT06672705). Epcoritamab for the Treatment of Relapsed or Refractory Post Transplant Lymphoproliferative Disorders. This phase Ib trial tests the safety and effectiveness…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06672705.mp4</video:content_loc>
      <video:publication_date>2026-10-20T05:39:08.970Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/eradicate-nct07198724/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07198724.jpg</video:thumbnail_loc>
      <video:title>Elacestrant + T-DXd trial for HR-Positive, HER2-Low or Ultralow… (NCT07198724): short film</video:title>
      <video:description>Elacestrant + T-DXd trial for HR-Positive, HER2-Low or Ultralow Metastatic Breast Cancer (NCT07198724). ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07198724.mp4</video:content_loc>
      <video:publication_date>2026-10-20T01:09:33.284Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/eradicate-nct07198724/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07198724.jpg</video:thumbnail_loc>
      <video:title>Elacestrant + T-DXd trial for HR-Positive, HER2-Low or Ultralow… (NCT07198724): vídeo corto</video:title>
      <video:description>Elacestrant + T-DXd trial for HR-Positive, HER2-Low or Ultralow Metastatic Breast Cancer (NCT07198724). ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07198724.mp4</video:content_loc>
      <video:publication_date>2026-10-20T01:09:33.284Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/fenofibrate-nct06191133/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06191133.jpg</video:thumbnail_loc>
      <video:title>Fenofibrate trial for Cervical Intraepithelial Neoplasia and Invasive… (NCT06191133): short film</video:title>
      <video:description>Fenofibrate trial for Cervical Intraepithelial Neoplasia and Invasive Cervical Cancer (NCT06191133). Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma. Normally, p53 helps prevent tumors from forming in the body.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06191133.mp4</video:content_loc>
      <video:publication_date>2026-10-19T12:33:53.681Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/fenofibrate-nct06191133/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06191133.jpg</video:thumbnail_loc>
      <video:title>Fenofibrate trial for Cervical Intraepithelial Neoplasia and Invasive… (NCT06191133): vídeo corto</video:title>
      <video:description>Fenofibrate trial for Cervical Intraepithelial Neoplasia and Invasive Cervical Cancer (NCT06191133). Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma. Normally, p53 helps prevent tumors from forming in the body.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06191133.mp4</video:content_loc>
      <video:publication_date>2026-10-19T12:33:53.681Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/fgfr4-car-t-cells-nct06865664/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06865664.jpg</video:thumbnail_loc>
      <video:title>FGFR4-CAR T Cells trial for Rhabdomyosarcoma (NCT06865664): short film</video:title>
      <video:description>FGFR4-CAR T Cells trial for Rhabdomyosarcoma (NCT06865664). FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma. Background: Rhabdomyosarcoma (RMS)…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06865664.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:20:55.536Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/fgfr4-car-t-cells-nct06865664/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06865664.jpg</video:thumbnail_loc>
      <video:title>FGFR4-CAR T Cells trial for Rhabdomyosarcoma (NCT06865664): vídeo corto</video:title>
      <video:description>FGFR4-CAR T Cells trial for Rhabdomyosarcoma (NCT06865664). FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma. Background: Rhabdomyosarcoma (RMS)…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06865664.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:20:55.536Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/fhd-286-nct07283094/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07283094.jpg</video:thumbnail_loc>
      <video:title>FHD-286 + Decitabine/Venetoclax trial for Acute Myeloid Leukemia and… (NCT07283094): short film</video:title>
      <video:description>FHD-286 + Decitabine/Venetoclax trial for Acute Myeloid Leukemia and Myelodysplastic Syndrome (NCT07283094). FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia. This is a Phase 1, uncontrolled, single-arm, open-label,…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07283094.mp4</video:content_loc>
      <video:publication_date>2026-10-19T02:45:17.350Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/fhd-286-nct07283094/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07283094.jpg</video:thumbnail_loc>
      <video:title>FHD-286 + Decitabine/Venetoclax trial for Acute Myeloid Leukemia and… (NCT07283094): vídeo corto</video:title>
      <video:description>FHD-286 + Decitabine/Venetoclax trial for Acute Myeloid Leukemia and Myelodysplastic Syndrome (NCT07283094). FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia. This is a Phase 1, uncontrolled, single-arm, open-label,…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07283094.mp4</video:content_loc>
      <video:publication_date>2026-10-19T02:45:17.350Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/flinn-nct07355205/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07355205.jpg</video:thumbnail_loc>
      <video:title>N-803 + Nivolumab/Ipilimumab trial for Untreated Stage IV or Recurrent… (NCT07355205): short film</video:title>
      <video:description>N-803 + Nivolumab/Ipilimumab trial for Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer (NCT07355205). First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) in Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer. This is a…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07355205.mp4</video:content_loc>
      <video:publication_date>2026-10-20T02:10:32.820Z</video:publication_date>
      <video:duration>88</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/flinn-nct07355205/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07355205.jpg</video:thumbnail_loc>
      <video:title>N-803 + Nivolumab/Ipilimumab trial for Untreated Stage IV or Recurrent… (NCT07355205): vídeo corto</video:title>
      <video:description>N-803 + Nivolumab/Ipilimumab trial for Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer (NCT07355205). First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) in Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer. This is a…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07355205.mp4</video:content_loc>
      <video:publication_date>2026-10-20T02:10:32.820Z</video:publication_date>
      <video:duration>88</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/flt3-mertk-inhibitor-mrx-2843-nct04762199/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04762199.jpg</video:thumbnail_loc>
      <video:title>MRX-2843 + Osimertinib trial for Advanced EGFR-Mutant Non-Small Cell… (NCT04762199): short film</video:title>
      <video:description>MRX-2843 + Osimertinib trial for Advanced EGFR-Mutant Non-Small Cell Lung Cancer (NCT04762199). MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer. This phase Ib trial evaluates the best dose and side effects of…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04762199.mp4</video:content_loc>
      <video:publication_date>2026-10-20T03:27:17.703Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/flt3-mertk-inhibitor-mrx-2843-nct04762199/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04762199.jpg</video:thumbnail_loc>
      <video:title>MRX-2843 + Osimertinib trial for Advanced EGFR-Mutant Non-Small Cell… (NCT04762199): vídeo corto</video:title>
      <video:description>MRX-2843 + Osimertinib trial for Advanced EGFR-Mutant Non-Small Cell Lung Cancer (NCT04762199). MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer. This phase Ib trial evaluates the best dose and side effects of…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04762199.mp4</video:content_loc>
      <video:publication_date>2026-10-20T03:27:17.703Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/fluoxetine-nct06225011/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06225011.jpg</video:thumbnail_loc>
      <video:title>Fluoxetine trial for Colorectal Adenocarcinoma Planning Surgery (NCT06225011): short film</video:title>
      <video:description>Fluoxetine trial for Colorectal Adenocarcinoma Planning Surgery (NCT06225011). Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer. This phase I trial tests whether…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06225011.mp4</video:content_loc>
      <video:publication_date>2026-10-19T15:54:16.415Z</video:publication_date>
      <video:duration>65</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/fluoxetine-nct06225011/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06225011.jpg</video:thumbnail_loc>
      <video:title>Fluoxetine trial for Colorectal Adenocarcinoma Planning Surgery (NCT06225011): vídeo corto</video:title>
      <video:description>Fluoxetine trial for Colorectal Adenocarcinoma Planning Surgery (NCT06225011). Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer. This phase I trial tests whether…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06225011.mp4</video:content_loc>
      <video:publication_date>2026-10-19T15:54:16.415Z</video:publication_date>
      <video:duration>65</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/folfox-nct04808323/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04808323.jpg</video:thumbnail_loc>
      <video:title>MRI-Guided Adaptive RT trial for Locally Advanced Rectal Adenocarcinoma (NCT04808323): short film</video:title>
      <video:description>MRI-Guided Adaptive RT trial for Locally Advanced Rectal Adenocarcinoma (NCT04808323). MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer. This study is a prospective, open-label, phase I design.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04808323.mp4</video:content_loc>
      <video:publication_date>2026-10-20T05:28:59.496Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/folfox-nct04808323/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04808323.jpg</video:thumbnail_loc>
      <video:title>MRI-Guided Adaptive RT trial for Locally Advanced Rectal Adenocarcinoma (NCT04808323): vídeo corto</video:title>
      <video:description>MRI-Guided Adaptive RT trial for Locally Advanced Rectal Adenocarcinoma (NCT04808323). MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer. This study is a prospective, open-label, phase I design.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04808323.mp4</video:content_loc>
      <video:publication_date>2026-10-20T05:28:59.496Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/folr1-car-t-cells-nct06609928/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06609928.jpg</video:thumbnail_loc>
      <video:title>FOLR1 CAR T-cells trial for Recurrent Childhood Acute Myeloid Leukemia (NCT06609928): short film</video:title>
      <video:description>FOLR1 CAR T-cells trial for Recurrent Childhood Acute Myeloid Leukemia (NCT06609928). FH-FOLR1 Chimeric Antigen Receptor T Cell Therapy for Treating Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia. This phase I trial tests…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06609928.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:14:00.614Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/folr1-car-t-cells-nct06609928/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06609928.jpg</video:thumbnail_loc>
      <video:title>FOLR1 CAR T-cells trial for Recurrent Childhood Acute Myeloid Leukemia (NCT06609928): vídeo corto</video:title>
      <video:description>FOLR1 CAR T-cells trial for Recurrent Childhood Acute Myeloid Leukemia (NCT06609928). FH-FOLR1 Chimeric Antigen Receptor T Cell Therapy for Treating Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia. This phase I trial tests…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06609928.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:14:00.614Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/fostamatinib-nct06639724/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06639724.jpg</video:thumbnail_loc>
      <video:title>Fostamatinib trial for Pancreatic Ductal Adenocarcinoma (PDAC) (NCT06639724): short film</video:title>
      <video:description>Fostamatinib trial for Pancreatic Ductal Adenocarcinoma (PDAC) (NCT06639724). Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer. This is a Phase 1b trial evaluating the combination of…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06639724.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:53:06.080Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/fostamatinib-nct06639724/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06639724.jpg</video:thumbnail_loc>
      <video:title>Fostamatinib trial for Pancreatic Ductal Adenocarcinoma (PDAC) (NCT06639724): vídeo corto</video:title>
      <video:description>Fostamatinib trial for Pancreatic Ductal Adenocarcinoma (PDAC) (NCT06639724). Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer. This is a Phase 1b trial evaluating the combination of…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06639724.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:53:06.080Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/g207-nct03911388/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03911388.jpg</video:thumbnail_loc>
      <video:title>G207 trial for Neoplasms, Brain (NCT03911388): short film</video:title>
      <video:description>G207 trial for Neoplasms, Brain (NCT03911388). HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors. This study is a clinical trial to determine the safety of inoculating G207 (an…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03911388.mp4</video:content_loc>
      <video:publication_date>2026-09-12T13:45:09.092Z</video:publication_date>
      <video:duration>252</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/g207-nct03911388/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03911388.jpg</video:thumbnail_loc>
      <video:title>G207 trial for Neoplasms, Brain (NCT03911388): vídeo corto</video:title>
      <video:description>G207 trial for Neoplasms, Brain (NCT03911388). HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors. This study is a clinical trial to determine the safety of inoculating G207 (an…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03911388.mp4</video:content_loc>
      <video:publication_date>2026-09-12T13:45:09.092Z</video:publication_date>
      <video:duration>252</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/gavel-nct07439211/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07439211.jpg</video:thumbnail_loc>
      <video:title>GAVEL trial for Acute Myeloid Leukemia (NCT07439211): short film</video:title>
      <video:description>GAVEL trial for Acute Myeloid Leukemia (NCT07439211). Assessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid Leukemia. This study is to evaluate the safety and…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07439211.mp4</video:content_loc>
      <video:publication_date>2026-10-20T04:33:52.929Z</video:publication_date>
      <video:duration>57</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/gavel-nct07439211/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07439211.jpg</video:thumbnail_loc>
      <video:title>GAVEL trial for Acute Myeloid Leukemia (NCT07439211): vídeo corto</video:title>
      <video:description>GAVEL trial for Acute Myeloid Leukemia (NCT07439211). Assessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid Leukemia. This study is to evaluate the safety and…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07439211.mp4</video:content_loc>
      <video:publication_date>2026-10-20T04:33:52.929Z</video:publication_date>
      <video:duration>57</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/gc511b-car-t-cell-nct07249879/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07249879.jpg</video:thumbnail_loc>
      <video:title>GC511B CAR-T Cell trial for Relapsed/Refractory Small Cell Lung Cancer (NCT07249879): short film</video:title>
      <video:description>GC511B CAR-T Cell trial for Relapsed/Refractory Small Cell Lung Cancer (NCT07249879). This Study is an Open-lable, Early Study to Evaluate the Safety, Feasibility, Cytokinetics, and Preliminary Efficacy of GC511B in DLL3+ Relapsed/Refractory…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07249879.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:53:53.917Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/gc511b-car-t-cell-nct07249879/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07249879.jpg</video:thumbnail_loc>
      <video:title>GC511B CAR-T Cell trial for Relapsed/Refractory Small Cell Lung Cancer (NCT07249879): vídeo corto</video:title>
      <video:description>GC511B CAR-T Cell trial for Relapsed/Refractory Small Cell Lung Cancer (NCT07249879). This Study is an Open-lable, Early Study to Evaluate the Safety, Feasibility, Cytokinetics, and Preliminary Efficacy of GC511B in DLL3+ Relapsed/Refractory…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07249879.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:53:53.917Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/gd2-car-t-cells-nct04196413/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04196413.jpg</video:thumbnail_loc>
      <video:title>GD2 CAR T cells trial for Glioma of Spinal Cord (NCT04196413): short film</video:title>
      <video:description>GD2 CAR T cells trial for Glioma of Spinal Cord (NCT04196413). GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) &amp; Spinal Diffuse Midline Glioma(DMG). The primary purpose of this study is to test whether CAR T…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04196413.mp4</video:content_loc>
      <video:publication_date>2026-09-12T15:20:59.968Z</video:publication_date>
      <video:duration>250</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/gd2-car-t-cells-nct04196413/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04196413.jpg</video:thumbnail_loc>
      <video:title>GD2 CAR T cells trial for Glioma of Spinal Cord (NCT04196413): vídeo corto</video:title>
      <video:description>GD2 CAR T cells trial for Glioma of Spinal Cord (NCT04196413). GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) &amp; Spinal Diffuse Midline Glioma(DMG). The primary purpose of this study is to test whether CAR T…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04196413.mp4</video:content_loc>
      <video:publication_date>2026-09-12T15:20:59.968Z</video:publication_date>
      <video:duration>250</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/gemtuzumab-ozogamicin-nct05558124/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05558124.jpg</video:thumbnail_loc>
      <video:title>CPX-351 + Gemtuzumab Ozogamicin trial for Newly Diagnosed Acute Myeloid… (NCT05558124): short film</video:title>
      <video:description>CPX-351 + Gemtuzumab Ozogamicin trial for Newly Diagnosed Acute Myeloid Leukemia (NCT05558124). CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML. The purpose of the study is to determine the safety of combining the drugs…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05558124.mp4</video:content_loc>
      <video:publication_date>2026-10-20T04:48:37.487Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/gemtuzumab-ozogamicin-nct05558124/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05558124.jpg</video:thumbnail_loc>
      <video:title>CPX-351 + Gemtuzumab Ozogamicin trial for Newly Diagnosed Acute Myeloid… (NCT05558124): vídeo corto</video:title>
      <video:description>CPX-351 + Gemtuzumab Ozogamicin trial for Newly Diagnosed Acute Myeloid Leukemia (NCT05558124). CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML. The purpose of the study is to determine the safety of combining the drugs…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05558124.mp4</video:content_loc>
      <video:publication_date>2026-10-20T04:48:37.487Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/gilteritinib-nct06225427/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06225427.jpg</video:thumbnail_loc>
      <video:title>Gilteritinib trial for Lung Non-Small Cell Carcinoma (NCT06225427): short film</video:title>
      <video:description>Gilteritinib trial for Lung Non-Small Cell Carcinoma (NCT06225427). Gilteritinib for the Treatment of ALK NSCLC. This phase I trial is studying the safety, side effects, and best dose of gilteritinib in treating patients with…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06225427.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:26:57.507Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/gilteritinib-nct06225427/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06225427.jpg</video:thumbnail_loc>
      <video:title>Gilteritinib trial for Lung Non-Small Cell Carcinoma (NCT06225427): vídeo corto</video:title>
      <video:description>Gilteritinib trial for Lung Non-Small Cell Carcinoma (NCT06225427). Gilteritinib for the Treatment of ALK NSCLC. This phase I trial is studying the safety, side effects, and best dose of gilteritinib in treating patients with…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06225427.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:26:57.507Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/ginakit2-nct03294954/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03294954.jpg</video:thumbnail_loc>
      <video:title>GINAKIT2 trial for Neuroblastoma (NCT03294954): short film</video:title>
      <video:description>GINAKIT2 trial for Neuroblastoma (NCT03294954). GD2 Specific CAR and Interleukin-15 Expressing Autologous NKT Cells to Treat Children With Neuroblastoma. This research study combines two different ways of…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03294954.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:42:11.104Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/ginakit2-nct03294954/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03294954.jpg</video:thumbnail_loc>
      <video:title>GINAKIT2 trial for Neuroblastoma (NCT03294954): vídeo corto</video:title>
      <video:description>GINAKIT2 trial for Neuroblastoma (NCT03294954). GD2 Specific CAR and Interleukin-15 Expressing Autologous NKT Cells to Treat Children With Neuroblastoma. This research study combines two different ways of…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03294954.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:42:11.104Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/grale-nct01555892/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT01555892.jpg</video:thumbnail_loc>
      <video:title>GRALE trial for EBV-Positive Hodgkin and Non-Hodgkin Lymphoma (NCT01555892): short film</video:title>
      <video:description>GRALE trial for EBV-Positive Hodgkin and Non-Hodgkin Lymphoma (NCT01555892). Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE. Subjects have a type of lymph gland disease called Hodgkin or non-Hodgkin Lymphoma or…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT01555892.mp4</video:content_loc>
      <video:publication_date>2026-10-19T00:55:50.468Z</video:publication_date>
      <video:duration>55</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/grale-nct01555892/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT01555892.jpg</video:thumbnail_loc>
      <video:title>GRALE trial for EBV-Positive Hodgkin and Non-Hodgkin Lymphoma (NCT01555892): vídeo corto</video:title>
      <video:description>GRALE trial for EBV-Positive Hodgkin and Non-Hodgkin Lymphoma (NCT01555892). Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE. Subjects have a type of lymph gland disease called Hodgkin or non-Hodgkin Lymphoma or…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT01555892.mp4</video:content_loc>
      <video:publication_date>2026-10-19T00:55:50.468Z</video:publication_date>
      <video:duration>55</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/high-dose-ascorbate-nct07177079/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07177079.jpg</video:thumbnail_loc>
      <video:title>High-Dose Ascorbate + Aza/Ven trial for Newly Diagnosed Acute Myeloid… (NCT07177079): short film</video:title>
      <video:description>High-Dose Ascorbate + Aza/Ven trial for Newly Diagnosed Acute Myeloid Leukemia (NCT07177079). High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML). This is a randomized, open-label,…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07177079.mp4</video:content_loc>
      <video:publication_date>2026-10-19T15:14:05.718Z</video:publication_date>
      <video:duration>66</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/high-dose-ascorbate-nct07177079/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07177079.jpg</video:thumbnail_loc>
      <video:title>High-Dose Ascorbate + Aza/Ven trial for Newly Diagnosed Acute Myeloid… (NCT07177079): vídeo corto</video:title>
      <video:description>High-Dose Ascorbate + Aza/Ven trial for Newly Diagnosed Acute Myeloid Leukemia (NCT07177079). High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML). This is a randomized, open-label,…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07177079.mp4</video:content_loc>
      <video:publication_date>2026-10-19T15:14:05.718Z</video:publication_date>
      <video:duration>66</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/honokiol-nct06566443/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06566443.jpg</video:thumbnail_loc>
      <video:title>Honokiol trial for Early-Stage Resectable Non-Small Cell Lung Cancer (NCT06566443): short film</video:title>
      <video:description>Honokiol trial for Early-Stage Resectable Non-Small Cell Lung Cancer (NCT06566443). Honokiol in Early-Stage Resectable Non-Small Cell Lung Cancer. This is a Phase I Trial evaluating the safety of the dietary supplement honokiol for lung…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06566443.mp4</video:content_loc>
      <video:publication_date>2026-10-19T00:26:16.599Z</video:publication_date>
      <video:duration>62</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/honokiol-nct06566443/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06566443.jpg</video:thumbnail_loc>
      <video:title>Honokiol trial for Early-Stage Resectable Non-Small Cell Lung Cancer (NCT06566443): vídeo corto</video:title>
      <video:description>Honokiol trial for Early-Stage Resectable Non-Small Cell Lung Cancer (NCT06566443). Honokiol in Early-Stage Resectable Non-Small Cell Lung Cancer. This is a Phase I Trial evaluating the safety of the dietary supplement honokiol for lung…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06566443.mp4</video:content_loc>
      <video:publication_date>2026-10-19T00:26:16.599Z</video:publication_date>
      <video:duration>62</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/ig-imrt-nct01659203/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT01659203.jpg</video:thumbnail_loc>
      <video:title>Proton or Photon RT trial for Retroperitoneal Sarcoma (NCT01659203): short film</video:title>
      <video:description>Proton or Photon RT trial for Retroperitoneal Sarcoma (NCT01659203). Proton or Photon RT for Retroperitoneal Sarcomas. This research study is a Phase I clinical trial.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT01659203.mp4</video:content_loc>
      <video:publication_date>2026-10-20T05:46:24.370Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/ig-imrt-nct01659203/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT01659203.jpg</video:thumbnail_loc>
      <video:title>Proton or Photon RT trial for Retroperitoneal Sarcoma (NCT01659203): vídeo corto</video:title>
      <video:description>Proton or Photon RT trial for Retroperitoneal Sarcoma (NCT01659203). Proton or Photon RT for Retroperitoneal Sarcomas. This research study is a Phase I clinical trial.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT01659203.mp4</video:content_loc>
      <video:publication_date>2026-10-20T05:46:24.370Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/il13ralpha2-specific-hinge-optimized-41bb-co-stimulatory-nct04510051/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04510051.jpg</video:thumbnail_loc>
      <video:title>CAR T Cells After… trial for Malignant Brain Neoplasm (NCT04510051): short film</video:title>
      <video:description>CAR T Cells After Lymphodepletion for the… trial for Malignant Brain Neoplasm (NCT04510051). CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children. This phase I trial investigates the…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04510051.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:29:13.976Z</video:publication_date>
      <video:duration>65</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/il13ralpha2-specific-hinge-optimized-41bb-co-stimulatory-nct04510051/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04510051.jpg</video:thumbnail_loc>
      <video:title>CAR T Cells After… trial for Malignant Brain Neoplasm (NCT04510051): vídeo corto</video:title>
      <video:description>CAR T Cells After Lymphodepletion for the… trial for Malignant Brain Neoplasm (NCT04510051). CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children. This phase I trial investigates the…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04510051.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:29:13.976Z</video:publication_date>
      <video:duration>65</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/impact-nct06193759/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06193759.jpg</video:thumbnail_loc>
      <video:title>IMPACT trial for Medulloblastoma, Childhood (NCT06193759): short film</video:title>
      <video:description>IMPACT trial for Medulloblastoma, Childhood (NCT06193759). Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT). This is an open-label phase 1 safety and feasibility study…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06193759.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:46:13.677Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/impact-nct06193759/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06193759.jpg</video:thumbnail_loc>
      <video:title>IMPACT trial for Medulloblastoma, Childhood (NCT06193759): vídeo corto</video:title>
      <video:description>IMPACT trial for Medulloblastoma, Childhood (NCT06193759). Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT). This is an open-label phase 1 safety and feasibility study…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06193759.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:46:13.677Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/impact-nct07148050/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07148050.jpg</video:thumbnail_loc>
      <video:title>IMPACT trial for Solid Tumor (Excluding CNS) (NCT07148050): short film</video:title>
      <video:description>IMPACT trial for Solid Tumor (Excluding CNS) (NCT07148050). Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells. This…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07148050.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:51:35.445Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/impact-nct07148050/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07148050.jpg</video:thumbnail_loc>
      <video:title>IMPACT trial for Solid Tumor (Excluding CNS) (NCT07148050): vídeo corto</video:title>
      <video:description>IMPACT trial for Solid Tumor (Excluding CNS) (NCT07148050). Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells. This…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07148050.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:51:35.445Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/implantable-microdevice-imd-nct05700461/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05700461.jpg</video:thumbnail_loc>
      <video:title>Implantable Microdevice trial for Metastatic Renal Cell Carcinoma (NCT05700461): short film</video:title>
      <video:description>Implantable Microdevice trial for Metastatic Renal Cell Carcinoma (NCT05700461). Drug Screening Using Novel IMD in Renal Cell Carcinoma. This research is being done to study the safety and feasibility of implanting and retrieving a…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05700461.mp4</video:content_loc>
      <video:publication_date>2026-10-20T03:41:09.500Z</video:publication_date>
      <video:duration>65</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/implantable-microdevice-imd-nct05700461/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05700461.jpg</video:thumbnail_loc>
      <video:title>Implantable Microdevice trial for Metastatic Renal Cell Carcinoma (NCT05700461): vídeo corto</video:title>
      <video:description>Implantable Microdevice trial for Metastatic Renal Cell Carcinoma (NCT05700461). Drug Screening Using Novel IMD in Renal Cell Carcinoma. This research is being done to study the safety and feasibility of implanting and retrieving a…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05700461.mp4</video:content_loc>
      <video:publication_date>2026-10-20T03:41:09.500Z</video:publication_date>
      <video:duration>65</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/indoximod-nct05106296/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05106296.jpg</video:thumbnail_loc>
      <video:title>Ibrutinib + Indoximod trial for Pediatric Brain Cancer (NCT05106296): short film</video:title>
      <video:description>Ibrutinib + Indoximod trial for Pediatric Brain Cancer (NCT05106296). Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer. Recent lab-based discoveries suggest that IDO (indoleamine…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05106296.mp4</video:content_loc>
      <video:publication_date>2026-10-19T01:48:51.137Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/indoximod-nct05106296/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05106296.jpg</video:thumbnail_loc>
      <video:title>Ibrutinib + Indoximod trial for Pediatric Brain Cancer (NCT05106296): vídeo corto</video:title>
      <video:description>Ibrutinib + Indoximod trial for Pediatric Brain Cancer (NCT05106296). Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer. Recent lab-based discoveries suggest that IDO (indoleamine…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05106296.mp4</video:content_loc>
      <video:publication_date>2026-10-19T01:48:51.137Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/inm176-nct06600698/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06600698.jpg</video:thumbnail_loc>
      <video:title>INM176 trial for Prostate Cancer With Rising PSA (NCT06600698): short film</video:title>
      <video:description>INM176 trial for Prostate Cancer With Rising PSA (NCT06600698). AGN-INM176 in Prostate Patients With Rising PSA. This Phase I/II open-label trial aims to evaluate the safety and efficacy of the herbal supplement INM176 in…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06600698.mp4</video:content_loc>
      <video:publication_date>2026-10-19T15:01:26.887Z</video:publication_date>
      <video:duration>59</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/inm176-nct06600698/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06600698.jpg</video:thumbnail_loc>
      <video:title>INM176 trial for Prostate Cancer With Rising PSA (NCT06600698): vídeo corto</video:title>
      <video:description>INM176 trial for Prostate Cancer With Rising PSA (NCT06600698). AGN-INM176 in Prostate Patients With Rising PSA. This Phase I/II open-label trial aims to evaluate the safety and efficacy of the herbal supplement INM176 in…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06600698.mp4</video:content_loc>
      <video:publication_date>2026-10-19T15:01:26.887Z</video:publication_date>
      <video:duration>59</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/inotuzumab-ozogamicin-nct01371630/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT01371630.jpg</video:thumbnail_loc>
      <video:title>Inotuzumab Ozogamicin trial for B Acute Lymphoblastic Leukemia With… (NCT01371630): short film</video:title>
      <video:description>Inotuzumab Ozogamicin trial for B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 (NCT01371630). Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia. This phase I/II trial studies the side effects and…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT01371630.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:28:14.945Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/inotuzumab-ozogamicin-nct01371630/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT01371630.jpg</video:thumbnail_loc>
      <video:title>Inotuzumab Ozogamicin trial for B Acute Lymphoblastic Leukemia With… (NCT01371630): vídeo corto</video:title>
      <video:description>Inotuzumab Ozogamicin trial for B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 (NCT01371630). Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia. This phase I/II trial studies the side effects and…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT01371630.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:28:14.945Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/intradermal-injection-of-cadi-05-nct07455032/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07455032.jpg</video:thumbnail_loc>
      <video:title>CADI-05 + Pembrolizumab trial for Resectable Locally Advanced Head and… (NCT07455032): short film</video:title>
      <video:description>CADI-05 + Pembrolizumab trial for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma (NCT07455032). Neoadjuvant CADI-05 in Combination With Pembrolizumab for Surgically Resectable Locally Advanced Head and Neck Squamous Cell Carcinomas. The goal of this…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07455032.mp4</video:content_loc>
      <video:publication_date>2026-10-19T12:53:43.522Z</video:publication_date>
      <video:duration>58</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/intradermal-injection-of-cadi-05-nct07455032/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07455032.jpg</video:thumbnail_loc>
      <video:title>CADI-05 + Pembrolizumab trial for Resectable Locally Advanced Head and… (NCT07455032): vídeo corto</video:title>
      <video:description>CADI-05 + Pembrolizumab trial for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma (NCT07455032). Neoadjuvant CADI-05 in Combination With Pembrolizumab for Surgically Resectable Locally Advanced Head and Neck Squamous Cell Carcinomas. The goal of this…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07455032.mp4</video:content_loc>
      <video:publication_date>2026-10-19T12:53:43.522Z</video:publication_date>
      <video:duration>58</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/ipilimumab-and-nivolumab-nct07075120/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07075120.jpg</video:thumbnail_loc>
      <video:title>Ipilimumab and Nivolumab trial for Hepatocellular Carcinoma (HCC) (NCT07075120): short film</video:title>
      <video:description>Ipilimumab and Nivolumab trial for Hepatocellular Carcinoma (HCC) (NCT07075120). Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular Cancer. Hepatocellular carcinoma (HCC) is a major cause of cancer-related deaths…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07075120.mp4</video:content_loc>
      <video:publication_date>2026-10-19T01:01:49.545Z</video:publication_date>
      <video:duration>64</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/ipilimumab-and-nivolumab-nct07075120/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07075120.jpg</video:thumbnail_loc>
      <video:title>Ipilimumab and Nivolumab trial for Hepatocellular Carcinoma (HCC) (NCT07075120): vídeo corto</video:title>
      <video:description>Ipilimumab and Nivolumab trial for Hepatocellular Carcinoma (HCC) (NCT07075120). Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular Cancer. Hepatocellular carcinoma (HCC) is a major cause of cancer-related deaths…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07075120.mp4</video:content_loc>
      <video:publication_date>2026-10-19T01:01:49.545Z</video:publication_date>
      <video:duration>64</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/ipilimumab-nct07128680/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07128680.jpg</video:thumbnail_loc>
      <video:title>EXL01 + Nivolumab/Ipilimumab trial for Metastatic Clear Cell or… (NCT07128680): short film</video:title>
      <video:description>EXL01 + Nivolumab/Ipilimumab trial for Metastatic Clear Cell or Sarcomatoid Renal Cell Carcinoma (NCT07128680). Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer. This phase…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07128680.mp4</video:content_loc>
      <video:publication_date>2026-10-20T03:06:44.812Z</video:publication_date>
      <video:duration>64</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/ipilimumab-nct07128680/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07128680.jpg</video:thumbnail_loc>
      <video:title>EXL01 + Nivolumab/Ipilimumab trial for Metastatic Clear Cell or… (NCT07128680): vídeo corto</video:title>
      <video:description>EXL01 + Nivolumab/Ipilimumab trial for Metastatic Clear Cell or Sarcomatoid Renal Cell Carcinoma (NCT07128680). Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer. This phase…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07128680.mp4</video:content_loc>
      <video:publication_date>2026-10-20T03:06:44.812Z</video:publication_date>
      <video:duration>64</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/ivonescimab-nct07535463/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07535463.jpg</video:thumbnail_loc>
      <video:title>Ivonescimab + Radiosurgery trial for Non-Small Cell Lung Cancer With… (NCT07535463): short film</video:title>
      <video:description>Ivonescimab + Radiosurgery trial for Non-Small Cell Lung Cancer With Brain Metastases (NCT07535463). Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer. The researchers are doing this study to test the safety…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07535463.mp4</video:content_loc>
      <video:publication_date>2026-10-20T02:45:30.160Z</video:publication_date>
      <video:duration>64</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/ivonescimab-nct07535463/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07535463.jpg</video:thumbnail_loc>
      <video:title>Ivonescimab + Radiosurgery trial for Non-Small Cell Lung Cancer With… (NCT07535463): vídeo corto</video:title>
      <video:description>Ivonescimab + Radiosurgery trial for Non-Small Cell Lung Cancer With Brain Metastases (NCT07535463). Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer. The researchers are doing this study to test the safety…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07535463.mp4</video:content_loc>
      <video:publication_date>2026-10-20T02:45:30.160Z</video:publication_date>
      <video:duration>64</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/leflunomide-nct04997993/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04997993.jpg</video:thumbnail_loc>
      <video:title>Leflunomide trial for PTEN-Altered Advanced Solid Tumors and… (NCT04997993): short film</video:title>
      <video:description>Leflunomide trial for PTEN-Altered Advanced Solid Tumors and HER2-Negative Breast Cancer (NCT04997993). Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast Cancer. Leflunomide in patients with PTEN-Altered advanced…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04997993.mp4</video:content_loc>
      <video:publication_date>2026-10-19T15:41:57.522Z</video:publication_date>
      <video:duration>62</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/leflunomide-nct04997993/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04997993.jpg</video:thumbnail_loc>
      <video:title>Leflunomide trial for PTEN-Altered Advanced Solid Tumors and… (NCT04997993): vídeo corto</video:title>
      <video:description>Leflunomide trial for PTEN-Altered Advanced Solid Tumors and HER2-Negative Breast Cancer (NCT04997993). Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast Cancer. Leflunomide in patients with PTEN-Altered advanced…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04997993.mp4</video:content_loc>
      <video:publication_date>2026-10-19T15:41:57.522Z</video:publication_date>
      <video:duration>62</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/lenvatinib-nct05603910/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05603910.jpg</video:thumbnail_loc>
      <video:title>Lenvatinib + Pembrolizumab + RT trial for Recurrent or Unresectable pMMR… (NCT05603910): short film</video:title>
      <video:description>Lenvatinib + Pembrolizumab + RT trial for Recurrent or Unresectable pMMR Endometrial (Uterine) Cancer (NCT05603910). Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma. The purpose of this research…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05603910.mp4</video:content_loc>
      <video:publication_date>2026-10-20T03:32:40.160Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/lenvatinib-nct05603910/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05603910.jpg</video:thumbnail_loc>
      <video:title>Lenvatinib + Pembrolizumab + RT trial for Recurrent or Unresectable… (NCT05603910): vídeo corto</video:title>
      <video:description>Lenvatinib + Pembrolizumab + RT trial for Recurrent or Unresectable pMMR Endometrial (Uterine) Cancer (NCT05603910). Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma. The purpose of this research…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05603910.mp4</video:content_loc>
      <video:publication_date>2026-10-20T03:32:40.160Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/lifileucel-ln-144-ln-145-nct05607095/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05607095.jpg</video:thumbnail_loc>
      <video:title>Lifileucel (LN-144/LN-145) trial for Uveal Melanoma (NCT05607095): short film</video:title>
      <video:description>Lifileucel (LN-144/LN-145) trial for Uveal Melanoma (NCT05607095). LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma. This is an open…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05607095.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:21:54.523Z</video:publication_date>
      <video:duration>67</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/lifileucel-ln-144-ln-145-nct05607095/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05607095.jpg</video:thumbnail_loc>
      <video:title>Lifileucel (LN-144/LN-145) trial for Uveal Melanoma (NCT05607095): vídeo corto</video:title>
      <video:description>Lifileucel (LN-144/LN-145) trial for Uveal Melanoma (NCT05607095). LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma. This is an open…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05607095.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:21:54.523Z</video:publication_date>
      <video:duration>67</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/lm-gucy2c-vaccine-nct07417488/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07417488.jpg</video:thumbnail_loc>
      <video:title>Lm-GUCY2C vaccine trial for Colorectal Cancer and Small Bowel… (NCT07417488): short film</video:title>
      <video:description>Lm-GUCY2C vaccine trial for Colorectal Cancer and Small Bowel Adenocarcinoma (NCT07417488). GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas. This is an open-label, non-randomized, single-center, dose-escalation…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07417488.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:50:09.080Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/lm-gucy2c-vaccine-nct07417488/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07417488.jpg</video:thumbnail_loc>
      <video:title>Lm-GUCY2C vaccine trial for Colorectal Cancer and Small Bowel… (NCT07417488): vídeo corto</video:title>
      <video:description>Lm-GUCY2C vaccine trial for Colorectal Cancer and Small Bowel Adenocarcinoma (NCT07417488). GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas. This is an open-label, non-randomized, single-center, dose-escalation…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07417488.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:50:09.080Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/lnk001-nct07564232/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07564232.jpg</video:thumbnail_loc>
      <video:title>LNK001 trial for Advanced or Metastatic Clear Cell Renal Cell Carcinoma (NCT07564232): short film</video:title>
      <video:description>LNK001 trial for Advanced or Metastatic Clear Cell Renal Cell Carcinoma (NCT07564232). LNK001 In Advanced Or Metastatic Clear Cell Renal Cell Carcinoma. There are 2 parts to this clinical research study: Part 1 (Dose Escalation) and Part 2 (Dose…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07564232.mp4</video:content_loc>
      <video:publication_date>2026-10-20T06:06:17.595Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/lnk001-nct07564232/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07564232.jpg</video:thumbnail_loc>
      <video:title>LNK001 trial for Advanced or Metastatic Clear Cell Renal Cell Carcinoma (NCT07564232): vídeo corto</video:title>
      <video:description>LNK001 trial for Advanced or Metastatic Clear Cell Renal Cell Carcinoma (NCT07564232). LNK001 In Advanced Or Metastatic Clear Cell Renal Cell Carcinoma. There are 2 parts to this clinical research study: Part 1 (Dose Escalation) and Part 2 (Dose…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07564232.mp4</video:content_loc>
      <video:publication_date>2026-10-20T06:06:17.595Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/lomustine-nct07145112/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07145112.jpg</video:thumbnail_loc>
      <video:title>LITT + Lomustine trial for Recurrent Glioblastoma (NCT07145112): short film</video:title>
      <video:description>LITT + Lomustine trial for Recurrent Glioblastoma (NCT07145112). Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma. This is a phase 1 study evaluating the safety and feasibility of…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07145112.mp4</video:content_loc>
      <video:publication_date>2026-10-19T13:18:26.663Z</video:publication_date>
      <video:duration>56</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/lomustine-nct07145112/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07145112.jpg</video:thumbnail_loc>
      <video:title>LITT + Lomustine trial for Recurrent Glioblastoma (NCT07145112): vídeo corto</video:title>
      <video:description>LITT + Lomustine trial for Recurrent Glioblastoma (NCT07145112). Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma. This is a phase 1 study evaluating the safety and feasibility of…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07145112.mp4</video:content_loc>
      <video:publication_date>2026-10-19T13:18:26.663Z</video:publication_date>
      <video:duration>56</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/lu-177-dotatate-nct04086485/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04086485.jpg</video:thumbnail_loc>
      <video:title>Lu-177-DOTATATE trial for Inoperable Gastroenteropancreatic… (NCT04086485): short film</video:title>
      <video:description>Lu-177-DOTATATE trial for Inoperable Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) (NCT04086485). Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET). Background: A neuroendocrine…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04086485.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:12:00.601Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/lu-177-dotatate-nct04086485/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04086485.jpg</video:thumbnail_loc>
      <video:title>Lu-177-DOTATATE trial for Inoperable Gastroenteropancreatic… (NCT04086485): vídeo corto</video:title>
      <video:description>Lu-177-DOTATATE trial for Inoperable Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) (NCT04086485). Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET). Background: A neuroendocrine…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04086485.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:12:00.601Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/lutathera-lutetium-lu-177-dotatate-nct05278208/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05278208.jpg</video:thumbnail_loc>
      <video:title>LUTATHERA (Lutetium Lu 177 dotatate) trial for High Grade Glioma (NCT05278208): short film</video:title>
      <video:description>LUTATHERA (Lutetium Lu 177 dotatate) trial for High Grade Glioma (NCT05278208). Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors. This study will evaluate the safety and efficacy of Lutathera (177Lu-DOTATATE) in…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05278208.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:35:38.632Z</video:publication_date>
      <video:duration>81</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/lutathera-lutetium-lu-177-dotatate-nct05278208/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05278208.jpg</video:thumbnail_loc>
      <video:title>LUTATHERA (Lutetium Lu 177 dotatate) trial for High Grade Glioma (NCT05278208): vídeo corto</video:title>
      <video:description>LUTATHERA (Lutetium Lu 177 dotatate) trial for High Grade Glioma (NCT05278208). Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors. This study will evaluate the safety and efficacy of Lutathera (177Lu-DOTATATE) in…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05278208.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:35:38.632Z</video:publication_date>
      <video:duration>81</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/m032-nct05084430/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05084430.jpg</video:thumbnail_loc>
      <video:title>M032 + Pembrolizumab trial for Malignant Glioma (NCT05084430): short film</video:title>
      <video:description>M032 + Pembrolizumab trial for Malignant Glioma (NCT05084430). Pembrolizumab and M032 (NSC 733972). This Phase I (Cohort I and Cohort II) and Phase II trial is designed to confirm the safety and tolerability of…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05084430.mp4</video:content_loc>
      <video:publication_date>2026-10-19T13:07:48.662Z</video:publication_date>
      <video:duration>68</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/m032-nct05084430/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05084430.jpg</video:thumbnail_loc>
      <video:title>M032 + Pembrolizumab trial for Malignant Glioma (NCT05084430): vídeo corto</video:title>
      <video:description>M032 + Pembrolizumab trial for Malignant Glioma (NCT05084430). Pembrolizumab and M032 (NSC 733972). This Phase I (Cohort I and Cohort II) and Phase II trial is designed to confirm the safety and tolerability of…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05084430.mp4</video:content_loc>
      <video:publication_date>2026-10-19T13:07:48.662Z</video:publication_date>
      <video:duration>68</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/m28z1xxpd1dnr-car-nct06623396/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06623396.jpg</video:thumbnail_loc>
      <video:title>M28z1XXPD1DNR CAR trial for Mesothelin-Expressing Tumors (NCT06623396): short film</video:title>
      <video:description>M28z1XXPD1DNR CAR trial for Mesothelin-Expressing Tumors (NCT06623396). Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer. Participants will have a sample of their white blood cells, called T cells,…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06623396.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:25:14.270Z</video:publication_date>
      <video:duration>81</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/m28z1xxpd1dnr-car-nct06623396/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06623396.jpg</video:thumbnail_loc>
      <video:title>M28z1XXPD1DNR CAR trial for Mesothelin-Expressing Tumors (NCT06623396): vídeo corto</video:title>
      <video:description>M28z1XXPD1DNR CAR trial for Mesothelin-Expressing Tumors (NCT06623396). Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer. Participants will have a sample of their white blood cells, called T cells,…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06623396.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:25:14.270Z</video:publication_date>
      <video:duration>81</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/magenta-nct03081910/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03081910.jpg</video:thumbnail_loc>
      <video:title>MAGENTA trial for T-cell Acute Lymphoblastic Lymphoma (NCT03081910): short film</video:title>
      <video:description>MAGENTA trial for T-cell Acute Lymphoblastic Lymphoma (NCT03081910). Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen. Patients eligible for this study have a…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03081910.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:19:58.614Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/magenta-nct03081910/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03081910.jpg</video:thumbnail_loc>
      <video:title>MAGENTA trial for T-cell Acute Lymphoblastic Lymphoma (NCT03081910): vídeo corto</video:title>
      <video:description>MAGENTA trial for T-cell Acute Lymphoblastic Lymphoma (NCT03081910). Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen. Patients eligible for this study have a…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03081910.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:19:58.614Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/magenta-nct07032714/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07032714.jpg</video:thumbnail_loc>
      <video:title>MAGENTA trial for Relapsed or Refractory Multiple Myeloma (NCT07032714): short film</video:title>
      <video:description>MAGENTA trial for Relapsed or Refractory Multiple Myeloma (NCT07032714). Mezigdomide and Talquetamab in Relapsed and Refractory Multiple Myeloma. This is a phase 1 study to find the recommended dose and schedule of mezigdomide and…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07032714.mp4</video:content_loc>
      <video:publication_date>2026-10-20T05:21:19.174Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/magenta-nct07032714/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07032714.jpg</video:thumbnail_loc>
      <video:title>MAGENTA trial for Relapsed or Refractory Multiple Myeloma (NCT07032714): vídeo corto</video:title>
      <video:description>MAGENTA trial for Relapsed or Refractory Multiple Myeloma (NCT07032714). Mezigdomide and Talquetamab in Relapsed and Refractory Multiple Myeloma. This is a phase 1 study to find the recommended dose and schedule of mezigdomide and…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07032714.mp4</video:content_loc>
      <video:publication_date>2026-10-20T05:21:19.174Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/melphalan-nct04483206/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04483206.jpg</video:thumbnail_loc>
      <video:title>PK-Directed Melphalan trial for Multiple Myeloma (NCT04483206): short film</video:title>
      <video:description>PK-Directed Melphalan trial for Multiple Myeloma (NCT04483206). Personalized Autologous Transplant for Multiple Myeloma. This phase I trial studies the best dose and side effects of mephalan in treating patients with…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04483206.mp4</video:content_loc>
      <video:publication_date>2026-10-19T11:49:23.712Z</video:publication_date>
      <video:duration>62</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/melphalan-nct04483206/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04483206.jpg</video:thumbnail_loc>
      <video:title>PK-Directed Melphalan trial for Multiple Myeloma (NCT04483206): vídeo corto</video:title>
      <video:description>PK-Directed Melphalan trial for Multiple Myeloma (NCT04483206). Personalized Autologous Transplant for Multiple Myeloma. This phase I trial studies the best dose and side effects of mephalan in treating patients with…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04483206.mp4</video:content_loc>
      <video:publication_date>2026-10-19T11:49:23.712Z</video:publication_date>
      <video:duration>62</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/mesenchymal-stromal-cells-derived-exosomes-with-kras-g12-nct03608631/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03608631.jpg</video:thumbnail_loc>
      <video:title>iExosomes in Treating… trial for Metastatic Pancreatic… (NCT03608631): short film</video:title>
      <video:description>iExosomes in Treating Participants With M… trial for Metastatic Pancreatic Adenocarcinoma (NCT03608631). IExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation. This phase I trial studies the best dose and side effects of…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03608631.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:15:44.188Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/mesenchymal-stromal-cells-derived-exosomes-with-kras-g12-nct03608631/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03608631.jpg</video:thumbnail_loc>
      <video:title>iExosomes in Treating… trial for Metastatic Pancreatic… (NCT03608631): vídeo corto</video:title>
      <video:description>iExosomes in Treating Participants With M… trial for Metastatic Pancreatic Adenocarcinoma (NCT03608631). IExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation. This phase I trial studies the best dose and side effects of…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03608631.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:15:44.188Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/mir-126-inhibitor-miristen-nct07025564/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07025564.jpg</video:thumbnail_loc>
      <video:title>miRisten trial for Relapsed or Refractory Acute Myeloid Leukemia (NCT07025564): short film</video:title>
      <video:description>miRisten trial for Relapsed or Refractory Acute Myeloid Leukemia (NCT07025564). MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia. This phase I trial tests the safety, side effects, and best dose of miRisten in…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07025564.mp4</video:content_loc>
      <video:publication_date>2026-10-20T02:38:30.698Z</video:publication_date>
      <video:duration>66</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/mir-126-inhibitor-miristen-nct07025564/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07025564.jpg</video:thumbnail_loc>
      <video:title>miRisten trial for Relapsed or Refractory Acute Myeloid Leukemia (NCT07025564): vídeo corto</video:title>
      <video:description>miRisten trial for Relapsed or Refractory Acute Myeloid Leukemia (NCT07025564). MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia. This phase I trial tests the safety, side effects, and best dose of miRisten in…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07025564.mp4</video:content_loc>
      <video:publication_date>2026-10-20T02:38:30.698Z</video:publication_date>
      <video:duration>66</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/mirda-nct06159166/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06159166.jpg</video:thumbnail_loc>
      <video:title>Mirdametinib trial for Neurofibromatosis Type 1 With Cutaneous… (NCT06159166): short film</video:title>
      <video:description>Mirdametinib trial for Neurofibromatosis Type 1 With Cutaneous Neurofibromas (NCT06159166). Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF). This is a Phase 1/2a, open-label, non-randomized,…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06159166.mp4</video:content_loc>
      <video:publication_date>2026-10-20T06:12:50.258Z</video:publication_date>
      <video:duration>58</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/mirda-nct06159166/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06159166.jpg</video:thumbnail_loc>
      <video:title>Mirdametinib trial for Neurofibromatosis Type 1 With Cutaneous… (NCT06159166): vídeo corto</video:title>
      <video:description>Mirdametinib trial for Neurofibromatosis Type 1 With Cutaneous Neurofibromas (NCT06159166). Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF). This is a Phase 1/2a, open-label, non-randomized,…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06159166.mp4</video:content_loc>
      <video:publication_date>2026-10-20T06:12:50.258Z</video:publication_date>
      <video:duration>58</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/mosunetuzumab-nct06249191/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06249191.jpg</video:thumbnail_loc>
      <video:title>Mosunetuzumab + Chemotherapy trial for C-Myc Rearranged High-Grade… (NCT06249191): short film</video:title>
      <video:description>Mosunetuzumab + Chemotherapy trial for C-Myc Rearranged High-Grade B-Cell Lymphoma or DLBCL (NCT06249191). Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06249191.mp4</video:content_loc>
      <video:publication_date>2026-10-19T01:59:18.528Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/mosunetuzumab-nct06249191/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06249191.jpg</video:thumbnail_loc>
      <video:title>Mosunetuzumab + Chemotherapy trial for C-Myc Rearranged High-Grade… (NCT06249191): vídeo corto</video:title>
      <video:description>Mosunetuzumab + Chemotherapy trial for C-Myc Rearranged High-Grade B-Cell Lymphoma or DLBCL (NCT06249191). Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06249191.mp4</video:content_loc>
      <video:publication_date>2026-10-19T01:59:18.528Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/natural-killer-cell-therapy-nct05588453/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05588453.jpg</video:thumbnail_loc>
      <video:title>Donor NK Cells + Temozolomide trial for Stage IV Melanoma With Brain… (NCT05588453): short film</video:title>
      <video:description>Donor NK Cells + Temozolomide trial for Stage IV Melanoma With Brain Metastases (NCT05588453). Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain. This phase I/II trial…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05588453.mp4</video:content_loc>
      <video:publication_date>2026-10-20T00:37:45.548Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/natural-killer-cell-therapy-nct05588453/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05588453.jpg</video:thumbnail_loc>
      <video:title>Donor NK Cells + Temozolomide trial for Stage IV Melanoma With Brain… (NCT05588453): vídeo corto</video:title>
      <video:description>Donor NK Cells + Temozolomide trial for Stage IV Melanoma With Brain Metastases (NCT05588453). Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain. This phase I/II trial…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05588453.mp4</video:content_loc>
      <video:publication_date>2026-10-20T00:37:45.548Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/navlimetostat-nct07579221/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07579221.jpg</video:thumbnail_loc>
      <video:title>Navlimetostat + Pumitamig trial for MTAP-Deleted Advanced Non-Small Cell… (NCT07579221): short film</video:title>
      <video:description>Navlimetostat + Pumitamig trial for MTAP-Deleted Advanced Non-Small Cell Lung Cancer (NCT07579221). Ph1/2 Trial Of Navlimetostat With Pumitamig In MTAP-Deficient Advanced Non-Small Cell Lung Cancer. The goal of this clinical research study is to find a safe…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07579221.mp4</video:content_loc>
      <video:publication_date>2026-10-20T02:51:52.037Z</video:publication_date>
      <video:duration>62</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/navlimetostat-nct07579221/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07579221.jpg</video:thumbnail_loc>
      <video:title>Navlimetostat + Pumitamig trial for MTAP-Deleted Advanced Non-Small… (NCT07579221): vídeo corto</video:title>
      <video:description>Navlimetostat + Pumitamig trial for MTAP-Deleted Advanced Non-Small Cell Lung Cancer (NCT07579221). Ph1/2 Trial Of Navlimetostat With Pumitamig In MTAP-Deficient Advanced Non-Small Cell Lung Cancer. The goal of this clinical research study is to find a safe…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07579221.mp4</video:content_loc>
      <video:publication_date>2026-10-20T02:51:52.037Z</video:publication_date>
      <video:duration>62</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/neo-combatxl-nct06902376/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06902376.jpg</video:thumbnail_loc>
      <video:title>NEO-COMBATXL trial for BRAF V600E Wild-Type Anaplastic Thyroid Cancer (NCT06902376): short film</video:title>
      <video:description>NEO-COMBATXL trial for BRAF V600E Wild-Type Anaplastic Thyroid Cancer (NCT06902376). XL092 and Cemiplimab in BRAF WT Thyroid Cancer. This multicenter study examines the safety and feasibility of the combination of neoadjuvant XL092 and…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06902376.mp4</video:content_loc>
      <video:publication_date>2026-10-19T13:13:43.759Z</video:publication_date>
      <video:duration>65</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/neo-combatxl-nct06902376/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06902376.jpg</video:thumbnail_loc>
      <video:title>NEO-COMBATXL trial for BRAF V600E Wild-Type Anaplastic Thyroid Cancer (NCT06902376): vídeo corto</video:title>
      <video:description>NEO-COMBATXL trial for BRAF V600E Wild-Type Anaplastic Thyroid Cancer (NCT06902376). XL092 and Cemiplimab in BRAF WT Thyroid Cancer. This multicenter study examines the safety and feasibility of the combination of neoadjuvant XL092 and…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06902376.mp4</video:content_loc>
      <video:publication_date>2026-10-19T13:13:43.759Z</video:publication_date>
      <video:duration>65</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/neratinib-pill-nct05274048/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05274048.jpg</video:thumbnail_loc>
      <video:title>Neratinib + Trastuzumab Deruxtecan trial for HER2-Positive Advanced… (NCT05274048): short film</video:title>
      <video:description>Neratinib + Trastuzumab Deruxtecan trial for HER2-Positive Advanced Gastro-Esophageal and GI Cancers (NCT05274048). Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients. This is Phase 1 dose finding trial with potential dose expansion to…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05274048.mp4</video:content_loc>
      <video:publication_date>2026-10-19T12:39:38.410Z</video:publication_date>
      <video:duration>68</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/neratinib-pill-nct05274048/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05274048.jpg</video:thumbnail_loc>
      <video:title>Neratinib + Trastuzumab Deruxtecan trial for HER2-Positive Advanced… (NCT05274048): vídeo corto</video:title>
      <video:description>Neratinib + Trastuzumab Deruxtecan trial for HER2-Positive Advanced Gastro-Esophageal and GI Cancers (NCT05274048). Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients. This is Phase 1 dose finding trial with potential dose expansion to…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05274048.mp4</video:content_loc>
      <video:publication_date>2026-10-19T12:39:38.410Z</video:publication_date>
      <video:duration>68</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/neural-stem-cells-expressing-crad-s-pk7-nct05139056/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05139056.jpg</video:thumbnail_loc>
      <video:title>Neural Stem Cells-expressing… trial for Currently Only Enrolling… (NCT05139056): short film</video:title>
      <video:description>Neural Stem Cells-expressing CRAd-S-pk7 trial for Currently Only Enrolling Glioblastoma Patients at First Recurrence (NCT05139056). Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas. This phase I trial…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05139056.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:23:42.134Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/neural-stem-cells-expressing-crad-s-pk7-nct05139056/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05139056.jpg</video:thumbnail_loc>
      <video:title>Neural Stem Cells-expressing… trial for Currently Only Enrolling… (NCT05139056): vídeo corto</video:title>
      <video:description>Neural Stem Cells-expressing CRAd-S-pk7 trial for Currently Only Enrolling Glioblastoma Patients at First Recurrence (NCT05139056). Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas. This phase I trial…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05139056.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:23:42.134Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/nilotinib-nct04903119/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04903119.jpg</video:thumbnail_loc>
      <video:title>Nilotinib trial for BRAF V600 Metastatic or Unresectable Melanoma (NCT04903119): short film</video:title>
      <video:description>Nilotinib trial for BRAF V600 Metastatic or Unresectable Melanoma (NCT04903119). Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma. This is a phase 1 dose-escalation study of nilotinib in combination…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04903119.mp4</video:content_loc>
      <video:publication_date>2026-10-19T16:13:18.166Z</video:publication_date>
      <video:duration>61</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/nilotinib-nct04903119/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04903119.jpg</video:thumbnail_loc>
      <video:title>Nilotinib trial for BRAF V600 Metastatic or Unresectable Melanoma (NCT04903119): vídeo corto</video:title>
      <video:description>Nilotinib trial for BRAF V600 Metastatic or Unresectable Melanoma (NCT04903119). Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma. This is a phase 1 dose-escalation study of nilotinib in combination…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04903119.mp4</video:content_loc>
      <video:publication_date>2026-10-19T16:13:18.166Z</video:publication_date>
      <video:duration>61</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/nk-cells-nct07411599/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07411599.jpg</video:thumbnail_loc>
      <video:title>TROP2-Directed CAR-NK trial for Colorectal Cancer (NCT07411599): short film</video:title>
      <video:description>TROP2-Directed CAR-NK trial for Colorectal Cancer (NCT07411599). Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07411599.mp4</video:content_loc>
      <video:publication_date>2026-10-18T18:57:42.825Z</video:publication_date>
      <video:duration>66</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/nk-cells-nct07411599/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07411599.jpg</video:thumbnail_loc>
      <video:title>TROP2-Directed CAR-NK trial for Colorectal Cancer (NCT07411599): vídeo corto</video:title>
      <video:description>TROP2-Directed CAR-NK trial for Colorectal Cancer (NCT07411599). Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07411599.mp4</video:content_loc>
      <video:publication_date>2026-10-18T18:57:42.825Z</video:publication_date>
      <video:duration>66</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/nk-cells-nct07579208/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07579208.jpg</video:thumbnail_loc>
      <video:title>NK Cells trial for Recurrent Glioblastoma (NCT07579208): short film</video:title>
      <video:description>NK Cells trial for Recurrent Glioblastoma (NCT07579208). Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07579208.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:12:12.662Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/nk-cells-nct07579208/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07579208.jpg</video:thumbnail_loc>
      <video:title>NK Cells trial for Recurrent Glioblastoma (NCT07579208): vídeo corto</video:title>
      <video:description>NK Cells trial for Recurrent Glioblastoma (NCT07579208). Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07579208.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:12:12.662Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/nt-i7-nct07052305/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07052305.jpg</video:thumbnail_loc>
      <video:title>NT-I7 for large B-cell lymphoma trial for Large B-cell Lymphoma (NCT07052305): short film</video:title>
      <video:description>NT-I7 for large B-cell lymphoma trial for Large B-cell Lymphoma (NCT07052305). NT-I7 (Efineptakin Alfa), a Long-acting Human IL-7, Post-Axicabtagene Ciloleucel or Post-Lisocabtagene Maraleucel in Subjects With Relapsed/Refractory Large…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07052305.mp4</video:content_loc>
      <video:publication_date>2026-10-18T18:55:42.288Z</video:publication_date>
      <video:duration>67</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/nt-i7-nct07052305/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07052305.jpg</video:thumbnail_loc>
      <video:title>NT-I7 for large B-cell lymphoma trial for Large B-cell Lymphoma (NCT07052305): vídeo corto</video:title>
      <video:description>NT-I7 for large B-cell lymphoma trial for Large B-cell Lymphoma (NCT07052305). NT-I7 (Efineptakin Alfa), a Long-acting Human IL-7, Post-Axicabtagene Ciloleucel or Post-Lisocabtagene Maraleucel in Subjects With Relapsed/Refractory Large…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07052305.mp4</video:content_loc>
      <video:publication_date>2026-10-18T18:55:42.288Z</video:publication_date>
      <video:duration>67</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/nt-i7-nct07200089/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07200089.jpg</video:thumbnail_loc>
      <video:title>NT-I7 for multiple myeloma trial for Multiple Myeloma (NCT07200089): short film</video:title>
      <video:description>NT-I7 for multiple myeloma trial for Multiple Myeloma (NCT07200089). Recombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA CAR-T Therapy (Cilta-cel). CAR-T cell therapy is an emerging treatment…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07200089.mp4</video:content_loc>
      <video:publication_date>2026-10-18T19:50:53.082Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/nt-i7-nct07200089/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07200089.jpg</video:thumbnail_loc>
      <video:title>NT-I7 for multiple myeloma trial for Multiple Myeloma (NCT07200089): vídeo corto</video:title>
      <video:description>NT-I7 for multiple myeloma trial for Multiple Myeloma (NCT07200089). Recombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA CAR-T Therapy (Cilta-cel). CAR-T cell therapy is an emerging treatment…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07200089.mp4</video:content_loc>
      <video:publication_date>2026-10-18T19:50:53.082Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/oncolytic-adenovirus-ad5-dnx-2401-nct03896568/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03896568.jpg</video:thumbnail_loc>
      <video:title>Oncolytic Adenovirus Ad5-DNX-2401 trial for Recurrent Glioblastoma (NCT03896568): short film</video:title>
      <video:description>Oncolytic Adenovirus Ad5-DNX-2401 trial for Recurrent Glioblastoma (NCT03896568). MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma. This phase I trial studies best dose and side effects of oncolytic adenovirus DNX-2401 in…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03896568.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:23:42.652Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/oncolytic-adenovirus-ad5-dnx-2401-nct03896568/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03896568.jpg</video:thumbnail_loc>
      <video:title>Oncolytic Adenovirus Ad5-DNX-2401 trial for Recurrent Glioblastoma (NCT03896568): vídeo corto</video:title>
      <video:description>Oncolytic Adenovirus Ad5-DNX-2401 trial for Recurrent Glioblastoma (NCT03896568). MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma. This phase I trial studies best dose and side effects of oncolytic adenovirus DNX-2401 in…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03896568.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:23:42.652Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/ont01-nct06904378/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06904378.jpg</video:thumbnail_loc>
      <video:title>ONT01 + Gem/Nab-Paclitaxel trial for Metastatic Pancreatic Ductal… (NCT06904378): short film</video:title>
      <video:description>ONT01 + Gem/Nab-Paclitaxel trial for Metastatic Pancreatic Ductal Adenocarcinoma (Second Line) (NCT06904378). ONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma. The investigators hypothesize that CD11b agonism…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06904378.mp4</video:content_loc>
      <video:publication_date>2026-10-20T06:22:06.226Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/ont01-nct06904378/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06904378.jpg</video:thumbnail_loc>
      <video:title>ONT01 + Gem/Nab-Paclitaxel trial for Metastatic Pancreatic Ductal… (NCT06904378): vídeo corto</video:title>
      <video:description>ONT01 + Gem/Nab-Paclitaxel trial for Metastatic Pancreatic Ductal Adenocarcinoma (Second Line) (NCT06904378). ONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma. The investigators hypothesize that CD11b agonism…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06904378.mp4</video:content_loc>
      <video:publication_date>2026-10-20T06:22:06.226Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/papaverine-nct05136846/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05136846.jpg</video:thumbnail_loc>
      <video:title>Papaverine trial for Locally Advanced Lung Non-Small Cell Carcinoma (NCT05136846): short film</video:title>
      <video:description>Papaverine trial for Locally Advanced Lung Non-Small Cell Carcinoma (NCT05136846). Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer. This phase I trial finds out the best dose,…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05136846.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:02:38.704Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/papaverine-nct05136846/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05136846.jpg</video:thumbnail_loc>
      <video:title>Papaverine trial for Locally Advanced Lung Non-Small Cell Carcinoma (NCT05136846): vídeo corto</video:title>
      <video:description>Papaverine trial for Locally Advanced Lung Non-Small Cell Carcinoma (NCT05136846). Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer. This phase I trial finds out the best dose,…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05136846.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:02:38.704Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/pembrolizumab-nct03760575/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03760575.jpg</video:thumbnail_loc>
      <video:title>Pembrolizumab + Image-Guided… trial for Malignant Pleural… (NCT03760575): short film</video:title>
      <video:description>Pembrolizumab + Image-Guided Surgery trial for Malignant Pleural Mesothelioma (NCT03760575). Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM). The study is a single-arm phase I trial to…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03760575.mp4</video:content_loc>
      <video:publication_date>2026-10-19T11:43:41.202Z</video:publication_date>
      <video:duration>62</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/pembrolizumab-nct03760575/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03760575.jpg</video:thumbnail_loc>
      <video:title>Pembrolizumab + Image-Guided… trial for Malignant Pleural… (NCT03760575): vídeo corto</video:title>
      <video:description>Pembrolizumab + Image-Guided Surgery trial for Malignant Pleural Mesothelioma (NCT03760575). Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM). The study is a single-arm phase I trial to…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03760575.mp4</video:content_loc>
      <video:publication_date>2026-10-19T11:43:41.202Z</video:publication_date>
      <video:duration>62</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/pembrolizumab-nct04297605/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04297605.jpg</video:thumbnail_loc>
      <video:title>Pembrolizumab + Single-Agent… trial for Locally Advanced or… (NCT04297605): short film</video:title>
      <video:description>Pembrolizumab + Single-Agent Chemotherapy trial for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (ECOG 2) (NCT04297605). Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04297605.mp4</video:content_loc>
      <video:publication_date>2026-10-19T11:20:56.783Z</video:publication_date>
      <video:duration>63</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/pembrolizumab-nct04297605/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04297605.jpg</video:thumbnail_loc>
      <video:title>Pembrolizumab + Single-Agent… trial for Locally Advanced or… (NCT04297605): vídeo corto</video:title>
      <video:description>Pembrolizumab + Single-Agent Chemotherapy trial for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (ECOG 2) (NCT04297605). Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04297605.mp4</video:content_loc>
      <video:publication_date>2026-10-19T11:20:56.783Z</video:publication_date>
      <video:duration>63</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/pembrolizumab-nct06868433/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06868433.jpg</video:thumbnail_loc>
      <video:title>TMV Vaccine With Pembrolizumab trial for Recurrent or Metastatic Head… (NCT06868433): short film</video:title>
      <video:description>TMV Vaccine With Pembrolizumab trial for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (NCT06868433). TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer. This phase Ib trial…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06868433.mp4</video:content_loc>
      <video:publication_date>2026-10-19T02:39:37.475Z</video:publication_date>
      <video:duration>60</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/pembrolizumab-nct06868433/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06868433.jpg</video:thumbnail_loc>
      <video:title>TMV Vaccine With Pembrolizumab trial for Recurrent or Metastatic Head… (NCT06868433): vídeo corto</video:title>
      <video:description>TMV Vaccine With Pembrolizumab trial for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (NCT06868433). TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer. This phase Ib trial…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06868433.mp4</video:content_loc>
      <video:publication_date>2026-10-19T02:39:37.475Z</video:publication_date>
      <video:duration>60</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/pemigatinib-nct04659616/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04659616.jpg</video:thumbnail_loc>
      <video:title>Pemigatinib After Chemotherapy trial for Newly Diagnosed Acute Myeloid… (NCT04659616): short film</video:title>
      <video:description>Pemigatinib After Chemotherapy trial for Newly Diagnosed Acute Myeloid Leukemia (NCT04659616). Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia. This phase I trial identifies the best dose and clinical benefit…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04659616.mp4</video:content_loc>
      <video:publication_date>2026-10-19T11:27:50.719Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/pemigatinib-nct04659616/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04659616.jpg</video:thumbnail_loc>
      <video:title>Pemigatinib After Chemotherapy trial for Newly Diagnosed Acute Myeloid… (NCT04659616): vídeo corto</video:title>
      <video:description>Pemigatinib After Chemotherapy trial for Newly Diagnosed Acute Myeloid Leukemia (NCT04659616). Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia. This phase I trial identifies the best dose and clinical benefit…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04659616.mp4</video:content_loc>
      <video:publication_date>2026-10-19T11:27:50.719Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/personalized-neoantigen-dna-vaccine-nct03988283/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03988283.jpg</video:thumbnail_loc>
      <video:title>Personalized neoantigen DNA… trial for Pediatric Recurrent Central… (NCT03988283): short film</video:title>
      <video:description>Personalized neoantigen DNA vaccine trial for Pediatric Recurrent Central Nervous System Tumors (NCT03988283). Neoepitope-based Personalized DNA Vaccine Approach in Pediatric Patients With Recurrent Central Nervous System Tumors. The purpose of this research study is…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03988283.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:07:58.512Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/personalized-neoantigen-dna-vaccine-nct03988283/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03988283.jpg</video:thumbnail_loc>
      <video:title>Personalized neoantigen DNA… trial for Pediatric Recurrent… (NCT03988283): vídeo corto</video:title>
      <video:description>Personalized neoantigen DNA vaccine trial for Pediatric Recurrent Central Nervous System Tumors (NCT03988283). Neoepitope-based Personalized DNA Vaccine Approach in Pediatric Patients With Recurrent Central Nervous System Tumors. The purpose of this research study is…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03988283.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:07:58.512Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/phoebe-nct05900895/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05900895.jpg</video:thumbnail_loc>
      <video:title>PHOEBE trial for Advanced ER-Positive HER2-Negative Breast Cancer (NCT05900895): short film</video:title>
      <video:description>PHOEBE trial for Advanced ER-Positive HER2-Negative Breast Cancer (NCT05900895). Estradiol Plus Olaparib for Breast Cancer (PHOEBE). Determine the safety and recommended Phase II dose of olaparib in combination with 17b-estradiol in…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05900895.mp4</video:content_loc>
      <video:publication_date>2026-10-19T15:47:30.156Z</video:publication_date>
      <video:duration>58</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/phoebe-nct05900895/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05900895.jpg</video:thumbnail_loc>
      <video:title>PHOEBE trial for Advanced ER-Positive HER2-Negative Breast Cancer (NCT05900895): vídeo corto</video:title>
      <video:description>PHOEBE trial for Advanced ER-Positive HER2-Negative Breast Cancer (NCT05900895). Estradiol Plus Olaparib for Breast Cancer (PHOEBE). Determine the safety and recommended Phase II dose of olaparib in combination with 17b-estradiol in…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05900895.mp4</video:content_loc>
      <video:publication_date>2026-10-19T15:47:30.156Z</video:publication_date>
      <video:duration>58</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/photodynamic-therapy-nct06307548/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06307548.jpg</video:thumbnail_loc>
      <video:title>Photodynamic Therapy trial for Locally Advanced or Recurrent Colorectal… (NCT06307548): short film</video:title>
      <video:description>Photodynamic Therapy trial for Locally Advanced or Recurrent Colorectal Cancer (NCT06307548). Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06307548.mp4</video:content_loc>
      <video:publication_date>2026-10-19T14:54:10.110Z</video:publication_date>
      <video:duration>60</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/photodynamic-therapy-nct06307548/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06307548.jpg</video:thumbnail_loc>
      <video:title>Photodynamic Therapy trial for Locally Advanced or Recurrent Colorectal… (NCT06307548): vídeo corto</video:title>
      <video:description>Photodynamic Therapy trial for Locally Advanced or Recurrent Colorectal Cancer (NCT06307548). Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06307548.mp4</video:content_loc>
      <video:publication_date>2026-10-19T14:54:10.110Z</video:publication_date>
      <video:duration>60</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/pmd-026-nct07379125/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07379125.jpg</video:thumbnail_loc>
      <video:title>PMD-026 trial for Myelofibrosis (NCT07379125): short film</video:title>
      <video:description>PMD-026 trial for Myelofibrosis (NCT07379125). Therapeutic RSK1 Targeting in Myelofibrosis. This is a phase Ib study evaluating PMD-026, an oral inhibitor of ribosomal protein S6 kinase A1 (RSK1), in…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07379125.mp4</video:content_loc>
      <video:publication_date>2026-10-20T04:20:35.000Z</video:publication_date>
      <video:duration>63</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/pmd-026-nct07379125/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07379125.jpg</video:thumbnail_loc>
      <video:title>PMD-026 trial for Myelofibrosis (NCT07379125): vídeo corto</video:title>
      <video:description>PMD-026 trial for Myelofibrosis (NCT07379125). Therapeutic RSK1 Targeting in Myelofibrosis. This is a phase Ib study evaluating PMD-026, an oral inhibitor of ribosomal protein S6 kinase A1 (RSK1), in…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07379125.mp4</video:content_loc>
      <video:publication_date>2026-10-20T04:20:35.000Z</video:publication_date>
      <video:duration>63</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/pnoc020-nct04573140/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04573140.jpg</video:thumbnail_loc>
      <video:title>PNOC020 trial for Adult Glioblastoma (NCT04573140): short film</video:title>
      <video:description>PNOC020 trial for Adult Glioblastoma (NCT04573140). RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM). The primary objective will be to…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04573140.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:23:45.097Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/pnoc020-nct04573140/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04573140.jpg</video:thumbnail_loc>
      <video:title>PNOC020 trial for Adult Glioblastoma (NCT04573140): vídeo corto</video:title>
      <video:description>PNOC020 trial for Adult Glioblastoma (NCT04573140). RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM). The primary objective will be to…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04573140.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:23:45.097Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/pomalidomide-nct05389423/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05389423.jpg</video:thumbnail_loc>
      <video:title>Pomalidomide for HIV-associated lymphoma trial for HIV-Associated Lymphoma (NCT05389423): short film</video:title>
      <video:description>Pomalidomide for HIV-associated lymphoma trial for HIV-Associated Lymphoma (NCT05389423). Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas. Background: Non-Hodgkin lymphoma (NHL) is the most common cancer among people…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05389423.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:21:13.005Z</video:publication_date>
      <video:duration>65</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/pomalidomide-nct05389423/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05389423.jpg</video:thumbnail_loc>
      <video:title>Pomalidomide for HIV-associated… trial for HIV-Associated Lymphoma (NCT05389423): vídeo corto</video:title>
      <video:description>Pomalidomide for HIV-associated lymphoma trial for HIV-Associated Lymphoma (NCT05389423). Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas. Background: Non-Hodgkin lymphoma (NHL) is the most common cancer among people…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05389423.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:21:13.005Z</video:publication_date>
      <video:duration>65</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/pomalidomide-nct07532525/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07532525.jpg</video:thumbnail_loc>
      <video:title>Pomalidomide after CAR T trial for Recurrent B Acute Lymphoblastic… (NCT07532525): short film</video:title>
      <video:description>Pomalidomide after CAR T trial for Recurrent B Acute Lymphoblastic Leukemia (NCT07532525). Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or Lymphoma. This phase I trial tests the safety and…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07532525.mp4</video:content_loc>
      <video:publication_date>2026-10-18T19:36:46.786Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/pomalidomide-nct07532525/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07532525.jpg</video:thumbnail_loc>
      <video:title>Pomalidomide after CAR T trial for Recurrent B Acute Lymphoblastic… (NCT07532525): vídeo corto</video:title>
      <video:description>Pomalidomide after CAR T trial for Recurrent B Acute Lymphoblastic Leukemia (NCT07532525). Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or Lymphoma. This phase I trial tests the safety and…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07532525.mp4</video:content_loc>
      <video:publication_date>2026-10-18T19:36:46.786Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/pralatrexate-nct07225985/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07225985.jpg</video:thumbnail_loc>
      <video:title>Pralatrexate Conditioning trial for Relapsed or Refractory T-Cell… (NCT07225985): short film</video:title>
      <video:description>Pralatrexate Conditioning trial for Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma (NCT07225985). Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory T-Cell…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07225985.mp4</video:content_loc>
      <video:publication_date>2026-10-20T04:15:12.807Z</video:publication_date>
      <video:duration>66</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/pralatrexate-nct07225985/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07225985.jpg</video:thumbnail_loc>
      <video:title>Pralatrexate Conditioning trial for Relapsed or Refractory T-Cell… (NCT07225985): vídeo corto</video:title>
      <video:description>Pralatrexate Conditioning trial for Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma (NCT07225985). Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory T-Cell…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07225985.mp4</video:content_loc>
      <video:publication_date>2026-10-20T04:15:12.807Z</video:publication_date>
      <video:duration>66</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/prism-nct07139990/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07139990.jpg</video:thumbnail_loc>
      <video:title>PRISM trial for Extensive-Stage SCLC, Brain Metastases, Soft… (NCT07139990): short film</video:title>
      <video:description>PRISM trial for Extensive-Stage SCLC, Brain Metastases, Soft Tissue Sarcoma and Head and Neck Cancer (NCT07139990). Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM). To characterize feasibility, safety, and/or preliminary efficacy of…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07139990.mp4</video:content_loc>
      <video:publication_date>2026-10-19T13:57:44.541Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/prism-nct07139990/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07139990.jpg</video:thumbnail_loc>
      <video:title>PRISM trial for Extensive-Stage SCLC, Brain Metastases, Soft… (NCT07139990): vídeo corto</video:title>
      <video:description>PRISM trial for Extensive-Stage SCLC, Brain Metastases, Soft Tissue Sarcoma and Head and Neck Cancer (NCT07139990). Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM). To characterize feasibility, safety, and/or preliminary efficacy of…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07139990.mp4</video:content_loc>
      <video:publication_date>2026-10-19T13:57:44.541Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/prmt5-inhibitor-bms-986504-nct07594626/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07594626.jpg</video:thumbnail_loc>
      <video:title>BMS-986504 + Pemetrexed trial for Metastatic MTAP-Deleted Solid Tumors (NCT07594626): short film</video:title>
      <video:description>BMS-986504 + Pemetrexed trial for Metastatic MTAP-Deleted Solid Tumors (NCT07594626). BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion. This phase Ib/II trial tests the safety and side…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07594626.mp4</video:content_loc>
      <video:publication_date>2026-10-19T13:48:49.834Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/prmt5-inhibitor-bms-986504-nct07594626/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07594626.jpg</video:thumbnail_loc>
      <video:title>BMS-986504 + Pemetrexed trial for Metastatic MTAP-Deleted Solid Tumors (NCT07594626): vídeo corto</video:title>
      <video:description>BMS-986504 + Pemetrexed trial for Metastatic MTAP-Deleted Solid Tumors (NCT07594626). BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion. This phase Ib/II trial tests the safety and side…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07594626.mp4</video:content_loc>
      <video:publication_date>2026-10-19T13:48:49.834Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/rabbit-nct06814496/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06814496.jpg</video:thumbnail_loc>
      <video:title>RABBIT trial for Relapsed/Refractory DLL3-Expressing Tumors (NCT06814496): short film</video:title>
      <video:description>RABBIT trial for Relapsed/Refractory DLL3-Expressing Tumors (NCT06814496). Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors. Phase I study to examine safety of the addition of concurrent tarlatamab with…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06814496.mp4</video:content_loc>
      <video:publication_date>2026-10-19T12:07:51.190Z</video:publication_date>
      <video:duration>64</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/rabbit-nct06814496/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06814496.jpg</video:thumbnail_loc>
      <video:title>RABBIT trial for Relapsed/Refractory DLL3-Expressing Tumors (NCT06814496): vídeo corto</video:title>
      <video:description>RABBIT trial for Relapsed/Refractory DLL3-Expressing Tumors (NCT06814496). Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors. Phase I study to examine safety of the addition of concurrent tarlatamab with…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06814496.mp4</video:content_loc>
      <video:publication_date>2026-10-19T12:07:51.190Z</video:publication_date>
      <video:duration>64</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/ramucirumab-nct06675136/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06675136.jpg</video:thumbnail_loc>
      <video:title>PIPAC Nab-Paclitaxel trial for Gastric Cancer With Peritoneal Metastases (NCT06675136): short film</video:title>
      <video:description>PIPAC Nab-Paclitaxel trial for Gastric Cancer With Peritoneal Metastases (NCT06675136). Nab-Paclitaxel PIPAC in Combination With Paclitaxel and Ramucirumab for the Treatment of Stomach Cancer With Peritoneal Metastases. This phase I trial tests…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06675136.mp4</video:content_loc>
      <video:publication_date>2026-10-20T01:49:38.602Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/ramucirumab-nct06675136/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06675136.jpg</video:thumbnail_loc>
      <video:title>PIPAC Nab-Paclitaxel trial for Gastric Cancer With Peritoneal Metastases (NCT06675136): vídeo corto</video:title>
      <video:description>PIPAC Nab-Paclitaxel trial for Gastric Cancer With Peritoneal Metastases (NCT06675136). Nab-Paclitaxel PIPAC in Combination With Paclitaxel and Ramucirumab for the Treatment of Stomach Cancer With Peritoneal Metastases. This phase I trial tests…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06675136.mp4</video:content_loc>
      <video:publication_date>2026-10-20T01:49:38.602Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/recombinant-interferon-alpha-2b-like-protein-nct04380545/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04380545.jpg</video:thumbnail_loc>
      <video:title>Nivolumab, Fluorouracil, and… trial for Unresectable Fibrolamellar… (NCT04380545): short film</video:title>
      <video:description>Nivolumab, Fluorouracil, and Interferon Alpha 2B trial for Unresectable Fibrolamellar Carcinoma (NCT04380545). Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer. This phase I/II trial studies the side effects and…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04380545.mp4</video:content_loc>
      <video:publication_date>2026-10-18T18:46:59.020Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/recombinant-interferon-alpha-2b-like-protein-nct04380545/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04380545.jpg</video:thumbnail_loc>
      <video:title>Nivolumab, Fluorouracil, and… trial for Unresectable Fibrolamellar… (NCT04380545): vídeo corto</video:title>
      <video:description>Nivolumab, Fluorouracil, and Interferon Alpha 2B trial for Unresectable Fibrolamellar Carcinoma (NCT04380545). Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer. This phase I/II trial studies the side effects and…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04380545.mp4</video:content_loc>
      <video:publication_date>2026-10-18T18:46:59.020Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/rely-30-nct02917083/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT02917083.jpg</video:thumbnail_loc>
      <video:title>RELY-30 trial for Hodgkin's Lymphoma (NCT02917083): short film</video:title>
      <video:description>RELY-30 trial for Hodgkin's Lymphoma (NCT02917083). CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30). The subject has a type of lymph gland cancer called Lymphoma.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT02917083.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:30:21.899Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/rely-30-nct02917083/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT02917083.jpg</video:thumbnail_loc>
      <video:title>RELY-30 trial for Hodgkin's Lymphoma (NCT02917083): vídeo corto</video:title>
      <video:description>RELY-30 trial for Hodgkin's Lymphoma (NCT02917083). CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30). The subject has a type of lymph gland cancer called Lymphoma.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT02917083.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:30:21.899Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/replay-nct07237594/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07237594.jpg</video:thumbnail_loc>
      <video:title>REPLAY trial for Metastatic Melanoma After Immune-Related Toxicity (NCT07237594): short film</video:title>
      <video:description>REPLAY trial for Metastatic Melanoma After Immune-Related Toxicity (NCT07237594). IL-17 Blockade to Decrease irAEs (REPLAY). The primary objective of this study is to determine the safety and feasibility of administering an IL-17A (human…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07237594.mp4</video:content_loc>
      <video:publication_date>2026-10-19T16:26:21.467Z</video:publication_date>
      <video:duration>62</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/replay-nct07237594/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07237594.jpg</video:thumbnail_loc>
      <video:title>REPLAY trial for Metastatic Melanoma After Immune-Related Toxicity (NCT07237594): vídeo corto</video:title>
      <video:description>REPLAY trial for Metastatic Melanoma After Immune-Related Toxicity (NCT07237594). IL-17 Blockade to Decrease irAEs (REPLAY). The primary objective of this study is to determine the safety and feasibility of administering an IL-17A (human…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07237594.mp4</video:content_loc>
      <video:publication_date>2026-10-19T16:26:21.467Z</video:publication_date>
      <video:duration>62</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/revlimid-lenalidomide-nct03223610/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03223610.jpg</video:thumbnail_loc>
      <video:title>ViPOR Combination trial for Relapsed/Refractory B-Cell Lymphoma (NCT03223610): short film</video:title>
      <video:description>ViPOR Combination trial for Relapsed/Refractory B-Cell Lymphoma (NCT03223610). Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma. Background: B-cell lymphoma is a cancer of white…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03223610.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:12:52.157Z</video:publication_date>
      <video:duration>63</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/revlimid-lenalidomide-nct03223610/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03223610.jpg</video:thumbnail_loc>
      <video:title>ViPOR Combination trial for Relapsed/Refractory B-Cell Lymphoma (NCT03223610): vídeo corto</video:title>
      <video:description>ViPOR Combination trial for Relapsed/Refractory B-Cell Lymphoma (NCT03223610). Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma. Background: B-cell lymphoma is a cancer of white…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03223610.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:12:52.157Z</video:publication_date>
      <video:duration>63</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/revumenib-nct06313437/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06313437.jpg</video:thumbnail_loc>
      <video:title>Revumenib + 7+3 + Midostaurin trial for Newly Diagnosed NPM1- and… (NCT06313437): short film</video:title>
      <video:description>Revumenib + 7+3 + Midostaurin trial for Newly Diagnosed NPM1- and FLT3-Mutated AML (NCT06313437). Revumenib in Combination With 7+3 + Midostaurin in AML. This research is being conducted to determine a safe and effective dose of revumenib that can be given…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06313437.mp4</video:content_loc>
      <video:publication_date>2026-10-20T05:01:48.550Z</video:publication_date>
      <video:duration>66</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/revumenib-nct06313437/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06313437.jpg</video:thumbnail_loc>
      <video:title>Revumenib + 7+3 + Midostaurin trial for Newly Diagnosed NPM1- and… (NCT06313437): vídeo corto</video:title>
      <video:description>Revumenib + 7+3 + Midostaurin trial for Newly Diagnosed NPM1- and FLT3-Mutated AML (NCT06313437). Revumenib in Combination With 7+3 + Midostaurin in AML. This research is being conducted to determine a safe and effective dose of revumenib that can be given…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06313437.mp4</video:content_loc>
      <video:publication_date>2026-10-20T05:01:48.550Z</video:publication_date>
      <video:duration>66</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/rhdnase-i-nct07361224/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07361224.jpg</video:thumbnail_loc>
      <video:title>RhDNase I trial for Large B-Cell Lymphoma (LBCL) (NCT07361224): short film</video:title>
      <video:description>RhDNase I trial for Large B-Cell Lymphoma (LBCL) (NCT07361224). Combination of CLS-015 With Anti-CD-19 CAR-T Cells in Patients With Stable/Progressive Large B Cell Lymphoma at Lymphodepletion. This is a Phase 1,…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07361224.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:05:38.316Z</video:publication_date>
      <video:duration>71</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/rhdnase-i-nct07361224/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07361224.jpg</video:thumbnail_loc>
      <video:title>RhDNase I trial for Large B-Cell Lymphoma (LBCL) (NCT07361224): vídeo corto</video:title>
      <video:description>RhDNase I trial for Large B-Cell Lymphoma (LBCL) (NCT07361224). Combination of CLS-015 With Anti-CD-19 CAR-T Cells in Patients With Stable/Progressive Large B Cell Lymphoma at Lymphodepletion. This is a Phase 1,…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07361224.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:05:38.316Z</video:publication_date>
      <video:duration>71</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/riot-4a-nct07192900/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07192900.jpg</video:thumbnail_loc>
      <video:title>(RIOT 4A) trial for Malignant Pleural Effusion (NCT07192900): short film</video:title>
      <video:description>(RIOT 4A) trial for Malignant Pleural Effusion (NCT07192900). Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease. This research study aims to evaluate the safety and effectiveness of a novel…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07192900.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:56:07.710Z</video:publication_date>
      <video:duration>67</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/riot-4a-nct07192900/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07192900.jpg</video:thumbnail_loc>
      <video:title>(RIOT 4A) trial for Malignant Pleural Effusion (NCT07192900): vídeo corto</video:title>
      <video:description>(RIOT 4A) trial for Malignant Pleural Effusion (NCT07192900). Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease. This research study aims to evaluate the safety and effectiveness of a novel…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07192900.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:56:07.710Z</video:publication_date>
      <video:duration>67</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/riot-4b-nct07443020/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07443020.jpg</video:thumbnail_loc>
      <video:title>RIOT 4B trial for Malignant Pleural Effusion (NCT07443020): short film</video:title>
      <video:description>RIOT 4B trial for Malignant Pleural Effusion (NCT07443020). Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors. This research study aims to evaluate the safety and…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07443020.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:45:42.418Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/riot-4b-nct07443020/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07443020.jpg</video:thumbnail_loc>
      <video:title>RIOT 4B trial for Malignant Pleural Effusion (NCT07443020): vídeo corto</video:title>
      <video:description>RIOT 4B trial for Malignant Pleural Effusion (NCT07443020). Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors. This research study aims to evaluate the safety and…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07443020.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:45:42.418Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/rituximab-nct06209619/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06209619.jpg</video:thumbnail_loc>
      <video:title>CC-99282 + Rituximab trial for Relapsed/Refractory B-Cell Non-Hodgkin… (NCT06209619): short film</video:title>
      <video:description>CC-99282 + Rituximab trial for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (NCT06209619). CC-99282 + Rituximab Early Post CART for Non-Hodgkin's Lymphoma. This phase I trial tests the safety, side effects and best dose of CC-99282 with rituximab…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06209619.mp4</video:content_loc>
      <video:publication_date>2026-10-19T01:08:29.681Z</video:publication_date>
      <video:duration>66</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/rituximab-nct06209619/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06209619.jpg</video:thumbnail_loc>
      <video:title>CC-99282 + Rituximab trial for Relapsed/Refractory B-Cell Non-Hodgkin… (NCT06209619): vídeo corto</video:title>
      <video:description>CC-99282 + Rituximab trial for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (NCT06209619). CC-99282 + Rituximab Early Post CART for Non-Hodgkin's Lymphoma. This phase I trial tests the safety, side effects and best dose of CC-99282 with rituximab…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06209619.mp4</video:content_loc>
      <video:publication_date>2026-10-19T01:08:29.681Z</video:publication_date>
      <video:duration>66</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/roginolisib-nct06644183/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06644183.jpg</video:thumbnail_loc>
      <video:title>Roginolisib + Venetoclax +… trial for Relapsed or Refractory… (NCT06644183): short film</video:title>
      <video:description>Roginolisib + Venetoclax + Rituximab trial for Relapsed or Refractory Chronic Lymphocytic Leukemia (NCT06644183). Roginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL). This research study will test the safety and…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06644183.mp4</video:content_loc>
      <video:publication_date>2026-10-20T05:15:17.471Z</video:publication_date>
      <video:duration>68</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/roginolisib-nct06644183/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06644183.jpg</video:thumbnail_loc>
      <video:title>Roginolisib + Venetoclax +… trial for Relapsed or Refractory… (NCT06644183): vídeo corto</video:title>
      <video:description>Roginolisib + Venetoclax + Rituximab trial for Relapsed or Refractory Chronic Lymphocytic Leukemia (NCT06644183). Roginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL). This research study will test the safety and…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06644183.mp4</video:content_loc>
      <video:publication_date>2026-10-20T05:15:17.471Z</video:publication_date>
      <video:duration>68</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/ruxolitinib-nct03874052/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03874052.jpg</video:thumbnail_loc>
      <video:title>Ruxolitinib + Venetoclax trial for Relapsed/Refractory Acute Myeloid… (NCT03874052): short film</video:title>
      <video:description>Ruxolitinib + Venetoclax trial for Relapsed/Refractory Acute Myeloid Leukemia (NCT03874052). Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia. This phase I…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03874052.mp4</video:content_loc>
      <video:publication_date>2026-10-19T02:54:37.648Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/ruxolitinib-nct03874052/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03874052.jpg</video:thumbnail_loc>
      <video:title>Ruxolitinib + Venetoclax trial for Relapsed/Refractory Acute Myeloid… (NCT03874052): vídeo corto</video:title>
      <video:description>Ruxolitinib + Venetoclax trial for Relapsed/Refractory Acute Myeloid Leukemia (NCT03874052). Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia. This phase I…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03874052.mp4</video:content_loc>
      <video:publication_date>2026-10-19T02:54:37.648Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/ruxolitinib-phosphate-nct07278856/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07278856.jpg</video:thumbnail_loc>
      <video:title>Ruxolitinib + CHOP trial for Untreated Nodal T Follicular Helper Cell… (NCT07278856): short film</video:title>
      <video:description>Ruxolitinib + CHOP trial for Untreated Nodal T Follicular Helper Cell Lymphoma (NCT07278856). Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas. This phase I trial tests the…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07278856.mp4</video:content_loc>
      <video:publication_date>2026-10-20T02:02:32.921Z</video:publication_date>
      <video:duration>62</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/ruxolitinib-phosphate-nct07278856/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07278856.jpg</video:thumbnail_loc>
      <video:title>Ruxolitinib + CHOP trial for Untreated Nodal T Follicular Helper Cell… (NCT07278856): vídeo corto</video:title>
      <video:description>Ruxolitinib + CHOP trial for Untreated Nodal T Follicular Helper Cell Lymphoma (NCT07278856). Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas. This phase I trial tests the…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07278856.mp4</video:content_loc>
      <video:publication_date>2026-10-20T02:02:32.921Z</video:publication_date>
      <video:duration>62</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/sabre-nct07172958/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07172958.jpg</video:thumbnail_loc>
      <video:title>SABRE trial for Relapsed/Refractory Embryonal Tumors (NCT07172958): short film</video:title>
      <video:description>SABRE trial for Relapsed/Refractory Embryonal Tumors (NCT07172958). Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE). This is a phase I dose-escalation study to…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07172958.mp4</video:content_loc>
      <video:publication_date>2026-10-19T01:15:04.890Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/sabre-nct07172958/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07172958.jpg</video:thumbnail_loc>
      <video:title>SABRE trial for Relapsed/Refractory Embryonal Tumors (NCT07172958): vídeo corto</video:title>
      <video:description>SABRE trial for Relapsed/Refractory Embryonal Tumors (NCT07172958). Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE). This is a phase I dose-escalation study to…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07172958.mp4</video:content_loc>
      <video:publication_date>2026-10-19T01:15:04.890Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/sacituzumab-nct06040970/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06040970.jpg</video:thumbnail_loc>
      <video:title>Sacituzumab Govitecan + Cisplatin trial for Platinum-Sensitive Recurrent… (NCT06040970): short film</video:title>
      <video:description>Sacituzumab Govitecan + Cisplatin trial for Platinum-Sensitive Recurrent Ovarian and Endometrial Cancer (NCT06040970). Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer. This is an open-label, Phase 1 study with…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06040970.mp4</video:content_loc>
      <video:publication_date>2026-10-19T12:24:46.983Z</video:publication_date>
      <video:duration>60</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/sacituzumab-nct06040970/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06040970.jpg</video:thumbnail_loc>
      <video:title>Sacituzumab Govitecan + Cisplatin trial for Platinum-Sensitive… (NCT06040970): vídeo corto</video:title>
      <video:description>Sacituzumab Govitecan + Cisplatin trial for Platinum-Sensitive Recurrent Ovarian and Endometrial Cancer (NCT06040970). Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer. This is an open-label, Phase 1 study with…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06040970.mp4</video:content_loc>
      <video:publication_date>2026-10-19T12:24:46.983Z</video:publication_date>
      <video:duration>60</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/sbrt-atezolizumab-and-bevacizumab-nct05488522/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05488522.jpg</video:thumbnail_loc>
      <video:title>SBRT + atezolizumab and… trial for Unresectable Hepatocellular… (NCT05488522): short film</video:title>
      <video:description>SBRT + atezolizumab and bevacizumab trial for Unresectable Hepatocellular Carcinoma (NCT05488522). SBRT With Atezo/Bev for HCC. A phase I dose escalation and pharmacodynamic study of repeated dose stereotactic body radiotherapy (SBRT) administered with…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05488522.mp4</video:content_loc>
      <video:publication_date>2026-10-19T11:38:06.321Z</video:publication_date>
      <video:duration>71</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/sbrt-atezolizumab-and-bevacizumab-nct05488522/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05488522.jpg</video:thumbnail_loc>
      <video:title>SBRT + atezolizumab and… trial for Unresectable… (NCT05488522): vídeo corto</video:title>
      <video:description>SBRT + atezolizumab and bevacizumab trial for Unresectable Hepatocellular Carcinoma (NCT05488522). SBRT With Atezo/Bev for HCC. A phase I dose escalation and pharmacodynamic study of repeated dose stereotactic body radiotherapy (SBRT) administered with…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05488522.mp4</video:content_loc>
      <video:publication_date>2026-10-19T11:38:06.321Z</video:publication_date>
      <video:duration>71</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/scri-carb7h3-s-b7h3-specific-chimeric-antigen-receptor-c-nct04185038/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04185038.jpg</video:thumbnail_loc>
      <video:title>Study of B7-H3-Specific CAR T… trial for Central Nervous System Tumor (NCT04185038): short film</video:title>
      <video:description>Study of B7-H3-Specific CAR T Cell Locore… trial for Central Nervous System Tumor (NCT04185038). B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04185038.mp4</video:content_loc>
      <video:publication_date>2026-09-12T19:58:00.472Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/scri-carb7h3-s-b7h3-specific-chimeric-antigen-receptor-c-nct04185038/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04185038.jpg</video:thumbnail_loc>
      <video:title>Study of B7-H3-Specific CAR T… trial for Central Nervous System Tumor (NCT04185038): vídeo corto</video:title>
      <video:description>Study of B7-H3-Specific CAR T Cell Locore… trial for Central Nervous System Tumor (NCT04185038). B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04185038.mp4</video:content_loc>
      <video:publication_date>2026-09-12T19:58:00.472Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/selinexor-nct07200102/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07200102.jpg</video:thumbnail_loc>
      <video:title>Selinexor Maintenance trial for Relapsed Multiple Myeloma After CAR… (NCT07200102): short film</video:title>
      <video:description>Selinexor Maintenance trial for Relapsed Multiple Myeloma After CAR T-Cell Therapy (NCT07200102). Selinexor Maintenance Post CAR-T Cell Therapy for Multiple Myeloma. The outcomes in patients with relapsed multiple myeloma refractory to triple-therapy…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07200102.mp4</video:content_loc>
      <video:publication_date>2026-10-20T00:30:14.036Z</video:publication_date>
      <video:duration>66</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/selinexor-nct07200102/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07200102.jpg</video:thumbnail_loc>
      <video:title>Selinexor Maintenance trial for Relapsed Multiple Myeloma After CAR… (NCT07200102): vídeo corto</video:title>
      <video:description>Selinexor Maintenance trial for Relapsed Multiple Myeloma After CAR T-Cell Therapy (NCT07200102). Selinexor Maintenance Post CAR-T Cell Therapy for Multiple Myeloma. The outcomes in patients with relapsed multiple myeloma refractory to triple-therapy…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07200102.mp4</video:content_loc>
      <video:publication_date>2026-10-20T00:30:14.036Z</video:publication_date>
      <video:duration>66</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/seneca-valley-virus-001-svv-001-nct06889493/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06889493.jpg</video:thumbnail_loc>
      <video:title>Seneca Valley Virus-001 (SVV-001) trial for Neuroendocrine Carcinoma (NCT06889493): short film</video:title>
      <video:description>Seneca Valley Virus-001 (SVV-001) trial for Neuroendocrine Carcinoma (NCT06889493). SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06889493.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:39:38.147Z</video:publication_date>
      <video:duration>68</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/seneca-valley-virus-001-svv-001-nct06889493/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06889493.jpg</video:thumbnail_loc>
      <video:title>Seneca Valley Virus-001 (SVV-001) trial for Neuroendocrine Carcinoma (NCT06889493): vídeo corto</video:title>
      <video:description>Seneca Valley Virus-001 (SVV-001) trial for Neuroendocrine Carcinoma (NCT06889493). SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06889493.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:39:38.147Z</video:publication_date>
      <video:duration>68</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/siaci-of-cetuximab-and-bevacizumab-nct05956821/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05956821.jpg</video:thumbnail_loc>
      <video:title>SIACI of cetuximab and bevacizumab trial for Relapsed/Refractory… (NCT05956821): short film</video:title>
      <video:description>SIACI of cetuximab and bevacizumab trial for Relapsed/Refractory Intracranial Glioma (NCT05956821). Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age. This study assesses the safety and efficacy of repeat monthly dosing…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05956821.mp4</video:content_loc>
      <video:publication_date>2026-10-19T01:41:42.249Z</video:publication_date>
      <video:duration>61</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/siaci-of-cetuximab-and-bevacizumab-nct05956821/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05956821.jpg</video:thumbnail_loc>
      <video:title>SIACI of cetuximab and bevacizumab trial for Relapsed/Refractory… (NCT05956821): vídeo corto</video:title>
      <video:description>SIACI of cetuximab and bevacizumab trial for Relapsed/Refractory Intracranial Glioma (NCT05956821). Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age. This study assesses the safety and efficacy of repeat monthly dosing…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05956821.mp4</video:content_loc>
      <video:publication_date>2026-10-19T01:41:42.249Z</video:publication_date>
      <video:duration>61</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/sirolimus-nct07581704/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07581704.jpg</video:thumbnail_loc>
      <video:title>Sirolimus trial for Multiple Myeloma (NCT07581704): short film</video:title>
      <video:description>Sirolimus trial for Multiple Myeloma (NCT07581704). Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody Efficacy in Multiple Myeloma. This is a single center, single arm Phase…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07581704.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:52:18.717Z</video:publication_date>
      <video:duration>65</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/sirolimus-nct07581704/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07581704.jpg</video:thumbnail_loc>
      <video:title>Sirolimus trial for Multiple Myeloma (NCT07581704): vídeo corto</video:title>
      <video:description>Sirolimus trial for Multiple Myeloma (NCT07581704). Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody Efficacy in Multiple Myeloma. This is a single center, single arm Phase…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07581704.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:52:18.717Z</video:publication_date>
      <video:duration>65</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/sitagliptin-nct07541781/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07541781.jpg</video:thumbnail_loc>
      <video:title>Sitagliptin trial for Glioma (NCT07541781): short film</video:title>
      <video:description>Sitagliptin trial for Glioma (NCT07541781). Sitagliptin in Recurrent/Progressive Grade 4 Glioma. Sitagliptin, when combined with standard-of-care drug bevacizumab, is being tested to 1) find out if it…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07541781.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:50:46.819Z</video:publication_date>
      <video:duration>64</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/sitagliptin-nct07541781/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07541781.jpg</video:thumbnail_loc>
      <video:title>Sitagliptin trial for Glioma (NCT07541781): vídeo corto</video:title>
      <video:description>Sitagliptin trial for Glioma (NCT07541781). Sitagliptin in Recurrent/Progressive Grade 4 Glioma. Sitagliptin, when combined with standard-of-care drug bevacizumab, is being tested to 1) find out if it…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07541781.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:50:46.819Z</video:publication_date>
      <video:duration>64</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/sl-401-nct03113643/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03113643.jpg</video:thumbnail_loc>
      <video:title>SL-401 trial for Acute Myeloid Leukemia (NCT03113643): short film</video:title>
      <video:description>SL-401 trial for Acute Myeloid Leukemia (NCT03113643). SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03113643.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:40:15.055Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/sl-401-nct03113643/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03113643.jpg</video:thumbnail_loc>
      <video:title>SL-401 trial for Acute Myeloid Leukemia (NCT03113643): vídeo corto</video:title>
      <video:description>SL-401 trial for Acute Myeloid Leukemia (NCT03113643). SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03113643.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:40:15.055Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/solar-nct06607549/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06607549.jpg</video:thumbnail_loc>
      <video:title>SOLAR trial for Central Nervous System Lymphoma (NCT06607549): short film</video:title>
      <video:description>SOLAR trial for Central Nervous System Lymphoma (NCT06607549). Loncastuximab Tesirine and Rituximab Following Stereotactic Radiosurgery in Patients With Central Nervous System Lymphomas (SOLAR). The purpose of this…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06607549.mp4</video:content_loc>
      <video:publication_date>2026-10-19T15:07:06.006Z</video:publication_date>
      <video:duration>65</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/solar-nct06607549/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06607549.jpg</video:thumbnail_loc>
      <video:title>SOLAR trial for Central Nervous System Lymphoma (NCT06607549): vídeo corto</video:title>
      <video:description>SOLAR trial for Central Nervous System Lymphoma (NCT06607549). Loncastuximab Tesirine and Rituximab Following Stereotactic Radiosurgery in Patients With Central Nervous System Lymphomas (SOLAR). The purpose of this…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06607549.mp4</video:content_loc>
      <video:publication_date>2026-10-19T15:07:06.006Z</video:publication_date>
      <video:duration>65</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/sorafenib-nct05468359/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05468359.jpg</video:thumbnail_loc>
      <video:title>Sorafenib, Bevacizumab and… trial for Refractory Pediatric Solid… (NCT05468359): short film</video:title>
      <video:description>Sorafenib, Bevacizumab and Atezolizumab trial for Refractory Pediatric Solid Tumors (NCT05468359). Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients. This is a phase I/II study to evaluate the safety of combining…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05468359.mp4</video:content_loc>
      <video:publication_date>2026-10-19T02:23:12.050Z</video:publication_date>
      <video:duration>61</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/sorafenib-nct05468359/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05468359.jpg</video:thumbnail_loc>
      <video:title>Sorafenib, Bevacizumab and… trial for Refractory Pediatric Solid… (NCT05468359): vídeo corto</video:title>
      <video:description>Sorafenib, Bevacizumab and Atezolizumab trial for Refractory Pediatric Solid Tumors (NCT05468359). Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients. This is a phase I/II study to evaluate the safety of combining…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05468359.mp4</video:content_loc>
      <video:publication_date>2026-10-19T02:23:12.050Z</video:publication_date>
      <video:duration>61</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/sotorasib-nct05815173/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05815173.jpg</video:thumbnail_loc>
      <video:title>Ladarixin + Sotorasib trial for Advanced KRAS G12C-Mutant Non-Small Cell… (NCT05815173): short film</video:title>
      <video:description>Ladarixin + Sotorasib trial for Advanced KRAS G12C-Mutant Non-Small Cell Lung Cancer (NCT05815173). Ladarixin With Sotorasib in Advanced NSCLC. This is a phase I/II, open-label, study of twice-daily oral ladarixin with sotorasib in participants with advanced…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05815173.mp4</video:content_loc>
      <video:publication_date>2026-10-19T12:01:06.298Z</video:publication_date>
      <video:duration>62</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/sotorasib-nct05815173/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05815173.jpg</video:thumbnail_loc>
      <video:title>Ladarixin + Sotorasib trial for Advanced KRAS G12C-Mutant Non-Small… (NCT05815173): vídeo corto</video:title>
      <video:description>Ladarixin + Sotorasib trial for Advanced KRAS G12C-Mutant Non-Small Cell Lung Cancer (NCT05815173). Ladarixin With Sotorasib in Advanced NSCLC. This is a phase I/II, open-label, study of twice-daily oral ladarixin with sotorasib in participants with advanced…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05815173.mp4</video:content_loc>
      <video:publication_date>2026-10-19T12:01:06.298Z</video:publication_date>
      <video:duration>62</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/spatially-fractionated-rt-nct06546969/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06546969.jpg</video:thumbnail_loc>
      <video:title>Chemoimmunotherapy + SFRT and… trial for Advanced Biliary Tract Cancer (NCT06546969): short film</video:title>
      <video:description>Chemoimmunotherapy + SFRT and Hyperthermia trial for Advanced Biliary Tract Cancer (NCT06546969). Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer. This study is being done to see if the…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06546969.mp4</video:content_loc>
      <video:publication_date>2026-10-19T12:47:22.054Z</video:publication_date>
      <video:duration>63</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/spatially-fractionated-rt-nct06546969/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06546969.jpg</video:thumbnail_loc>
      <video:title>Chemoimmunotherapy + SFRT and… trial for Advanced Biliary Tract… (NCT06546969): vídeo corto</video:title>
      <video:description>Chemoimmunotherapy + SFRT and Hyperthermia trial for Advanced Biliary Tract Cancer (NCT06546969). Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer. This study is being done to see if the…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06546969.mp4</video:content_loc>
      <video:publication_date>2026-10-19T12:47:22.054Z</video:publication_date>
      <video:duration>63</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/starlite-nct06428045/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06428045.jpg</video:thumbnail_loc>
      <video:title>STARLITE trial for High Grade Glioma (NCT06428045): short film</video:title>
      <video:description>STARLITE trial for High Grade Glioma (NCT06428045). STARLITE for Unresectable High-Grade Gliomas. The purpose of this study is to determine whether newly diagnosed high-grade glioma(s) that cannot be removed…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06428045.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:38:43.467Z</video:publication_date>
      <video:duration>67</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/starlite-nct06428045/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06428045.jpg</video:thumbnail_loc>
      <video:title>STARLITE trial for High Grade Glioma (NCT06428045): vídeo corto</video:title>
      <video:description>STARLITE trial for High Grade Glioma (NCT06428045). STARLITE for Unresectable High-Grade Gliomas. The purpose of this study is to determine whether newly diagnosed high-grade glioma(s) that cannot be removed…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06428045.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:38:43.467Z</video:publication_date>
      <video:duration>67</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/sx-682-nct07814352/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07814352.jpg</video:thumbnail_loc>
      <video:title>SX-682 + Proton CSI trial for Leptomeningeal Disease From Melanoma or… (NCT07814352): short film</video:title>
      <video:description>SX-682 + Proton CSI trial for Leptomeningeal Disease From Melanoma or NSCLC (NCT07814352). SX-682 in Combination With Proton Craniospinal Irradiation (pCSI) in People With Leptomeningeal Disease. The researchers are doing this study to find out…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07814352.mp4</video:content_loc>
      <video:publication_date>2026-10-20T03:19:39.464Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/sx-682-nct07814352/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07814352.jpg</video:thumbnail_loc>
      <video:title>SX-682 + Proton CSI trial for Leptomeningeal Disease From Melanoma or… (NCT07814352): vídeo corto</video:title>
      <video:description>SX-682 + Proton CSI trial for Leptomeningeal Disease From Melanoma or NSCLC (NCT07814352). SX-682 in Combination With Proton Craniospinal Irradiation (pCSI) in People With Leptomeningeal Disease. The researchers are doing this study to find out…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07814352.mp4</video:content_loc>
      <video:publication_date>2026-10-20T03:19:39.464Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/tafasitamab-nct07225439/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07225439.jpg</video:thumbnail_loc>
      <video:title>Tafasitamab trial for Non Hodgkin Lymphoma (NCT07225439): short film</video:title>
      <video:description>Tafasitamab trial for Non Hodgkin Lymphoma (NCT07225439). Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL). This…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07225439.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:21:47.247Z</video:publication_date>
      <video:duration>68</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/tafasitamab-nct07225439/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07225439.jpg</video:thumbnail_loc>
      <video:title>Tafasitamab trial for Non Hodgkin Lymphoma (NCT07225439): vídeo corto</video:title>
      <video:description>Tafasitamab trial for Non Hodgkin Lymphoma (NCT07225439). Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL). This…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07225439.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:21:47.247Z</video:publication_date>
      <video:duration>68</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/talquetamab-nct07093554/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07093554.jpg</video:thumbnail_loc>
      <video:title>Talquetamab trial for Relapsed/Refractory Multiple Myeloma (NCT07093554): short film</video:title>
      <video:description>Talquetamab trial for Relapsed/Refractory Multiple Myeloma (NCT07093554). Cilta-Talq Fusion Study: A Phase 1b Study of Talquetamab Bridging Therapy Followed by Ciltacabtagene Autoleucel in Patients With Relapsed/Refractory Multiple…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07093554.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:04:25.727Z</video:publication_date>
      <video:duration>59</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/talquetamab-nct07093554/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07093554.jpg</video:thumbnail_loc>
      <video:title>Talquetamab trial for Relapsed/Refractory Multiple Myeloma (NCT07093554): vídeo corto</video:title>
      <video:description>Talquetamab trial for Relapsed/Refractory Multiple Myeloma (NCT07093554). Cilta-Talq Fusion Study: A Phase 1b Study of Talquetamab Bridging Therapy Followed by Ciltacabtagene Autoleucel in Patients With Relapsed/Refractory Multiple…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07093554.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:04:25.727Z</video:publication_date>
      <video:duration>59</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/tazemetostat-nct05627232/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05627232.jpg</video:thumbnail_loc>
      <video:title>Tazemetostat trial for Relapsed or Refractory Acute Myeloid Leukemia (NCT05627232): short film</video:title>
      <video:description>Tazemetostat trial for Relapsed or Refractory Acute Myeloid Leukemia (NCT05627232). Tazemetostat and Palbociclib With CPX-351for R/R AML. This is a two-part phase Ib dose escalation study to evaluate the safety and preliminary efficacy of the…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05627232.mp4</video:content_loc>
      <video:publication_date>2026-10-19T15:31:09.507Z</video:publication_date>
      <video:duration>65</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/tazemetostat-nct05627232/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05627232.jpg</video:thumbnail_loc>
      <video:title>Tazemetostat trial for Relapsed or Refractory Acute Myeloid Leukemia (NCT05627232): vídeo corto</video:title>
      <video:description>Tazemetostat trial for Relapsed or Refractory Acute Myeloid Leukemia (NCT05627232). Tazemetostat and Palbociclib With CPX-351for R/R AML. This is a two-part phase Ib dose escalation study to evaluate the safety and preliminary efficacy of the…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05627232.mp4</video:content_loc>
      <video:publication_date>2026-10-19T15:31:09.507Z</video:publication_date>
      <video:duration>65</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/tegavivint-nct05755087/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05755087.jpg</video:thumbnail_loc>
      <video:title>Tegavivint trial for Relapsed or Refractory Large B-Cell Lymphoma (NCT05755087): short film</video:title>
      <video:description>Tegavivint trial for Relapsed or Refractory Large B-Cell Lymphoma (NCT05755087). Tegavivint for Treating Patients With Relapsed or Refractory Large B-Cell Lymphoma. This phase I trial tests the safety, side effects, and best dose of…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05755087.mp4</video:content_loc>
      <video:publication_date>2026-10-20T04:55:27.219Z</video:publication_date>
      <video:duration>58</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/tegavivint-nct05755087/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05755087.jpg</video:thumbnail_loc>
      <video:title>Tegavivint trial for Relapsed or Refractory Large B-Cell Lymphoma (NCT05755087): vídeo corto</video:title>
      <video:description>Tegavivint trial for Relapsed or Refractory Large B-Cell Lymphoma (NCT05755087). Tegavivint for Treating Patients With Relapsed or Refractory Large B-Cell Lymphoma. This phase I trial tests the safety, side effects, and best dose of…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05755087.mp4</video:content_loc>
      <video:publication_date>2026-10-20T04:55:27.219Z</video:publication_date>
      <video:duration>58</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/tepotinib-nct07619339/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07619339.jpg</video:thumbnail_loc>
      <video:title>Tepotinib + Ivonescimab trial for MET Exon 14 Skipping Non-Small Cell… (NCT07619339): short film</video:title>
      <video:description>Tepotinib + Ivonescimab trial for MET Exon 14 Skipping Non-Small Cell Lung Cancer (NCT07619339). Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer. The researchers are doing this study to find out whether the combination of tepotinib and…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07619339.mp4</video:content_loc>
      <video:publication_date>2026-10-20T02:18:32.125Z</video:publication_date>
      <video:duration>63</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/tepotinib-nct07619339/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07619339.jpg</video:thumbnail_loc>
      <video:title>Tepotinib + Ivonescimab trial for MET Exon 14 Skipping Non-Small Cell… (NCT07619339): vídeo corto</video:title>
      <video:description>Tepotinib + Ivonescimab trial for MET Exon 14 Skipping Non-Small Cell Lung Cancer (NCT07619339). Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer. The researchers are doing this study to find out whether the combination of tepotinib and…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07619339.mp4</video:content_loc>
      <video:publication_date>2026-10-20T02:18:32.125Z</video:publication_date>
      <video:duration>63</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/tgfbr2-ko-car27-il-15-nk-cells-nct07444632/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07444632.jpg</video:thumbnail_loc>
      <video:title>CAR.70 NK Cells trial for Relapsed or Refractory Lymphomas and B-ALL (NCT07444632): short film</video:title>
      <video:description>CAR.70 NK Cells trial for Relapsed or Refractory Lymphomas and B-ALL (NCT07444632). CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies. This is a phase 1 basket…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07444632.mp4</video:content_loc>
      <video:publication_date>2026-10-20T03:47:53.059Z</video:publication_date>
      <video:duration>66</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/tgfbr2-ko-car27-il-15-nk-cells-nct07444632/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07444632.jpg</video:thumbnail_loc>
      <video:title>CAR.70 NK Cells trial for Relapsed or Refractory Lymphomas and B-ALL (NCT07444632): vídeo corto</video:title>
      <video:description>CAR.70 NK Cells trial for Relapsed or Refractory Lymphomas and B-ALL (NCT07444632). CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies. This is a phase 1 basket…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07444632.mp4</video:content_loc>
      <video:publication_date>2026-10-20T03:47:53.059Z</video:publication_date>
      <video:duration>66</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/tgfbr2-ko-car27-il-15-nk-cells-nct07509008/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07509008.jpg</video:thumbnail_loc>
      <video:title>TROP2 CAR/IL-15 TGFBR2 KO NK Cells trial for Gastric Cancer, Metastatic (NCT07509008): short film</video:title>
      <video:description>TROP2 CAR/IL-15 TGFBR2 KO NK Cells trial for Gastric Cancer, Metastatic (NCT07509008). TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The Peritoneum. The goal of this clinical…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07509008.mp4</video:content_loc>
      <video:publication_date>2026-10-18T18:46:13.500Z</video:publication_date>
      <video:duration>67</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/tgfbr2-ko-car27-il-15-nk-cells-nct07509008/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07509008.jpg</video:thumbnail_loc>
      <video:title>TROP2 CAR/IL-15 TGFBR2 KO NK Cells trial for Gastric Cancer, Metastatic (NCT07509008): vídeo corto</video:title>
      <video:description>TROP2 CAR/IL-15 TGFBR2 KO NK Cells trial for Gastric Cancer, Metastatic (NCT07509008). TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The Peritoneum. The goal of this clinical…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07509008.mp4</video:content_loc>
      <video:publication_date>2026-10-18T18:46:13.500Z</video:publication_date>
      <video:duration>67</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/tinks-nct05634369/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05634369.jpg</video:thumbnail_loc>
      <video:title>TINKS trial for Relapsed/Refractory Pediatric Sarcoma (NCT05634369): short film</video:title>
      <video:description>TINKS trial for Relapsed/Refractory Pediatric Sarcoma (NCT05634369). A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05634369.mp4</video:content_loc>
      <video:publication_date>2026-10-19T00:50:34.757Z</video:publication_date>
      <video:duration>63</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/tinks-nct05634369/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05634369.jpg</video:thumbnail_loc>
      <video:title>TINKS trial for Relapsed/Refractory Pediatric Sarcoma (NCT05634369): vídeo corto</video:title>
      <video:description>TINKS trial for Relapsed/Refractory Pediatric Sarcoma (NCT05634369). A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05634369.mp4</video:content_loc>
      <video:publication_date>2026-10-19T00:50:34.757Z</video:publication_date>
      <video:duration>63</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/tnhyp218-car-t-cells-nct06885697/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06885697.jpg</video:thumbnail_loc>
      <video:title>TNhYP218 CAR T Cells trial for Mesothelioma (NCT06885697): short film</video:title>
      <video:description>TNhYP218 CAR T Cells trial for Mesothelioma (NCT06885697). Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma. Background:…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06885697.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:43:33.857Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/tnhyp218-car-t-cells-nct06885697/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06885697.jpg</video:thumbnail_loc>
      <video:title>TNhYP218 CAR T Cells trial for Mesothelioma (NCT06885697): vídeo corto</video:title>
      <video:description>TNhYP218 CAR T Cells trial for Mesothelioma (NCT06885697). Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma. Background:…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06885697.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:43:33.857Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/total-body-irradiation-nct06928662/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06928662.jpg</video:thumbnail_loc>
      <video:title>Decitabine + FLAG-Ida and… trial for Acute Myeloid Leukemia and… (NCT06928662): short film</video:title>
      <video:description>Decitabine + FLAG-Ida and Total-Body Irradiation trial for Acute Myeloid Leukemia and Other Myeloid Malignancies (NCT06928662). Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06928662.mp4</video:content_loc>
      <video:publication_date>2026-10-19T02:16:47.708Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/total-body-irradiation-nct06928662/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06928662.jpg</video:thumbnail_loc>
      <video:title>Decitabine + FLAG-Ida and… trial for Acute Myeloid Leukemia and… (NCT06928662): vídeo corto</video:title>
      <video:description>Decitabine + FLAG-Ida and Total-Body Irradiation trial for Acute Myeloid Leukemia and Other Myeloid Malignancies (NCT06928662). Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06928662.mp4</video:content_loc>
      <video:publication_date>2026-10-19T02:16:47.708Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/tpt-ced-rhgg-nct06666712/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06666712.jpg</video:thumbnail_loc>
      <video:title>TPT CED rHGG trial for Brain Tumor, Recurrent (NCT06666712): short film</video:title>
      <video:description>TPT CED rHGG trial for Brain Tumor, Recurrent (NCT06666712). Chronic CED of TPT for Recurrent Malignant Glioma. The primary goal of this study is to establish the safety of chronic Convection Enhanced Delivery (CED) of…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06666712.mp4</video:content_loc>
      <video:publication_date>2026-09-12T15:30:58.168Z</video:publication_date>
      <video:duration>259</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/tpt-ced-rhgg-nct06666712/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06666712.jpg</video:thumbnail_loc>
      <video:title>TPT CED rHGG trial for Brain Tumor, Recurrent (NCT06666712): vídeo corto</video:title>
      <video:description>TPT CED rHGG trial for Brain Tumor, Recurrent (NCT06666712). Chronic CED of TPT for Recurrent Malignant Glioma. The primary goal of this study is to establish the safety of chronic Convection Enhanced Delivery (CED) of…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06666712.mp4</video:content_loc>
      <video:publication_date>2026-09-12T15:30:58.168Z</video:publication_date>
      <video:duration>259</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/trabedersen-nct06579196/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06579196.jpg</video:thumbnail_loc>
      <video:title>Trabedersen trial for Non-small Cell Lung Cancer (NCT06579196): short film</video:title>
      <video:description>Trabedersen trial for Non-small Cell Lung Cancer (NCT06579196). Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed Advanced NSCLC and Positive PD-L1. The goal of this clinical trial is to: 1) evaluate the safety…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06579196.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:19:58.663Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/trabedersen-nct06579196/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06579196.jpg</video:thumbnail_loc>
      <video:title>Trabedersen trial for Non-small Cell Lung Cancer (NCT06579196): vídeo corto</video:title>
      <video:description>Trabedersen trial for Non-small Cell Lung Cancer (NCT06579196). Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed Advanced NSCLC and Positive PD-L1. The goal of this clinical trial is to: 1) evaluate the safety…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06579196.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:19:58.663Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/tumor-infiltrating-lymphocytes-til-nct05681780/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05681780.jpg</video:thumbnail_loc>
      <video:title>Tumor-infiltrating Lymphocytes (TIL) trial for Non Small Cell Lung Cancer (NCT05681780): short film</video:title>
      <video:description>Tumor-infiltrating Lymphocytes (TIL) trial for Non Small Cell Lung Cancer (NCT05681780). CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC. To determine the effect of a special preparation of cells, called…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05681780.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:13:05.644Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/tumor-infiltrating-lymphocytes-til-nct05681780/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05681780.jpg</video:thumbnail_loc>
      <video:title>Tumor-infiltrating Lymphocytes (TIL) trial for Non Small Cell Lung Cancer (NCT05681780): vídeo corto</video:title>
      <video:description>Tumor-infiltrating Lymphocytes (TIL) trial for Non Small Cell Lung Cancer (NCT05681780). CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC. To determine the effect of a special preparation of cells, called…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05681780.mp4</video:content_loc>
      <video:publication_date>2026-09-12T20:13:05.644Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/ultrasound-induced-microbubble-cavitation-nct07501650/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07501650.jpg</video:thumbnail_loc>
      <video:title>Ultrasound Microbubble Cavitation trial for Recurrent or Metastatic Head… (NCT07501650): short film</video:title>
      <video:description>Ultrasound Microbubble Cavitation trial for Recurrent or Metastatic Head and Neck Cancer (NCT07501650). Pembrolizumab Plus Ultrasound-Induced Microbubble Cavitation in Head and Neck Cancer. This is a feasibility trial studying anti-PD-1 therapy (Pembrolizumab)…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07501650.mp4</video:content_loc>
      <video:publication_date>2026-10-19T16:08:36.195Z</video:publication_date>
      <video:duration>62</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/ultrasound-induced-microbubble-cavitation-nct07501650/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07501650.jpg</video:thumbnail_loc>
      <video:title>Ultrasound Microbubble Cavitation trial for Recurrent or Metastatic… (NCT07501650): vídeo corto</video:title>
      <video:description>Ultrasound Microbubble Cavitation trial for Recurrent or Metastatic Head and Neck Cancer (NCT07501650). Pembrolizumab Plus Ultrasound-Induced Microbubble Cavitation in Head and Neck Cancer. This is a feasibility trial studying anti-PD-1 therapy (Pembrolizumab)…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07501650.mp4</video:content_loc>
      <video:publication_date>2026-10-19T16:08:36.195Z</video:publication_date>
      <video:duration>62</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/vaccine-therapy-nct06324240/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06324240.jpg</video:thumbnail_loc>
      <video:title>Personalized TMV Tumor Vaccine trial for Triple-Negative Breast Cancer (NCT06324240): short film</video:title>
      <video:description>Personalized TMV Tumor Vaccine trial for Triple-Negative Breast Cancer (NCT06324240). Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer. This phase I trial tests the…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06324240.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:37:34.639Z</video:publication_date>
      <video:duration>64</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/vaccine-therapy-nct06324240/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06324240.jpg</video:thumbnail_loc>
      <video:title>Personalized TMV Tumor Vaccine trial for Triple-Negative Breast Cancer (NCT06324240): vídeo corto</video:title>
      <video:description>Personalized TMV Tumor Vaccine trial for Triple-Negative Breast Cancer (NCT06324240). Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer. This phase I trial tests the…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06324240.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:37:34.639Z</video:publication_date>
      <video:duration>64</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/valemetostat-nct06807632/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06807632.jpg</video:thumbnail_loc>
      <video:title>Valemetostat trial for Extensive-stage Small-cell Lung Cancer (NCT06807632): short film</video:title>
      <video:description>Valemetostat trial for Extensive-stage Small-cell Lung Cancer (NCT06807632). Valemetostat in Combination With Atezolizumab in People With Lung Cancer. This study will test whether valemetostat in combination with atezolizumab is a safe…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06807632.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:27:50.200Z</video:publication_date>
      <video:duration>68</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/valemetostat-nct06807632/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06807632.jpg</video:thumbnail_loc>
      <video:title>Valemetostat trial for Extensive-stage Small-cell Lung Cancer (NCT06807632): vídeo corto</video:title>
      <video:description>Valemetostat trial for Extensive-stage Small-cell Lung Cancer (NCT06807632). Valemetostat in Combination With Atezolizumab in People With Lung Cancer. This study will test whether valemetostat in combination with atezolizumab is a safe…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06807632.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:27:50.200Z</video:publication_date>
      <video:duration>68</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/venetoclax-nct03214562/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03214562.jpg</video:thumbnail_loc>
      <video:title>Venetoclax trial for Acute Myeloid Leukemia (NCT03214562): short film</video:title>
      <video:description>Venetoclax trial for Acute Myeloid Leukemia (NCT03214562). Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia. This phase Ib/II trial…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03214562.mp4</video:content_loc>
      <video:publication_date>2026-10-18T18:48:23.484Z</video:publication_date>
      <video:duration>64</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/venetoclax-nct03214562/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03214562.jpg</video:thumbnail_loc>
      <video:title>Venetoclax trial for Acute Myeloid Leukemia (NCT03214562): vídeo corto</video:title>
      <video:description>Venetoclax trial for Acute Myeloid Leukemia (NCT03214562). Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia. This phase Ib/II trial…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03214562.mp4</video:content_loc>
      <video:publication_date>2026-10-18T18:48:23.484Z</video:publication_date>
      <video:duration>64</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/venetoclax-nct06129734/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06129734.jpg</video:thumbnail_loc>
      <video:title>Decitabine + Venetoclax… trial for Acute Myeloid Leukemia and… (NCT06129734): short film</video:title>
      <video:description>Decitabine + Venetoclax Maintenance trial for Acute Myeloid Leukemia and Myelodysplastic Syndromes After Allogeneic Transplant (NCT06129734). Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant. The goal of this interventional clinical trial is…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06129734.mp4</video:content_loc>
      <video:publication_date>2026-10-19T14:06:34.675Z</video:publication_date>
      <video:duration>63</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/venetoclax-nct06129734/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06129734.jpg</video:thumbnail_loc>
      <video:title>Decitabine + Venetoclax… trial for Acute Myeloid Leukemia and… (NCT06129734): vídeo corto</video:title>
      <video:description>Decitabine + Venetoclax Maintenance trial for Acute Myeloid Leukemia and Myelodysplastic Syndromes After Allogeneic Transplant (NCT06129734). Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant. The goal of this interventional clinical trial is…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06129734.mp4</video:content_loc>
      <video:publication_date>2026-10-19T14:06:34.675Z</video:publication_date>
      <video:duration>63</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/victory-nct05609994/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05609994.jpg</video:thumbnail_loc>
      <video:title>ViCToRy trial for Low Grade Glioma of Brain (NCT05609994): short film</video:title>
      <video:description>ViCToRy trial for Low Grade Glioma of Brain (NCT05609994). ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas. The purpose of this study is to…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05609994.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:00:02.588Z</video:publication_date>
      <video:duration>61</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/victory-nct05609994/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05609994.jpg</video:thumbnail_loc>
      <video:title>ViCToRy trial for Low Grade Glioma of Brain (NCT05609994): vídeo corto</video:title>
      <video:description>ViCToRy trial for Low Grade Glioma of Brain (NCT05609994). ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas. The purpose of this study is to…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05609994.mp4</video:content_loc>
      <video:publication_date>2026-10-18T22:00:02.588Z</video:publication_date>
      <video:duration>61</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/vista-nct03740256/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03740256.jpg</video:thumbnail_loc>
      <video:title>VISTA trial for Bladder Cancer (NCT03740256): short film</video:title>
      <video:description>VISTA trial for Bladder Cancer (NCT03740256). Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors. This study is a first in human Phase 1…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03740256.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:06:49.473Z</video:publication_date>
      <video:duration>88</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/vista-nct03740256/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03740256.jpg</video:thumbnail_loc>
      <video:title>VISTA trial for Bladder Cancer (NCT03740256): vídeo corto</video:title>
      <video:description>VISTA trial for Bladder Cancer (NCT03740256). Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors. This study is a first in human Phase 1…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03740256.mp4</video:content_loc>
      <video:publication_date>2026-09-12T21:06:49.473Z</video:publication_date>
      <video:duration>88</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/withaferin-a-nct05610735/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05610735.jpg</video:thumbnail_loc>
      <video:title>Ashwagandha + Liposomal Doxorubicin trial for Recurrent Ovarian Cancer (NCT05610735): short film</video:title>
      <video:description>Ashwagandha + Liposomal Doxorubicin trial for Recurrent Ovarian Cancer (NCT05610735). Combination Therapy for Recurrent Ovarian Cancer. The proposed study &quot;combination therapy with liposomal doxorubicin and withaferin A (Ashwagandha, ASWD) in…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05610735.mp4</video:content_loc>
      <video:publication_date>2026-10-19T13:47:11.465Z</video:publication_date>
      <video:duration>71</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/withaferin-a-nct05610735/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05610735.jpg</video:thumbnail_loc>
      <video:title>Ashwagandha + Liposomal Doxorubicin trial for Recurrent Ovarian Cancer (NCT05610735): vídeo corto</video:title>
      <video:description>Ashwagandha + Liposomal Doxorubicin trial for Recurrent Ovarian Cancer (NCT05610735). Combination Therapy for Recurrent Ovarian Cancer. The proposed study &quot;combination therapy with liposomal doxorubicin and withaferin A (Ashwagandha, ASWD) in…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05610735.mp4</video:content_loc>
      <video:publication_date>2026-10-19T13:47:11.465Z</video:publication_date>
      <video:duration>71</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/ws-cart-cs1-nct06185751/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06185751.jpg</video:thumbnail_loc>
      <video:title>WS-CART-CS1 trial for Multiple Myeloma (NCT06185751): short film</video:title>
      <video:description>WS-CART-CS1 trial for Multiple Myeloma (NCT06185751). CS1 CAR-T (WS-CART-CS1) in Subjects With Multiple Myeloma. Despite recent therapeutic advances, multiple myeloma (MM) remains an incurable disease.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06185751.mp4</video:content_loc>
      <video:publication_date>2026-10-18T18:54:51.976Z</video:publication_date>
      <video:duration>61</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/ws-cart-cs1-nct06185751/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06185751.jpg</video:thumbnail_loc>
      <video:title>WS-CART-CS1 trial for Multiple Myeloma (NCT06185751): vídeo corto</video:title>
      <video:description>WS-CART-CS1 trial for Multiple Myeloma (NCT06185751). CS1 CAR-T (WS-CART-CS1) in Subjects With Multiple Myeloma. Despite recent therapeutic advances, multiple myeloma (MM) remains an incurable disease.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06185751.mp4</video:content_loc>
      <video:publication_date>2026-10-18T18:54:51.976Z</video:publication_date>
      <video:duration>61</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/zanu-tafa-nct06029309/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06029309.jpg</video:thumbnail_loc>
      <video:title>Zanubrutinib + Tafasitamab trial for Mantle Cell Lymphoma (NCT06029309): short film</video:title>
      <video:description>Zanubrutinib + Tafasitamab trial for Mantle Cell Lymphoma (NCT06029309). Zanubrutinib and Tafasitamab in Mantle Cell Lymphoma. The main purpose of this study to find the ideal dose for the combination treatment of Zanubrutinib and…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06029309.mp4</video:content_loc>
      <video:publication_date>2026-10-20T03:59:00.526Z</video:publication_date>
      <video:duration>51</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/zanu-tafa-nct06029309/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06029309.jpg</video:thumbnail_loc>
      <video:title>Zanubrutinib + Tafasitamab trial for Mantle Cell Lymphoma (NCT06029309): vídeo corto</video:title>
      <video:description>Zanubrutinib + Tafasitamab trial for Mantle Cell Lymphoma (NCT06029309). Zanubrutinib and Tafasitamab in Mantle Cell Lymphoma. The main purpose of this study to find the ideal dose for the combination treatment of Zanubrutinib and…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06029309.mp4</video:content_loc>
      <video:publication_date>2026-10-20T03:59:00.526Z</video:publication_date>
      <video:duration>51</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/zanubrutinib-nct06730542/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06730542.jpg</video:thumbnail_loc>
      <video:title>Zanubrutinib + Pola-R-CHP trial for Secondary CNS Lymphoma (NCT06730542): short film</video:title>
      <video:description>Zanubrutinib + Pola-R-CHP trial for Secondary CNS Lymphoma (NCT06730542). Zanubrutinib in Combination With Pola-R-CHP and High-dose Methotrexate in Patients With Secondary CNS Lymphoma. The purpose of this study is to is to…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06730542.mp4</video:content_loc>
      <video:publication_date>2026-10-20T04:05:26.635Z</video:publication_date>
      <video:duration>65</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/zanubrutinib-nct06730542/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06730542.jpg</video:thumbnail_loc>
      <video:title>Zanubrutinib + Pola-R-CHP trial for Secondary CNS Lymphoma (NCT06730542): vídeo corto</video:title>
      <video:description>Zanubrutinib + Pola-R-CHP trial for Secondary CNS Lymphoma (NCT06730542). Zanubrutinib in Combination With Pola-R-CHP and High-dose Methotrexate in Patients With Secondary CNS Lymphoma. The purpose of this study is to is to…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06730542.mp4</video:content_loc>
      <video:publication_date>2026-10-20T04:05:26.635Z</video:publication_date>
      <video:duration>65</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-1/ziftomenib-nct06440135/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06440135.jpg</video:thumbnail_loc>
      <video:title>Ziftomenib Maintenance trial for NPM1-Mutated AML in Remission After… (NCT06440135): short film</video:title>
      <video:description>Ziftomenib Maintenance trial for NPM1-Mutated AML in Remission After Allogeneic Transplant (NCT06440135). Ziftomenib Maintenance Post Allo-HCT. The purpose of this study is to test the safety, effects, and recommended dose of an investigational drug, ziftomenib,…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06440135.mp4</video:content_loc>
      <video:publication_date>2026-10-20T05:07:08.263Z</video:publication_date>
      <video:duration>64</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/es/phase-1/ziftomenib-nct06440135/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06440135.jpg</video:thumbnail_loc>
      <video:title>Ziftomenib Maintenance trial for NPM1-Mutated AML in Remission After… (NCT06440135): vídeo corto</video:title>
      <video:description>Ziftomenib Maintenance trial for NPM1-Mutated AML in Remission After Allogeneic Transplant (NCT06440135). Ziftomenib Maintenance Post Allo-HCT. The purpose of this study is to test the safety, effects, and recommended dose of an investigational drug, ziftomenib,…</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06440135.mp4</video:content_loc>
      <video:publication_date>2026-10-20T05:07:08.263Z</video:publication_date>
      <video:duration>64</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/24bro681-alternating-gnp-and-mfolfirinox-for-br-pdac-nct07043270/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07043270.jpg</video:thumbnail_loc>
      <video:title>Nab-paclitaxel + Gemcitabine trial for Pancreas Adenocarcinoma (NCT07043270): short film</video:title>
      <video:description>Nab-paclitaxel + Gemcitabine trial for Pancreas Adenocarcinoma (NCT07043270). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07043270.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07043270.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:16:43.025Z</video:publication_date>
      <video:duration>87</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/3-5-fraction-stereotactic-body-radiation-therapy-for-palliation-nct05674396/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05674396.jpg</video:thumbnail_loc>
      <video:title>Stereotactic body radiotherapy trial for Head and Neck Squamous Cell… (NCT05674396): short film</video:title>
      <video:description>Stereotactic body radiotherapy trial for Head and Neck Squamous Cell Carcinoma (NCT05674396). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05674396.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05674396.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:11:41.058Z</video:publication_date>
      <video:duration>98</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/5-azacytidine-and-or-nivolumab-in-resectable-hpv-associated-hnsc-nct05317000/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05317000.jpg</video:thumbnail_loc>
      <video:title>Combination 5-azacytidine and… trial for Squamous Cell Carcinoma of… (NCT05317000): short film</video:title>
      <video:description>Combination 5-azacytidine and nivolumab trial for Squamous Cell Carcinoma of Head and Neck (NCT05317000). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05317000.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05317000.mp4</video:content_loc>
      <video:publication_date>2026-11-01T00:07:58.978Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/5-day-preoperative-radiation-for-soft-tissue-sarcoma-nct06087861/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06087861.jpg</video:thumbnail_loc>
      <video:title>External Beam Radiotherapy trial for Soft Tissue Sarcoma (NCT06087861): short film</video:title>
      <video:description>External Beam Radiotherapy trial for Soft Tissue Sarcoma (NCT06087861). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06087861.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06087861.mp4</video:content_loc>
      <video:publication_date>2026-11-01T00:05:35.745Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/5-fluorouracil-leucovorin-5fu-lv-in-combination-with-regorafenib-nct06887218/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06887218.jpg</video:thumbnail_loc>
      <video:title>Regorafenib (BAY 73-4506) trial for Metastatic Colorectal Cancer (CRC) (NCT06887218): short film</video:title>
      <video:description>Regorafenib (BAY 73-4506) trial for Metastatic Colorectal Cancer (CRC) (NCT06887218). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06887218.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06887218.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:39:56.651Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-cancer-vaccine-stemvac-in-combination-with-chemotherapy-for-th-nct07078604/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07078604.jpg</video:thumbnail_loc>
      <video:title>CD105/Yb-1/SOX2/CDH3/MDM2-polyepi… trial for Anatomic Stage IV Breast… (NCT07078604): short film</video:title>
      <video:description>CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine trial for Anatomic Stage IV Breast Cancer AJCC v8 (NCT07078604). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07078604.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07078604.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:29:29.257Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-clinical-study-of-calderasib-mk-1084-in-people-with-advanced-s-nct07209111/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07209111.jpg</video:thumbnail_loc>
      <video:title>Calderasib trial for Neoplasm Malignant (NCT07209111): short film</video:title>
      <video:description>Calderasib trial for Neoplasm Malignant (NCT07209111). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07209111.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07209111.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:51:23.029Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-clinical-study-of-intismeran-autogene-v940-and-pembrolizumab-m-nct06961006/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06961006.jpg</video:thumbnail_loc>
      <video:title>Intismeran autogene trial for Malignant Melanoma (NCT06961006): short film</video:title>
      <video:description>Intismeran autogene trial for Malignant Melanoma (NCT06961006). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06961006.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06961006.mp4</video:content_loc>
      <video:publication_date>2026-10-31T14:56:25.670Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-clinical-study-of-zilovertamab-vedotin-mk-2140-plus-rituximab-nct06890884/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06890884.jpg</video:thumbnail_loc>
      <video:title>Zilovertamab vedotin trial for Lymphoma, Large B-Cell, Diffuse (NCT06890884): short film</video:title>
      <video:description>Zilovertamab vedotin trial for Lymphoma, Large B-Cell, Diffuse (NCT06890884). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06890884.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06890884.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:06:02.504Z</video:publication_date>
      <video:duration>93</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-long-term-treatment-extension-study-of-niraparib-in-participan-nct04641247/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04641247.jpg</video:thumbnail_loc>
      <video:title>Niraparib trial for Ovarian Neoplasms (NCT04641247): short film</video:title>
      <video:description>Niraparib trial for Ovarian Neoplasms (NCT04641247). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04641247.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04641247.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:55:09.848Z</video:publication_date>
      <video:duration>85</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-multicenter-trial-to-identify-optimal-atezolizumab-biomarkers-nct06069726/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06069726.jpg</video:thumbnail_loc>
      <video:title>Atezolizumab trial for Recurrent Glioblastoma (NCT06069726): short film</video:title>
      <video:description>Atezolizumab trial for Recurrent Glioblastoma (NCT06069726). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06069726.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06069726.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:44:12.723Z</video:publication_date>
      <video:duration>89</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-multiple-antigen-vaccine-stemvac-for-the-treatment-of-patients-nct05242965/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05242965.jpg</video:thumbnail_loc>
      <video:title>CD105/Yb-1/SOX2/CDH3/MDM2-polyepi… trial for Lung Non-Small Cell Carcinoma (NCT05242965): short film</video:title>
      <video:description>CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine trial for Lung Non-Small Cell Carcinoma (NCT05242965). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05242965.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05242965.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:07:38.788Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-neoadjuvant-study-of-tislelizumab-and-sx-682-for-resectable-pa-nct05604560/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05604560.jpg</video:thumbnail_loc>
      <video:title>Tislelizumab trial for Pancreatic Cancer (NCT05604560): short film</video:title>
      <video:description>Tislelizumab trial for Pancreatic Cancer (NCT05604560). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05604560.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05604560.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:34:24.429Z</video:publication_date>
      <video:duration>85</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-2-and-pharmacodynamic-study-of-sitagliptin-in-patients-w-nct07003542/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07003542.jpg</video:thumbnail_loc>
      <video:title>Sitagliptin trial for Glioblastoma (NCT07003542): short film</video:title>
      <video:description>Sitagliptin trial for Glioblastoma (NCT07003542). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07003542.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07003542.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:16:40.902Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-2-neoadjuvant-study-of-zanidatamab-in-combination-with-c-nct07102381/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07102381.jpg</video:thumbnail_loc>
      <video:title>Zanidatamab trial for HER2-positive Breast Cancer (NCT07102381): short film</video:title>
      <video:description>Zanidatamab trial for HER2-positive Breast Cancer (NCT07102381). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07102381.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07102381.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:25:35.534Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-2-open-label-single-arm-study-of-autologous-m-cenk-adopt-nct06710288/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06710288.jpg</video:thumbnail_loc>
      <video:title>Gemcitabine trial for Platinum-resistant Ovarian Cancer (NCT06710288): short film</video:title>
      <video:description>Gemcitabine trial for Platinum-resistant Ovarian Cancer (NCT06710288). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06710288.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06710288.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:33:18.378Z</video:publication_date>
      <video:duration>91</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-2-platform-study-of-immunomodulatory-compounds-in-ici-re-nct07133425/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07133425.jpg</video:thumbnail_loc>
      <video:title>SAR445877 trial for Non-Small Cell Lung Cancer (NCT07133425): short film</video:title>
      <video:description>SAR445877 trial for Non-Small Cell Lung Cancer (NCT07133425). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07133425.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07133425.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:46:22.037Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-2-single-arm-open-label-pilot-trial-evaluating-zanidatam-nct05035836/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05035836.jpg</video:thumbnail_loc>
      <video:title>Zanidatamab trial for Breast Cancer (NCT05035836): short film</video:title>
      <video:description>Zanidatamab trial for Breast Cancer (NCT05035836). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05035836.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05035836.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:44:05.053Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-2-study-evaluating-olutasidenib-in-patients-with-idh1-mu-nct06566742/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06566742.jpg</video:thumbnail_loc>
      <video:title>Olutasidenib trial for Myelodysplastic Syndromes (NCT06566742): short film</video:title>
      <video:description>Olutasidenib trial for Myelodysplastic Syndromes (NCT06566742). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06566742.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06566742.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:13:10.078Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-2-study-of-acr-368-in-endometrial-adenocarcinoma-nct05548296/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05548296.jpg</video:thumbnail_loc>
      <video:title>ACR-368 trial for Endometrial Adenocarcinoma (NCT05548296): short film</video:title>
      <video:description>ACR-368 trial for Endometrial Adenocarcinoma (NCT05548296). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05548296.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05548296.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:50:03.762Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-2-study-of-ptx-100-in-patients-with-relapsed-refractory-nct06854653/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06854653.jpg</video:thumbnail_loc>
      <video:title>PTX-100 trial for CTCL (NCT06854653): short film</video:title>
      <video:description>PTX-100 trial for CTCL (NCT06854653). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06854653.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06854653.mp4</video:content_loc>
      <video:publication_date>2026-10-31T17:42:14.302Z</video:publication_date>
      <video:duration>71</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-2-study-of-the-ketogenic-diet-vs-standard-anti-cancer-di-nct05708352/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05708352.jpg</video:thumbnail_loc>
      <video:title>Keto Diet trial for Glioblastoma Multiforme (NCT05708352): short film</video:title>
      <video:description>Keto Diet trial for Glioblastoma Multiforme (NCT05708352). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05708352.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05708352.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:24:46.998Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-2-study-of-vs-7375-in-patients-with-kras-g12d-mutated-co-nct07659795/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07659795.jpg</video:thumbnail_loc>
      <video:title>VS-7375 trial for Colorectal Cancer (NCT07659795): short film</video:title>
      <video:description>VS-7375 trial for Colorectal Cancer (NCT07659795). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07659795.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07659795.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:32:01.199Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-2-study-of-vs-7375-in-patients-with-kras-g12d-mutated-pa-nct07644559/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07644559.jpg</video:thumbnail_loc>
      <video:title>VS-7375 trial for Pancreatic Ductal Adenocarcinoma (PDAC) (NCT07644559): short film</video:title>
      <video:description>VS-7375 trial for Pancreatic Ductal Adenocarcinoma (PDAC) (NCT07644559). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07644559.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07644559.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:53:41.198Z</video:publication_date>
      <video:duration>87</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-2-study-of-wu-cart-007-an-anti-cd7-allogeneic-car-t-cell-nct06514794/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06514794.jpg</video:thumbnail_loc>
      <video:title>WU-CART-007 trial for T-cell Acute Lymphoblastic Leukemia (NCT06514794): short film</video:title>
      <video:description>WU-CART-007 trial for T-cell Acute Lymphoblastic Leukemia (NCT06514794). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06514794.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06514794.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:40:12.392Z</video:publication_date>
      <video:duration>87</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-2-study-of-zanidatamab-in-patients-with-her2-expressing-nct06695845/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06695845.jpg</video:thumbnail_loc>
      <video:title>Zanidatamab trial for Breast Cancer (NCT06695845): short film</video:title>
      <video:description>Zanidatamab trial for Breast Cancer (NCT06695845). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06695845.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06695845.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:23:52.637Z</video:publication_date>
      <video:duration>85</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-2-study-to-evaluate-efficacy-of-calaspargase-pegol-mknl-nct06561074/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06561074.jpg</video:thumbnail_loc>
      <video:title>Decitabine trial for T-cell Acute Lymphoblastic Leukemia (NCT06561074): short film</video:title>
      <video:description>Decitabine trial for T-cell Acute Lymphoblastic Leukemia (NCT06561074). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06561074.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06561074.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:27:53.756Z</video:publication_date>
      <video:duration>81</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-2-study-to-evaluate-the-effects-of-asp5541-in-participan-nct07005154/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07005154.jpg</video:thumbnail_loc>
      <video:title>ASP5541 trial for Prostate Cancer (NCT07005154): short film</video:title>
      <video:description>ASP5541 trial for Prostate Cancer (NCT07005154). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07005154.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07005154.mp4</video:content_loc>
      <video:publication_date>2026-10-31T19:47:30.728Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-2-trial-for-metastatic-melanoma-using-adoptive-cell-ther-nct02621021/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02621021.jpg</video:thumbnail_loc>
      <video:title>young TIL trial for Melanoma (NCT02621021): short film</video:title>
      <video:description>young TIL trial for Melanoma (NCT02621021). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT02621021.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02621021.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:48:46.285Z</video:publication_date>
      <video:duration>87</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-2-trial-of-ivonescimab-for-patients-with-advanced-metast-nct06805617/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06805617.jpg</video:thumbnail_loc>
      <video:title>Ivonescimab trial for Salivary Gland Cancer (NCT06805617): short film</video:title>
      <video:description>Ivonescimab trial for Salivary Gland Cancer (NCT06805617). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06805617.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06805617.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:06:12.459Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-2-trial-of-mosunetuzumab-and-zanubrutinib-for-patients-w-nct06563505/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06563505.jpg</video:thumbnail_loc>
      <video:title>Mosunetuzumab trial for Lymphoma (NCT06563505): short film</video:title>
      <video:description>Mosunetuzumab trial for Lymphoma (NCT06563505). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06563505.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06563505.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:42:16.250Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-2-trial-of-the-bruton-tyrosine-kinase-degrader-bgb-16673-nct07508995/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07508995.jpg</video:thumbnail_loc>
      <video:title>BGB-16673 trial for Chronic Lymphocytic Leukemia (CLL) (NCT07508995): short film</video:title>
      <video:description>BGB-16673 trial for Chronic Lymphocytic Leukemia (CLL) (NCT07508995). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07508995.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07508995.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:19:08.079Z</video:publication_date>
      <video:duration>81</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-2-trial-of-zanzalintinib-in-advanced-metastatic-bone-sar-nct07193550/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07193550.jpg</video:thumbnail_loc>
      <video:title>Zanzalintinib trial for Bone Sarcomas (NCT07193550): short film</video:title>
      <video:description>Zanzalintinib trial for Bone Sarcomas (NCT07193550). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07193550.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07193550.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:57:35.833Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-2-trial-to-assess-safety-and-efficacy-of-tofacitinib-2-c-nct06698822/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06698822.jpg</video:thumbnail_loc>
      <video:title>tofacitinib 2% cream trial for Cutaneous T-Cell Lymphoma (NCT06698822): short film</video:title>
      <video:description>tofacitinib 2% cream trial for Cutaneous T-Cell Lymphoma (NCT06698822). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06698822.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06698822.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:13:44.628Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-ii-clinical-study-to-evaluate-hlx43-in-subjects-with-adv-nct06907615/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06907615.jpg</video:thumbnail_loc>
      <video:title>HLX43 DOSE 1 (2.0 mg/kg) trial for Non Small Cell Lung Cancer (NCT06907615): short film</video:title>
      <video:description>HLX43 DOSE 1 (2.0 mg/kg) trial for Non Small Cell Lung Cancer (NCT06907615). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06907615.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06907615.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:07:45.365Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-ii-evaluation-of-afatinib-in-patients-with-persistent-or-nct02491099/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02491099.jpg</video:thumbnail_loc>
      <video:title>Afatinib trial for HER2/Neu+ Uterine Serous Carcinoma (NCT02491099): short film</video:title>
      <video:description>Afatinib trial for HER2/Neu+ Uterine Serous Carcinoma (NCT02491099). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT02491099.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02491099.mp4</video:content_loc>
      <video:publication_date>2026-10-31T23:44:20.316Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-ii-open-label-study-of-olutasidenib-post-transplant-main-nct06668584/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06668584.jpg</video:thumbnail_loc>
      <video:title>Olutasidenib trial for Myeloid Malignancies (NCT06668584): short film</video:title>
      <video:description>Olutasidenib trial for Myeloid Malignancies (NCT06668584). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06668584.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06668584.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:15:33.322Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-ii-single-center-single-arm-study-evaluating-the-safety-nct06630091/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06630091.jpg</video:thumbnail_loc>
      <video:title>Golidocitinib trial for Peripheral T Cell Lymphoma (NCT06630091): short film</video:title>
      <video:description>Golidocitinib trial for Peripheral T Cell Lymphoma (NCT06630091). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06630091.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06630091.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:15:48.780Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-ii-study-evaluating-t-cell-clonality-after-stereotactic-nct05361798/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05361798.jpg</video:thumbnail_loc>
      <video:title>PDS01ADC trial for Cancer Of Prostate (NCT05361798): short film</video:title>
      <video:description>PDS01ADC trial for Cancer Of Prostate (NCT05361798). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05361798.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05361798.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:06:51.336Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-ii-study-of-axicabtagene-ciloleucel-an-anti-cd19-chimeri-nct06043323/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06043323.jpg</video:thumbnail_loc>
      <video:title>Axicabtagene Ciloleucel trial for Follicular Lymphoma (NCT06043323): short film</video:title>
      <video:description>Axicabtagene Ciloleucel trial for Follicular Lymphoma (NCT06043323). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06043323.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06043323.mp4</video:content_loc>
      <video:publication_date>2026-10-31T19:45:13.501Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-ii-study-of-loncastuximab-tesirine-as-consolidation-stra-nct05464719/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05464719.jpg</video:thumbnail_loc>
      <video:title>Loncastuximab Tesirine trial for Large B-cell Lymphoma (NCT05464719): short film</video:title>
      <video:description>Loncastuximab Tesirine trial for Large B-cell Lymphoma (NCT05464719). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05464719.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05464719.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:00:33.935Z</video:publication_date>
      <video:duration>86</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-ii-study-of-pemigatinib-plus-durvalumab-in-previously-tr-nct06728410/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06728410.jpg</video:thumbnail_loc>
      <video:title>Pemigatinib trial for Intrahepatic Cholangiocarcinoma (NCT06728410): short film</video:title>
      <video:description>Pemigatinib trial for Intrahepatic Cholangiocarcinoma (NCT06728410). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06728410.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06728410.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:33:00.999Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-ii-study-of-the-menin-inhibitor-revumenib-in-leukemia-as-nct06229912/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06229912.jpg</video:thumbnail_loc>
      <video:title>Revumenib trial for Leukemia (NCT06229912): short film</video:title>
      <video:description>Revumenib trial for Leukemia (NCT06229912). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06229912.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06229912.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:48:37.801Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-ii-study-of-tucatinib-and-ado-trastuzumab-emtansine-t-dm-nct05673928/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05673928.jpg</video:thumbnail_loc>
      <video:title>Trastuzumab emtansine trial for Metastatic Solid Tumor (NCT05673928): short film</video:title>
      <video:description>Trastuzumab emtansine trial for Metastatic Solid Tumor (NCT05673928). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05673928.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05673928.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:51:21.971Z</video:publication_date>
      <video:duration>94</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-ii-study-with-a-safety-run-in-of-the-addition-of-n-803-t-nct07085338/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07085338.jpg</video:thumbnail_loc>
      <video:title>Temozolomide trial for Neuroblastoma Recurrent (NCT07085338): short film</video:title>
      <video:description>Temozolomide trial for Neuroblastoma Recurrent (NCT07085338). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07085338.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07085338.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:16:15.671Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-ii-trial-of-mosunetuzumab-polatuzumab-tafasitamab-and-le-nct05615636/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05615636.jpg</video:thumbnail_loc>
      <video:title>Mosunetuzumab trial for Hodgkin Lymphoma (NCT05615636): short film</video:title>
      <video:description>Mosunetuzumab trial for Hodgkin Lymphoma (NCT05615636). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05615636.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05615636.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:49:32.581Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-ii-trial-of-sacituzumab-govitecan-in-patients-with-advan-nct06248515/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06248515.jpg</video:thumbnail_loc>
      <video:title>Sacituzumab govitecan-hziy trial for Thymoma (NCT06248515): short film</video:title>
      <video:description>Sacituzumab govitecan-hziy trial for Thymoma (NCT06248515). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06248515.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06248515.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:17:09.454Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-ii-trial-of-tebentafusp-in-hla-a-02-01-positive-patients-nct06942442/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06942442.jpg</video:thumbnail_loc>
      <video:title>Physician's Choice trial for HLA-A*0201 Positive Cells Present (NCT06942442): short film</video:title>
      <video:description>Physician's Choice trial for HLA-A*0201 Positive Cells Present (NCT06942442). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06942442.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06942442.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:21:53.813Z</video:publication_date>
      <video:duration>86</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-phase-ii-trial-to-evaluate-the-effect-of-itraconazole-on-patho-nct05563766/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05563766.jpg</video:thumbnail_loc>
      <video:title>Itraconazole trial for Esophageal Adenocarcinoma (NCT05563766): short film</video:title>
      <video:description>Itraconazole trial for Esophageal Adenocarcinoma (NCT05563766). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05563766.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05563766.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:39:20.646Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-pivotal-phase-ii-clinical-trial-of-utidelone-injection-plus-ca-nct06764940/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06764940.jpg</video:thumbnail_loc>
      <video:title>Utidelone trial for HER2-negative Breast Cancer Patients With Brain… (NCT06764940): short film</video:title>
      <video:description>Utidelone trial for HER2-negative Breast Cancer Patients With Brain Metastases (NCT06764940). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06764940.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06764940.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:48:14.915Z</video:publication_date>
      <video:duration>81</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-randomized-phase-2-trial-of-fruquintinib-and-tas-102-as-compar-nct06992258/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06992258.jpg</video:thumbnail_loc>
      <video:title>Fruquintinib+ Lonsurf… trial for Colorectal Cancer (NCT06992258): short film</video:title>
      <video:description>Fruquintinib+ Lonsurf (trifluridine and tipiracil) trial for Colorectal Cancer (NCT06992258). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06992258.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06992258.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:20:41.161Z</video:publication_date>
      <video:duration>91</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-randomized-study-of-astx727-with-or-without-iadademstat-in-adv-nct06661915/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06661915.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Accelerated Phase Myeloproliferative… (NCT06661915): short film</video:title>
      <video:description>Biospecimen Collection trial for Accelerated Phase Myeloproliferative Neoplasm (NCT06661915). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06661915.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06661915.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:35:06.073Z</video:publication_date>
      <video:duration>81</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-randomized-trial-of-fianlimab-and-cemiplimab-ipilimumab-or-ipi-nct07188896/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07188896.jpg</video:thumbnail_loc>
      <video:title>Fianlimab trial for Advanced Renal Cell Carcinoma (aRCC) (NCT07188896): short film</video:title>
      <video:description>Fianlimab trial for Advanced Renal Cell Carcinoma (aRCC) (NCT07188896). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07188896.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07188896.mp4</video:content_loc>
      <video:publication_date>2026-10-31T19:07:37.468Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-randomized-trial-of-maintenance-systemic-therapy-after-radiati-nct06004336/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06004336.jpg</video:thumbnail_loc>
      <video:title>Pembrolizumab trial for Oligometastatic Renal Cell Carcinoma (NCT06004336): short film</video:title>
      <video:description>Pembrolizumab trial for Oligometastatic Renal Cell Carcinoma (NCT06004336). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06004336.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06004336.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:40:05.500Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-single-arm-phase-ii-study-of-neoadjuvant-intensified-androgen-nct05593497/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05593497.jpg</video:thumbnail_loc>
      <video:title>Capivasertib trial for High-Risk Prostate Cancer (NCT05593497): short film</video:title>
      <video:description>Capivasertib trial for High-Risk Prostate Cancer (NCT05593497). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05593497.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05593497.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:11:48.878Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-single-arm-study-of-pembrolizumab-with-gemcitabine-and-cisplat-nct05967182/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05967182.jpg</video:thumbnail_loc>
      <video:title>Pembrolizumab trial for Cholangiocarcinoma (NCT05967182): short film</video:title>
      <video:description>Pembrolizumab trial for Cholangiocarcinoma (NCT05967182). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05967182.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05967182.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:24:36.080Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-comparing-two-immunotherapy-options-for-human-papillomav-nct07179315/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07179315.jpg</video:thumbnail_loc>
      <video:title>cemiplimab+fianlimab trial for Head and Neck Cancer (NCT07179315): short film</video:title>
      <video:description>cemiplimab+fianlimab trial for Head and Neck Cancer (NCT07179315). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07179315.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07179315.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:37:24.761Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-evaluating-ficerafusp-alfa-bca101-qw-in-combination-with-nct07807163/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07807163.jpg</video:thumbnail_loc>
      <video:title>Ficerafusp alfa trial for Metastatic Head and Neck Squamous Cell Carcinoma (NCT07807163): short film</video:title>
      <video:description>Ficerafusp alfa trial for Metastatic Head and Neck Squamous Cell Carcinoma (NCT07807163). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07807163.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07807163.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:19:40.599Z</video:publication_date>
      <video:duration>88</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-evaluating-the-combination-of-immunotherapy-with-radioth-nct07603856/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07603856.jpg</video:thumbnail_loc>
      <video:title>Investigator Choice… trial for Non-Small Cell Lung Cancer (NCT07603856): short film</video:title>
      <video:description>Investigator Choice Immunotherapy (for example: pembrolizumab, cemiplimab, durvalumab, ipilimumab plus nivolumab) trial for Non-Small Cell Lung Cancer (NCT07603856). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07603856.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07603856.mp4</video:content_loc>
      <video:publication_date>2026-10-31T23:54:52.145Z</video:publication_date>
      <video:duration>88</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-evaluating-the-safety-of-inavolisib-and-fulvestrant-with-nct07748208/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07748208.jpg</video:thumbnail_loc>
      <video:title>Inavolisib trial for Breast Cancer (NCT07748208): short film</video:title>
      <video:description>Inavolisib trial for Breast Cancer (NCT07748208). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07748208.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07748208.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:19:10.905Z</video:publication_date>
      <video:duration>95</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-a-new-way-to-treat-children-and-young-adults-with-a-b-nct04684368/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04684368.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Central Nervous System Nongerminomatous… (NCT04684368): short film</video:title>
      <video:description>Biospecimen Collection trial for Central Nervous System Nongerminomatous Germ Cell Tumor (NCT04684368). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04684368.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04684368.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:04:39.079Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-a-vaccine-in-combination-with-beta-glucan-in-people-w-nct06057948/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06057948.jpg</video:thumbnail_loc>
      <video:title>OPT-821 (QS-21) trial for Neuroblastoma (NCT06057948): short film</video:title>
      <video:description>OPT-821 (QS-21) trial for Neuroblastoma (NCT06057948). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06057948.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06057948.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:24:36.380Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-alisertib-in-patients-with-extensive-stage-small-cell-nct06095505/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06095505.jpg</video:thumbnail_loc>
      <video:title>Alisertib trial for Small Cell Lung Cancer (NCT06095505): short film</video:title>
      <video:description>Alisertib trial for Small Cell Lung Cancer (NCT06095505). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06095505.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06095505.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:59:16.457Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-amivantamab-in-combination-with-lazertinib-or-amivant-nct06667076/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06667076.jpg</video:thumbnail_loc>
      <video:title>Amivantamab trial for Carcinoma, Non-Small-Cell Lung (NCT06667076): short film</video:title>
      <video:description>Amivantamab trial for Carcinoma, Non-Small-Cell Lung (NCT06667076). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06667076.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06667076.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:07:30.710Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-amivantamab-in-participants-with-advanced-or-metastat-nct05498428/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05498428.jpg</video:thumbnail_loc>
      <video:title>Amivantamab trial for Carcinoma, Non-small-Cell Lung (NCT05498428): short film</video:title>
      <video:description>Amivantamab trial for Carcinoma, Non-small-Cell Lung (NCT05498428). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05498428.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05498428.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:49:41.196Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-avutometinib-and-defactinib-in-people-with-thyroid-ca-nct06007924/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06007924.jpg</video:thumbnail_loc>
      <video:title>Avutometinib trial for Thyroid Cancer (NCT06007924): short film</video:title>
      <video:description>Avutometinib trial for Thyroid Cancer (NCT06007924). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06007924.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06007924.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:21:33.579Z</video:publication_date>
      <video:duration>87</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-avutometinib-defactinib-and-letrozole-in-people-with-nct06394804/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06394804.jpg</video:thumbnail_loc>
      <video:title>Avutometinib trial for Low-Grade Serous Ovarian Cancer (NCT06394804): short film</video:title>
      <video:description>Avutometinib trial for Low-Grade Serous Ovarian Cancer (NCT06394804). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06394804.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06394804.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:56:17.116Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-axicabtagene-ciloleucel-and-glofitamab-as-second-line-nct06213311/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06213311.jpg</video:thumbnail_loc>
      <video:title>Glofitamab trial for B Cell Lymphoma (NCT06213311): short film</video:title>
      <video:description>Glofitamab trial for B Cell Lymphoma (NCT06213311). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06213311.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06213311.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:00:58.118Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-azenosertib-zn-c3-in-subjects-with-platinum-resistant-nct05128825/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05128825.jpg</video:thumbnail_loc>
      <video:title>azenosertib trial for High-Grade Serous Ovarian, Fallopian Tube or… (NCT05128825): short film</video:title>
      <video:description>azenosertib trial for High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer (NCT05128825). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05128825.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05128825.mp4</video:content_loc>
      <video:publication_date>2026-10-31T14:54:15.700Z</video:publication_date>
      <video:duration>87</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-belzutifan-in-adolescent-participants-with-solid-tumo-nct07700758/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07700758.jpg</video:thumbnail_loc>
      <video:title>Belzutifan trial for Malignant Neoplasm (NCT07700758): short film</video:title>
      <video:description>Belzutifan trial for Malignant Neoplasm (NCT07700758). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07700758.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07700758.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:52:50.647Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-botensilimab-and-balstilimab-for-colorectal-cancer-wi-nct07227636/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07227636.jpg</video:thumbnail_loc>
      <video:title>Botensilimab trial for Colorectal Cancer (NCT07227636): short film</video:title>
      <video:description>Botensilimab trial for Colorectal Cancer (NCT07227636). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07227636.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07227636.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:04:57.268Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-botensilimab-and-balstilimab-for-rectal-adenocarcinom-nct06843434/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06843434.jpg</video:thumbnail_loc>
      <video:title>Balstilimab trial for Microsatellite Stable Rectal Carcinoma (NCT06843434): short film</video:title>
      <video:description>Balstilimab trial for Microsatellite Stable Rectal Carcinoma (NCT06843434). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06843434.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06843434.mp4</video:content_loc>
      <video:publication_date>2026-10-31T23:59:52.102Z</video:publication_date>
      <video:duration>95</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-cadonilimab-combined-with-chemotherapy-in-people-with-nct07631000/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07631000.jpg</video:thumbnail_loc>
      <video:title>Cadonilimab trial for Gastric Cancer (NCT07631000): short film</video:title>
      <video:description>Cadonilimab trial for Gastric Cancer (NCT07631000). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07631000.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07631000.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:30:52.182Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-combination-chemotherapy-for-patients-with-newly-diag-nct04322318/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04322318.jpg</video:thumbnail_loc>
      <video:title>Biopsy Procedure trial for Anaplastic Kidney Wilms Tumor (NCT04322318): short film</video:title>
      <video:description>Biopsy Procedure trial for Anaplastic Kidney Wilms Tumor (NCT04322318). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04322318.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04322318.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:42:49.055Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-cybord-cyclophosphamide-bortezomib-dexamethasone-plus-nct06083922/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06083922.jpg</video:thumbnail_loc>
      <video:title>Cyclophosphamide trial for Multiple Myeloma (NCT06083922): short film</video:title>
      <video:description>Cyclophosphamide trial for Multiple Myeloma (NCT06083922). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06083922.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06083922.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:29:48.947Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-disitamab-vedotin-alone-or-with-pembrolizumab-in-urot-nct04879329/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04879329.jpg</video:thumbnail_loc>
      <video:title>disitamab vedotin trial for Urothelial Carcinoma (NCT04879329): short film</video:title>
      <video:description>disitamab vedotin trial for Urothelial Carcinoma (NCT04879329). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04879329.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04879329.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:23:44.595Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-emavusertib-an-approved-bruton-tyrosine-kinase-inhibi-nct07271667/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07271667.jpg</video:thumbnail_loc>
      <video:title>Emavusertib trial for Chronic Lymphocytic Leukemia (NCT07271667): short film</video:title>
      <video:description>Emavusertib trial for Chronic Lymphocytic Leukemia (NCT07271667). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07271667.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07271667.mp4</video:content_loc>
      <video:publication_date>2026-11-01T00:00:14.636Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-enzalutamide-plus-the-glucocorticoid-receptor-antagon-nct05726292/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05726292.jpg</video:thumbnail_loc>
      <video:title>Relacorilant trial for Prostate Cancer (NCT05726292): short film</video:title>
      <video:description>Relacorilant trial for Prostate Cancer (NCT05726292). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05726292.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05726292.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:37:43.726Z</video:publication_date>
      <video:duration>81</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-fg-3246-in-participants-with-metastatic-castration-re-nct06842498/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06842498.jpg</video:thumbnail_loc>
      <video:title>FG-3246 trial for Metastatic Castration-Resistant Prostate Cancer (NCT06842498): short film</video:title>
      <video:description>FG-3246 trial for Metastatic Castration-Resistant Prostate Cancer (NCT06842498). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06842498.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06842498.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:58:19.655Z</video:publication_date>
      <video:duration>88</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-fianlimab-cemiplimab-and-ipilimumab-in-people-with-me-nct06594991/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06594991.jpg</video:thumbnail_loc>
      <video:title>Fianlimab trial for Advanced Melanoma (NCT06594991): short film</video:title>
      <video:description>Fianlimab trial for Advanced Melanoma (NCT06594991). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06594991.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06594991.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:17:27.996Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-imlunestrant-ly3484356-in-premenopausal-women-with-es-nct07287098/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07287098.jpg</video:thumbnail_loc>
      <video:title>Imlunestrant trial for Breast Neoplasms (NCT07287098): short film</video:title>
      <video:description>Imlunestrant trial for Breast Neoplasms (NCT07287098). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07287098.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07287098.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:52:09.949Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-incb123667-in-participants-with-platinum-resistant-ov-nct07023627/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07023627.jpg</video:thumbnail_loc>
      <video:title>INCB123667 trial for Ovarian Cancer (NCT07023627): short film</video:title>
      <video:description>INCB123667 trial for Ovarian Cancer (NCT07023627). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07023627.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07023627.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:18:11.227Z</video:publication_date>
      <video:duration>90</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-investigational-agents-in-participants-with-previousl-nct06780085/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06780085.jpg</video:thumbnail_loc>
      <video:title>Raludotatug Deruxtecan trial for Carcinoma, Non-Small-Cell Lung (NCT06780085): short film</video:title>
      <video:description>Raludotatug Deruxtecan trial for Carcinoma, Non-Small-Cell Lung (NCT06780085). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06780085.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06780085.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:22:45.192Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-ivonescimab-in-people-with-endometrial-and-cervical-c-nct06925724/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06925724.jpg</video:thumbnail_loc>
      <video:title>Ivonescimab trial for Endometrial Cancer (NCT06925724): short film</video:title>
      <video:description>Ivonescimab trial for Endometrial Cancer (NCT06925724). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06925724.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06925724.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:19:52.902Z</video:publication_date>
      <video:duration>68</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-ivonescimab-in-people-with-leiomyosarcoma-nct07516925/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07516925.jpg</video:thumbnail_loc>
      <video:title>Ivonescimab trial for Leiomyosarcoma (NCT07516925): short film</video:title>
      <video:description>Ivonescimab trial for Leiomyosarcoma (NCT07516925). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07516925.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07516925.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:19:54.246Z</video:publication_date>
      <video:duration>88</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-jnj-101556143-in-participants-with-metastatic-prostat-nct07832292/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07832292.jpg</video:thumbnail_loc>
      <video:title>JNJ-101556143 trial for Prostatic Neoplasms (NCT07832292): short film</video:title>
      <video:description>JNJ-101556143 trial for Prostatic Neoplasms (NCT07832292). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07832292.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07832292.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:41:23.746Z</video:publication_date>
      <video:duration>85</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-jnj-90301900-in-combination-with-chemoradiation-follo-nct06667908/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06667908.jpg</video:thumbnail_loc>
      <video:title>JNJ-90301900 trial for Carcinoma, Non-Small-Cell Lung (NCT06667908): short film</video:title>
      <video:description>JNJ-90301900 trial for Carcinoma, Non-Small-Cell Lung (NCT06667908). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06667908.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06667908.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:42:25.870Z</video:publication_date>
      <video:duration>90</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-jzp3507-onc206-in-recurrent-grade-2-or-3-meningioma-nct07533942/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07533942.jpg</video:thumbnail_loc>
      <video:title>JZP3507 trial for Meningioma (NCT07533942): short film</video:title>
      <video:description>JZP3507 trial for Meningioma (NCT07533942). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07533942.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07533942.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:24:05.571Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-lifileucel-tumor-infiltrating-lymphocytes-in-adults-w-nct07741877/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07741877.jpg</video:thumbnail_loc>
      <video:title>Lifileucel trial for Sarcoma (NCT07741877): short film</video:title>
      <video:description>Lifileucel trial for Sarcoma (NCT07741877). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07741877.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07741877.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:28:06.888Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-lower-dose-radiation-therapy-for-people-with-prostate-nct07635238/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07635238.jpg</video:thumbnail_loc>
      <video:title>MR-guided Stereotactic Body Radiation Therapy trial for Prostate Cancer (NCT07635238): short film</video:title>
      <video:description>MR-guided Stereotactic Body Radiation Therapy trial for Prostate Cancer (NCT07635238). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07635238.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07635238.mp4</video:content_loc>
      <video:publication_date>2026-10-31T23:47:14.748Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-lower-radiotherapy-dose-to-treat-children-with-cns-ge-nct06368817/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06368817.jpg</video:thumbnail_loc>
      <video:title>3-Dimensional Conformal Proton… trial for Basal Ganglia Germinoma (NCT06368817): short film</video:title>
      <video:description>3-Dimensional Conformal Proton Radiation Therapy trial for Basal Ganglia Germinoma (NCT06368817). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06368817.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06368817.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:40:27.824Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-lurbinectedin-in-combination-with-durvalumab-for-the-nct07459634/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07459634.jpg</video:thumbnail_loc>
      <video:title>Lurbinectedin trial for Extensive-stage Small-cell Lung Cancer (NCT07459634): short film</video:title>
      <video:description>Lurbinectedin trial for Extensive-stage Small-cell Lung Cancer (NCT07459634). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07459634.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07459634.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:57:52.674Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-mosunetuzumab-alone-or-with-zanubrutinib-in-people-wi-nct05389293/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05389293.jpg</video:thumbnail_loc>
      <video:title>Mosunetuzumab trial for Follicular Lymphoma (NCT05389293): short film</video:title>
      <video:description>Mosunetuzumab trial for Follicular Lymphoma (NCT05389293). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05389293.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05389293.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:11:16.709Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-multiple-therapies-in-biomarker-selected-participants-nct04302025/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04302025.jpg</video:thumbnail_loc>
      <video:title>Alectinib trial for Non-small Cell Lung Cancer (NCT04302025): short film</video:title>
      <video:description>Alectinib trial for Non-small Cell Lung Cancer (NCT04302025). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04302025.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04302025.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:10:07.019Z</video:publication_date>
      <video:duration>96</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-nalirifox-in-combination-with-radiation-therapy-in-pe-nct05851924/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05851924.jpg</video:thumbnail_loc>
      <video:title>NALIRIFOX trial for Pancreatic Ductal Adenocarcinoma (NCT05851924): short film</video:title>
      <video:description>NALIRIFOX trial for Pancreatic Ductal Adenocarcinoma (NCT05851924). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05851924.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05851924.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:30:47.344Z</video:publication_date>
      <video:duration>85</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-navlimetostat-bms-986504-alone-or-in-combination-with-nct06855771/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06855771.jpg</video:thumbnail_loc>
      <video:title>BMS-986504 trial for Carcinoma, Non-Small-Cell Lung (NCT06855771): short film</video:title>
      <video:description>BMS-986504 trial for Carcinoma, Non-Small-Cell Lung (NCT06855771). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06855771.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06855771.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:27:26.751Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-neoadjuvant-amivantamab-with-either-lazertinib-or-che-nct07586202/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07586202.jpg</video:thumbnail_loc>
      <video:title>Amivantamab trial for Carcinoma, Non-Small-Cell Lung (NCT07586202): short film</video:title>
      <video:description>Amivantamab trial for Carcinoma, Non-Small-Cell Lung (NCT07586202). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07586202.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07586202.mp4</video:content_loc>
      <video:publication_date>2026-10-31T14:58:33.359Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-novel-agents-or-combinations-as-perioperative-treatme-nct07069712/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07069712.jpg</video:thumbnail_loc>
      <video:title>Sonesitatug Vedotin trial for Gastroesophageal Adenocarcinoma (NCT07069712): short film</video:title>
      <video:description>Sonesitatug Vedotin trial for Gastroesophageal Adenocarcinoma (NCT07069712). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07069712.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07069712.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:21:23.841Z</video:publication_date>
      <video:duration>91</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-nuzefatide-pevedotin-bt5528-in-patients-with-metastat-nct07450859/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07450859.jpg</video:thumbnail_loc>
      <video:title>nuzefatide pevedotin (BT5528) trial for Pancreatic Ductal Adenocarcinoma… (NCT07450859): short film</video:title>
      <video:description>nuzefatide pevedotin (BT5528) trial for Pancreatic Ductal Adenocarcinoma (PDAC) (NCT07450859). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07450859.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07450859.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:35:04.018Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-nx-5948-in-adults-with-cll-sll-previously-treated-wit-nct07221500/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07221500.jpg</video:thumbnail_loc>
      <video:title>NX-5948 trial for Chronic Lymphocytic Leukemia (CLL) (NCT07221500): short film</video:title>
      <video:description>NX-5948 trial for Chronic Lymphocytic Leukemia (CLL) (NCT07221500). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07221500.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07221500.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:29:55.673Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-obecabtagene-autoleucel-in-people-with-b-cell-acute-l-nct07400029/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07400029.jpg</video:thumbnail_loc>
      <video:title>Obecabtagene Autoleucel trial for Acute Lymphoblastic Leukemia (NCT07400029): short film</video:title>
      <video:description>Obecabtagene Autoleucel trial for Acute Lymphoblastic Leukemia (NCT07400029). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07400029.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07400029.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:16:38.889Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-pembrolizumab-in-people-with-ultra-rare-sarcomas-nct07089992/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07089992.jpg</video:thumbnail_loc>
      <video:title>Pembrolizumab trial for Sarcoma (NCT07089992): short film</video:title>
      <video:description>Pembrolizumab trial for Sarcoma (NCT07089992). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07089992.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07089992.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:51:36.019Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-pembrolizumab-with-or-without-chemotherapy-in-combina-nct06731907/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06731907.jpg</video:thumbnail_loc>
      <video:title>Pembrolizumab trial for Non-small Cell Lung Cancer (NCT06731907): short film</video:title>
      <video:description>Pembrolizumab trial for Non-small Cell Lung Cancer (NCT06731907). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06731907.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06731907.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:33:39.952Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-pembrolizumab-with-trastuzumab-and-chemotherapy-in-pe-nct06123338/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06123338.jpg</video:thumbnail_loc>
      <video:title>Pembrolizumab trial for Esophageal Cancer (NCT06123338): short film</video:title>
      <video:description>Pembrolizumab trial for Esophageal Cancer (NCT06123338). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06123338.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06123338.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:05:01.503Z</video:publication_date>
      <video:duration>85</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-pirtobrutinib-venetoclax-and-rituximab-in-people-with-nct07231952/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07231952.jpg</video:thumbnail_loc>
      <video:title>Pirtobrutinib trial for Waldenstrom Macroglobulinemia (NCT07231952): short film</video:title>
      <video:description>Pirtobrutinib trial for Waldenstrom Macroglobulinemia (NCT07231952). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07231952.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07231952.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:58:44.809Z</video:publication_date>
      <video:duration>89</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-response-adapted-ultra-low-dose-4-gy-radiation-for-de-nct05929612/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05929612.jpg</video:thumbnail_loc>
      <video:title>Ultra Low Dose 4 Gy Radiation trial for Lymphoma (NCT05929612): short film</video:title>
      <video:description>Ultra Low Dose 4 Gy Radiation trial for Lymphoma (NCT05929612). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05929612.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05929612.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:42:48.022Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-sacituzumab-govitecan-immu-132-in-patients-with-recur-nct05838521/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05838521.jpg</video:thumbnail_loc>
      <video:title>Sacituzumab govitecan trial for Cervical Cancer (NCT05838521): short film</video:title>
      <video:description>Sacituzumab govitecan trial for Cervical Cancer (NCT05838521). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05838521.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05838521.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:07:08.614Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-sasanlimab-palbociclib-and-axitinib-in-metastatic-ren-nct07123090/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07123090.jpg</video:thumbnail_loc>
      <video:title>Sasanlimab trial for Metastatic Renal Cell Carcinoma (NCT07123090): short film</video:title>
      <video:description>Sasanlimab trial for Metastatic Renal Cell Carcinoma (NCT07123090). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07123090.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07123090.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:46:58.805Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-sdx-7320-in-combination-with-eribulin-for-people-with-nct05570253/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05570253.jpg</video:thumbnail_loc>
      <video:title>Eribulin trial for Breast Cancer (NCT05570253): short film</video:title>
      <video:description>Eribulin trial for Breast Cancer (NCT05570253). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05570253.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05570253.mp4</video:content_loc>
      <video:publication_date>2026-10-31T18:14:07.651Z</video:publication_date>
      <video:duration>85</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-selinexor-in-combination-with-carfilzomib-daratumumab-nct04661137/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04661137.jpg</video:thumbnail_loc>
      <video:title>Selinexor 60 MG trial for Multiple Myeloma (NCT04661137): short film</video:title>
      <video:description>Selinexor 60 MG trial for Multiple Myeloma (NCT04661137). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04661137.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04661137.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:33:57.619Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-selinexor-in-people-with-wilms-tumors-and-other-solid-nct05985161/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05985161.jpg</video:thumbnail_loc>
      <video:title>Selinexor trial for Wilms Tumor (NCT05985161): short film</video:title>
      <video:description>Selinexor trial for Wilms Tumor (NCT05985161). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05985161.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05985161.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:56:39.974Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-sotorasib-in-people-with-non-small-cell-lung-cancer-nct06582771/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06582771.jpg</video:thumbnail_loc>
      <video:title>Sotorasib trial for Non Small Lung Cancer (NCT06582771): short film</video:title>
      <video:description>Sotorasib trial for Non Small Lung Cancer (NCT06582771). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06582771.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06582771.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:41:37.625Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-stereotactic-radiosurgery-srs-and-standard-treatment-nct06741085/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06741085.jpg</video:thumbnail_loc>
      <video:title>osimertinib trial for Non Small Cell Lung Cancer Metastatic (NCT06741085): short film</video:title>
      <video:description>osimertinib trial for Non Small Cell Lung Cancer Metastatic (NCT06741085). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06741085.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06741085.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:20:09.318Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-stereotactic-radiosurgery-srs-for-people-with-lung-ca-nct05419076/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05419076.jpg</video:thumbnail_loc>
      <video:title>Stereotactic Radiosurgery trial for Lung Cancer (NCT05419076): short film</video:title>
      <video:description>Stereotactic Radiosurgery trial for Lung Cancer (NCT05419076). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05419076.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05419076.mp4</video:content_loc>
      <video:publication_date>2026-11-01T00:08:15.854Z</video:publication_date>
      <video:duration>81</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-sync-t-therapy-sv-102-in-participants-with-metastatic-nct06533644/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06533644.jpg</video:thumbnail_loc>
      <video:title>Partial Oncolysis trial for Metastatic Castration-resistant Prostate… (NCT06533644): short film</video:title>
      <video:description>Partial Oncolysis trial for Metastatic Castration-resistant Prostate Cancer (NCT06533644). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06533644.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06533644.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:57:09.771Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-t3011-in-patients-with-bcg-unresponsive-nmibc-or-bcg-nct06971614/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06971614.jpg</video:thumbnail_loc>
      <video:title>T3011 trial for Nonmuscle-invasive Bladder Cancer (NCT06971614): short film</video:title>
      <video:description>T3011 trial for Nonmuscle-invasive Bladder Cancer (NCT06971614). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06971614.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06971614.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:54:02.157Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-talazoparib-with-or-without-enzalutamide-in-people-wi-nct06844383/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06844383.jpg</video:thumbnail_loc>
      <video:title>Talazoparib with enzalutamide trial for Prostate Cancer (Adenocarcinoma) (NCT06844383): short film</video:title>
      <video:description>Talazoparib with enzalutamide trial for Prostate Cancer (Adenocarcinoma) (NCT06844383). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06844383.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06844383.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:44:29.566Z</video:publication_date>
      <video:duration>86</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-talquetamab-in-participants-with-relapsed-or-refracto-nct04634552/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04634552.jpg</video:thumbnail_loc>
      <video:title>Talquetamab trial for Hematological Malignancies (NCT04634552): short film</video:title>
      <video:description>Talquetamab trial for Hematological Malignancies (NCT04634552). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04634552.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04634552.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:48:44.618Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-targeted-post-surgery-radiation-therapy-for-non-small-nct07293247/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07293247.jpg</video:thumbnail_loc>
      <video:title>Chemotherapy trial for Lung Non-Small Cell Carcinoma (NCT07293247): short film</video:title>
      <video:description>Chemotherapy trial for Lung Non-Small Cell Carcinoma (NCT07293247). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07293247.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07293247.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:09:57.117Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-tarlatamab-for-people-with-prostate-cancer-nct07111507/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07111507.jpg</video:thumbnail_loc>
      <video:title>Tarlatamab trial for Metastatic Prostate Cancer (NCT07111507): short film</video:title>
      <video:description>Tarlatamab trial for Metastatic Prostate Cancer (NCT07111507). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07111507.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07111507.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:21:04.395Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-trk-950-when-used-in-combination-with-ramucirumab-and-nct06038578/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06038578.jpg</video:thumbnail_loc>
      <video:title>TRK-950 trial for Gastric Adenocarcinoma (NCT06038578): short film</video:title>
      <video:description>TRK-950 trial for Gastric Adenocarcinoma (NCT06038578). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06038578.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06038578.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:43:29.907Z</video:publication_date>
      <video:duration>89</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-venetoclax-in-combination-with-conventional-chemother-nct05955261/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05955261.jpg</video:thumbnail_loc>
      <video:title>Venetoclax trial for Acute Myeloid Leukemia (NCT05955261): short film</video:title>
      <video:description>Venetoclax trial for Acute Myeloid Leukemia (NCT05955261). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05955261.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05955261.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:30:24.336Z</video:publication_date>
      <video:duration>87</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-zanzalintinib-in-participants-with-recurrent-or-progr-nct07428616/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07428616.jpg</video:thumbnail_loc>
      <video:title>Zanzalintinib trial for Meningioma (NCT07428616): short film</video:title>
      <video:description>Zanzalintinib trial for Meningioma (NCT07428616). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07428616.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07428616.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:27:49.609Z</video:publication_date>
      <video:duration>60</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-of-zen003694-in-people-with-squamous-cell-lung-cancer-nct05607108/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05607108.jpg</video:thumbnail_loc>
      <video:title>ZEN003694 trial for Squamous Cell Lung Cancer (NCT05607108): short film</video:title>
      <video:description>ZEN003694 trial for Squamous Cell Lung Cancer (NCT05607108). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05607108.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05607108.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:03:24.253Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-testing-the-combination-of-dasatinib-or-imatinib-to-chem-nct06124157/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06124157.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for B Acute Lymphoblastic Leukemia (NCT06124157): short film</video:title>
      <video:description>Biospecimen Collection trial for B Acute Lymphoblastic Leukemia (NCT06124157). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06124157.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06124157.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:53:26.391Z</video:publication_date>
      <video:duration>89</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-to-assess-adverse-events-and-change-in-disease-activity-nct07023289/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07023289.jpg</video:thumbnail_loc>
      <video:title>Telisotuzumab Adizutecan trial for Colorectal Cancer (NCT07023289): short film</video:title>
      <video:description>Telisotuzumab Adizutecan trial for Colorectal Cancer (NCT07023289). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07023289.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07023289.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:41:45.185Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-to-assess-adverse-events-and-change-in-disease-activity-nct07059845/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07059845.jpg</video:thumbnail_loc>
      <video:title>Mirvetuximab Soravtansine trial for Ovarian Cancer (NCT07059845): short film</video:title>
      <video:description>Mirvetuximab Soravtansine trial for Ovarian Cancer (NCT07059845). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07059845.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07059845.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:03:02.959Z</video:publication_date>
      <video:duration>95</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-to-assess-adverse-events-and-how-intravenously-iv-infuse-nct06568939/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06568939.jpg</video:thumbnail_loc>
      <video:title>Telisotuzumab Vedotin trial for Non-Small Cell Lung Cancer (NCT06568939): short film</video:title>
      <video:description>Telisotuzumab Vedotin trial for Non-Small Cell Lung Cancer (NCT06568939). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06568939.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06568939.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:29:23.651Z</video:publication_date>
      <video:duration>81</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-to-assess-adverse-events-change-in-disease-activity-and-nct07744126/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07744126.jpg</video:thumbnail_loc>
      <video:title>Telisotuzumab Adizutecan trial for Head and Neck Squamous Cell Carcinoma (NCT07744126): short film</video:title>
      <video:description>Telisotuzumab Adizutecan trial for Head and Neck Squamous Cell Carcinoma (NCT07744126). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07744126.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07744126.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:32:05.058Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-to-assess-anti-tumor-activity-of-intravenously-iv-infuse-nct06890338/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06890338.jpg</video:thumbnail_loc>
      <video:title>Carboplatin trial for Epithelial Ovarian Cancer (NCT06890338): short film</video:title>
      <video:description>Carboplatin trial for Epithelial Ovarian Cancer (NCT06890338). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06890338.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06890338.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:04:16.575Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-to-assess-the-efficacy-and-safety-of-fore8394-in-partici-nct05503797/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05503797.jpg</video:thumbnail_loc>
      <video:title>Plixorafenib trial for Cancer Harboring BRAF Alterations (NCT05503797): short film</video:title>
      <video:description>Plixorafenib trial for Cancer Harboring BRAF Alterations (NCT05503797). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05503797.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05503797.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:07:41.462Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-to-compare-the-administration-of-encorafenib-binimetinib-nct04511013/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04511013.jpg</video:thumbnail_loc>
      <video:title>Binimetinib trial for Acral Lentiginous Melanoma (NCT04511013): short film</video:title>
      <video:description>Binimetinib trial for Acral Lentiginous Melanoma (NCT04511013). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04511013.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04511013.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:42:00.880Z</video:publication_date>
      <video:duration>87</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-to-estimate-early-clinical-efficacy-signals-of-glp-1-ago-nct07107334/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07107334.jpg</video:thumbnail_loc>
      <video:title>Glucagon-like peptide 1 receptor… trial for Endometrioid Endometrial… (NCT07107334): short film</video:title>
      <video:description>Glucagon-like peptide 1 receptor agonist trial for Endometrioid Endometrial Adenocarcinoma (NCT07107334). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07107334.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07107334.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:16:33.335Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-to-evaluate-efficacy-and-safety-of-ciltacabtagene-autole-nct07149857/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07149857.jpg</video:thumbnail_loc>
      <video:title>Cilta-cel trial for Multiple Myeloma (NCT07149857): short film</video:title>
      <video:description>Cilta-cel trial for Multiple Myeloma (NCT07149857). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07149857.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07149857.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:06:43.835Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-to-evaluate-the-adverse-events-and-efficacy-of-intraveno-nct06820463/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06820463.jpg</video:thumbnail_loc>
      <video:title>Telisotuzumab Adizutecan trial for Metastatic Colorectal Cancer (NCT06820463): short film</video:title>
      <video:description>Telisotuzumab Adizutecan trial for Metastatic Colorectal Cancer (NCT06820463). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06820463.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06820463.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:22:23.406Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-to-evaluate-the-efficacy-and-safety-of-belantamab-mafodo-nct07227311/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07227311.jpg</video:thumbnail_loc>
      <video:title>Belantamab mafodotin trial for Multiple Myeloma (NCT07227311): short film</video:title>
      <video:description>Belantamab mafodotin trial for Multiple Myeloma (NCT07227311). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07227311.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07227311.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:38:02.357Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-to-evaluate-the-efficacy-and-safety-of-tl118-in-solid-tu-nct06010342/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06010342.jpg</video:thumbnail_loc>
      <video:title>TL118 Capsule trial for Solid Tumor (NCT06010342): short film</video:title>
      <video:description>TL118 Capsule trial for Solid Tumor (NCT06010342). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06010342.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06010342.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:23:14.629Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-to-evaluate-the-efficacy-of-cemsidomide-dexamethasone-in-nct07284758/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07284758.jpg</video:thumbnail_loc>
      <video:title>Cemsidomide trial for Multiple Myeloma (NCT07284758): short film</video:title>
      <video:description>Cemsidomide trial for Multiple Myeloma (NCT07284758). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07284758.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07284758.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:15:37.256Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-to-evaluate-the-optimal-dose-adverse-events-and-change-i-nct07155174/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07155174.jpg</video:thumbnail_loc>
      <video:title>ABBV-706 trial for Small Cell Lung Cancer (NCT07155174): short film</video:title>
      <video:description>ABBV-706 trial for Small Cell Lung Cancer (NCT07155174). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07155174.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07155174.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:34:00.004Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-to-evaluate-the-safety-and-efficacy-of-two-dose-levels-o-nct06948448/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06948448.jpg</video:thumbnail_loc>
      <video:title>ONO-4578 trial for Colorectal Cancer (NCT06948448): short film</video:title>
      <video:description>ONO-4578 trial for Colorectal Cancer (NCT06948448). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06948448.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06948448.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:38:49.829Z</video:publication_date>
      <video:duration>96</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-to-find-out-if-enfortumab-vedotin-given-with-pembrolizum-nct07475806/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07475806.jpg</video:thumbnail_loc>
      <video:title>Enfortumab Vedotin trial for Muscle-invasive Bladder Cancer (NCT07475806): short film</video:title>
      <video:description>Enfortumab Vedotin trial for Muscle-invasive Bladder Cancer (NCT07475806). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07475806.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07475806.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:27:57.618Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-to-give-treatment-inside-the-eye-to-treat-retinoblastoma-nct05504291/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05504291.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Bilateral Retinoblastoma (NCT05504291): short film</video:title>
      <video:description>Biospecimen Collection trial for Bilateral Retinoblastoma (NCT05504291). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05504291.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05504291.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:40:59.283Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-to-investigate-ubamatamab-with-and-without-marlotamig-re-nct07154290/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07154290.jpg</video:thumbnail_loc>
      <video:title>Ubamatamab trial for Non Small Cell Lung Cancer (NCT07154290): short film</video:title>
      <video:description>Ubamatamab trial for Non Small Cell Lung Cancer (NCT07154290). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07154290.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07154290.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:21:11.456Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-to-learn-more-about-how-well-treatment-with-sevabertinib-nct06760819/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06760819.jpg</video:thumbnail_loc>
      <video:title>BAY2927088 trial for Advanced Solid Tumors (NCT06760819): short film</video:title>
      <video:description>BAY2927088 trial for Advanced Solid Tumors (NCT06760819). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06760819.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06760819.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:48:41.932Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-to-see-if-giving-fianlimab-and-cemiplimab-together-is-be-nct06769698/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06769698.jpg</video:thumbnail_loc>
      <video:title>FDC fianlimab+cemiplimab trial for Head and Neck Squamous Cell Carcinoma… (NCT06769698): short film</video:title>
      <video:description>FDC fianlimab+cemiplimab trial for Head and Neck Squamous Cell Carcinoma (HNSCC) (NCT06769698). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06769698.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06769698.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:22:21.323Z</video:publication_date>
      <video:duration>91</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-to-test-dsp107-in-combination-with-atezolizumab-in-compa-nct07235293/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07235293.jpg</video:thumbnail_loc>
      <video:title>DSP107 + Atezolizumab trial for Colorectal Cancer (NCT07235293): short film</video:title>
      <video:description>DSP107 + Atezolizumab trial for Colorectal Cancer (NCT07235293). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07235293.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07235293.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:21:31.312Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-to-test-inavolisib-treatments-in-participants-with-early-nct07054190/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07054190.jpg</video:thumbnail_loc>
      <video:title>Inavolisib trial for Breast Cancer (NCT07054190): short film</video:title>
      <video:description>Inavolisib trial for Breast Cancer (NCT07054190). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07054190.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07054190.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:28:43.562Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-study-using-nivolumab-in-combination-with-chemotherapy-drugs-t-nct06064097/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06064097.jpg</video:thumbnail_loc>
      <video:title>Biopsy Procedure trial for Stage II Nasopharyngeal Carcinoma AJCC v8 (NCT06064097): short film</video:title>
      <video:description>Biopsy Procedure trial for Stage II Nasopharyngeal Carcinoma AJCC v8 (NCT06064097). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06064097.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06064097.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:18:24.653Z</video:publication_date>
      <video:duration>87</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-trial-evaluating-the-efficacy-of-ivonescimab-in-metastatic-end-nct07229417/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07229417.jpg</video:thumbnail_loc>
      <video:title>Ivonescimab trial for Metastatic Endocrine Refractory (NCT07229417): short film</video:title>
      <video:description>Ivonescimab trial for Metastatic Endocrine Refractory (NCT07229417). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07229417.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07229417.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:49:34.341Z</video:publication_date>
      <video:duration>90</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-trial-of-durvalumab-medi4736-plus-monalizumab-in-non-muscle-in-nct06503614/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06503614.jpg</video:thumbnail_loc>
      <video:title>Durvalumab trial for Non-muscle Invasive Bladder Cancer (NCT06503614): short film</video:title>
      <video:description>Durvalumab trial for Non-muscle Invasive Bladder Cancer (NCT06503614). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06503614.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06503614.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:45:45.736Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/a-ugt1a1-genotype-directed-study-of-belinostat-pharmacokinetics-nct06406465/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06406465.jpg</video:thumbnail_loc>
      <video:title>Belinostat trial for Carcinoma, Neuroendocrine (NCT06406465): short film</video:title>
      <video:description>Belinostat trial for Carcinoma, Neuroendocrine (NCT06406465). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06406465.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06406465.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:26:22.983Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/abemaciclib-for-bone-and-soft-tissue-sarcoma-with-cyclin-depende-nct04040205/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04040205.jpg</video:thumbnail_loc>
      <video:title>Abemaciclib trial for Chondrosarcoma (NCT04040205): short film</video:title>
      <video:description>Abemaciclib trial for Chondrosarcoma (NCT04040205). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04040205.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04040205.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:02:13.255Z</video:publication_date>
      <video:duration>89</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/abemaciclib-for-the-treatment-of-recurrent-ovarian-or-endometria-nct04469764/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04469764.jpg</video:thumbnail_loc>
      <video:title>Abemaciclib trial for Recurrent Endometrial Carcinoma (NCT04469764): short film</video:title>
      <video:description>Abemaciclib trial for Recurrent Endometrial Carcinoma (NCT04469764). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04469764.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04469764.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:34:37.404Z</video:publication_date>
      <video:duration>87</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/abi-pred-adt-vs-adt-in-psma-positive-conventionally-node-negativ-nct07237269/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07237269.jpg</video:thumbnail_loc>
      <video:title>Androgen Deprivation Therapy (ADT) trial for Prostate Cancer (NCT07237269): short film</video:title>
      <video:description>Androgen Deprivation Therapy (ADT) trial for Prostate Cancer (NCT07237269). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07237269.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07237269.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:10:29.225Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/abiraterone-enzalutamide-or-apalutamide-in-castrate-sensitive-pr-nct05422911/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05422911.jpg</video:thumbnail_loc>
      <video:title>Abiraterone acetate trial for Metastatic Cancer (NCT05422911): short film</video:title>
      <video:description>Abiraterone acetate trial for Metastatic Cancer (NCT05422911). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05422911.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05422911.mp4</video:content_loc>
      <video:publication_date>2026-11-01T00:00:24.359Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/acalabrutinib-in-combination-with-venetoclax-for-the-treatment-o-nct04941716/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04941716.jpg</video:thumbnail_loc>
      <video:title>Acalabrutinib trial for Recurrent Chronic Lymphocytic Leukemia (NCT04941716): short film</video:title>
      <video:description>Acalabrutinib trial for Recurrent Chronic Lymphocytic Leukemia (NCT04941716). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04941716.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04941716.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:59:12.631Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/acalabrutinib-lenalidomide-and-rituximab-for-the-treatment-of-cd-nct04404088/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04404088.jpg</video:thumbnail_loc>
      <video:title>Acalabrutinib trial for Ann Arbor Stage III Grade 1 Follicular Lymphoma (NCT04404088): short film</video:title>
      <video:description>Acalabrutinib trial for Ann Arbor Stage III Grade 1 Follicular Lymphoma (NCT04404088). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04404088.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04404088.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:41:06.582Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/acalabrutinib-with-da-epoch-r-or-r-chop-for-people-with-untreate-nct04002947/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04002947.jpg</video:thumbnail_loc>
      <video:title>DA-EPOCH trial for Non-Hodgkin's Lymphoma (NCT04002947): short film</video:title>
      <video:description>DA-EPOCH trial for Non-Hodgkin's Lymphoma (NCT04002947). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04002947.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04002947.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:14:44.321Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/acalabrutinib-with-or-without-obinutuzumab-in-treating-patients-nct03516617/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03516617.jpg</video:thumbnail_loc>
      <video:title>Acalabrutinib trial for Chronic Lymphocytic Leukemia (NCT03516617): short film</video:title>
      <video:description>Acalabrutinib trial for Chronic Lymphocytic Leukemia (NCT03516617). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03516617.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03516617.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:15:05.770Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/acoustic-cluster-therapy-act-with-chemotherapy-for-the-treatment-nct06850623/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06850623.jpg</video:thumbnail_loc>
      <video:title>Acoustic Cluster Therapy trial for Locally Advanced Pancreatic… (NCT06850623): short film</video:title>
      <video:description>Acoustic Cluster Therapy trial for Locally Advanced Pancreatic Adenocarcinoma (NCT06850623). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06850623.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06850623.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:47:32.111Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/act001-for-the-treatment-of-diffuse-intrinsic-pontine-gliomas-an-nct06838676/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06838676.jpg</video:thumbnail_loc>
      <video:title>ACT001 trial for Diffuse Intrinsic Pontine Gliomas (DIPG) (NCT06838676): short film</video:title>
      <video:description>ACT001 trial for Diffuse Intrinsic Pontine Gliomas (DIPG) (NCT06838676). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06838676.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06838676.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:55:19.540Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/ad-hoc-trial-artificial-intelligence-based-drug-dosing-in-hepato-nct05669339/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05669339.jpg</video:thumbnail_loc>
      <video:title>Irinotecan trial for Hepatocellular Carcinoma (NCT05669339): short film</video:title>
      <video:description>Irinotecan trial for Hepatocellular Carcinoma (NCT05669339). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05669339.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05669339.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:04:49.249Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/adaptive-dosing-of-immune-checkpoint-inhibitors-for-hepatocellul-nct07689175/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07689175.jpg</video:thumbnail_loc>
      <video:title>Nivolumab trial for Hepatocellular Carcinoma (HCC) (NCT07689175): short film</video:title>
      <video:description>Nivolumab trial for Hepatocellular Carcinoma (HCC) (NCT07689175). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07689175.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07689175.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:10:12.634Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/adaptive-therapy-with-capecitabine-for-treatment-of-metastatic-e-nct06525766/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06525766.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Anatomic Stage IV Breast Cancer AJCC v8 (NCT06525766): short film</video:title>
      <video:description>Biospecimen Collection trial for Anatomic Stage IV Breast Cancer AJCC v8 (NCT06525766). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06525766.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06525766.mp4</video:content_loc>
      <video:publication_date>2026-10-31T23:01:50.837Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/adding-a-live-biotherapeutic-product-cbm588-to-pembrolizumab-for-nct07037004/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07037004.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Clear Cell Renal Cell Carcinoma (NCT07037004): short film</video:title>
      <video:description>Biospecimen Collection trial for Clear Cell Renal Cell Carcinoma (NCT07037004). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07037004.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07037004.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:11:43.045Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/adding-dasatinib-or-venetoclax-to-improve-responses-in-children-nct06390319/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06390319.jpg</video:thumbnail_loc>
      <video:title>Dexamethasone trial for T-cell Acute Lymphoblastic Leukemia (NCT06390319): short film</video:title>
      <video:description>Dexamethasone trial for T-cell Acute Lymphoblastic Leukemia (NCT06390319). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06390319.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06390319.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:08:51.443Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/addition-of-antibiotics-to-upfront-treatment-regimen-for-colorec-nct06728072/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06728072.jpg</video:thumbnail_loc>
      <video:title>Standard of Care Chemotherapy +… trial for Colorectal Cancer (NCT06728072): short film</video:title>
      <video:description>Standard of Care Chemotherapy + Metronidazole, ciprofloxacin, aspirin trial for Colorectal Cancer (NCT06728072). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06728072.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06728072.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:54:48.293Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/adjuvant-chemotherapy-and-immunotherapy-for-completely-resected-nct07149363/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07149363.jpg</video:thumbnail_loc>
      <video:title>Durvalumab 50 MG/ML trial for Small Cell Lung Cancer (SCLC) (NCT07149363): short film</video:title>
      <video:description>Durvalumab 50 MG/ML trial for Small Cell Lung Cancer (SCLC) (NCT07149363). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07149363.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07149363.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:45:51.027Z</video:publication_date>
      <video:duration>86</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/adjuvant-ip-001-treatment-for-hcc-patients-following-surgical-re-nct06526338/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06526338.jpg</video:thumbnail_loc>
      <video:title>1.0% IP-001 for injection trial for Hepatocellular Carcinoma (NCT06526338): short film</video:title>
      <video:description>1.0% IP-001 for injection trial for Hepatocellular Carcinoma (NCT06526338). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06526338.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06526338.mp4</video:content_loc>
      <video:publication_date>2026-10-31T19:38:34.290Z</video:publication_date>
      <video:duration>71</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/adjuvant-quisinostat-in-high-risk-uveal-melanoma-nct06932757/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06932757.jpg</video:thumbnail_loc>
      <video:title>Quisinostat trial for Uveal Melanoma (NCT06932757): short film</video:title>
      <video:description>Quisinostat trial for Uveal Melanoma (NCT06932757). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06932757.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06932757.mp4</video:content_loc>
      <video:publication_date>2026-10-31T23:47:06.423Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/administration-of-autologous-t-cells-genetically-engineered-to-e-nct03412877/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03412877.jpg</video:thumbnail_loc>
      <video:title>Cyclophosphamide trial for Endocrine Tumors (NCT03412877): short film</video:title>
      <video:description>Cyclophosphamide trial for Endocrine Tumors (NCT03412877). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03412877.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03412877.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:01:27.469Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/all-backbone-in-ayas-nct07227584/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07227584.jpg</video:thumbnail_loc>
      <video:title>Blinatumomab trial for Acute Lymphoblastic Leukemia (NCT07227584): short film</video:title>
      <video:description>Blinatumomab trial for Acute Lymphoblastic Leukemia (NCT07227584). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07227584.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07227584.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:57:28.109Z</video:publication_date>
      <video:duration>87</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/allo-hsct-using-ric-and-ptcy-for-hematological-diseases-nct05805605/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05805605.jpg</video:thumbnail_loc>
      <video:title>Peripheral Blood Stem Cell Transplant trial for Acute Myelogenous Leukemia (NCT05805605): short film</video:title>
      <video:description>Peripheral Blood Stem Cell Transplant trial for Acute Myelogenous Leukemia (NCT05805605). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05805605.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05805605.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:26:23.145Z</video:publication_date>
      <video:duration>92</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/allosct-for-malignant-and-non-malignant-hematologic-diseases-uti-nct04099966/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04099966.jpg</video:thumbnail_loc>
      <video:title>alpha beta depletion trial for Acute Leukemia (NCT04099966): short film</video:title>
      <video:description>alpha beta depletion trial for Acute Leukemia (NCT04099966). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04099966.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04099966.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:01:30.606Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/alternate-doses-and-dosing-schedules-of-belantamab-mafodotin-for-nct05847569/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05847569.jpg</video:thumbnail_loc>
      <video:title>Belantamab Mafodotin trial for Recurrent Multiple Myeloma (NCT05847569): short film</video:title>
      <video:description>Belantamab Mafodotin trial for Recurrent Multiple Myeloma (NCT05847569). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05847569.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05847569.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:06:52.112Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/alternating-chemo-immunotherapy-and-fgfr-inhibitor-for-fgfr-posi-nct07780838/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07780838.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Locally Advanced Ampulla of Vater… (NCT07780838): short film</video:title>
      <video:description>Biospecimen Collection trial for Locally Advanced Ampulla of Vater Carcinoma (NCT07780838). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07780838.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07780838.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:29:16.305Z</video:publication_date>
      <video:duration>88</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/an-adjuvant-study-to-evaluate-sms001-paclitaxel-in-non-small-cel-nct06693336/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06693336.jpg</video:thumbnail_loc>
      <video:title>SMS001 trial for Carcinoma, Non-Small-Cell Lung Cancer (NSCLC) (NCT06693336): short film</video:title>
      <video:description>SMS001 trial for Carcinoma, Non-Small-Cell Lung Cancer (NSCLC) (NCT06693336). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06693336.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06693336.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:00:35.455Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/an-evaluation-of-maintenance-therapy-combination-mirvetuximab-so-nct05887609/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05887609.jpg</video:thumbnail_loc>
      <video:title>Mirvetuximab Soravtansine-gynx trial for Ovary Cancer (NCT05887609): short film</video:title>
      <video:description>Mirvetuximab Soravtansine-gynx trial for Ovary Cancer (NCT05887609). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05887609.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05887609.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:14:58.419Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/androgen-ablation-therapy-with-or-without-niraparib-after-radiat-nct04947254/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04947254.jpg</video:thumbnail_loc>
      <video:title>Abiraterone Acetate trial for Prostate Carcinoma (NCT04947254): short film</video:title>
      <video:description>Abiraterone Acetate trial for Prostate Carcinoma (NCT04947254). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04947254.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04947254.mp4</video:content_loc>
      <video:publication_date>2026-10-31T23:02:19.057Z</video:publication_date>
      <video:duration>86</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/anti-pd-1-mab-plus-metabolic-modulator-in-solid-tumor-malignanci-nct04114136/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04114136.jpg</video:thumbnail_loc>
      <video:title>Nivolumab or Pembrolizumab… trial for Melanoma (NCT04114136): short film</video:title>
      <video:description>Nivolumab or Pembrolizumab (dependent upon approved indication) trial for Melanoma (NCT04114136). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04114136.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04114136.mp4</video:content_loc>
      <video:publication_date>2026-10-31T23:02:55.305Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/apollo-a-randomized-phase-ii-double-blind-study-of-olaparib-vers-nct04858334/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04858334.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Pancreatic Acinar Cell Carcinoma (NCT04858334): short film</video:title>
      <video:description>Biospecimen Collection trial for Pancreatic Acinar Cell Carcinoma (NCT04858334). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04858334.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04858334.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:50:35.027Z</video:publication_date>
      <video:duration>85</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/asparaginase-erwinia-chrysanthemi-with-chemotherapy-for-the-trea-nct06918431/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06918431.jpg</video:thumbnail_loc>
      <video:title>Asparaginase Erwinia chrysanthemi trial for B Acute Lymphoblastic… (NCT06918431): short film</video:title>
      <video:description>Asparaginase Erwinia chrysanthemi trial for B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative (NCT06918431). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06918431.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06918431.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:46:22.147Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/aspen-09-03-a-study-of-evorpacept-in-combination-with-trastuzuma-nct07007559/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07007559.jpg</video:thumbnail_loc>
      <video:title>Evorpacept (ALX148) trial for Breast Cancer, Metastatic (NCT07007559): short film</video:title>
      <video:description>Evorpacept (ALX148) trial for Breast Cancer, Metastatic (NCT07007559). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07007559.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07007559.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:11:14.680Z</video:publication_date>
      <video:duration>81</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/assessment-of-decision-tool-to-select-women-for-gynecologic-spar-nct06184516/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06184516.jpg</video:thumbnail_loc>
      <video:title>Reproductive organ sparing… trial for Urothelial Carcinoma Bladder (NCT06184516): short film</video:title>
      <video:description>Reproductive organ sparing radical cystectomy trial for Urothelial Carcinoma Bladder (NCT06184516). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06184516.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06184516.mp4</video:content_loc>
      <video:publication_date>2026-10-31T17:57:11.414Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/atempt-2-0-adjuvant-t-dm1-vs-th-nct04893109/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04893109.jpg</video:thumbnail_loc>
      <video:title>trastuzumab-emtansine trial for Breast Cancer (NCT04893109): short film</video:title>
      <video:description>trastuzumab-emtansine trial for Breast Cancer (NCT04893109). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04893109.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04893109.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:50:51.820Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/atezolizumab-and-cabozantinib-for-the-treatment-of-adolescents-a-nct05019703/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05019703.jpg</video:thumbnail_loc>
      <video:title>Atezolizumab trial for Locally Advanced Osteosarcoma (NCT05019703): short film</video:title>
      <video:description>Atezolizumab trial for Locally Advanced Osteosarcoma (NCT05019703). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05019703.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05019703.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:43:35.593Z</video:publication_date>
      <video:duration>87</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/atezolizumab-in-combination-with-a-multi-kinase-inhibitor-for-th-nct05168163/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05168163.jpg</video:thumbnail_loc>
      <video:title>Atezolizumab trial for Locally Advanced Hepatocellular Carcinoma (NCT05168163): short film</video:title>
      <video:description>Atezolizumab trial for Locally Advanced Hepatocellular Carcinoma (NCT05168163). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05168163.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05168163.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:37:20.192Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/atezolizumab-plus-etoposide-and-platinum-in-small-cell-bladder-c-nct05312671/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05312671.jpg</video:thumbnail_loc>
      <video:title>Atezolizumab trial for Small Cell Neuroendocrine Carcinoma of Bladder (NCT05312671): short film</video:title>
      <video:description>Atezolizumab trial for Small Cell Neuroendocrine Carcinoma of Bladder (NCT05312671). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05312671.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05312671.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:49:23.425Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/autologous-ln-145-in-patients-with-metastatic-non-small-cell-lun-nct04614103/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04614103.jpg</video:thumbnail_loc>
      <video:title>LN-145 trial for Metastatic Non Small Cell Lung Cancer (NCT04614103): short film</video:title>
      <video:description>LN-145 trial for Metastatic Non Small Cell Lung Cancer (NCT04614103). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04614103.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04614103.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:48:14.401Z</video:publication_date>
      <video:duration>88</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/azacitidine-and-enasidenib-in-treating-patients-with-idh2-mutant-nct03383575/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03383575.jpg</video:thumbnail_loc>
      <video:title>Azacitidine trial for Acute Myeloid Leukemia (NCT03383575): short film</video:title>
      <video:description>Azacitidine trial for Acute Myeloid Leukemia (NCT03383575). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03383575.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03383575.mp4</video:content_loc>
      <video:publication_date>2026-10-31T19:47:10.318Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/azd0901-in-participants-with-advanced-solid-tumours-expressing-c-nct06219941/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06219941.jpg</video:thumbnail_loc>
      <video:title>AZD0901 trial for Gastric Cancer (NCT06219941): short film</video:title>
      <video:description>AZD0901 trial for Gastric Cancer (NCT06219941). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06219941.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06219941.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:30:37.508Z</video:publication_date>
      <video:duration>88</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/bal-bot-agent-797-in-pmmr-crc-with-liver-metastases-nct07550088/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07550088.jpg</video:thumbnail_loc>
      <video:title>Balstilimab (BAL) trial for Colorectal Cancer Metastatic (NCT07550088): short film</video:title>
      <video:description>Balstilimab (BAL) trial for Colorectal Cancer Metastatic (NCT07550088). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07550088.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07550088.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:05:34.541Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/belantamab-mafodotin-pomalidomide-and-dexamethasone-for-the-trea-nct05208307/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05208307.jpg</video:thumbnail_loc>
      <video:title>Belantamab Mafodotin trial for Plasma Cell Myeloma (NCT05208307): short film</video:title>
      <video:description>Belantamab Mafodotin trial for Plasma Cell Myeloma (NCT05208307). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05208307.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05208307.mp4</video:content_loc>
      <video:publication_date>2026-10-31T19:55:09.455Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/belzutifan-mk-6482-for-the-treatment-of-advanced-pheochromocytom-nct04924075/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04924075.jpg</video:thumbnail_loc>
      <video:title>Belzutifan trial for Pheochromocytoma/Paraganglioma (NCT04924075): short film</video:title>
      <video:description>Belzutifan trial for Pheochromocytoma/Paraganglioma (NCT04924075). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04924075.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04924075.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:55:32.999Z</video:publication_date>
      <video:duration>89</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/bicazo-a-study-combining-two-immunotherapies-cabozantinib-and-ni-nct05136196/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05136196.jpg</video:thumbnail_loc>
      <video:title>Biopsy Procedure trial for Clinical Stage III Cutaneous Melanoma AJCC v8 (NCT05136196): short film</video:title>
      <video:description>Biopsy Procedure trial for Clinical Stage III Cutaneous Melanoma AJCC v8 (NCT05136196). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05136196.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05136196.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:27:10.043Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/binimetinib-and-imatinib-for-unresectable-stage-iii-iv-kit-mutan-nct04598009/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04598009.jpg</video:thumbnail_loc>
      <video:title>Binimetinib trial for Melanoma Stage III (NCT04598009): short film</video:title>
      <video:description>Binimetinib trial for Melanoma Stage III (NCT04598009). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04598009.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04598009.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:35:49.336Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/binimetinib-for-people-with-relapsed-refractory-braf-wild-type-h-nct04322383/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04322383.jpg</video:thumbnail_loc>
      <video:title>binimetinib trial for Hairy Cell Leukemia (NCT04322383): short film</video:title>
      <video:description>binimetinib trial for Hairy Cell Leukemia (NCT04322383). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04322383.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04322383.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:04:33.178Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/biologically-guided-radiation-therapy-bgrt-and-stereotactic-body-nct06014827/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06014827.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Lung Non-Small Cell Carcinoma (NCT06014827): short film</video:title>
      <video:description>Biospecimen Collection trial for Lung Non-Small Cell Carcinoma (NCT06014827). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06014827.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06014827.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:29:01.289Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/bladder-preservation-for-patients-with-muscle-invasive-bladder-c-nct06417190/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06417190.jpg</video:thumbnail_loc>
      <video:title>Trimodal therapy (TMT) within 45… trial for Muscle-Invasive Bladder… (NCT06417190): short film</video:title>
      <video:description>Trimodal therapy (TMT) within 45 days of neoadjuvant chemotherapy (NAC) trial for Muscle-Invasive Bladder Carcinoma (NCT06417190). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06417190.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06417190.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:19:17.655Z</video:publication_date>
      <video:duration>88</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/bms-986340-in-combination-with-nivolumab-gemcitabine-and-nab-pac-nct07226856/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07226856.jpg</video:thumbnail_loc>
      <video:title>Biopsy Procedure trial for Metastatic Pancreatic Adenocarcinoma (NCT07226856): short film</video:title>
      <video:description>Biopsy Procedure trial for Metastatic Pancreatic Adenocarcinoma (NCT07226856). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07226856.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07226856.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:23:59.738Z</video:publication_date>
      <video:duration>86</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/brain-metastases-in-greater-size-hypofractionated-options-trial-nct07227610/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07227610.jpg</video:thumbnail_loc>
      <video:title>Staged Stereotactic Radiosurgery (SSRS) trial for Brain Metastases (NCT07227610): short film</video:title>
      <video:description>Staged Stereotactic Radiosurgery (SSRS) trial for Brain Metastases (NCT07227610). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07227610.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07227610.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:26:50.602Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/bre-10-biomarker-optimization-of-neoadjuvant-therapy-in-breast-c-nct06441890/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06441890.jpg</video:thumbnail_loc>
      <video:title>Paclitaxel trial for Breast Cancer (NCT06441890): short film</video:title>
      <video:description>Paclitaxel trial for Breast Cancer (NCT06441890). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06441890.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06441890.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:49:06.540Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/brentuximab-vedotin-and-bendamustine-for-the-treatment-of-relaps-nct04587687/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04587687.jpg</video:thumbnail_loc>
      <video:title>Bendamustine Hydrochloride trial for Recurrent Follicular Lymphoma (NCT04587687): short film</video:title>
      <video:description>Bendamustine Hydrochloride trial for Recurrent Follicular Lymphoma (NCT04587687). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04587687.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04587687.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:42:15.122Z</video:publication_date>
      <video:duration>81</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/brentuximab-vedotin-and-nivolumab-for-the-treatment-of-patients-nct04561206/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04561206.jpg</video:thumbnail_loc>
      <video:title>Brentuximab Vedotin trial for Relapsed Classic Hodgkin Lymphoma (NCT04561206): short film</video:title>
      <video:description>Brentuximab Vedotin trial for Relapsed Classic Hodgkin Lymphoma (NCT04561206). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04561206.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04561206.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:05:51.422Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/brentuximab-vedotin-and-nivolumab-for-the-treatment-of-relapsed-nct05039073/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05039073.jpg</video:thumbnail_loc>
      <video:title>Brentuximab Vedotin trial for Recurrent Classic Hodgkin Lymphoma (NCT05039073): short film</video:title>
      <video:description>Brentuximab Vedotin trial for Recurrent Classic Hodgkin Lymphoma (NCT05039073). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05039073.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05039073.mp4</video:content_loc>
      <video:publication_date>2026-10-31T18:41:11.709Z</video:publication_date>
      <video:duration>81</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/cabazitaxel-carboplatin-vs-177lu-psma-617-in-metastatic-castrate-nct06738303/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06738303.jpg</video:thumbnail_loc>
      <video:title>Cabazitaxel and carboplatin trial for Metastatic Prostate Cancer (NCT06738303): short film</video:title>
      <video:description>Cabazitaxel and carboplatin trial for Metastatic Prostate Cancer (NCT06738303). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06738303.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06738303.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:56:44.033Z</video:publication_date>
      <video:duration>81</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/cabozantinib-combined-with-ipilimumab-nivolumab-and-tace-in-pati-nct04472767/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04472767.jpg</video:thumbnail_loc>
      <video:title>Nivolumab trial for Hepatocellular Carcinoma (NCT04472767): short film</video:title>
      <video:description>Nivolumab trial for Hepatocellular Carcinoma (NCT04472767). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04472767.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04472767.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:13:50.612Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/cabozantinib-in-patients-with-ret-fusion-positive-advanced-non-s-nct01639508/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT01639508.jpg</video:thumbnail_loc>
      <video:title>Cabozantinib trial for Non-Small Cell Lung Cancer (NCT01639508): short film</video:title>
      <video:description>Cabozantinib trial for Non-Small Cell Lung Cancer (NCT01639508). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT01639508.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT01639508.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:23:47.059Z</video:publication_date>
      <video:duration>90</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/candida-therapeutic-vaccine-in-head-and-neck-cancer-patients-to-nct05952934/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05952934.jpg</video:thumbnail_loc>
      <video:title>0.5 mL Candin®/injection trial for Squamous Cell Carcinoma of Head and… (NCT05952934): short film</video:title>
      <video:description>0.5 mL Candin®/injection trial for Squamous Cell Carcinoma of Head and Neck (NCT05952934). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05952934.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05952934.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:22:12.837Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/captemy90-for-grade-2-3-net-liver-metastases-nct04339036/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04339036.jpg</video:thumbnail_loc>
      <video:title>Capecitabine Oral Product trial for Neuroendocrine Tumor Grade 2 (NCT04339036): short film</video:title>
      <video:description>Capecitabine Oral Product trial for Neuroendocrine Tumor Grade 2 (NCT04339036). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04339036.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04339036.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:49:36.447Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/car-t-cell-therapy-in-patients-with-renal-dysfunction-nct05909059/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05909059.jpg</video:thumbnail_loc>
      <video:title>Fludarabine trial for Non-hodgkin Lymphoma,B Cell (NCT05909059): short film</video:title>
      <video:description>Fludarabine trial for Non-hodgkin Lymphoma,B Cell (NCT05909059). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05909059.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05909059.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:18:51.835Z</video:publication_date>
      <video:duration>86</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/carboplatin-taxane-and-ramucirumab-for-patients-with-nsclc-after-nct04332367/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04332367.jpg</video:thumbnail_loc>
      <video:title>Carboplatin trial for Non-small Cell Lung Cancer (NCT04332367): short film</video:title>
      <video:description>Carboplatin trial for Non-small Cell Lung Cancer (NCT04332367). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04332367.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04332367.mp4</video:content_loc>
      <video:publication_date>2026-11-01T00:09:22.133Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/cd22-car-t-cells-to-extend-remission-following-commercial-cd19-c-nct07328503/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07328503.jpg</video:thumbnail_loc>
      <video:title>CD22 CAR-transduced T cells trial for Acute Lymphoblastic Leukemia (NCT07328503): short film</video:title>
      <video:description>CD22 CAR-transduced T cells trial for Acute Lymphoblastic Leukemia (NCT07328503). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07328503.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07328503.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:24:43.670Z</video:publication_date>
      <video:duration>67</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/cemiplimab-and-cetuximab-prior-salvage-surgery-in-patients-with-nct06448026/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06448026.jpg</video:thumbnail_loc>
      <video:title>Cemiplimab trial for Locally Recurrent Oral Cavity Squamous Cell Carcinoma (NCT06448026): short film</video:title>
      <video:description>Cemiplimab trial for Locally Recurrent Oral Cavity Squamous Cell Carcinoma (NCT06448026). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06448026.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06448026.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:43:38.775Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/cemiplimab-for-the-treatment-of-incurable-metastatic-or-unresect-nct07050186/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07050186.jpg</video:thumbnail_loc>
      <video:title>Biopsy Procedure trial for Metastatic NUT Carcinoma (NCT07050186): short film</video:title>
      <video:description>Biopsy Procedure trial for Metastatic NUT Carcinoma (NCT07050186). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07050186.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07050186.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:52:52.354Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/cemiplimab-plus-gemcitabine-in-patients-with-metastatic-pancreat-nct06790602/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06790602.jpg</video:thumbnail_loc>
      <video:title>Cemiplimab Plus Gemcitabine trial for Pancreatic Ductal Adenocarcinoma… (NCT06790602): short film</video:title>
      <video:description>Cemiplimab Plus Gemcitabine trial for Pancreatic Ductal Adenocarcinoma (mPDAC) (NCT06790602). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06790602.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06790602.mp4</video:content_loc>
      <video:publication_date>2026-11-01T00:09:27.796Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/cetuximab-after-immunotherapy-for-the-treatment-of-head-and-neck-nct04375384/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04375384.jpg</video:thumbnail_loc>
      <video:title>Cetuximab trial for Head and Neck Squamous Cell Carcinoma (NCT04375384): short film</video:title>
      <video:description>Cetuximab trial for Head and Neck Squamous Cell Carcinoma (NCT04375384). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04375384.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04375384.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:35:08.231Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/chemotherapy-anakinra-in-patients-with-pancreatic-adenocarcinoma-nct04926467/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04926467.jpg</video:thumbnail_loc>
      <video:title>Anakinra trial for Pancreatic Adenocarcinoma (NCT04926467): short film</video:title>
      <video:description>Anakinra trial for Pancreatic Adenocarcinoma (NCT04926467). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04926467.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04926467.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:50:39.815Z</video:publication_date>
      <video:duration>88</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/chemotherapy-and-radiation-therapy-for-the-treatment-of-idh-wild-nct04623931/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04623931.jpg</video:thumbnail_loc>
      <video:title>Quality-of-Life Assessment trial for Anaplastic Astrocytoma, IDH-Wildtype (NCT04623931): short film</video:title>
      <video:description>Quality-of-Life Assessment trial for Anaplastic Astrocytoma, IDH-Wildtype (NCT04623931). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04623931.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04623931.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:58:55.794Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/chemotherapy-with-or-without-immunotherapy-for-peritoneal-mesoth-nct05001880/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05001880.jpg</video:thumbnail_loc>
      <video:title>Atezolizumab trial for Peritoneal Malignant Mesothelioma (NCT05001880): short film</video:title>
      <video:description>Atezolizumab trial for Peritoneal Malignant Mesothelioma (NCT05001880). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05001880.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05001880.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:13:15.346Z</video:publication_date>
      <video:duration>81</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/chemotherapy-with-or-without-radiation-or-surgery-in-treating-pa-nct03161522/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03161522.jpg</video:thumbnail_loc>
      <video:title>Capecitabine trial for Gastric Adenocarcinoma (NCT03161522): short film</video:title>
      <video:description>Capecitabine trial for Gastric Adenocarcinoma (NCT03161522). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03161522.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03161522.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:21:19.505Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/circulating-tumor-dna-nct06923527/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06923527.jpg</video:thumbnail_loc>
      <video:title>Elacestrant trial for ER+ Breast Cancer (NCT06923527): short film</video:title>
      <video:description>Elacestrant trial for ER+ Breast Cancer (NCT06923527). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06923527.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06923527.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:21:49.412Z</video:publication_date>
      <video:duration>71</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/circulating-tumor-dna-to-guide-changes-in-standard-of-care-chemo-nct05770531/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05770531.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Metastatic HER2-Negative Breast Carcinoma (NCT05770531): short film</video:title>
      <video:description>Biospecimen Collection trial for Metastatic HER2-Negative Breast Carcinoma (NCT05770531). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05770531.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05770531.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:48:33.530Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/cladribine-and-rituximab-in-treating-patients-with-hairy-cell-le-nct00412594/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT00412594.jpg</video:thumbnail_loc>
      <video:title>Cladribine trial for Hairy Cell Leukemia (NCT00412594): short film</video:title>
      <video:description>Cladribine trial for Hairy Cell Leukemia (NCT00412594). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT00412594.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT00412594.mp4</video:content_loc>
      <video:publication_date>2026-11-01T00:04:53.671Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/clag-go-for-patients-with-persistent-relapsed-or-refractory-aml-nct04050280/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04050280.jpg</video:thumbnail_loc>
      <video:title>Cladribine, Cytarabine, and… trial for Acute Myeloid Leukemia, Adult (NCT04050280): short film</video:title>
      <video:description>Cladribine, Cytarabine, and Granulocyte-Colony Stimulating Factor with Fractionated Gemtuzumab Ozogamicin (CLAG-GO) trial for Acute Myeloid Leukemia, Adult (NCT04050280). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04050280.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04050280.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:37:46.986Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/cobimetinib-in-refractory-langerhans-cell-histiocytosis-lch-and-nct04079179/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04079179.jpg</video:thumbnail_loc>
      <video:title>Cobimetinib trial for Langerhan's Cell Histiocytosis (NCT04079179): short film</video:title>
      <video:description>Cobimetinib trial for Langerhan's Cell Histiocytosis (NCT04079179). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04079179.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04079179.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:14:06.933Z</video:publication_date>
      <video:duration>63</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/combination-chemotherapy-in-treating-patients-with-relapsed-or-r-nct03136146/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03136146.jpg</video:thumbnail_loc>
      <video:title>Bortezomib trial for Recurrent Acute Lymphoblastic Leukemia (NCT03136146): short film</video:title>
      <video:description>Bortezomib trial for Recurrent Acute Lymphoblastic Leukemia (NCT03136146). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03136146.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03136146.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:13:08.111Z</video:publication_date>
      <video:duration>68</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/combination-therapy-for-the-treatment-of-diffuse-midline-gliomas-nct05009992/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05009992.jpg</video:thumbnail_loc>
      <video:title>ONC201 trial for Diffuse Intrinsic Pontine Glioma (NCT05009992): short film</video:title>
      <video:description>ONC201 trial for Diffuse Intrinsic Pontine Glioma (NCT05009992). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05009992.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05009992.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:45:40.212Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/combination-therapy-using-durvalumab-and-histotripsy-for-treatme-nct07766187/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07766187.jpg</video:thumbnail_loc>
      <video:title>Histotripsy trial for Intrahepatic Cholangiocarcinoma (NCT07766187): short film</video:title>
      <video:description>Histotripsy trial for Intrahepatic Cholangiocarcinoma (NCT07766187). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07766187.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07766187.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:20:21.888Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/combined-systemic-and-intraperitoneal-chemotherapy-for-synchrono-nct07475286/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07475286.jpg</video:thumbnail_loc>
      <video:title>Cisplatin trial for Synchronous Gastric Peritoneal Carcinomatosis (NCT07475286): short film</video:title>
      <video:description>Cisplatin trial for Synchronous Gastric Peritoneal Carcinomatosis (NCT07475286). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07475286.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07475286.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:17:31.454Z</video:publication_date>
      <video:duration>91</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/comparing-cytarabine-daunorubicin-therapy-versus-cytarabine-daun-nct05554393/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05554393.jpg</video:thumbnail_loc>
      <video:title>Azacitidine trial for Acute Myeloid Leukemia (NCT05554393): short film</video:title>
      <video:description>Azacitidine trial for Acute Myeloid Leukemia (NCT05554393). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05554393.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05554393.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:30:13.977Z</video:publication_date>
      <video:duration>91</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/comparing-different-treatment-lengths-for-venetoclax-in-older-pe-nct07437950/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07437950.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Acute Myeloid Leukemia (NCT07437950): short film</video:title>
      <video:description>Biospecimen Collection trial for Acute Myeloid Leukemia (NCT07437950). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07437950.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07437950.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:24:28.360Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/comparing-new-treatments-for-people-with-newly-diagnosed-acute-m-nct06672146/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06672146.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Acute Myeloid Leukemia (NCT06672146): short film</video:title>
      <video:description>Biospecimen Collection trial for Acute Myeloid Leukemia (NCT06672146). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06672146.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06672146.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:34:43.112Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/comparing-the-effectiveness-of-the-immunotherapy-agents-rituxima-nct05886036/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05886036.jpg</video:thumbnail_loc>
      <video:title>Biopsy Procedure trial for Nodular Lymphocyte Predominant B-Cell Lymphoma (NCT05886036): short film</video:title>
      <video:description>Biopsy Procedure trial for Nodular Lymphocyte Predominant B-Cell Lymphoma (NCT05886036). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05886036.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05886036.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:19:16.706Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/comparing-the-radiopharmaceutical-drug-177lu-lu-dotatate-to-stan-nct06955169/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06955169.jpg</video:thumbnail_loc>
      <video:title>[177Lu]Lu-DOTATATE trial for Intracranial Meningioma (NCT06955169): short film</video:title>
      <video:description>[177Lu]Lu-DOTATATE trial for Intracranial Meningioma (NCT06955169). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06955169.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06955169.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:48:50.291Z</video:publication_date>
      <video:duration>85</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/concurrent-immunotherapy-and-systemic-therapy-with-stereotactic-nct07770100/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07770100.jpg</video:thumbnail_loc>
      <video:title>Stereotactic Body Radiation Therapy (SBRT) trial for Head and Neck Cancer (NCT07770100): short film</video:title>
      <video:description>Stereotactic Body Radiation Therapy (SBRT) trial for Head and Neck Cancer (NCT07770100). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07770100.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07770100.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:23:51.227Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/consolidation-of-first-line-mrd-remission-with-cema-cel-in-patie-nct06500273/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06500273.jpg</video:thumbnail_loc>
      <video:title>cemacabtagene ansegedleucel trial for Large B-cell Lymphoma (NCT06500273): short film</video:title>
      <video:description>cemacabtagene ansegedleucel trial for Large B-cell Lymphoma (NCT06500273). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06500273.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06500273.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:28:23.228Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/consolidative-local-therapy-clt-in-oligo-metastatic-urothelial-c-nct07048457/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07048457.jpg</video:thumbnail_loc>
      <video:title>Radical cystectomy trial for Locally Advanced Urothelial Carcinoma (NCT07048457): short film</video:title>
      <video:description>Radical cystectomy trial for Locally Advanced Urothelial Carcinoma (NCT07048457). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07048457.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07048457.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:53:40.346Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/cord-blood-transplant-cyclophosphamide-fludarabine-and-total-bod-nct06013423/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06013423.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Acute Leukemia of Ambiguous Lineage (NCT06013423): short film</video:title>
      <video:description>Biospecimen Collection trial for Acute Leukemia of Ambiguous Lineage (NCT06013423). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06013423.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06013423.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:09:14.734Z</video:publication_date>
      <video:duration>88</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/cpx-351-and-ivosidenib-for-the-treatment-of-idh1-mutated-acute-m-nct04493164/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04493164.jpg</video:thumbnail_loc>
      <video:title>Ivosidenib trial for Acute Myeloid Leukemia With Gene Mutations (NCT04493164): short film</video:title>
      <video:description>Ivosidenib trial for Acute Myeloid Leukemia With Gene Mutations (NCT04493164). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04493164.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04493164.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:41:57.500Z</video:publication_date>
      <video:duration>85</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/cryoablation-ipilimumab-nivolumab-in-melanoma-nct05779423/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05779423.jpg</video:thumbnail_loc>
      <video:title>Ipilimumab trial for Metastatic Melanoma (NCT05779423): short film</video:title>
      <video:description>Ipilimumab trial for Metastatic Melanoma (NCT05779423). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05779423.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05779423.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:55:14.084Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/ctdna-guided-addition-of-ipilimumab-to-patients-receiving-nivolu-nct07504796/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07504796.jpg</video:thumbnail_loc>
      <video:title>Nivolumab trial for Metastatic Melanoma (NCT07504796): short film</video:title>
      <video:description>Nivolumab trial for Metastatic Melanoma (NCT07504796). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07504796.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07504796.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:43:39.368Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/ctdna-guided-sunitinib-and-regorafenib-therapy-for-gist-nct05366816/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05366816.jpg</video:thumbnail_loc>
      <video:title>Sunitinib trial for Gastrointestinal Stromal Tumors (NCT05366816): short film</video:title>
      <video:description>Sunitinib trial for Gastrointestinal Stromal Tumors (NCT05366816). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05366816.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05366816.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:57:49.263Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/ctdna-guided-therapy-for-relapsed-refractory-hodgkin-lymphoma-nct07021989/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07021989.jpg</video:thumbnail_loc>
      <video:title>Pembrolizumab trial for Hodgkin Lymphoma, Adult (NCT07021989): short film</video:title>
      <video:description>Pembrolizumab trial for Hodgkin Lymphoma, Adult (NCT07021989). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07021989.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07021989.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:03:26.742Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/cthpvdna-response-adapted-chemoradiation-retifanlimab-treatment-nct07425054/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07425054.jpg</video:thumbnail_loc>
      <video:title>HPV ctDNA Response based radiation trial for Anal Cancer (NCT07425054): short film</video:title>
      <video:description>HPV ctDNA Response based radiation trial for Anal Cancer (NCT07425054). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07425054.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07425054.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:40:45.408Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/cyclophosphamide-and-sirolimus-for-the-treatment-of-metastatic-r-nct03099356/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03099356.jpg</video:thumbnail_loc>
      <video:title>Cyclophosphamide trial for Metastatic Thyroid Cancer (NCT03099356): short film</video:title>
      <video:description>Cyclophosphamide trial for Metastatic Thyroid Cancer (NCT03099356). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03099356.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03099356.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:43:12.529Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/dabrafenib-and-trametinib-for-braf-v600-mutant-low-grade-gliomas-nct07110246/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07110246.jpg</video:thumbnail_loc>
      <video:title>Dabrafenib trial for BRAF V600 Mutation (NCT07110246): short film</video:title>
      <video:description>Dabrafenib trial for BRAF V600 Mutation (NCT07110246). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07110246.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07110246.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:27:27.432Z</video:publication_date>
      <video:duration>86</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/daly-ii-usa-mb-cart2019-1-for-dlbcl-nct04792489/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04792489.jpg</video:thumbnail_loc>
      <video:title>zamtocabtagene autoleucel… trial for Refractory Diffuse Large B… (NCT04792489): short film</video:title>
      <video:description>zamtocabtagene autoleucel (MB-CART2019.1) trial for Refractory Diffuse Large B Cell Lymphoma (DLBCL) (NCT04792489). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04792489.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04792489.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:18:29.614Z</video:publication_date>
      <video:duration>86</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/daratumumab-for-chemotherapy-refractory-minimal-residual-disease-nct05289687/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05289687.jpg</video:thumbnail_loc>
      <video:title>Daratumumab / Hyaluronidase… trial for T-cell Acute Lymphoblastic… (NCT05289687): short film</video:title>
      <video:description>Daratumumab / Hyaluronidase Injection trial for T-cell Acute Lymphoblastic Leukemia (NCT05289687). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05289687.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05289687.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:36:36.236Z</video:publication_date>
      <video:duration>90</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/daratumumab-for-relapsed-refractory-primary-effusion-lymphoma-pl-nct05907759/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05907759.jpg</video:thumbnail_loc>
      <video:title>Daratumumab SC trial for Lymphoma, Primary Effusion (NCT05907759): short film</video:title>
      <video:description>Daratumumab SC trial for Lymphoma, Primary Effusion (NCT05907759). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05907759.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05907759.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:30:03.988Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/dareontm-5-a-study-to-test-whether-different-doses-of-bi-764532-nct05882058/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05882058.jpg</video:thumbnail_loc>
      <video:title>BI 764532, dose 1 trial for Small Cell Lung Carcinoma (NCT05882058): short film</video:title>
      <video:description>BI 764532, dose 1 trial for Small Cell Lung Carcinoma (NCT05882058). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05882058.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05882058.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:16:27.263Z</video:publication_date>
      <video:duration>87</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/dasatinib-and-quercetin-with-car-t-therapy-for-the-treatment-of-nct06940297/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06940297.jpg</video:thumbnail_loc>
      <video:title>Biopsy Procedure trial for Recurrent Multiple Myeloma (NCT06940297): short film</video:title>
      <video:description>Biopsy Procedure trial for Recurrent Multiple Myeloma (NCT06940297). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06940297.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06940297.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:09:12.373Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/dato-base-datopotamab-deruxtecan-for-breast-cancer-brain-metasta-nct06176261/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06176261.jpg</video:thumbnail_loc>
      <video:title>Datopotamab Deruxtecan trial for Breast Cancer (NCT06176261): short film</video:title>
      <video:description>Datopotamab Deruxtecan trial for Breast Cancer (NCT06176261). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06176261.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06176261.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:18:40.869Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/dcis-recast-trial-ductal-carcinoma-in-situ-re-evaluating-conditi-nct06075953/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06075953.jpg</video:thumbnail_loc>
      <video:title>Tamoxifen trial for Ductal Carcinoma in Situ (NCT06075953): short film</video:title>
      <video:description>Tamoxifen trial for Ductal Carcinoma in Situ (NCT06075953). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06075953.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06075953.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:29:51.976Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/decitabine-cedazuridine-inqovi-an-oral-dna-demethylating-agent-i-nct05960773/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05960773.jpg</video:thumbnail_loc>
      <video:title>Decitabine/cedazuridine trial for Mesothelioma (NCT05960773): short film</video:title>
      <video:description>Decitabine/cedazuridine trial for Mesothelioma (NCT05960773). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05960773.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05960773.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:28:58.826Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/decitabine-with-ruxolitinib-fedratinib-or-pacritinib-for-the-tre-nct04282187/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04282187.jpg</video:thumbnail_loc>
      <video:title>Decitabine trial for Acute Myeloid Leukemia (NCT04282187): short film</video:title>
      <video:description>Decitabine trial for Acute Myeloid Leukemia (NCT04282187). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04282187.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04282187.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:32:26.376Z</video:publication_date>
      <video:duration>71</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/defining-the-ablative-dose-for-y-90-tare-nct07586046/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07586046.jpg</video:thumbnail_loc>
      <video:title>Yttrium-90 Radiation… trial for HCC - Hepatocellular… (NCT07586046): short film</video:title>
      <video:description>Yttrium-90 Radiation Segmentectomy (Y90 RS) using glass microspheres trial for HCC - Hepatocellular Carcinoma (NCT07586046). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07586046.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07586046.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:36:29.849Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/dfmo-as-maintenance-therapy-for-molecular-high-very-high-risk-an-nct04696029/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04696029.jpg</video:thumbnail_loc>
      <video:title>Difluoromethylornithine trial for Medulloblastoma (NCT04696029): short film</video:title>
      <video:description>Difluoromethylornithine trial for Medulloblastoma (NCT04696029). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04696029.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04696029.mp4</video:content_loc>
      <video:publication_date>2026-10-31T17:01:00.751Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/digoxin-medulloblastoma-study-nct06701812/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06701812.jpg</video:thumbnail_loc>
      <video:title>Digoxin trial for Medulloblastoma (NCT06701812): short film</video:title>
      <video:description>Digoxin trial for Medulloblastoma (NCT06701812). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06701812.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06701812.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:09:28.825Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/discern-dual-versus-single-icb-in-pdl-1-negative-nsclc-nct06364917/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06364917.jpg</video:thumbnail_loc>
      <video:title>Pembrolizumab trial for Non Small Cell Lung Cancer (NCT06364917): short film</video:title>
      <video:description>Pembrolizumab trial for Non Small Cell Lung Cancer (NCT06364917). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06364917.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06364917.mp4</video:content_loc>
      <video:publication_date>2026-10-31T23:59:45.646Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/doc1021-dendritic-cell-immunotherapy-for-treatment-of-newly-diag-nct06805305/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06805305.jpg</video:thumbnail_loc>
      <video:title>DOC1021 trial for Glioblastoma (GBM) (NCT06805305): short film</video:title>
      <video:description>DOC1021 trial for Glioblastoma (GBM) (NCT06805305). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06805305.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06805305.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:29:57.049Z</video:publication_date>
      <video:duration>89</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/dose-adjusted-epoch-with-or-without-rituximab-plus-ponatinib-for-nct07224100/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07224100.jpg</video:thumbnail_loc>
      <video:title>Cyclophosphamide trial for B Acute Lymphoblastic Leukemia With… (NCT07224100): short film</video:title>
      <video:description>Cyclophosphamide trial for B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 (NCT07224100). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07224100.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07224100.mp4</video:content_loc>
      <video:publication_date>2026-10-31T23:00:19.502Z</video:publication_date>
      <video:duration>87</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/durvalumab-in-combination-with-chemotherapy-in-treating-patients-nct03907475/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03907475.jpg</video:thumbnail_loc>
      <video:title>Biopsy Procedure trial for Locally Advanced Malignant Solid Neoplasm (NCT03907475): short film</video:title>
      <video:description>Biopsy Procedure trial for Locally Advanced Malignant Solid Neoplasm (NCT03907475). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03907475.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03907475.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:18:21.990Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/duvelisib-maintenance-for-the-treatment-of-peripheral-t-cell-lym-nct07293403/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07293403.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Follicular Helper T-Cell Lymphoma (NCT07293403): short film</video:title>
      <video:description>Biospecimen Collection trial for Follicular Helper T-Cell Lymphoma (NCT07293403). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07293403.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07293403.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:09:20.161Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/e7-tcr-t-cell-immunotherapy-for-human-papillomavirus-hpv-associa-nct05686226/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05686226.jpg</video:thumbnail_loc>
      <video:title>E7 TCR-T cells trial for Cervical Cancer (NCT05686226): short film</video:title>
      <video:description>E7 TCR-T cells trial for Cervical Cancer (NCT05686226). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05686226.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05686226.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:29:48.571Z</video:publication_date>
      <video:duration>87</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/effects-of-infusion-timing-on-treatment-response-in-solid-tumors-nct07630168/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07630168.jpg</video:thumbnail_loc>
      <video:title>PD-1/PD-L1 inhibitor monotherapy… trial for Lung Cancer (NCT07630168): short film</video:title>
      <video:description>PD-1/PD-L1 inhibitor monotherapy - 4 cycles before 12:00PM trial for Lung Cancer (NCT07630168). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07630168.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07630168.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:06:18.277Z</video:publication_date>
      <video:duration>81</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/efficacy-and-safety-of-nemtabrutinib-mk-1026-in-participants-wit-nct04728893/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04728893.jpg</video:thumbnail_loc>
      <video:title>Nemtabrutinib trial for Hematologic Malignancies (NCT04728893): short film</video:title>
      <video:description>Nemtabrutinib trial for Hematologic Malignancies (NCT04728893). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04728893.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04728893.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:18:34.078Z</video:publication_date>
      <video:duration>85</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/efficacy-and-safety-of-tyra-300-in-participants-with-fgfr3-alter-nct06995677/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06995677.jpg</video:thumbnail_loc>
      <video:title>TYRA-300 60mg trial for Low-grade NMIBC (NCT06995677): short film</video:title>
      <video:description>TYRA-300 60mg trial for Low-grade NMIBC (NCT06995677). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06995677.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06995677.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:34:21.827Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/efficacy-of-hypomethylating-agents-vs-intensive-chemotherapy-in-nct07060001/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07060001.jpg</video:thumbnail_loc>
      <video:title>5hmC Biomarker trial for Acute Myeloid Leukemia (AML) (NCT07060001): short film</video:title>
      <video:description>5hmC Biomarker trial for Acute Myeloid Leukemia (AML) (NCT07060001). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07060001.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07060001.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:00:21.663Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/elranatamab-in-r-r-multiple-myeloma-nct06138275/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06138275.jpg</video:thumbnail_loc>
      <video:title>Elranatamab trial for Refractory Multiple Myeloma (NCT06138275): short film</video:title>
      <video:description>Elranatamab trial for Refractory Multiple Myeloma (NCT06138275). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06138275.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06138275.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:32:16.606Z</video:publication_date>
      <video:duration>88</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/enasidenib-and-azacitidine-in-treating-patients-with-recurrent-o-nct03683433/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03683433.jpg</video:thumbnail_loc>
      <video:title>Azacitidine trial for Acute Bilineal Leukemia (NCT03683433): short film</video:title>
      <video:description>Azacitidine trial for Acute Bilineal Leukemia (NCT03683433). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03683433.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03683433.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:40:51.272Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/enasidenib-in-idh2-mutated-malignant-sinonasal-and-skull-base-tu-nct06176989/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06176989.jpg</video:thumbnail_loc>
      <video:title>Enasidenib trial for Metastatic Chondrosarcoma (NCT06176989): short film</video:title>
      <video:description>Enasidenib trial for Metastatic Chondrosarcoma (NCT06176989). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06176989.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06176989.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:24:47.590Z</video:publication_date>
      <video:duration>91</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/endocrine-treatment-alone-for-elderly-patients-with-estrogen-rec-nct02476786/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02476786.jpg</video:thumbnail_loc>
      <video:title>FACT-B trial for Breast Cancer (NCT02476786): short film</video:title>
      <video:description>FACT-B trial for Breast Cancer (NCT02476786). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT02476786.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02476786.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:12:10.740Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/enfortumab-vedotin-with-or-without-pembrolizumab-in-rare-genitou-nct06041503/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06041503.jpg</video:thumbnail_loc>
      <video:title>Pembrolizumab trial for Adenocarcinoma of the Bladder (NCT06041503): short film</video:title>
      <video:description>Pembrolizumab trial for Adenocarcinoma of the Bladder (NCT06041503). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06041503.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06041503.mp4</video:content_loc>
      <video:publication_date>2026-10-31T23:00:41.798Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/enzalutamide-and-pds01adc-in-pet-positive-recurrent-prostate-can-nct06096870/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06096870.jpg</video:thumbnail_loc>
      <video:title>Enzalutamide trial for Prostate Cancer (NCT06096870): short film</video:title>
      <video:description>Enzalutamide trial for Prostate Cancer (NCT06096870). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06096870.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06096870.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:27:38.223Z</video:publication_date>
      <video:duration>96</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/epco-zanu-ritux-for-r-r-fl-or-mzl-nct06563596/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06563596.jpg</video:thumbnail_loc>
      <video:title>Zanubrutinib trial for Follicular Lymphoma (NCT06563596): short film</video:title>
      <video:description>Zanubrutinib trial for Follicular Lymphoma (NCT06563596). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06563596.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06563596.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:17:37.738Z</video:publication_date>
      <video:duration>88</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/epcoritamab-and-lenalidomide-in-treating-patients-with-refractor-nct06723457/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06723457.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Recurrent B-Cell Non-Hodgkin Lymphoma (NCT06723457): short film</video:title>
      <video:description>Biospecimen Collection trial for Recurrent B-Cell Non-Hodgkin Lymphoma (NCT06723457). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06723457.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06723457.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:21:36.541Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/epcoritamab-in-combination-with-loncastuximab-tesirine-in-relaps-nct06919939/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06919939.jpg</video:thumbnail_loc>
      <video:title>Epcoritamab trial for Large B-cell Lymphoma (NCT06919939): short film</video:title>
      <video:description>Epcoritamab trial for Large B-cell Lymphoma (NCT06919939). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06919939.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06919939.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:21:06.847Z</video:publication_date>
      <video:duration>96</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/epcoritamab-rituximab-gemcitabine-and-oxaliplatin-r-gemox-as-sal-nct07365306/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07365306.jpg</video:thumbnail_loc>
      <video:title>Autologous Hematopoietic Stem… trial for Recurrent Diffuse Large… (NCT07365306): short film</video:title>
      <video:description>Autologous Hematopoietic Stem Cell Transplantation trial for Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified (NCT07365306). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07365306.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07365306.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:48:17.554Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/epcoritamab-with-dose-adjusted-etoposide-cyclophosphamide-vincri-nct07097363/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07097363.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for B-Cell Non-Hodgkin Lymphoma (NCT07097363): short film</video:title>
      <video:description>Biospecimen Collection trial for B-Cell Non-Hodgkin Lymphoma (NCT07097363). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07097363.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07097363.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:24:44.979Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/estrogen-to-improve-quality-of-life-for-men-with-newly-diagnosed-nct07466498/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07466498.jpg</video:thumbnail_loc>
      <video:title>Androgen Receptor Pathway… trial for Castration-Sensitive… (NCT07466498): short film</video:title>
      <video:description>Androgen Receptor Pathway Inhibitor trial for Castration-Sensitive Prostate Adenocarcinoma (NCT07466498). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07466498.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07466498.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:16:10.249Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/ethan-et-for-male-bc-nct05501704/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05501704.jpg</video:thumbnail_loc>
      <video:title>Tamoxifen trial for Male Breast Cancer (NCT05501704): short film</video:title>
      <video:description>Tamoxifen trial for Male Breast Cancer (NCT05501704). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05501704.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05501704.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:42:24.917Z</video:publication_date>
      <video:duration>93</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/eus-rfa-pancardinal-1-trial-nct04990609/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04990609.jpg</video:thumbnail_loc>
      <video:title>Endoscopic Ultrasound… trial for Pancreatic Ductal… (NCT04990609): short film</video:title>
      <video:description>Endoscopic Ultrasound (EUS)-Guided Radiofrequency Ablation (RFA) trial for Pancreatic Ductal Adenocarcinoma (PDAC) (NCT04990609). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04990609.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04990609.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:50:51.123Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/evaluate-optimization-of-crs-profile-for-glofit-monotherapy-and-nct06806033/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06806033.jpg</video:thumbnail_loc>
      <video:title>Obinutuzumab trial for Relapsed or Refractory Aggressive B-Cell… (NCT06806033): short film</video:title>
      <video:description>Obinutuzumab trial for Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma (NCT06806033). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06806033.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06806033.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:35:14.817Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/evaluating-a-decreased-dose-of-radiation-therapy-to-the-elective-nct07178301/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07178301.jpg</video:thumbnail_loc>
      <video:title>Computed Tomography trial for Clinical Stage I HPV-Mediated… (NCT07178301): short film</video:title>
      <video:description>Computed Tomography trial for Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (NCT07178301). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07178301.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07178301.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:03:48.463Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/evaluating-efficacy-of-b7-h3-car-t-cells-administered-at-the-end-nct07428993/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07428993.jpg</video:thumbnail_loc>
      <video:title>Cyclophosphamide trial for Pediatric Osteosarcoma (NCT07428993): short film</video:title>
      <video:description>Cyclophosphamide trial for Pediatric Osteosarcoma (NCT07428993). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07428993.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07428993.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:02:03.478Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/evaluation-of-alternative-site-goserelin-acetate-injection-for-o-nct07460752/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07460752.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Anatomic Stage I Breast Cancer AJCC v8 (NCT07460752): short film</video:title>
      <video:description>Biospecimen Collection trial for Anatomic Stage I Breast Cancer AJCC v8 (NCT07460752). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07460752.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07460752.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:03:36.670Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/evaluation-of-mirvetuximab-soravtansine-imgn853-in-women-with-fo-nct03832361/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03832361.jpg</video:thumbnail_loc>
      <video:title>IMGN853 trial for Endometrial Cancer (NCT03832361): short film</video:title>
      <video:description>IMGN853 trial for Endometrial Cancer (NCT03832361). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03832361.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03832361.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:47:44.450Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/evaluation-of-the-safety-and-efficacy-of-treatment-w-high-dose-m-nct06607458/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06607458.jpg</video:thumbnail_loc>
      <video:title>Melphalan/HDS Followed by… trial for Refractory Metastatic… (NCT06607458): short film</video:title>
      <video:description>Melphalan/HDS Followed by Consolidation Treatment with Trifluridine-tipiracil plus Bevacizumab trial for Refractory Metastatic Colorectal Cancer (NCT06607458). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06607458.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06607458.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:05:19.926Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/evaluation-of-the-safety-and-efficacy-of-treatment-w-high-dose-m-nct06875128/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06875128.jpg</video:thumbnail_loc>
      <video:title>Melphalan/HDS followed by… trial for Metastatic Breast Cancer in… (NCT06875128): short film</video:title>
      <video:description>Melphalan/HDS followed by Physician's choice of SOC (eribulin, vinorelbine, or capecitabine) trial for Metastatic Breast Cancer in the Liver (NCT06875128). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06875128.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06875128.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:12:19.550Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/evaluation-of-two-dose-levels-of-quizartinib-as-maintenance-in-f-nct06824168/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06824168.jpg</video:thumbnail_loc>
      <video:title>Quizartinib High Dose trial for Acute Myeloid Leukemia (NCT06824168): short film</video:title>
      <video:description>Quizartinib High Dose trial for Acute Myeloid Leukemia (NCT06824168). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06824168.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06824168.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:33:12.097Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/exclaim-exploring-combined-local-and-systemic-approaches-in-brai-nct06649058/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06649058.jpg</video:thumbnail_loc>
      <video:title>Systemic Therapy trial for Brain Metastases (NCT06649058): short film</video:title>
      <video:description>Systemic Therapy trial for Brain Metastases (NCT06649058). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06649058.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06649058.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:37:05.538Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/extracorporeal-photopheresis-and-mogamulizumab-for-the-treatment-nct04930653/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04930653.jpg</video:thumbnail_loc>
      <video:title>Extracorporeal Photopheresis trial for Folliculotropic Mycosis Fungoides (NCT04930653): short film</video:title>
      <video:description>Extracorporeal Photopheresis trial for Folliculotropic Mycosis Fungoides (NCT04930653). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04930653.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04930653.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:00:28.534Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/fdg-pet-guided-metastasis-directed-radiation-therapy-for-the-tre-nct06244004/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06244004.jpg</video:thumbnail_loc>
      <video:title>Antiandrogen Therapy trial for Castration-Sensitive Prostate Carcinoma (NCT06244004): short film</video:title>
      <video:description>Antiandrogen Therapy trial for Castration-Sensitive Prostate Carcinoma (NCT06244004). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06244004.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06244004.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:41:10.674Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/feasibility-study-to-treat-lung-cancer-with-the-permanently-impl-nct03290534/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03290534.jpg</video:thumbnail_loc>
      <video:title>CivaSheet trial for Lung Cancer (NCT03290534): short film</video:title>
      <video:description>CivaSheet trial for Lung Cancer (NCT03290534). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03290534.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03290534.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:18:43.289Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/fludarabine-phosphate-cytarabine-filgrastim-sndz-gemtuzumab-ozog-nct00801489/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT00801489.jpg</video:thumbnail_loc>
      <video:title>Cytarabine trial for Acute Myeloid Leukemia With Inv(16)(p13.1q22);… (NCT00801489): short film</video:title>
      <video:description>Cytarabine trial for Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 (NCT00801489). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT00801489.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT00801489.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:27:00.703Z</video:publication_date>
      <video:duration>92</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/fluorescence-guided-surgical-resection-for-reducing-unexpected-p-nct07650656/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07650656.jpg</video:thumbnail_loc>
      <video:title>Electronic Health Record Review trial for High Grade Sarcoma (NCT07650656): short film</video:title>
      <video:description>Electronic Health Record Review trial for High Grade Sarcoma (NCT07650656). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07650656.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07650656.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:15:44.219Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/focal-therapy-with-stereotactic-body-radiation-therapy-sbrt-for-nct05616650/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05616650.jpg</video:thumbnail_loc>
      <video:title>18F-DCFPyL trial for Prostatic Neoplasms (NCT05616650): short film</video:title>
      <video:description>18F-DCFPyL trial for Prostatic Neoplasms (NCT05616650). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05616650.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05616650.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:30:56.750Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/folate-receptor-alpha-dendritic-cells-fr-dcs-or-placebo-for-the-nct06639074/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06639074.jpg</video:thumbnail_loc>
      <video:title>Biopsy trial for Advanced Fallopian Tube Carcinoma (NCT06639074): short film</video:title>
      <video:description>Biopsy trial for Advanced Fallopian Tube Carcinoma (NCT06639074). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06639074.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06639074.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:57:59.549Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/folfiri-and-bevacizumab-with-or-without-pelareorep-for-second-li-nct07446322/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07446322.jpg</video:thumbnail_loc>
      <video:title>Bevacizumab trial for Ras-mutated Metastatic Colorectal Cancer (NCT07446322): short film</video:title>
      <video:description>Bevacizumab trial for Ras-mutated Metastatic Colorectal Cancer (NCT07446322). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07446322.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07446322.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:21:55.658Z</video:publication_date>
      <video:duration>87</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/folfox-botensilimab-and-balstilimab-for-the-treatment-of-localiz-nct06780787/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06780787.jpg</video:thumbnail_loc>
      <video:title>Balstilimab trial for Rectal Adenocarcinoma (NCT06780787): short film</video:title>
      <video:description>Balstilimab trial for Rectal Adenocarcinoma (NCT06780787). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06780787.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06780787.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:39:31.467Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/fractionated-gemtuzumab-ozogamicin-in-treating-measurable-residu-nct03737955/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03737955.jpg</video:thumbnail_loc>
      <video:title>Gemtuzumab Ozogamicin trial for Acute Myeloid Leukemia (NCT03737955): short film</video:title>
      <video:description>Gemtuzumab Ozogamicin trial for Acute Myeloid Leukemia (NCT03737955). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03737955.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03737955.mp4</video:content_loc>
      <video:publication_date>2026-10-31T23:01:08.654Z</video:publication_date>
      <video:duration>81</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/frameless-stereotactic-radiosurgery-for-intact-brain-metastases-nct02747303/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02747303.jpg</video:thumbnail_loc>
      <video:title>Stereotactic Radiosurgery trial for Brain Metastases (NCT02747303): short film</video:title>
      <video:description>Stereotactic Radiosurgery trial for Brain Metastases (NCT02747303). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT02747303.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02747303.mp4</video:content_loc>
      <video:publication_date>2026-10-31T17:00:20.324Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/functional-precision-oncology-to-predict-prevent-and-treat-early-nct05464082/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05464082.jpg</video:thumbnail_loc>
      <video:title>Functional Precision Oncology trial for Breast Cancer Recurrent (NCT05464082): short film</video:title>
      <video:description>Functional Precision Oncology trial for Breast Cancer Recurrent (NCT05464082). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05464082.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05464082.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:43:02.341Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/futibatinib-in-combination-with-durvalumab-prior-to-cystectomy-f-nct06263153/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06263153.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Bladder Urothelial Carcinoma (NCT06263153): short film</video:title>
      <video:description>Biospecimen Collection trial for Bladder Urothelial Carcinoma (NCT06263153). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06263153.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06263153.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:28:52.765Z</video:publication_date>
      <video:duration>90</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/gemcitabine-and-oxaliplatin-chemotherapy-with-or-without-a-floxu-nct04891289/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04891289.jpg</video:thumbnail_loc>
      <video:title>Gemcitabine trial for Intrahepatic Cholangiocarcinoma (NCT04891289): short film</video:title>
      <video:description>Gemcitabine trial for Intrahepatic Cholangiocarcinoma (NCT04891289). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04891289.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04891289.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:04:16.421Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/gemcitabine-cisplatin-and-nab-paclitaxel-as-neoadjuvant-treatmen-nct06423326/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06423326.jpg</video:thumbnail_loc>
      <video:title>Biopsy trial for Borderline Resectable Pancreatic Ductal Adenocarcinoma (NCT06423326): short film</video:title>
      <video:description>Biopsy trial for Borderline Resectable Pancreatic Ductal Adenocarcinoma (NCT06423326). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06423326.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06423326.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:29:33.831Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/gemcitabine-docetaxel-toripalimab-induction-in-epstein-barr-viru-nct06592599/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06592599.jpg</video:thumbnail_loc>
      <video:title>Toripalimab trial for Nasopharyngeal Carcinoma (NCT06592599): short film</video:title>
      <video:description>Toripalimab trial for Nasopharyngeal Carcinoma (NCT06592599). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06592599.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06592599.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:53:28.823Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/gemcitabine-nab-paclitaxel-plus-the-therabionic-p1-an-amplitude-nct06576115/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06576115.jpg</video:thumbnail_loc>
      <video:title>Nab paclitaxel trial for Metastatic Pancreatic Adenocarcinoma (NCT06576115): short film</video:title>
      <video:description>Nab paclitaxel trial for Metastatic Pancreatic Adenocarcinoma (NCT06576115). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06576115.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06576115.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:07:04.019Z</video:publication_date>
      <video:duration>86</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/genetic-testing-to-select-therapy-for-the-treatment-of-advanced-nct05361720/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05361720.jpg</video:thumbnail_loc>
      <video:title>Cabozantinib trial for Advanced Clear Cell Renal Cell Carcinoma (NCT05361720): short film</video:title>
      <video:description>Cabozantinib trial for Advanced Clear Cell Renal Cell Carcinoma (NCT05361720). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05361720.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05361720.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:17:14.203Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/genomic-biomarker-selected-umbrella-neoadjuvant-study-for-high-r-nct04812366/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04812366.jpg</video:thumbnail_loc>
      <video:title>Apalutamide 60mg Tab trial for Prostate Cancer (NCT04812366): short film</video:title>
      <video:description>Apalutamide 60mg Tab trial for Prostate Cancer (NCT04812366). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04812366.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04812366.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:59:55.732Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/genomically-guided-radiation-therapy-in-the-management-of-triple-nct05528133/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05528133.jpg</video:thumbnail_loc>
      <video:title>Genomically Guided Radiation… trial for Triple Negative Breast Cancer (NCT05528133): short film</video:title>
      <video:description>Genomically Guided Radiation Therapy trial for Triple Negative Breast Cancer (NCT05528133). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05528133.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05528133.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:44:58.555Z</video:publication_date>
      <video:duration>71</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/gi-102-alone-or-with-pembrolizumab-before-surgery-for-treatment-nct07301268/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07301268.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Glioblastoma, IDH-Wildtype (NCT07301268): short film</video:title>
      <video:description>Biospecimen Collection trial for Glioblastoma, IDH-Wildtype (NCT07301268). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07301268.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07301268.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:57:16.031Z</video:publication_date>
      <video:duration>94</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/glioblastoma-temozolomide-with-or-without-wsd0922-fu-nct07708961/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07708961.jpg</video:thumbnail_loc>
      <video:title>Archive Sample Retrieval trial for Glioblastoma, IDH-Wildtype (NCT07708961): short film</video:title>
      <video:description>Archive Sample Retrieval trial for Glioblastoma, IDH-Wildtype (NCT07708961). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07708961.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07708961.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:17:53.369Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/glofitamab-with-pirtobrutinib-for-relapsed-or-refractory-mantle-nct06252675/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06252675.jpg</video:thumbnail_loc>
      <video:title>Obinutuzumab trial for Mantle Cell Lymphoma (NCT06252675): short film</video:title>
      <video:description>Obinutuzumab trial for Mantle Cell Lymphoma (NCT06252675). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06252675.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06252675.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:57:41.395Z</video:publication_date>
      <video:duration>90</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/glory-glofit-gemox-with-liso-cel-for-lymphoma-nct07711483/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07711483.jpg</video:thumbnail_loc>
      <video:title>Obinutuzumab trial for Lymphoma (NCT07711483): short film</video:title>
      <video:description>Obinutuzumab trial for Lymphoma (NCT07711483). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07711483.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07711483.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:26:32.418Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/golcadomide-and-rituximab-as-bridging-therapy-for-relapsed-or-re-nct06834373/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06834373.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Large B-Cell Lymphoma With IRF4… (NCT06834373): short film</video:title>
      <video:description>Biospecimen Collection trial for Large B-Cell Lymphoma With IRF4 Rearrangement (NCT06834373). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06834373.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06834373.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:04:58.828Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/graft-versus-host-disease-reduction-strategies-for-donor-blood-s-nct03970096/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03970096.jpg</video:thumbnail_loc>
      <video:title>Total-Body Irradiation trial for Acute Leukemia (NCT03970096): short film</video:title>
      <video:description>Total-Body Irradiation trial for Acute Leukemia (NCT03970096). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03970096.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03970096.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:07:25.688Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/gt103-in-combination-with-pembrolizumab-for-the-treatment-of-adv-nct07017829/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07017829.jpg</video:thumbnail_loc>
      <video:title>Anti-CFH Monoclonal Antibody GT103 trial for Advanced Lung Non-Small… (NCT07017829): short film</video:title>
      <video:description>Anti-CFH Monoclonal Antibody GT103 trial for Advanced Lung Non-Small Cell Carcinoma (NCT07017829). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07017829.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07017829.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:49:47.041Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/haplo-identical-transplantation-for-severe-aplastic-anemia-hypo-nct03520647/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03520647.jpg</video:thumbnail_loc>
      <video:title>Cyclophosphamide trial for Severe Aplastic Anemia (SAA) (NCT03520647): short film</video:title>
      <video:description>Cyclophosphamide trial for Severe Aplastic Anemia (SAA) (NCT03520647). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03520647.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03520647.mp4</video:content_loc>
      <video:publication_date>2026-10-31T19:00:46.210Z</video:publication_date>
      <video:duration>89</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/haploidentical-donor-cytokine-induced-memory-like-natural-killer-nct07635056/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07635056.jpg</video:thumbnail_loc>
      <video:title>CIML-NK Cells trial for Neuroblastoma (NCT07635056): short film</video:title>
      <video:description>CIML-NK Cells trial for Neuroblastoma (NCT07635056). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07635056.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07635056.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:43:17.412Z</video:publication_date>
      <video:duration>68</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/hcmt-mm2401-ph2-study-of-selinexor-bispecific-antibody-for-rrmm-nct06822972/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06822972.jpg</video:thumbnail_loc>
      <video:title>Selinexor 40 mg trial for Multiple Myeloma in Relapse (NCT06822972): short film</video:title>
      <video:description>Selinexor 40 mg trial for Multiple Myeloma in Relapse (NCT06822972). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06822972.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06822972.mp4</video:content_loc>
      <video:publication_date>2026-10-31T19:54:45.062Z</video:publication_date>
      <video:duration>81</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/herizon-breast-a-ctdna-guided-adaptive-study-of-sequential-anti-nct07459673/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07459673.jpg</video:thumbnail_loc>
      <video:title>Personalis NeXT Personal trial for Breast Cancer (NCT07459673): short film</video:title>
      <video:description>Personalis NeXT Personal trial for Breast Cancer (NCT07459673). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07459673.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07459673.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:23:42.488Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/high-dose-ruxolitinib-and-allogeneic-stem-cell-transplantation-i-nct06345495/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06345495.jpg</video:thumbnail_loc>
      <video:title>Ruxolitinib trial for Splenomegaly (NCT06345495): short film</video:title>
      <video:description>Ruxolitinib trial for Splenomegaly (NCT06345495). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06345495.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06345495.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:35:10.004Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/high-dose-testosterone-for-atm-cdk12-or-chek2-altered-prostate-c-nct05011383/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05011383.jpg</video:thumbnail_loc>
      <video:title>High dose testosterone trial for Metastatic Prostate Cancer (NCT05011383): short film</video:title>
      <video:description>High dose testosterone trial for Metastatic Prostate Cancer (NCT05011383). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05011383.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05011383.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:31:56.277Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/hippocampal-avoidance-in-craniospinal-irradiation-for-the-treatm-nct06518057/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06518057.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Anatomic Stage IV Breast Cancer AJCC v8 (NCT06518057): short film</video:title>
      <video:description>Biospecimen Collection trial for Anatomic Stage IV Breast Cancer AJCC v8 (NCT06518057). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06518057.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06518057.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:59:35.091Z</video:publication_date>
      <video:duration>67</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/hormone-therapy-apalutamide-and-image-guided-stereotactic-body-r-nct06067269/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06067269.jpg</video:thumbnail_loc>
      <video:title>Apalutamide trial for Prostate Adenocarcinoma (NCT06067269): short film</video:title>
      <video:description>Apalutamide trial for Prostate Adenocarcinoma (NCT06067269). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06067269.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06067269.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:34:59.166Z</video:publication_date>
      <video:duration>86</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/hotspot-stereotactic-ablative-radiotherapy-versus-traditional-st-nct07718672/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07718672.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Early Stage Lung Non-Small Cell Carcinoma (NCT07718672): short film</video:title>
      <video:description>Biospecimen Collection trial for Early Stage Lung Non-Small Cell Carcinoma (NCT07718672). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07718672.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07718672.mp4</video:content_loc>
      <video:publication_date>2026-10-31T17:01:11.790Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/hypofractionated-radiation-therapy-for-merkel-cell-carcinoma-nct05100095/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05100095.jpg</video:thumbnail_loc>
      <video:title>Radiation therapy trial for Merkel Cell Carcinoma (NCT05100095): short film</video:title>
      <video:description>Radiation therapy trial for Merkel Cell Carcinoma (NCT05100095). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05100095.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05100095.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:49:19.652Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/hypofractionated-radiochemotherapy-nct06331468/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06331468.jpg</video:thumbnail_loc>
      <video:title>Cisplatin trial for Uterine Cervix Cancer (NCT06331468): short film</video:title>
      <video:description>Cisplatin trial for Uterine Cervix Cancer (NCT06331468). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06331468.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06331468.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:48:07.633Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/iberdomide-and-daratumumab-as-maintenance-therapy-after-an-autol-nct06107738/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06107738.jpg</video:thumbnail_loc>
      <video:title>Iberdomide trial for Multiple Myeloma (NCT06107738): short film</video:title>
      <video:description>Iberdomide trial for Multiple Myeloma (NCT06107738). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06107738.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06107738.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:47:47.873Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/identifying-effective-and-cost-conscious-maintenance-daratumumab-nct07485647/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07485647.jpg</video:thumbnail_loc>
      <video:title>Daratumumab and Recombinant Human Hyaluronidase trial for Multiple Myeloma (NCT07485647): short film</video:title>
      <video:description>Daratumumab and Recombinant Human Hyaluronidase trial for Multiple Myeloma (NCT07485647). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07485647.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07485647.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:49:24.124Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/idh-targeted-non-targeted-vs-non-targeted-idh-targeted-approache-nct05401097/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05401097.jpg</video:thumbnail_loc>
      <video:title>Azacitidine trial for Acute Myeloid Leukemia (NCT05401097): short film</video:title>
      <video:description>Azacitidine trial for Acute Myeloid Leukemia (NCT05401097). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05401097.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05401097.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:57:41.354Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/igfbp-2-vaccine-to-prevent-ovarian-cancer-progression-in-patient-nct07495124/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07495124.jpg</video:thumbnail_loc>
      <video:title>pUMVC3-hIGFBP-2 Multi-epitope… trial for Fallopian Tube Carcinoma (NCT07495124): short film</video:title>
      <video:description>pUMVC3-hIGFBP-2 Multi-epitope Plasmid DNA Vaccine trial for Fallopian Tube Carcinoma (NCT07495124). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07495124.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07495124.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:24:01.170Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/iit2023-09-chung-upfronttad-upfront-tad-snb-in-patients-with-bre-nct06092892/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06092892.jpg</video:thumbnail_loc>
      <video:title>Breast Surgery (BCS or mastectomy) with TAD/SNB trial for Breast Cancer (NCT06092892): short film</video:title>
      <video:description>Breast Surgery (BCS or mastectomy) with TAD/SNB trial for Breast Cancer (NCT06092892). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06092892.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06092892.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:09:00.638Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/ilkn421h-plus-pembrolizumab-in-advanced-non-small-cell-lung-canc-nct07452224/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07452224.jpg</video:thumbnail_loc>
      <video:title>ILKN421H trial for Locally Advanced or Metastatic Non-Small Cell… (NCT07452224): short film</video:title>
      <video:description>ILKN421H trial for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) (NCT07452224). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07452224.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07452224.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:18:24.939Z</video:publication_date>
      <video:duration>87</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/illuminate-a-clinical-study-evaluating-car-t-immune-cell-therapy-nct07680439/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07680439.jpg</video:thumbnail_loc>
      <video:title>BCB-276 trial for Diffuse Intrinsic Pontine Glioma (NCT07680439): short film</video:title>
      <video:description>BCB-276 trial for Diffuse Intrinsic Pontine Glioma (NCT07680439). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07680439.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07680439.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:27:32.367Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/imlunestrant-and-abemaciclib-for-the-treatment-of-estrogen-recep-nct07191717/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07191717.jpg</video:thumbnail_loc>
      <video:title>Abemaciclib trial for Anatomic Stage I Breast Cancer AJCC v8 (NCT07191717): short film</video:title>
      <video:description>Abemaciclib trial for Anatomic Stage I Breast Cancer AJCC v8 (NCT07191717). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07191717.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07191717.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:46:04.250Z</video:publication_date>
      <video:duration>81</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/immunoplant-for-newly-diagnosed-multiple-myeloma-nct06376526/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06376526.jpg</video:thumbnail_loc>
      <video:title>Linvoseltamab trial for Multiple Myeloma (NCT06376526): short film</video:title>
      <video:description>Linvoseltamab trial for Multiple Myeloma (NCT06376526). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06376526.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06376526.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:56:13.303Z</video:publication_date>
      <video:duration>81</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/immunotherapy-and-nodal-sparing-irradiation-for-t-cell-induction-nct07773987/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07773987.jpg</video:thumbnail_loc>
      <video:title>Pembrolizumab trial for Head and Neck Cancer Squamous Cell Carcinoma (NCT07773987): short film</video:title>
      <video:description>Pembrolizumab trial for Head and Neck Cancer Squamous Cell Carcinoma (NCT07773987). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07773987.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07773987.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:08:27.315Z</video:publication_date>
      <video:duration>95</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/immunotherapy-biomarkers-to-predict-first-line-pd-l-1-based-immu-nct07288034/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07288034.jpg</video:thumbnail_loc>
      <video:title>Adagrasib trial for Lung Non-Small Cell Carcinoma (NCT07288034): short film</video:title>
      <video:description>Adagrasib trial for Lung Non-Small Cell Carcinoma (NCT07288034). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07288034.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07288034.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:16:08.247Z</video:publication_date>
      <video:duration>86</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/immunotherapy-platform-study-in-platinum-resistant-high-grade-se-nct04918186/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04918186.jpg</video:thumbnail_loc>
      <video:title>Durvalumab trial for Ovarian Cancer (NCT04918186): short film</video:title>
      <video:description>Durvalumab trial for Ovarian Cancer (NCT04918186). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04918186.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04918186.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:28:11.374Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/immunotherapy-toripalimab-for-reducing-recurrence-risk-after-sur-nct07140679/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07140679.jpg</video:thumbnail_loc>
      <video:title>Biopsy Procedure trial for Localized Colon Carcinoma (NCT07140679): short film</video:title>
      <video:description>Biopsy Procedure trial for Localized Colon Carcinoma (NCT07140679). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07140679.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07140679.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:32:31.885Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/immunotherapy-using-tumor-infiltrating-lymphocytes-for-patients-nct01174121/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT01174121.jpg</video:thumbnail_loc>
      <video:title>Pembrolizumab (Keytruda) trial for Metastatic Colorectal Cancer (NCT01174121): short film</video:title>
      <video:description>Pembrolizumab (Keytruda) trial for Metastatic Colorectal Cancer (NCT01174121). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT01174121.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT01174121.mp4</video:content_loc>
      <video:publication_date>2026-10-31T23:04:53.406Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/impact-of-vitamin-d-supplementation-on-the-rate-of-pathologic-co-nct04677816/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04677816.jpg</video:thumbnail_loc>
      <video:title>Standard of Care Neoadjuvant… trial for Triple Negative Breast Cancer (NCT04677816): short film</video:title>
      <video:description>Standard of Care Neoadjuvant Chemotherapy (NAC) trial for Triple Negative Breast Cancer (NCT04677816). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04677816.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04677816.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:38:51.480Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/individualized-screening-trial-of-innovative-glioblastoma-therap-nct02977780/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02977780.jpg</video:thumbnail_loc>
      <video:title>Temozolomide trial for Glioblastoma (NCT02977780): short film</video:title>
      <video:description>Temozolomide trial for Glioblastoma (NCT02977780). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT02977780.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02977780.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:26:49.433Z</video:publication_date>
      <video:duration>95</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/innovative-trial-for-understanding-the-impact-of-targeted-therap-nct04374305/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04374305.jpg</video:thumbnail_loc>
      <video:title>Brigatinib trial for Neurofibromatosis Type 2 (NCT04374305): short film</video:title>
      <video:description>Brigatinib trial for Neurofibromatosis Type 2 (NCT04374305). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04374305.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04374305.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:20:55.579Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/inobrodib-pomalidomide-and-dexamethasone-in-relapsed-or-refracto-nct07096778/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07096778.jpg</video:thumbnail_loc>
      <video:title>Inobrodib trial for Multiple Myeloma Refractory (NCT07096778): short film</video:title>
      <video:description>Inobrodib trial for Multiple Myeloma Refractory (NCT07096778). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07096778.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07096778.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:18:00.819Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/inotuzumab-ozogamicin-and-blinatumomab-with-or-without-ponatinib-nct03739814/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03739814.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for B Acute Lymphoblastic Leukemia,… (NCT03739814): short film</video:title>
      <video:description>Biospecimen Collection trial for B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative (NCT03739814). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03739814.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03739814.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:31:43.233Z</video:publication_date>
      <video:duration>81</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/intensity-modulated-total-marrow-irradiation-in-fully-human-leuk-nct06802315/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06802315.jpg</video:thumbnail_loc>
      <video:title>Intensity modulated total marrow… trial for Acute Myeloid Leukemia,… (NCT06802315): short film</video:title>
      <video:description>Intensity modulated total marrow irradiation trial for Acute Myeloid Leukemia, Relapsed, Adult (NCT06802315). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06802315.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06802315.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:46:59.564Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/interleukin-6-receptor-inhibitor-sarilumab-in-combination-with-i-nct05428007/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05428007.jpg</video:thumbnail_loc>
      <video:title>Sarilumab trial for Melanoma (NCT05428007): short film</video:title>
      <video:description>Sarilumab trial for Melanoma (NCT05428007). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05428007.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05428007.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:30:36.842Z</video:publication_date>
      <video:duration>81</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/intermittent-fasting-using-a-fasting-mimicking-diet-to-improve-p-nct05832086/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05832086.jpg</video:thumbnail_loc>
      <video:title>Fasting Mimicking Diet (FMD) trial for Prostate Adenocarcinoma (NCT05832086): short film</video:title>
      <video:description>Fasting Mimicking Diet (FMD) trial for Prostate Adenocarcinoma (NCT05832086). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05832086.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05832086.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:09:57.567Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/intralesional-chemotherapy-ic-cisplatin-epinephrine-nct07392580/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07392580.jpg</video:thumbnail_loc>
      <video:title>Cisplatin trial for Laryngeal Squamous Cell Carcinoma (NCT07392580): short film</video:title>
      <video:description>Cisplatin trial for Laryngeal Squamous Cell Carcinoma (NCT07392580). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07392580.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07392580.mp4</video:content_loc>
      <video:publication_date>2026-10-31T17:02:54.144Z</video:publication_date>
      <video:duration>67</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/investigation-of-ubamatamab-combination-therapy-in-adult-partici-nct06787612/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06787612.jpg</video:thumbnail_loc>
      <video:title>Ubamatamab trial for Ovarian Cancer (NCT06787612): short film</video:title>
      <video:description>Ubamatamab trial for Ovarian Cancer (NCT06787612). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06787612.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06787612.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:39:57.735Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/ivonescimab-alone-and-with-carboplatin-pemetrexed-for-nsclc-nct07405190/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07405190.jpg</video:thumbnail_loc>
      <video:title>Ivonescimab trial for Lung Cancer (NSCLC) (NCT07405190): short film</video:title>
      <video:description>Ivonescimab trial for Lung Cancer (NSCLC) (NCT07405190). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07405190.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07405190.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:01:24.801Z</video:publication_date>
      <video:duration>101</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/ivonescimab-before-surgery-for-the-treatment-of-resectable-stage-nct07094685/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07094685.jpg</video:thumbnail_loc>
      <video:title>Biopsy Procedure trial for Advanced Head and Neck Squamous Cell Carcinoma (NCT07094685): short film</video:title>
      <video:description>Biopsy Procedure trial for Advanced Head and Neck Squamous Cell Carcinoma (NCT07094685). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07094685.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07094685.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:41:22.625Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/ivonescimab-for-the-treatment-of-thymic-cancer-nct06980077/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06980077.jpg</video:thumbnail_loc>
      <video:title>Biopsy Procedure trial for Thymus Carcinoma (NCT06980077): short film</video:title>
      <video:description>Biopsy Procedure trial for Thymus Carcinoma (NCT06980077). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06980077.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06980077.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:29:47.231Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/ivonescimab-in-comb-with-folfox-in-advanced-her2-neg-gea-nct07070466/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07070466.jpg</video:thumbnail_loc>
      <video:title>Ivonescimab trial for Stomach Cancer Stage IV (NCT07070466): short film</video:title>
      <video:description>Ivonescimab trial for Stomach Cancer Stage IV (NCT07070466). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07070466.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07070466.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:06:58.278Z</video:publication_date>
      <video:duration>88</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/ivonescimab-prior-to-surgery-for-the-treatment-of-high-risk-loca-nct07226544/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07226544.jpg</video:thumbnail_loc>
      <video:title>Biopsy Procedure trial for Localized Clear Cell Renal Cell Carcinoma (NCT07226544): short film</video:title>
      <video:description>Biopsy Procedure trial for Localized Clear Cell Renal Cell Carcinoma (NCT07226544). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07226544.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07226544.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:54:28.971Z</video:publication_date>
      <video:duration>68</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/ivosidenib-as-post-hsct-maintenance-for-aml-nct06707493/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06707493.jpg</video:thumbnail_loc>
      <video:title>Ivosidenib trial for IDH1 Mutation (NCT06707493): short film</video:title>
      <video:description>Ivosidenib trial for IDH1 Mutation (NCT06707493). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06707493.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06707493.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:36:22.545Z</video:publication_date>
      <video:duration>85</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/keymaker-u01-substudy-01j-a-study-of-pembrolizumab-plus-mk-1084-nct07252739/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07252739.jpg</video:thumbnail_loc>
      <video:title>MK-1084 trial for Malignant Neoplasm (NCT07252739): short film</video:title>
      <video:description>MK-1084 trial for Malignant Neoplasm (NCT07252739). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07252739.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07252739.mp4</video:content_loc>
      <video:publication_date>2026-10-31T19:59:02.613Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/kqb198-in-combination-with-imatinib-in-participants-with-advance-nct07406633/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07406633.jpg</video:thumbnail_loc>
      <video:title>KQB198 trial for GIST - Gastrointestinal Stromal Tumor (NCT07406633): short film</video:title>
      <video:description>KQB198 trial for GIST - Gastrointestinal Stromal Tumor (NCT07406633). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07406633.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07406633.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:08:17.264Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/l19il2-l19tnf-in-patients-with-cutaneous-squamous-cell-carcinoma-nct07228442/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07228442.jpg</video:thumbnail_loc>
      <video:title>L19IL2/L19TNF trial for Locally Advanced Cutaneous Squamous Cell Carcinoma (NCT07228442): short film</video:title>
      <video:description>L19IL2/L19TNF trial for Locally Advanced Cutaneous Squamous Cell Carcinoma (NCT07228442). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07228442.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07228442.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:08:30.458Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/l19il2-tnf-in-patients-with-basal-cell-carcinoma-nct07227870/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07227870.jpg</video:thumbnail_loc>
      <video:title>L19IL2/L19TNF trial for Locally Advanced Basal Cell Carcinoma (NCT07227870): short film</video:title>
      <video:description>L19IL2/L19TNF trial for Locally Advanced Basal Cell Carcinoma (NCT07227870). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07227870.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07227870.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:27:06.419Z</video:publication_date>
      <video:duration>81</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/lerapolturev-pvsripo-in-gbm-nct06177964/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06177964.jpg</video:thumbnail_loc>
      <video:title>Lerapolturev trial for Recurrent Supratentorial Glioblastoma (NCT06177964): short film</video:title>
      <video:description>Lerapolturev trial for Recurrent Supratentorial Glioblastoma (NCT06177964). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06177964.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06177964.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:30:47.527Z</video:publication_date>
      <video:duration>87</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/letrozole-in-uterine-leiomyosarcoma-nct05649956/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05649956.jpg</video:thumbnail_loc>
      <video:title>Letrozole trial for Uterine Leiomyosarcoma (NCT05649956): short film</video:title>
      <video:description>Letrozole trial for Uterine Leiomyosarcoma (NCT05649956). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05649956.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05649956.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:47:47.824Z</video:publication_date>
      <video:duration>86</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/leuprolide-and-goserelin-for-ovarian-function-suppression-in-pre-nct07158021/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07158021.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Anatomic Stage I Breast Cancer AJCC v8 (NCT07158021): short film</video:title>
      <video:description>Biospecimen Collection trial for Anatomic Stage I Breast Cancer AJCC v8 (NCT07158021). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07158021.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07158021.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:58:27.968Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/liposomal-irinotecan-with-tas102-and-bevacizumab-for-patients-wi-nct05854498/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05854498.jpg</video:thumbnail_loc>
      <video:title>Liposomal irinotecan trial for Metastatic Colorectal Cancer (NCT05854498): short film</video:title>
      <video:description>Liposomal irinotecan trial for Metastatic Colorectal Cancer (NCT05854498). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05854498.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05854498.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:27:22.494Z</video:publication_date>
      <video:duration>91</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/liposome-encapsulated-daunorubicin-cytarabine-and-venetoclax-in-nct03629171/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03629171.jpg</video:thumbnail_loc>
      <video:title>Liposome-encapsulated… trial for Recurrent Acute Myeloid… (NCT03629171): short film</video:title>
      <video:description>Liposome-encapsulated Daunorubicin-Cytarabine trial for Recurrent Acute Myeloid Leukemia (NCT03629171). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03629171.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03629171.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:25:36.955Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/liquid-nitrogen-spray-cryotherapy-prior-to-neoadjuvant-systemic-nct07222657/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07222657.jpg</video:thumbnail_loc>
      <video:title>Standard of care chemotherapy trial for Esophageal Adenocarcinoma (NCT07222657): short film</video:title>
      <video:description>Standard of care chemotherapy trial for Esophageal Adenocarcinoma (NCT07222657). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07222657.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07222657.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:52:08.484Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/local-consolidative-therapy-and-durvalumab-for-oligoprogressive-nct04892953/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04892953.jpg</video:thumbnail_loc>
      <video:title>Carboplatin trial for Stage III Lung Cancer AJCC v8 (NCT04892953): short film</video:title>
      <video:description>Carboplatin trial for Stage III Lung Cancer AJCC v8 (NCT04892953). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04892953.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04892953.mp4</video:content_loc>
      <video:publication_date>2026-10-31T19:56:43.218Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/loncastuximab-tesirine-and-mosunetuzumab-for-the-treatment-of-re-nct05672251/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05672251.jpg</video:thumbnail_loc>
      <video:title>Biopsy trial for Recurrent Diffuse Large B-Cell Lymphoma (NCT05672251): short film</video:title>
      <video:description>Biopsy trial for Recurrent Diffuse Large B-Cell Lymphoma (NCT05672251). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05672251.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05672251.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:45:33.273Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/loncastuximab-tesirine-and-rituximab-as-bridging-therapy-before-nct06788964/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06788964.jpg</video:thumbnail_loc>
      <video:title>Loncastuximab Tesirine trial for Relapsed or Refractory Large B-cell… (NCT06788964): short film</video:title>
      <video:description>Loncastuximab Tesirine trial for Relapsed or Refractory Large B-cell Lymphoma (NCT06788964). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06788964.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06788964.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:33:14.946Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/low-dose-mosunetuzumab-for-the-treatment-of-patients-with-indole-nct06442475/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06442475.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Ann Arbor Stage II Follicular Lymphoma (NCT06442475): short film</video:title>
      <video:description>Biospecimen Collection trial for Ann Arbor Stage II Follicular Lymphoma (NCT06442475). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06442475.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06442475.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:51:50.745Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/low-psma-suv-boost-lps-boost-intensified-177lu-psma-617-treatmen-nct06526299/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06526299.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Metastatic Castration-Resistant… (NCT06526299): short film</video:title>
      <video:description>Biospecimen Collection trial for Metastatic Castration-Resistant Prostate Carcinoma (NCT06526299). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06526299.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06526299.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:23:33.513Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/lu-177-dotatate-lutathera-in-therapy-of-inoperable-pheochromocyt-nct03206060/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03206060.jpg</video:thumbnail_loc>
      <video:title>Lu-177-DOTATATE trial for Pheochromocytoma (NCT03206060): short film</video:title>
      <video:description>Lu-177-DOTATATE trial for Pheochromocytoma (NCT03206060). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03206060.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03206060.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:52:22.658Z</video:publication_date>
      <video:duration>81</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/luminal-bladder-cancer-effective-response-to-neoadjuvant-chemoth-nct07762586/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07762586.jpg</video:thumbnail_loc>
      <video:title>Neoadjuvant Therapy trial for Bladder Cancer (NCT07762586): short film</video:title>
      <video:description>Neoadjuvant Therapy trial for Bladder Cancer (NCT07762586). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07762586.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07762586.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:46:16.846Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/lurbinectedin-with-or-without-avelumab-in-small-cell-carcinoma-o-nct06228066/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06228066.jpg</video:thumbnail_loc>
      <video:title>Lurbinectedin trial for Small Cell Carcinoma of the Bladder (NCT06228066): short film</video:title>
      <video:description>Lurbinectedin trial for Small Cell Carcinoma of the Bladder (NCT06228066). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06228066.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06228066.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:23:33.352Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/lutathera-for-the-treatment-of-inoperable-progressive-meningioma-nct04082520/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04082520.jpg</video:thumbnail_loc>
      <video:title>Gallium Ga 68-DOTATATE trial for Grade 1 Meningioma (NCT04082520): short film</video:title>
      <video:description>Gallium Ga 68-DOTATATE trial for Grade 1 Meningioma (NCT04082520). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04082520.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04082520.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:14:32.325Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/maintenance-combinatorial-myeloid-immunotherapy-for-unresectable-nct07199764/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07199764.jpg</video:thumbnail_loc>
      <video:title>Odetiglucan trial for Pancreatic Ductal Adenocarcinoma (NCT07199764): short film</video:title>
      <video:description>Odetiglucan trial for Pancreatic Ductal Adenocarcinoma (NCT07199764). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07199764.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07199764.mp4</video:content_loc>
      <video:publication_date>2026-11-01T00:06:33.793Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/maintenance-niraparib-plus-ipilimumab-in-patients-with-metastati-nct06747845/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06747845.jpg</video:thumbnail_loc>
      <video:title>Niraparib trial for Pancreatic Adenocarcinoma Metastatic (NCT06747845): short film</video:title>
      <video:description>Niraparib trial for Pancreatic Adenocarcinoma Metastatic (NCT06747845). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06747845.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06747845.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:49:05.294Z</video:publication_date>
      <video:duration>91</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/maintenance-obinutuzumab-in-treating-patients-with-central-nervo-nct06175000/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06175000.jpg</video:thumbnail_loc>
      <video:title>Cognitive Assessment trial for Primary Central Nervous System Lymphoma (NCT06175000): short film</video:title>
      <video:description>Cognitive Assessment trial for Primary Central Nervous System Lymphoma (NCT06175000). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06175000.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06175000.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:01:37.585Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/marginal-zone-lymphoma-nemtabrutinib-and-rituximab-nct07583810/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07583810.jpg</video:thumbnail_loc>
      <video:title>Biopsy Procedure trial for Conjunctival Mucosa-Associated Lymphoid… (NCT07583810): short film</video:title>
      <video:description>Biopsy Procedure trial for Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma (NCT07583810). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07583810.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07583810.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:16:33.740Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/mavric-studies-2l-treatment-with-av-in-patients-with-cll-sll-who-nct07024706/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07024706.jpg</video:thumbnail_loc>
      <video:title>Acalabrutinib trial for Chronic Lymphocytic Leukemia (CLL) (NCT07024706): short film</video:title>
      <video:description>Acalabrutinib trial for Chronic Lymphocytic Leukemia (CLL) (NCT07024706). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07024706.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07024706.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:54:53.309Z</video:publication_date>
      <video:duration>85</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/mdrt-in-prostate-cancer-treated-with-long-term-androgen-deprivat-nct06150417/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06150417.jpg</video:thumbnail_loc>
      <video:title>Androgen deprivation therapy (ADT) trial for Prostate Cancer (NCT06150417): short film</video:title>
      <video:description>Androgen deprivation therapy (ADT) trial for Prostate Cancer (NCT06150417). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06150417.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06150417.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:37:19.705Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/measurable-residual-disease-guided-post-transplant-elranatamab-m-nct06483100/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06483100.jpg</video:thumbnail_loc>
      <video:title>Elrantamab trial for Multiple Myeloma (NCT06483100): short film</video:title>
      <video:description>Elrantamab trial for Multiple Myeloma (NCT06483100). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06483100.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06483100.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:16:07.153Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/metformin-hydrochloride-in-combination-with-standard-of-care-sys-nct07291297/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07291297.jpg</video:thumbnail_loc>
      <video:title>Metformin Hydrochloride ER trial for Sarcoma Metastatic (NCT07291297): short film</video:title>
      <video:description>Metformin Hydrochloride ER trial for Sarcoma Metastatic (NCT07291297). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07291297.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07291297.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:14:44.501Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/metformin-in-pseudomyxoma-peritonei-secondary-to-appendiceal-muc-nct07693452/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07693452.jpg</video:thumbnail_loc>
      <video:title>Metformin trial for Appendiceal Mucinous Neoplasm (NCT07693452): short film</video:title>
      <video:description>Metformin trial for Appendiceal Mucinous Neoplasm (NCT07693452). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07693452.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07693452.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:13:12.129Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/methylprednisolone-horse-anti-thymocyte-globulin-cyclosporine-fi-nct01624805/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT01624805.jpg</video:thumbnail_loc>
      <video:title>Anti-Thymocyte Globulin trial for Aplastic Anemia (NCT01624805): short film</video:title>
      <video:description>Anti-Thymocyte Globulin trial for Aplastic Anemia (NCT01624805). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT01624805.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT01624805.mp4</video:content_loc>
      <video:publication_date>2026-10-31T23:43:07.074Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/metronomic-decitabine-cedazuridine-and-venetoclax-in-r-r-aml-hr-nct07710534/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07710534.jpg</video:thumbnail_loc>
      <video:title>Decitabine-cedazuridine plus… trial for Relapsed / Refractory AML (NCT07710534): short film</video:title>
      <video:description>Decitabine-cedazuridine plus venetoclax (DEC-C+VEN) trial for Relapsed / Refractory AML (NCT07710534). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07710534.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07710534.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:09:40.058Z</video:publication_date>
      <video:duration>92</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/metronomic-gemcitabine-mitomycin-c-and-thalidomide-for-advanced-nct07671534/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07671534.jpg</video:thumbnail_loc>
      <video:title>Gemcitabine trial for Solid Tumor Cancer (NCT07671534): short film</video:title>
      <video:description>Gemcitabine trial for Solid Tumor Cancer (NCT07671534). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07671534.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07671534.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:41:28.725Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/mezigdomide-carfilzomib-and-dexamethasone-for-the-treatment-of-r-nct06627751/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06627751.jpg</video:thumbnail_loc>
      <video:title>Mezigdomide trial for Extramedullary Disease in Multiple Myeloma (NCT06627751): short film</video:title>
      <video:description>Mezigdomide trial for Extramedullary Disease in Multiple Myeloma (NCT06627751). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06627751.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06627751.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:55:32.038Z</video:publication_date>
      <video:duration>81</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/mogamulizumab-low-dose-total-skin-electron-beam-tx-in-mycosis-fu-nct04256018/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04256018.jpg</video:thumbnail_loc>
      <video:title>Mogamulizumab trial for Sezary Syndrome (NCT04256018): short film</video:title>
      <video:description>Mogamulizumab trial for Sezary Syndrome (NCT04256018). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04256018.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04256018.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:34:43.038Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/molecular-analyses-to-predict-pathways-of-endocrine-resistance-f-nct06361940/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06361940.jpg</video:thumbnail_loc>
      <video:title>Aromatase inhibitors or tamoxifen trial for Breast Cancer (NCT06361940): short film</video:title>
      <video:description>Aromatase inhibitors or tamoxifen trial for Breast Cancer (NCT06361940). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06361940.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06361940.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:05:44.324Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/molecular-and-clinical-risk-directed-therapy-for-infants-and-you-nct05535166/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05535166.jpg</video:thumbnail_loc>
      <video:title>Surgical resection trial for Medulloblastoma (NCT05535166): short film</video:title>
      <video:description>Surgical resection trial for Medulloblastoma (NCT05535166). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05535166.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05535166.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:38:22.360Z</video:publication_date>
      <video:duration>95</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/monthly-alternating-nalirifox-and-gnp-in-the-first-line-setting-nct07163273/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07163273.jpg</video:thumbnail_loc>
      <video:title>NALIRIFOX trial for Pancreatic Ductal Adenocarcinoma (NCT07163273): short film</video:title>
      <video:description>NALIRIFOX trial for Pancreatic Ductal Adenocarcinoma (NCT07163273). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07163273.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07163273.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:02:18.256Z</video:publication_date>
      <video:duration>89</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/mosunetuzumab-and-polatuzumab-vedotin-for-the-treatment-of-patie-nct06453044/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06453044.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Recurrent Grade 1 Follicular Lymphoma (NCT06453044): short film</video:title>
      <video:description>Biospecimen Collection trial for Recurrent Grade 1 Follicular Lymphoma (NCT06453044). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06453044.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06453044.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:05:20.739Z</video:publication_date>
      <video:duration>89</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/mosunetuzumab-and-polatuzumab-vedotin-with-split-dose-chp-chemot-nct06594939/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06594939.jpg</video:thumbnail_loc>
      <video:title>Polatuzumab Vedotin trial for Diffuse Large B Cell Lymphoma (DLBCL) (NCT06594939): short film</video:title>
      <video:description>Polatuzumab Vedotin trial for Diffuse Large B Cell Lymphoma (DLBCL) (NCT06594939). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06594939.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06594939.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:40:04.361Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/mosunetuzumab-with-lenalidomide-augmentation-as-first-line-thera-nct04792502/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04792502.jpg</video:thumbnail_loc>
      <video:title>Mosunetuzumab trial for Follicular Lymphoma (NCT04792502): short film</video:title>
      <video:description>Mosunetuzumab trial for Follicular Lymphoma (NCT04792502). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04792502.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04792502.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:48:12.540Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/mri-based-focal-intraprostatic-simultaneous-integrated-boost-sib-nct07644598/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07644598.jpg</video:thumbnail_loc>
      <video:title>Microboost SBRT trial for Prostate Cancer (NCT07644598): short film</video:title>
      <video:description>Microboost SBRT trial for Prostate Cancer (NCT07644598). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07644598.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07644598.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:50:26.562Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/mt2022-60-ph-2-study-of-pembro-beam-with-asct-for-relapsed-hodgk-nct06377540/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06377540.jpg</video:thumbnail_loc>
      <video:title>Pembrolizumab trial for Autologous Stem Cell Transplant (NCT06377540): short film</video:title>
      <video:description>Pembrolizumab trial for Autologous Stem Cell Transplant (NCT06377540). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06377540.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06377540.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:39:37.282Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/myeloablative-consolidation-therapy-and-tandem-autologous-stem-c-nct02605421/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02605421.jpg</video:thumbnail_loc>
      <video:title>Thiotepa trial for Neuroblastoma (NCT02605421): short film</video:title>
      <video:description>Thiotepa trial for Neuroblastoma (NCT02605421). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT02605421.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02605421.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:16:38.539Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/nalirifox-before-surgery-for-the-treatment-of-borderline-resecta-nct06821997/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06821997.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Borderline Resectable Pancreatic Ductal… (NCT06821997): short film</video:title>
      <video:description>Biospecimen Collection trial for Borderline Resectable Pancreatic Ductal Adenocarcinoma (NCT06821997). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06821997.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06821997.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:32:00.069Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/nant-2021-01-phase-ii-sting-sequential-temozolomide-irinotecan-n-nct06450041/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06450041.jpg</video:thumbnail_loc>
      <video:title>Universal Donor (UD) TGFβi NK Cells trial for Neuroblastoma (NCT06450041): short film</video:title>
      <video:description>Universal Donor (UD) TGFβi NK Cells trial for Neuroblastoma (NCT06450041). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06450041.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06450041.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:28:25.965Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/naxitamab-added-to-induction-for-newly-diagnosed-high-risk-neuro-nct05489887/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05489887.jpg</video:thumbnail_loc>
      <video:title>Naxitamab trial for Neuroblastoma (NCT05489887): short film</video:title>
      <video:description>Naxitamab trial for Neuroblastoma (NCT05489887). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05489887.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05489887.mp4</video:content_loc>
      <video:publication_date>2026-10-31T23:02:37.791Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/nemtabrutinib-and-lisocabtagene-maraleucel-for-the-treatment-of-nct07194980/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07194980.jpg</video:thumbnail_loc>
      <video:title>Nemtabrutinib trial for Recurrent Chronic Lymphocytic Leukemia/Small… (NCT07194980): short film</video:title>
      <video:description>Nemtabrutinib trial for Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (NCT07194980). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07194980.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07194980.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:25:14.638Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/nemtabrutinib-and-pembrolizumab-for-the-treatment-of-richter-tra-nct06863402/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06863402.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Richter Syndrome (NCT06863402): short film</video:title>
      <video:description>Biospecimen Collection trial for Richter Syndrome (NCT06863402). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06863402.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06863402.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:50:35.410Z</video:publication_date>
      <video:duration>86</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/nemtabrutinib-and-venetoclax-for-the-treatment-of-patients-with-nct07557056/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07557056.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Chronic Lymphocytic Leukemia (NCT07557056): short film</video:title>
      <video:description>Biospecimen Collection trial for Chronic Lymphocytic Leukemia (NCT07557056). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07557056.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07557056.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:35:46.070Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/nemtabrutinib-with-car-t-therapy-in-relapsed-refractory-mantle-c-nct07673367/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07673367.jpg</video:thumbnail_loc>
      <video:title>Nemtabrutinib trial for Recurrent Mantle Cell Lymphoma (NCT07673367): short film</video:title>
      <video:description>Nemtabrutinib trial for Recurrent Mantle Cell Lymphoma (NCT07673367). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07673367.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07673367.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:56:39.621Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/neoadjuvant-and-adjuvant-treatment-in-resectable-non-small-cell-nct05061550/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05061550.jpg</video:thumbnail_loc>
      <video:title>Durvalumab trial for Non-small Cell Lung Cancer (NCT05061550): short film</video:title>
      <video:description>Durvalumab trial for Non-small Cell Lung Cancer (NCT05061550). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05061550.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05061550.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:17:26.357Z</video:publication_date>
      <video:duration>89</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/neoadjuvant-botensilimab-and-balstilimab-for-the-treatment-of-ad-nct07595874/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07595874.jpg</video:thumbnail_loc>
      <video:title>Balstilimab trial for Advanced Colon Adenocarcinoma (NCT07595874): short film</video:title>
      <video:description>Balstilimab trial for Advanced Colon Adenocarcinoma (NCT07595874). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07595874.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07595874.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:08:51.211Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/neoadjuvant-chemo-immunotherapy-and-surgical-resection-in-locall-nct06449313/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06449313.jpg</video:thumbnail_loc>
      <video:title>Cemiplimab-Rwlc trial for Non-small Cell Lung Cancer Stage III (NCT06449313): short film</video:title>
      <video:description>Cemiplimab-Rwlc trial for Non-small Cell Lung Cancer Stage III (NCT06449313). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06449313.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06449313.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:17:18.156Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/neoadjuvant-chemotherapy-for-borderline-resectable-and-locally-a-nct05825066/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05825066.jpg</video:thumbnail_loc>
      <video:title>Nab paclitaxel trial for Pancreas Adenocarcinoma (NCT05825066): short film</video:title>
      <video:description>Nab paclitaxel trial for Pancreas Adenocarcinoma (NCT05825066). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05825066.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05825066.mp4</video:content_loc>
      <video:publication_date>2026-10-31T14:57:37.136Z</video:publication_date>
      <video:duration>88</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/neoadjuvant-folfirinox-combined-with-pembrolizumab-followed-by-s-nct05132504/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05132504.jpg</video:thumbnail_loc>
      <video:title>Pembrolizumab trial for Pancreatic Ductal Adenocarcinoma (NCT05132504): short film</video:title>
      <video:description>Pembrolizumab trial for Pancreatic Ductal Adenocarcinoma (NCT05132504). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05132504.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05132504.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:42:56.032Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/neoadjuvant-inbrx-106-in-combination-with-pembrolizumab-for-stag-nct06353997/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06353997.jpg</video:thumbnail_loc>
      <video:title>Pembrolizumab trial for Triple Negative Breast Cancer (NCT06353997): short film</video:title>
      <video:description>Pembrolizumab trial for Triple Negative Breast Cancer (NCT06353997). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06353997.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06353997.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:34:36.220Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/neoadjuvant-lenvatinib-and-pembrolizumab-for-ivc-tumor-thrombus-nct05319015/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05319015.jpg</video:thumbnail_loc>
      <video:title>Neoadjuvant Lenvatinib trial for Renal Cell Carcinoma (NCT05319015): short film</video:title>
      <video:description>Neoadjuvant Lenvatinib trial for Renal Cell Carcinoma (NCT05319015). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05319015.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05319015.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:36:09.039Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/neoadjuvant-neratinib-in-stage-i-iii-her2-mutated-lobular-breast-nct05919108/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05919108.jpg</video:thumbnail_loc>
      <video:title>Endocrine Therapy trial for Anatomic Stage I Breast Cancer (NCT05919108): short film</video:title>
      <video:description>Endocrine Therapy trial for Anatomic Stage I Breast Cancer (NCT05919108). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05919108.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05919108.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:50:07.387Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/neoadjuvant-pembrolizumab-and-porustobart-in-resectable-pmmr-mss-nct07808151/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07808151.jpg</video:thumbnail_loc>
      <video:title>Pembrolizumab trial for Colon Cancer (NCT07808151): short film</video:title>
      <video:description>Pembrolizumab trial for Colon Cancer (NCT07808151). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07808151.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07808151.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:21:18.584Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/neoadjuvant-spare-adjuvant-nasa-in-stage-iiib-iv-m1a-melanoma-nct07740941/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07740941.jpg</video:thumbnail_loc>
      <video:title>Pembrolizumab trial for Melanoma (Skin Cancer) (NCT07740941): short film</video:title>
      <video:description>Pembrolizumab trial for Melanoma (Skin Cancer) (NCT07740941). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07740941.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07740941.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:58:26.060Z</video:publication_date>
      <video:duration>71</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/neoadjuvant-tebentafusp-for-uveal-melanoma-nct06414590/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06414590.jpg</video:thumbnail_loc>
      <video:title>Tebentafusp-Tebn trial for Locally Advanced Unresectable Uveal Melanoma (NCT06414590): short film</video:title>
      <video:description>Tebentafusp-Tebn trial for Locally Advanced Unresectable Uveal Melanoma (NCT06414590). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06414590.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06414590.mp4</video:content_loc>
      <video:publication_date>2026-11-01T00:02:58.166Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/neoadjuvant-zanzalintinib-plus-nivolumab-in-patients-with-locall-nct06794229/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06794229.jpg</video:thumbnail_loc>
      <video:title>Zanzalintinib trial for Locally Advanced Renal Cell Carcinoma (NCT06794229): short film</video:title>
      <video:description>Zanzalintinib trial for Locally Advanced Renal Cell Carcinoma (NCT06794229). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06794229.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06794229.mp4</video:content_loc>
      <video:publication_date>2026-10-31T19:21:02.239Z</video:publication_date>
      <video:duration>71</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/newly-diagnosed-stage-iii-iv-ovarian-cancer-neoadjuvant-carbo-ta-nct05952453/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05952453.jpg</video:thumbnail_loc>
      <video:title>Carboplatin trial for Ovarian Cancer (NCT05952453): short film</video:title>
      <video:description>Carboplatin trial for Ovarian Cancer (NCT05952453). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05952453.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05952453.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:40:25.397Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/nirogacestat-in-patients-with-kaposi-sarcoma-nct07539454/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07539454.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for AIDS-Related Kaposi Sarcoma (NCT07539454): short film</video:title>
      <video:description>Biospecimen Collection trial for AIDS-Related Kaposi Sarcoma (NCT07539454). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07539454.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07539454.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:02:32.528Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/nivolumab-in-epstein-barr-virus-ebv-positive-lymphoproliferative-nct03258567/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03258567.jpg</video:thumbnail_loc>
      <video:title>Nivolumab trial for Epstein-Barr Virus Infections (NCT03258567): short film</video:title>
      <video:description>Nivolumab trial for Epstein-Barr Virus Infections (NCT03258567). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03258567.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03258567.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:10:19.919Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/nodal-radiation-therapy-for-sentinel-lymph-node-positive-melanom-nct04594187/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04594187.jpg</video:thumbnail_loc>
      <video:title>Immunotherapy trial for Melanoma (NCT04594187): short film</video:title>
      <video:description>Immunotherapy trial for Melanoma (NCT04594187). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04594187.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04594187.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:13:11.046Z</video:publication_date>
      <video:duration>63</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/obinutuzumab-and-ice-chemotherapy-in-refractory-recurrent-cd20-m-nct02393157/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02393157.jpg</video:thumbnail_loc>
      <video:title>Obinutuzumab trial for Non-Hodgkin Lymphoma (NCT02393157): short film</video:title>
      <video:description>Obinutuzumab trial for Non-Hodgkin Lymphoma (NCT02393157). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT02393157.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02393157.mp4</video:content_loc>
      <video:publication_date>2026-10-31T23:04:21.288Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/odronextamab-for-relapsed-and-refractory-large-b-cell-lymphomas-nct06784726/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06784726.jpg</video:thumbnail_loc>
      <video:title>Odronextamab trial for Recurrent Diffuse Large B-Cell Lymphoma (NCT06784726): short film</video:title>
      <video:description>Odronextamab trial for Recurrent Diffuse Large B-Cell Lymphoma (NCT06784726). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06784726.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06784726.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:25:09.402Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/olaparib-with-cediranib-or-azd6738-for-the-treatment-of-advanced-nct04090567/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04090567.jpg</video:thumbnail_loc>
      <video:title>Cediranib trial for Advanced Breast Carcinoma (NCT04090567): short film</video:title>
      <video:description>Cediranib trial for Advanced Breast Carcinoma (NCT04090567). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04090567.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04090567.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:57:21.493Z</video:publication_date>
      <video:duration>81</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/olutasidenib-in-relapsed-idh1-mutated-aml-patients-who-have-prev-nct07471841/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07471841.jpg</video:thumbnail_loc>
      <video:title>Olutasidenib trial for IDH1 Mutation (NCT07471841): short film</video:title>
      <video:description>Olutasidenib trial for IDH1 Mutation (NCT07471841). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07471841.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07471841.mp4</video:content_loc>
      <video:publication_date>2026-10-31T19:59:56.227Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/olutasidenib-with-azacitidine-followed-by-olutasidenib-maintenan-nct07304011/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07304011.jpg</video:thumbnail_loc>
      <video:title>Azacitidine trial for Acute Myeloid Leukemia (NCT07304011): short film</video:title>
      <video:description>Azacitidine trial for Acute Myeloid Leukemia (NCT07304011). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07304011.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07304011.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:33:17.273Z</video:publication_date>
      <video:duration>89</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/open-label-of-loncastuximab-tesirine-adct-402-in-relapsed-refrac-nct05296070/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05296070.jpg</video:thumbnail_loc>
      <video:title>Loncastuximab tesirine 150 µg/Kg trial for Marginal Zone Lymphoma (NCT05296070): short film</video:title>
      <video:description>Loncastuximab tesirine 150 µg/Kg trial for Marginal Zone Lymphoma (NCT05296070). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05296070.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05296070.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:33:06.918Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/open-label-phase-2-study-of-avutometinib-raf-mek-clamp-in-combin-nct06369259/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06369259.jpg</video:thumbnail_loc>
      <video:title>Defactinib trial for Advanced Colorectal Cancer (NCT06369259): short film</video:title>
      <video:description>Defactinib trial for Advanced Colorectal Cancer (NCT06369259). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06369259.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06369259.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:26:48.768Z</video:publication_date>
      <video:duration>87</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/optimal-psa-triggered-individual-management-of-androgen-sensitiv-nct07216248/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07216248.jpg</video:thumbnail_loc>
      <video:title>relugolix + ARPI trial for Metastatic Hormone-sensitive Prostate Cancer… (NCT07216248): short film</video:title>
      <video:description>relugolix + ARPI trial for Metastatic Hormone-sensitive Prostate Cancer (mHSPC) (NCT07216248). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07216248.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07216248.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:52:37.298Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/optimizing-neurocognition-with-whole-brain-radiation-therapy-wbr-nct05045950/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05045950.jpg</video:thumbnail_loc>
      <video:title>Memantine -Twice Daily or Extended Release trial for Brain Metastases (NCT05045950): short film</video:title>
      <video:description>Memantine -Twice Daily or Extended Release trial for Brain Metastases (NCT05045950). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05045950.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05045950.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:55:32.302Z</video:publication_date>
      <video:duration>71</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/oral-tgf-beta-receptor-i-inhibitor-vactosertib-in-soc-chemoradio-nct06044311/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06044311.jpg</video:thumbnail_loc>
      <video:title>Vactosertib trial for Adenocarcinoma Esophagus (NCT06044311): short film</video:title>
      <video:description>Vactosertib trial for Adenocarcinoma Esophagus (NCT06044311). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06044311.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06044311.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:39:01.257Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/osimertinib-alone-or-with-chemotherapy-for-egfr-mutant-lung-canc-nct04410796/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04410796.jpg</video:thumbnail_loc>
      <video:title>Osimertinib trial for Metastatic Non-small Cell Lung Cancer (NCT04410796): short film</video:title>
      <video:description>Osimertinib trial for Metastatic Non-small Cell Lung Cancer (NCT04410796). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04410796.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04410796.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:28:28.835Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/osimertinib-and-cyclosporine-a-to-enhance-antitumor-efficacy-in-nct07874490/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07874490.jpg</video:thumbnail_loc>
      <video:title>Osimertinib trial for Non-Small Cell Lung Cancer With Mutation in… (NCT07874490): short film</video:title>
      <video:description>Osimertinib trial for Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor (NCT07874490). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07874490.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07874490.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:18:59.106Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/oxaliplatin-and-liposomal-irinotecan-plus-trastuzumab-for-her2-p-nct04150640/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04150640.jpg</video:thumbnail_loc>
      <video:title>Nal-IRI trial for Esophageal Adenocarcinoma (NCT04150640): short film</video:title>
      <video:description>Nal-IRI trial for Esophageal Adenocarcinoma (NCT04150640). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04150640.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04150640.mp4</video:content_loc>
      <video:publication_date>2026-10-31T23:03:18.319Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/pacritinib-in-participants-with-metastatic-castrate-resistant-pr-nct07226713/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07226713.jpg</video:thumbnail_loc>
      <video:title>Pacritinib trial for Prostate Cancer (NCT07226713): short film</video:title>
      <video:description>Pacritinib trial for Prostate Cancer (NCT07226713). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07226713.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07226713.mp4</video:content_loc>
      <video:publication_date>2026-10-31T17:28:15.896Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/pacritinib-vs-hydroxyurea-in-advanced-proliferative-chronic-myel-nct07033598/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07033598.jpg</video:thumbnail_loc>
      <video:title>Pacritinib trial for Leukemia, Myelomonocytic, Chronic (NCT07033598): short film</video:title>
      <video:description>Pacritinib trial for Leukemia, Myelomonocytic, Chronic (NCT07033598). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07033598.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07033598.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:53:34.643Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/palbociclib-and-pembrolizumab-in-central-nervous-system-metastas-nct02896335/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02896335.jpg</video:thumbnail_loc>
      <video:title>Palbociclib trial for Metastatic Malignant Neoplasm to Brain (NCT02896335): short film</video:title>
      <video:description>Palbociclib trial for Metastatic Malignant Neoplasm to Brain (NCT02896335). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT02896335.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02896335.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:26:30.413Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/pancreatic-cancer-choose-preoperative-chemotherapy-by-smad4-stat-nct07748611/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07748611.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Borderline Resectable Pancreatic Ductal… (NCT07748611): short film</video:title>
      <video:description>Biospecimen Collection trial for Borderline Resectable Pancreatic Ductal Adenocarcinoma (NCT07748611). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07748611.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07748611.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:18:50.066Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/paxalisib-gdc-0084-in-recurrent-or-refractory-pcnsl-nct04906096/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04906096.jpg</video:thumbnail_loc>
      <video:title>PAXALISIB trial for Primary Central Nervous System Lymphoma (NCT04906096): short film</video:title>
      <video:description>PAXALISIB trial for Primary Central Nervous System Lymphoma (NCT04906096). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04906096.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04906096.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:24:43.252Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/pbi-11-ta-hpv-with-pembrolizumab-as-treatment-for-patients-w-adv-nct05799144/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05799144.jpg</video:thumbnail_loc>
      <video:title>DNA Vaccine trial for Metastatic Oropharyngeal Carcinoma (NCT05799144): short film</video:title>
      <video:description>DNA Vaccine trial for Metastatic Oropharyngeal Carcinoma (NCT05799144). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05799144.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05799144.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:00:59.182Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/pd-l1-t-hank-nai-il-15sa-and-cetuximab-for-recurrent-metastatic-nct06239220/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06239220.jpg</video:thumbnail_loc>
      <video:title>PD-L1 t-haNK trial for Head and Neck Cancer (NCT06239220): short film</video:title>
      <video:description>PD-L1 t-haNK trial for Head and Neck Cancer (NCT06239220). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06239220.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06239220.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:48:17.705Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/pds01adc-in-combination-with-hepatic-artery-infusion-pump-haip-a-nct05286814/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05286814.jpg</video:thumbnail_loc>
      <video:title>Dexamethasone trial for Metastatic Colorectal Cancer (Mcrc) (NCT05286814): short film</video:title>
      <video:description>Dexamethasone trial for Metastatic Colorectal Cancer (Mcrc) (NCT05286814). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05286814.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05286814.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:43:37.869Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/pembro-with-radiation-with-or-without-olaparib-nct05568550/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05568550.jpg</video:thumbnail_loc>
      <video:title>Pembrolizumab trial for Prostate Cancer (NCT05568550): short film</video:title>
      <video:description>Pembrolizumab trial for Prostate Cancer (NCT05568550). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05568550.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05568550.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:09:48.027Z</video:publication_date>
      <video:duration>81</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/pembrolizumab-and-enfortumab-vedotin-with-pembrolizumab-prior-to-nct05775471/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05775471.jpg</video:thumbnail_loc>
      <video:title>Biopsy trial for Renal Pelvis and Ureter Urothelial Carcinoma (NCT05775471): short film</video:title>
      <video:description>Biopsy trial for Renal Pelvis and Ureter Urothelial Carcinoma (NCT05775471). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05775471.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05775471.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:51:01.555Z</video:publication_date>
      <video:duration>86</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/pembrolizumab-and-hypofractionated-radiation-therapy-for-the-tre-nct04318717/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04318717.jpg</video:thumbnail_loc>
      <video:title>Pembrolizumab trial for Mucosal Melanoma of the Head and Neck (NCT04318717): short film</video:title>
      <video:description>Pembrolizumab trial for Mucosal Melanoma of the Head and Neck (NCT04318717). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04318717.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04318717.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:57:50.346Z</video:publication_date>
      <video:duration>66</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/pembrolizumab-and-lenvatinib-in-advanced-cervical-cancer-nct04865887/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04865887.jpg</video:thumbnail_loc>
      <video:title>Pembrolizumab trial for Cervical Cancer (NCT04865887): short film</video:title>
      <video:description>Pembrolizumab trial for Cervical Cancer (NCT04865887). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04865887.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04865887.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:44:17.561Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/pembrolizumab-and-lenvatinib-in-mismatch-repair-proficient-recur-nct07594015/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07594015.jpg</video:thumbnail_loc>
      <video:title>Pembrolizumab trial for Recurrent Endometrial Cancer (NCT07594015): short film</video:title>
      <video:description>Pembrolizumab trial for Recurrent Endometrial Cancer (NCT07594015). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07594015.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07594015.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:07:22.857Z</video:publication_date>
      <video:duration>85</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/pembrolizumab-and-odetiglucan-in-liver-predominant-metastatic-co-nct07082439/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07082439.jpg</video:thumbnail_loc>
      <video:title>Pembrolizumab trial for Colorectal Adenocarcinoma Metastatic in the Liver (NCT07082439): short film</video:title>
      <video:description>Pembrolizumab trial for Colorectal Adenocarcinoma Metastatic in the Liver (NCT07082439). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07082439.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07082439.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:45:00.095Z</video:publication_date>
      <video:duration>92</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/pembrolizumab-combined-with-bevacizumab-with-or-without-agonist-nct05231122/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05231122.jpg</video:thumbnail_loc>
      <video:title>Anti-CD40 Agonist Monoclonal… trial for Ovarian Clear Cell… (NCT05231122): short film</video:title>
      <video:description>Anti-CD40 Agonist Monoclonal Antibody CDX-1140 trial for Ovarian Clear Cell Adenocarcinoma (NCT05231122). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05231122.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05231122.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:45:44.708Z</video:publication_date>
      <video:duration>86</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/pembrolizumab-in-combination-with-chemotherapy-for-the-treatment-nct07275216/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07275216.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Classic Hodgkin Lymphoma (NCT07275216): short film</video:title>
      <video:description>Biospecimen Collection trial for Classic Hodgkin Lymphoma (NCT07275216). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07275216.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07275216.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:18:54.699Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/pembrolizumab-n-803-alone-or-in-combination-with-pd-l1-t-hank-ce-nct06161545/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06161545.jpg</video:thumbnail_loc>
      <video:title>PD-L1 t-haNK cells trial for Stage II Squamous Cell Carcinoma of the… (NCT06161545): short film</video:title>
      <video:description>PD-L1 t-haNK cells trial for Stage II Squamous Cell Carcinoma of the Head and Neck (NCT06161545). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06161545.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06161545.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:28:35.325Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/pembrolizumab-olaparib-and-temozolomide-for-people-with-glioma-nct05188508/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05188508.jpg</video:thumbnail_loc>
      <video:title>Pembrolizumab trial for Glioma (NCT05188508): short film</video:title>
      <video:description>Pembrolizumab trial for Glioma (NCT05188508). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05188508.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05188508.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:22:25.873Z</video:publication_date>
      <video:duration>86</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/pembrolizumab-plus-177lu-psma-617-in-patients-with-castration-re-nct05766371/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05766371.jpg</video:thumbnail_loc>
      <video:title>Pembrolizumab trial for Castrate Resistant Prostate Cancer (NCT05766371): short film</video:title>
      <video:description>Pembrolizumab trial for Castrate Resistant Prostate Cancer (NCT05766371). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05766371.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05766371.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:31:47.131Z</video:publication_date>
      <video:duration>88</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/pemetrexed-response-in-relation-to-tumor-alterations-of-gene-sta-nct06630416/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06630416.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Metastatic Bladder Urothelial Carcinoma (NCT06630416): short film</video:title>
      <video:description>Biospecimen Collection trial for Metastatic Bladder Urothelial Carcinoma (NCT06630416). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06630416.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06630416.mp4</video:content_loc>
      <video:publication_date>2026-11-01T00:01:40.644Z</video:publication_date>
      <video:duration>91</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/pep-cmv-vaccine-targeting-cmv-antigen-to-treat-newly-diagnosed-p-nct05096481/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05096481.jpg</video:thumbnail_loc>
      <video:title>PEP-CMV trial for High Grade Glioma (NCT05096481): short film</video:title>
      <video:description>PEP-CMV trial for High Grade Glioma (NCT05096481). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05096481.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05096481.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:43:42.493Z</video:publication_date>
      <video:duration>88</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/personalized-neck-radiation-therapy-directed-by-sentinel-lymph-n-nct07121595/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07121595.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Oral Cavity Squamous Cell Carcinoma (NCT07121595): short film</video:title>
      <video:description>Biospecimen Collection trial for Oral Cavity Squamous Cell Carcinoma (NCT07121595). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07121595.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07121595.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:40:40.199Z</video:publication_date>
      <video:duration>81</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/personalized-reduction-of-chemotherapy-intensity-through-ctdna-e-nct06745076/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06745076.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Advanced Hodgkin Lymphoma (NCT06745076): short film</video:title>
      <video:description>Biospecimen Collection trial for Advanced Hodgkin Lymphoma (NCT06745076). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06745076.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06745076.mp4</video:content_loc>
      <video:publication_date>2026-10-31T17:50:13.889Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/pet-dynamics-to-response-adapted-neoadjuvant-therapy-in-tnbc-nct06245889/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06245889.jpg</video:thumbnail_loc>
      <video:title>Paclitaxel trial for Triple Negative Breast Cancer (NCT06245889): short film</video:title>
      <video:description>Paclitaxel trial for Triple Negative Breast Cancer (NCT06245889). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06245889.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06245889.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:02:42.010Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/ph-ii-intraperitoneal-paclitaxel-system-therapy-in-gi-ca-w-perit-nct07795749/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07795749.jpg</video:thumbnail_loc>
      <video:title>Paclitaxel Q2W trial for Esophageal Carcinoma (NCT07795749): short film</video:title>
      <video:description>Paclitaxel Q2W trial for Esophageal Carcinoma (NCT07795749). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07795749.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07795749.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:10:50.196Z</video:publication_date>
      <video:duration>88</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/phase-2-single-arm-rectal-cancer-brachytherapy-for-patients-with-nct07292298/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07292298.jpg</video:thumbnail_loc>
      <video:title>High Rare Dose Rectal Brachytherapy Boost trial for Rectal Adenocarcinoma (NCT07292298): short film</video:title>
      <video:description>High Rare Dose Rectal Brachytherapy Boost trial for Rectal Adenocarcinoma (NCT07292298). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07292298.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07292298.mp4</video:content_loc>
      <video:publication_date>2026-10-31T19:59:25.508Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/phase-2-study-assessing-the-clinical-activity-and-safety-of-obec-nct07053059/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07053059.jpg</video:thumbnail_loc>
      <video:title>Obecabtagene autoleucel trial for Acute Lymphocytic Leukemia (ALL) (NCT07053059): short film</video:title>
      <video:description>Obecabtagene autoleucel trial for Acute Lymphocytic Leukemia (ALL) (NCT07053059). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07053059.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07053059.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:50:23.089Z</video:publication_date>
      <video:duration>87</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/phase-2-study-of-combination-tivozanib-and-nivolumab-in-advanced-nct06053658/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06053658.jpg</video:thumbnail_loc>
      <video:title>Tivozanib trial for Renal Cell Carcinoma (NCT06053658): short film</video:title>
      <video:description>Tivozanib trial for Renal Cell Carcinoma (NCT06053658). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06053658.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06053658.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:54:08.049Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/phase-2-study-of-glofitamab-monotherapy-with-polatuzumab-vedotin-nct06043674/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06043674.jpg</video:thumbnail_loc>
      <video:title>Glofitamab trial for Chronic Lymphocytic Leukemia (NCT06043674): short film</video:title>
      <video:description>Glofitamab trial for Chronic Lymphocytic Leukemia (NCT06043674). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06043674.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06043674.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:17:02.956Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/phase-2-study-of-mosunetuzumab-in-patients-with-chronic-lymphocy-nct07566364/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07566364.jpg</video:thumbnail_loc>
      <video:title>Mosunetuzumab trial for Lymphocytic Leukemia (NCT07566364): short film</video:title>
      <video:description>Mosunetuzumab trial for Lymphocytic Leukemia (NCT07566364). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07566364.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07566364.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:03:08.999Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/phase-2-study-of-sr-8541a-in-combination-with-botensilimab-and-b-nct06589440/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06589440.jpg</video:thumbnail_loc>
      <video:title>SR-8541A trial for Refractory Metastatic Microsatellite Stable… (NCT06589440): short film</video:title>
      <video:description>SR-8541A trial for Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) (NCT06589440). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06589440.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06589440.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:54:08.724Z</video:publication_date>
      <video:duration>89</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/phase-2-study-to-evaluate-safety-and-efficacy-of-cretostimogene-nct06567743/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06567743.jpg</video:thumbnail_loc>
      <video:title>Cretostimogene Grenadenorepvec trial for High-Risk Non-Muscle-Invasive… (NCT06567743): short film</video:title>
      <video:description>Cretostimogene Grenadenorepvec trial for High-Risk Non-Muscle-Invasive Bladder Cancer (NCT06567743). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06567743.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06567743.mp4</video:content_loc>
      <video:publication_date>2026-10-31T19:54:50.782Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/phase-2-trial-of-epcoritamab-in-combination-with-rituximab-mini-nct06045247/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06045247.jpg</video:thumbnail_loc>
      <video:title>Prednisone trial for Large B-cell Lymphoma (NCT06045247): short film</video:title>
      <video:description>Prednisone trial for Large B-cell Lymphoma (NCT06045247). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06045247.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06045247.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:21:09.371Z</video:publication_date>
      <video:duration>90</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/phase-2-trial-of-lisocabtagene-maraleucel-for-minimal-residual-d-nct07316010/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07316010.jpg</video:thumbnail_loc>
      <video:title>Leukapheresis trial for Large B-cell Lymphoma (NCT07316010): short film</video:title>
      <video:description>Leukapheresis trial for Large B-cell Lymphoma (NCT07316010). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07316010.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07316010.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:39:28.734Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/phase-2-trial-of-obinutuzumab-and-cc-99282-for-patients-with-pre-nct06108232/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06108232.jpg</video:thumbnail_loc>
      <video:title>Obinutuzumab trial for Follicular Lymphoma (NCT06108232): short film</video:title>
      <video:description>Obinutuzumab trial for Follicular Lymphoma (NCT06108232). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06108232.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06108232.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:03:51.365Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/phase-2-trial-of-zanzalintinib-and-pembrolizumab-in-select-subty-nct07283731/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07283731.jpg</video:thumbnail_loc>
      <video:title>Zanzalintinib trial for Phase 2 (NCT07283731): short film</video:title>
      <video:description>Zanzalintinib trial for Phase 2 (NCT07283731). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07283731.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07283731.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:45:40.006Z</video:publication_date>
      <video:duration>87</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/phase-ii-decentralized-pragmatic-trial-of-adjuvant-doxorubicin-t-nct07076186/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07076186.jpg</video:thumbnail_loc>
      <video:title>Trabectedin trial for Uterine Leiomyosarcoma (NCT07076186): short film</video:title>
      <video:description>Trabectedin trial for Uterine Leiomyosarcoma (NCT07076186). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07076186.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07076186.mp4</video:content_loc>
      <video:publication_date>2026-10-31T14:54:14.082Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/phase-ii-protocol-of-proton-therapy-for-partial-breast-irradiati-nct01766297/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT01766297.jpg</video:thumbnail_loc>
      <video:title>Proton Radiotherapy trial for Breast Cancer (NCT01766297): short film</video:title>
      <video:description>Proton Radiotherapy trial for Breast Cancer (NCT01766297). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT01766297.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT01766297.mp4</video:content_loc>
      <video:publication_date>2026-10-31T14:55:32.362Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/phase-ii-study-assessing-efficacy-and-safety-of-asciminib-in-pat-nct06236724/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06236724.jpg</video:thumbnail_loc>
      <video:title>Asciminib trial for Chronic Myeloid Leukemia (NCT06236724): short film</video:title>
      <video:description>Asciminib trial for Chronic Myeloid Leukemia (NCT06236724). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06236724.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06236724.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:00:22.072Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/phase-ii-study-assessing-the-safety-and-efficacy-of-dasatinib-in-nct07269470/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07269470.jpg</video:thumbnail_loc>
      <video:title>Dasatinib trial for Chronic Myeloid Leukemia (NCT07269470): short film</video:title>
      <video:description>Dasatinib trial for Chronic Myeloid Leukemia (NCT07269470). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07269470.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07269470.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:24:22.314Z</video:publication_date>
      <video:duration>87</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/phase-ii-study-of-asciminib-for-second-line-treatment-of-chronic-nct06629584/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06629584.jpg</video:thumbnail_loc>
      <video:title>Asciminib trial for Malignant Solid Tumors (NCT06629584): short film</video:title>
      <video:description>Asciminib trial for Malignant Solid Tumors (NCT06629584). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06629584.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06629584.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:51:38.750Z</video:publication_date>
      <video:duration>94</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/phase-ii-study-of-nivolumab-plus-avd-in-pediatric-adolescent-and-nct07551583/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07551583.jpg</video:thumbnail_loc>
      <video:title>Nivolumab trial for Hodgkin Lymphoma (NCT07551583): short film</video:title>
      <video:description>Nivolumab trial for Hodgkin Lymphoma (NCT07551583). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07551583.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07551583.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:18:36.615Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/phase-ii-study-of-peptide-receptor-radionuclide-therapy-in-combi-nct05583708/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05583708.jpg</video:thumbnail_loc>
      <video:title>Pembrolizumab trial for Merkel Cell Carcinoma (NCT05583708): short film</video:title>
      <video:description>Pembrolizumab trial for Merkel Cell Carcinoma (NCT05583708). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05583708.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05583708.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:38:07.822Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/phase-ii-study-of-platinum-etoposide-plus-ivonescimab-for-extens-nct07057791/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07057791.jpg</video:thumbnail_loc>
      <video:title>Ivonescimab 10 mg/kg trial for Extensive Stage Lung Small Cell Cancer (NCT07057791): short film</video:title>
      <video:description>Ivonescimab 10 mg/kg trial for Extensive Stage Lung Small Cell Cancer (NCT07057791). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07057791.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07057791.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:16:51.433Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/phase-ii-study-of-second-line-pembrolizumab-plus-gvd-for-relapse-nct03618550/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03618550.jpg</video:thumbnail_loc>
      <video:title>pembrolizumab trial for Hodgkin Lymphoma (NCT03618550): short film</video:title>
      <video:description>pembrolizumab trial for Hodgkin Lymphoma (NCT03618550). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03618550.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03618550.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:55:38.000Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/phase-ii-study-of-the-effects-of-laparoscopic-hyperthermic-intra-nct04107077/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04107077.jpg</video:thumbnail_loc>
      <video:title>Cisplatin trial for Gastric Cancer (NCT04107077): short film</video:title>
      <video:description>Cisplatin trial for Gastric Cancer (NCT04107077). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04107077.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04107077.mp4</video:content_loc>
      <video:publication_date>2026-10-31T18:53:37.805Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/phase-ii-trial-comparison-of-3-vs-4-fractions-brachy-fit-nct07022470/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07022470.jpg</video:thumbnail_loc>
      <video:title>3-Fraction HDR Brachytherapy trial for Cervical Cancers (NCT07022470): short film</video:title>
      <video:description>3-Fraction HDR Brachytherapy trial for Cervical Cancers (NCT07022470). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07022470.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07022470.mp4</video:content_loc>
      <video:publication_date>2026-11-01T00:00:12.015Z</video:publication_date>
      <video:duration>66</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/phase-ii-trial-of-combination-anti-pd-1-and-aldesleukin-for-meta-nct05155033/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05155033.jpg</video:thumbnail_loc>
      <video:title>Pembrolizumab trial for Metastatic Melanoma (NCT05155033): short film</video:title>
      <video:description>Pembrolizumab trial for Metastatic Melanoma (NCT05155033). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05155033.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05155033.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:45:54.932Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/phase-ii-trial-of-ivonescimab-in-combination-with-carboplatin-do-nct07017673/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07017673.jpg</video:thumbnail_loc>
      <video:title>Ivonescimab trial for TNBC (NCT07017673): short film</video:title>
      <video:description>Ivonescimab trial for TNBC (NCT07017673). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07017673.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07017673.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:29:10.204Z</video:publication_date>
      <video:duration>92</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/phase-ii-trial-of-ivonescimab-in-previously-treated-patients-wit-nct06940518/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06940518.jpg</video:thumbnail_loc>
      <video:title>Ivonescimab trial for Ivonescimab (NCT06940518): short film</video:title>
      <video:description>Ivonescimab trial for Ivonescimab (NCT06940518). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06940518.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06940518.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:47:21.886Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/phase-ii-trial-of-neoadjuvant-chemotherapy-nac-alone-or-in-combi-nct06223568/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06223568.jpg</video:thumbnail_loc>
      <video:title>Docetaxel trial for Squamous Cell Carcinoma of the Head and Neck (NCT06223568): short film</video:title>
      <video:description>Docetaxel trial for Squamous Cell Carcinoma of the Head and Neck (NCT06223568). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06223568.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06223568.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:14:47.141Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/phase-ii-trial-of-psa-response-based-androgen-deprivation-therap-nct07313241/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07313241.jpg</video:thumbnail_loc>
      <video:title>Prostate Fossa Radiotherapy trial for Prostate Cancer (NCT07313241): short film</video:title>
      <video:description>Prostate Fossa Radiotherapy trial for Prostate Cancer (NCT07313241). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07313241.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07313241.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:37:17.549Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/phase-ii-trial-of-puxitatug-samrotecan-azd8205-in-advanced-recur-nct07162480/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07162480.jpg</video:thumbnail_loc>
      <video:title>P-Sam trial for Adenoid Cystic Carcinoma (NCT07162480): short film</video:title>
      <video:description>P-Sam trial for Adenoid Cystic Carcinoma (NCT07162480). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07162480.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07162480.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:14:32.084Z</video:publication_date>
      <video:duration>88</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/phase-ii-trial-of-sacituzumab-govitecan-in-recurrent-and-or-meta-nct05884320/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05884320.jpg</video:thumbnail_loc>
      <video:title>Sacituzumab Govitecan trial for Gland (NCT05884320): short film</video:title>
      <video:description>Sacituzumab Govitecan trial for Gland (NCT05884320). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05884320.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05884320.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:44:33.902Z</video:publication_date>
      <video:duration>89</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/phase-ii-trial-of-sacituzumab-tirumotecan-in-patients-with-smarc-nct07438626/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07438626.jpg</video:thumbnail_loc>
      <video:title>Sacituzumab tirumotecan trial for Phase II (NCT07438626): short film</video:title>
      <video:description>Sacituzumab tirumotecan trial for Phase II (NCT07438626). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07438626.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07438626.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:58:48.535Z</video:publication_date>
      <video:duration>91</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/pilot-study-of-ivonescimab-in-advanced-metastatic-cutaneous-angi-nct07655570/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07655570.jpg</video:thumbnail_loc>
      <video:title>Ivonescimab trial for Cutaneous Angiosarcoma (NCT07655570): short film</video:title>
      <video:description>Ivonescimab trial for Cutaneous Angiosarcoma (NCT07655570). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07655570.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07655570.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:35:59.318Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/pilot-trial-of-fecal-microbiota-transplantation-for-lymphoma-pat-nct06218602/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06218602.jpg</video:thumbnail_loc>
      <video:title>Fecal Microbiota Transplantation trial for Lymphoma (NCT06218602): short film</video:title>
      <video:description>Fecal Microbiota Transplantation trial for Lymphoma (NCT06218602). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06218602.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06218602.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:58:53.772Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/pirtobrutinib-for-the-treatment-of-elderly-patients-with-chronic-nct07685717/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07685717.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Chronic Lymphocytic Leukemia/Small… (NCT07685717): short film</video:title>
      <video:description>Biospecimen Collection trial for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (NCT07685717). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07685717.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07685717.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:46:51.653Z</video:publication_date>
      <video:duration>88</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/post-autologous-transplant-maintenance-with-isatuximab-and-lenal-nct05344833/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05344833.jpg</video:thumbnail_loc>
      <video:title>Isatuximab trial for Multiple Myeloma (NCT05344833): short film</video:title>
      <video:description>Isatuximab trial for Multiple Myeloma (NCT05344833). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05344833.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05344833.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:33:52.431Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/post-transplant-maintenance-therapy-with-isatuximab-plus-lenalid-nct05776979/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05776979.jpg</video:thumbnail_loc>
      <video:title>Isatuximab trial for Multiple Myeloma (NCT05776979): short film</video:title>
      <video:description>Isatuximab trial for Multiple Myeloma (NCT05776979). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05776979.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05776979.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:06:14.386Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/pre-operative-atezolizumab-in-patients-with-resectable-human-pap-nct06254911/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06254911.jpg</video:thumbnail_loc>
      <video:title>Atezolizumab trial for Oropharynx Cancer, Stage I (NCT06254911): short film</video:title>
      <video:description>Atezolizumab trial for Oropharynx Cancer, Stage I (NCT06254911). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06254911.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06254911.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:21:44.987Z</video:publication_date>
      <video:duration>87</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/pre-radiation-chemotherapy-for-newly-diagnosed-high-grade-glioma-nct07439172/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07439172.jpg</video:thumbnail_loc>
      <video:title>Pre-radiation temozolomide. trial for High Grade Gliomas (NCT07439172): short film</video:title>
      <video:description>Pre-radiation temozolomide. trial for High Grade Gliomas (NCT07439172). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07439172.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07439172.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:31:59.936Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/pre-transplant-purging-and-post-transplant-mrd-guided-maintenanc-nct06207799/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06207799.jpg</video:thumbnail_loc>
      <video:title>Elranatamab trial for Multiple Myeloma (NCT06207799): short film</video:title>
      <video:description>Elranatamab trial for Multiple Myeloma (NCT06207799). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06207799.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06207799.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:07:41.048Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/precision-medicine-in-action-phase-ii-trial-of-response-adaptive-nct06444269/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06444269.jpg</video:thumbnail_loc>
      <video:title>Radiomics on MRI trial for Breast Cancer (NCT06444269): short film</video:title>
      <video:description>Radiomics on MRI trial for Breast Cancer (NCT06444269). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06444269.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06444269.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:22:17.764Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/preoperative-pembrolizumab-and-chemotherapy-in-resectable-recurr-nct05726370/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05726370.jpg</video:thumbnail_loc>
      <video:title>Pembrolizumab trial for Head and Neck Squamous Cell Carcinoma (NCT05726370): short film</video:title>
      <video:description>Pembrolizumab trial for Head and Neck Squamous Cell Carcinoma (NCT05726370). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05726370.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05726370.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:54:33.256Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/preoperative-radiotherapy-and-immunotherapy-for-sinonasal-and-an-nct05546827/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05546827.jpg</video:thumbnail_loc>
      <video:title>Surgical resection trial for Sinonasal Melanoma (NCT05546827): short film</video:title>
      <video:description>Surgical resection trial for Sinonasal Melanoma (NCT05546827). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05546827.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05546827.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:34:24.744Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/propranolol-with-chemotherapy-or-chemoradiation-for-esophageal-a-nct04682158/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04682158.jpg</video:thumbnail_loc>
      <video:title>Carboplatin trial for Esophageal Adenocarcinoma (NCT04682158): short film</video:title>
      <video:description>Carboplatin trial for Esophageal Adenocarcinoma (NCT04682158). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04682158.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04682158.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:23:33.995Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/prorad-5-prostate-radiation-in-5-fractions-phase-ii-five-fractio-nct06369246/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06369246.jpg</video:thumbnail_loc>
      <video:title>Stereotactic Body Radiation Therapy trial for Advanced Prostate Cancer (NCT06369246): short film</video:title>
      <video:description>Stereotactic Body Radiation Therapy trial for Advanced Prostate Cancer (NCT06369246). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06369246.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06369246.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:49:38.973Z</video:publication_date>
      <video:duration>86</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/prospective-trial-assessing-real-world-outcomes-response-to-pemb-nct06745882/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06745882.jpg</video:thumbnail_loc>
      <video:title>Cisplatin trial for Non-small Cell Lung Cancer (NCT06745882): short film</video:title>
      <video:description>Cisplatin trial for Non-small Cell Lung Cancer (NCT06745882). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06745882.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06745882.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:32:30.980Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/prostate-cancer-treatment-using-androgen-deprivation-therapy-and-nct05790213/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05790213.jpg</video:thumbnail_loc>
      <video:title>Androgen Deprivation Therapy (ADT) trial for Prostate Cancer (NCT05790213): short film</video:title>
      <video:description>Androgen Deprivation Therapy (ADT) trial for Prostate Cancer (NCT05790213). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05790213.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05790213.mp4</video:content_loc>
      <video:publication_date>2026-10-31T23:57:42.879Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/prostate-specific-membrane-antigen-psma-or-facbc-pet-ct-site-dir-nct04175431/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04175431.jpg</video:thumbnail_loc>
      <video:title>Positron Emission Tomography trial for Prostate Adenocarcinoma (NCT04175431): short film</video:title>
      <video:description>Positron Emission Tomography trial for Prostate Adenocarcinoma (NCT04175431). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04175431.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04175431.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:24:07.708Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/protocol-number-hjkc3-0003-treatment-free-remission-after-ascimi-nct04838041/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04838041.jpg</video:thumbnail_loc>
      <video:title>Asciminib 40 MG trial for Chronic Phase Chronic Myelogenous Leukemia (NCT04838041): short film</video:title>
      <video:description>Asciminib 40 MG trial for Chronic Phase Chronic Myelogenous Leukemia (NCT04838041). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04838041.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04838041.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:41:29.184Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/proton-beam-radiation-therapy-after-treatment-for-resected-n2-no-nct06008730/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06008730.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Resectable Lung Non-Small Cell Carcinoma (NCT06008730): short film</video:title>
      <video:description>Biospecimen Collection trial for Resectable Lung Non-Small Cell Carcinoma (NCT06008730). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06008730.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06008730.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:35:38.222Z</video:publication_date>
      <video:duration>63</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/proton-radiation-for-unresectable-borderline-resectable-or-medic-nct02598349/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02598349.jpg</video:thumbnail_loc>
      <video:title>Proton Radiation trial for Pancreatic Cancer (NCT02598349): short film</video:title>
      <video:description>Proton Radiation trial for Pancreatic Cancer (NCT02598349). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT02598349.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02598349.mp4</video:content_loc>
      <video:publication_date>2026-10-31T14:54:52.934Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/proton-therapy-for-post-surgical-treatment-of-gynecologic-cancer-nct05758688/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05758688.jpg</video:thumbnail_loc>
      <video:title>Whole Pelvis (WP) Pencil Beam… trial for Cervical Cancer (NCT05758688): short film</video:title>
      <video:description>Whole Pelvis (WP) Pencil Beam Scanning Proton Radiation (PBS PRT) trial for Cervical Cancer (NCT05758688). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05758688.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05758688.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:31:09.590Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/psma-directed-para-aortic-radiation-therapy-for-oligorecurrent-p-nct06392295/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06392295.jpg</video:thumbnail_loc>
      <video:title>Para Aortic Radiation Therapy: Photon Therapy trial for Prostate Cancer (NCT06392295): short film</video:title>
      <video:description>Para Aortic Radiation Therapy: Photon Therapy trial for Prostate Cancer (NCT06392295). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06392295.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06392295.mp4</video:content_loc>
      <video:publication_date>2026-10-31T23:56:05.972Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/psma-pet-guided-de-escalation-of-salvage-radiation-treatment-in-nct07234981/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07234981.jpg</video:thumbnail_loc>
      <video:title>PSMA-guided Salvage Radiation trial for Prostate Cancer (NCT07234981): short film</video:title>
      <video:description>PSMA-guided Salvage Radiation trial for Prostate Cancer (NCT07234981). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07234981.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07234981.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:11:19.412Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/pt-112-in-subjects-with-thymoma-and-thymic-carcinoma-nct05104736/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05104736.jpg</video:thumbnail_loc>
      <video:title>PT-112 trial for Thymic Epithelial Tumor (NCT05104736): short film</video:title>
      <video:description>PT-112 trial for Thymic Epithelial Tumor (NCT05104736). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05104736.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05104736.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:53:06.878Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/pulso-trial-pulsed-low-dose-rate-pldr-radiation-chemoradiation-c-nct06906887/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06906887.jpg</video:thumbnail_loc>
      <video:title>Induction Chemotherapy (modified… trial for Esophageal Cancer (NCT06906887): short film</video:title>
      <video:description>Induction Chemotherapy (modified FLOT or modified FOLFOX-6) trial for Esophageal Cancer (NCT06906887). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06906887.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06906887.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:00:34.010Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/radiation-and-tsr-042-dostarlimab-in-people-with-endometrial-can-nct04774419/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04774419.jpg</video:thumbnail_loc>
      <video:title>Intensity modulated radiation therapy (IMRT) trial for Endometrial Cancer (NCT04774419): short film</video:title>
      <video:description>Intensity modulated radiation therapy (IMRT) trial for Endometrial Cancer (NCT04774419). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04774419.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04774419.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:23:16.008Z</video:publication_date>
      <video:duration>85</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/radiation-prior-to-tki-to-delay-progression-in-advanced-driver-m-nct06305715/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06305715.jpg</video:thumbnail_loc>
      <video:title>Radiation Therapy trial for Non Small Cell Lung Cancer (NCT06305715): short film</video:title>
      <video:description>Radiation Therapy trial for Non Small Cell Lung Cancer (NCT06305715). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06305715.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06305715.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:14:09.471Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/radiation-therapy-approaches-for-people-with-prostate-cancer-nct07751159/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07751159.jpg</video:thumbnail_loc>
      <video:title>Standard of Care HDR Brachytherapy trial for Prostate Cancer Patients (NCT07751159): short film</video:title>
      <video:description>Standard of Care HDR Brachytherapy trial for Prostate Cancer Patients (NCT07751159). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07751159.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07751159.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:55:29.571Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/radiation-therapy-with-or-without-cisplatin-in-treating-patients-nct02734537/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02734537.jpg</video:thumbnail_loc>
      <video:title>Cisplatin trial for Head and Neck Squamous Cell Carcinoma (NCT02734537): short film</video:title>
      <video:description>Cisplatin trial for Head and Neck Squamous Cell Carcinoma (NCT02734537). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT02734537.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02734537.mp4</video:content_loc>
      <video:publication_date>2026-10-31T17:02:41.059Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/radiotherapy-in-combination-with-checkpoint-inhibition-for-patie-nct06601296/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06601296.jpg</video:thumbnail_loc>
      <video:title>IMSA101 trial for Metastatic Renal Cell Carcinoma ( mRCC) (NCT06601296): short film</video:title>
      <video:description>IMSA101 trial for Metastatic Renal Cell Carcinoma ( mRCC) (NCT06601296). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06601296.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06601296.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:19:29.932Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/ramucirumab-and-paclitaxel-or-folfiri-in-advanced-small-bowel-ca-nct04205968/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04205968.jpg</video:thumbnail_loc>
      <video:title>Fluorouracil trial for Metastatic Small Intestinal Adenocarcinoma (NCT04205968): short film</video:title>
      <video:description>Fluorouracil trial for Metastatic Small Intestinal Adenocarcinoma (NCT04205968). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04205968.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04205968.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:59:39.211Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/rapid-analysis-and-response-evaluation-of-combination-anti-neopl-nct04449549/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04449549.jpg</video:thumbnail_loc>
      <video:title>Nilotinib and Paclitaxel trial for Neoplasms (NCT04449549): short film</video:title>
      <video:description>Nilotinib and Paclitaxel trial for Neoplasms (NCT04449549). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04449549.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04449549.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:31:51.385Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/real-time-mri-guided-3-fraction-accelerated-partial-breast-irrad-nct03936478/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03936478.jpg</video:thumbnail_loc>
      <video:title>MRIdian Radiation Treatment Unit trial for Breast Cancer (NCT03936478): short film</video:title>
      <video:description>MRIdian Radiation Treatment Unit trial for Breast Cancer (NCT03936478). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03936478.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03936478.mp4</video:content_loc>
      <video:publication_date>2026-11-01T00:03:51.271Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/recombinant-glycosylated-human-interleukin-7-cyt107-for-the-trea-nct07308886/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07308886.jpg</video:thumbnail_loc>
      <video:title>CYT107 trial for Kaposi Sarcoma (NCT07308886): short film</video:title>
      <video:description>CYT107 trial for Kaposi Sarcoma (NCT07308886). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07308886.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07308886.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:36:26.076Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/rectify-1-neoadjuvant-botensilimab-balstilimab-in-mss-pmmr-early-nct07735624/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07735624.jpg</video:thumbnail_loc>
      <video:title>Botensilimab trial for Early Rectal Cancer (NCT07735624): short film</video:title>
      <video:description>Botensilimab trial for Early Rectal Cancer (NCT07735624). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07735624.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07735624.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:51:25.216Z</video:publication_date>
      <video:duration>85</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/recurrent-ovarian-cancers-after-parp-maintenance-sacituzumab-gov-nct07504588/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07504588.jpg</video:thumbnail_loc>
      <video:title>Anti-VEGF Monoclonal Antibody trial for Recurrent Platinum-Sensitive… (NCT07504588): short film</video:title>
      <video:description>Anti-VEGF Monoclonal Antibody trial for Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma (NCT07504588). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07504588.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07504588.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:21:22.813Z</video:publication_date>
      <video:duration>86</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/regorafenib-reg-and-lorigerlimab-lor-relo-regimen-in-treatment-o-nct07071961/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07071961.jpg</video:thumbnail_loc>
      <video:title>Regorafenib (CT) trial for Colorectal Cancer (NCT07071961): short film</video:title>
      <video:description>Regorafenib (CT) trial for Colorectal Cancer (NCT07071961). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07071961.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07071961.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:43:57.262Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/regulus-mri-guided-adaptive-sabr-for-liver-cancers-nct07223307/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07223307.jpg</video:thumbnail_loc>
      <video:title>MRI-guided adaptive stereotactic… trial for Liver Cancer (NCT07223307): short film</video:title>
      <video:description>MRI-guided adaptive stereotactic ablative body radiotherapy (SABR) trial for Liver Cancer (NCT07223307). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07223307.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07223307.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:33:37.219Z</video:publication_date>
      <video:duration>67</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/relacorilant-in-combination-with-different-treatment-regimens-in-nct06906341/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06906341.jpg</video:thumbnail_loc>
      <video:title>Relacorilant 150 mg once daily (QD) trial for Ovarian Cancer (NCT06906341): short film</video:title>
      <video:description>Relacorilant 150 mg once daily (QD) trial for Ovarian Cancer (NCT06906341). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06906341.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06906341.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:38:23.046Z</video:publication_date>
      <video:duration>81</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/relacorilant-with-nab-paclitaxel-and-gemcitabine-in-patients-wit-nct07259317/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07259317.jpg</video:thumbnail_loc>
      <video:title>Relacorilant trial for Adenocarcinoma (NCT07259317): short film</video:title>
      <video:description>Relacorilant trial for Adenocarcinoma (NCT07259317). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07259317.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07259317.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:52:54.080Z</video:publication_date>
      <video:duration>86</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/repeat-breast-conserving-surgery-followed-by-daily-partial-breas-nct06129747/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06129747.jpg</video:thumbnail_loc>
      <video:title>Radiation Therapy trial for Breast Cancer (NCT06129747): short film</video:title>
      <video:description>Radiation Therapy trial for Breast Cancer (NCT06129747). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06129747.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06129747.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:20:21.192Z</video:publication_date>
      <video:duration>67</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/repurposing-atovaquone-for-the-treatment-of-platinum-resistant-o-nct05998135/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05998135.jpg</video:thumbnail_loc>
      <video:title>Atovaquone trial for Ovarian High Grade Serous Adenocarcinoma (NCT05998135): short film</video:title>
      <video:description>Atovaquone trial for Ovarian High Grade Serous Adenocarcinoma (NCT05998135). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05998135.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05998135.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:57:56.513Z</video:publication_date>
      <video:duration>71</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/resectable-lung-cancer-cemiplimab-and-fianlimab-before-surgery-nct06918132/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06918132.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Lung Non-Small Cell Carcinoma (NCT06918132): short film</video:title>
      <video:description>Biospecimen Collection trial for Lung Non-Small Cell Carcinoma (NCT06918132). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06918132.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06918132.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:16:51.846Z</video:publication_date>
      <video:duration>86</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/restoring-lymphocytes-using-nktr-255-after-chemoradiotherapy-in-nct05632809/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05632809.jpg</video:thumbnail_loc>
      <video:title>NKTR-255 trial for Lung Cancer (NCT05632809): short film</video:title>
      <video:description>NKTR-255 trial for Lung Cancer (NCT05632809). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05632809.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05632809.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:57:28.726Z</video:publication_date>
      <video:duration>86</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/ribociclib-and-endocrine-treatment-of-physicians-choice-for-loco-nct05467891/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05467891.jpg</video:thumbnail_loc>
      <video:title>Ribociclib trial for Locoregional Recurrence (NCT05467891): short film</video:title>
      <video:description>Ribociclib trial for Locoregional Recurrence (NCT05467891). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05467891.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05467891.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:52:54.448Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/risk-adapted-proteomic-guided-systemic-therapy-for-previously-un-nct07250477/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07250477.jpg</video:thumbnail_loc>
      <video:title>Systemic (ICI)-based therapy… trial for Non-small Cell Lung Cancer… (NCT07250477): short film</video:title>
      <video:description>Systemic (ICI)-based therapy informed by the PROphet CB assay and the CARG-TT assessment. trial for Non-small Cell Lung Cancer Stage IIIC (NCT07250477). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07250477.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07250477.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:36:57.194Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/risk-adapted-therapy-in-hpv-oropharyngeal-cancer-using-circulati-nct04900623/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04900623.jpg</video:thumbnail_loc>
      <video:title>NavDx HPV ctDNA Testing trial for HPV-Associated Oropharyngeal Squamous… (NCT04900623): short film</video:title>
      <video:description>NavDx HPV ctDNA Testing trial for HPV-Associated Oropharyngeal Squamous Cell Carcinoma (NCT04900623). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04900623.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04900623.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:25:03.335Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/rituximab-and-zanubrutinib-in-patients-with-indolent-b-cell-lymp-nct06350318/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06350318.jpg</video:thumbnail_loc>
      <video:title>Zanubrutinib trial for Follicular Lymphoma (NCT06350318): short film</video:title>
      <video:description>Zanubrutinib trial for Follicular Lymphoma (NCT06350318). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06350318.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06350318.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:48:13.198Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/ruxolitinib-before-during-and-after-hematopoietic-cell-transplan-nct07228624/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07228624.jpg</video:thumbnail_loc>
      <video:title>Ruxolitinib trial for Myelodysplastic/Myeloproliferative Neoplasm (NCT07228624): short film</video:title>
      <video:description>Ruxolitinib trial for Myelodysplastic/Myeloproliferative Neoplasm (NCT07228624). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07228624.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07228624.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:10:58.138Z</video:publication_date>
      <video:duration>88</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/ruxolitinib-for-the-treatment-of-t-cell-large-granular-lymphocyt-nct05592015/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05592015.jpg</video:thumbnail_loc>
      <video:title>Ruxolitinib trial for T-Cell Large Granular Lymphocyte Leukemia (NCT05592015): short film</video:title>
      <video:description>Ruxolitinib trial for T-Cell Large Granular Lymphocyte Leukemia (NCT05592015). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05592015.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05592015.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:58:10.877Z</video:publication_date>
      <video:duration>65</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/ruxolitinib-maintenance-post-hematopoietic-stem-cell-transplant-nct07356245/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07356245.jpg</video:thumbnail_loc>
      <video:title>Ruxolitinib trial for T-cell Lymphoma (NCT07356245): short film</video:title>
      <video:description>Ruxolitinib trial for T-cell Lymphoma (NCT07356245). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07356245.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07356245.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:32:51.132Z</video:publication_date>
      <video:duration>86</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/ruxolitinib-with-radiation-and-temozolomide-compared-to-radiatio-nct06991101/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06991101.jpg</video:thumbnail_loc>
      <video:title>Ruxolitinib trial for Glioblastoma (NCT06991101): short film</video:title>
      <video:description>Ruxolitinib trial for Glioblastoma (NCT06991101). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06991101.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06991101.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:38:25.241Z</video:publication_date>
      <video:duration>85</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/sacituzumab-govitecan-with-or-without-atezolizumab-immunotherapy-nct06161532/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06161532.jpg</video:thumbnail_loc>
      <video:title>Sacituzumab govitecan trial for Small Cell Carcinoma of the Bladder (NCT06161532): short film</video:title>
      <video:description>Sacituzumab govitecan trial for Small Cell Carcinoma of the Bladder (NCT06161532). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06161532.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06161532.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:26:01.104Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/safety-and-efficacy-study-of-intravesical-instillation-of-tara-0-nct05951179/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05951179.jpg</video:thumbnail_loc>
      <video:title>TARA-002 trial for Non-muscle Invasive Bladder Cancer (NCT05951179): short film</video:title>
      <video:description>TARA-002 trial for Non-muscle Invasive Bladder Cancer (NCT05951179). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05951179.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05951179.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:44:05.125Z</video:publication_date>
      <video:duration>91</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/safety-and-efficacy-study-of-safusidenib-in-participants-with-id-nct07703436/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07703436.jpg</video:thumbnail_loc>
      <video:title>Safusidenib trial for Grade 2 IDH1-mutant Glioma (NCT07703436): short film</video:title>
      <video:description>Safusidenib trial for Grade 2 IDH1-mutant Glioma (NCT07703436). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07703436.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07703436.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:02:13.128Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/selinexor-and-pacritinib-in-jak-inhibitor-nai-ve-mf-patients-wit-nct07447817/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07447817.jpg</video:thumbnail_loc>
      <video:title>Pacritinib trial for Myelofibrosis (NCT07447817): short film</video:title>
      <video:description>Pacritinib trial for Myelofibrosis (NCT07447817). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07447817.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07447817.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:32:25.785Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/selpercatinib-pre-rai-in-patients-with-ret-fusion-thyroid-cancer-nct06458036/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06458036.jpg</video:thumbnail_loc>
      <video:title>Selpercatinib Monotherapy trial for Differentiated Thyroid Cancer (NCT06458036): short film</video:title>
      <video:description>Selpercatinib Monotherapy trial for Differentiated Thyroid Cancer (NCT06458036). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06458036.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06458036.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:11:24.142Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/sequencing-antibody-drug-conjugates-in-er-her2-low-ultra-low-mbc-nct06263543/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06263543.jpg</video:thumbnail_loc>
      <video:title>Sacituzumab govitecan trial for Breast Cancer (NCT06263543): short film</video:title>
      <video:description>Sacituzumab govitecan trial for Breast Cancer (NCT06263543). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06263543.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06263543.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:57:49.106Z</video:publication_date>
      <video:duration>92</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/sequential-testosterone-and-enzalutamide-prevents-unfavorable-pr-nct04363164/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04363164.jpg</video:thumbnail_loc>
      <video:title>Testosterone cypionate trial for Castration Resistant Metastatic… (NCT04363164): short film</video:title>
      <video:description>Testosterone cypionate trial for Castration Resistant Metastatic Prostate Cancer (NCT04363164). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04363164.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04363164.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:39:32.009Z</video:publication_date>
      <video:duration>89</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/sequential-treatment-of-cabozantinib-for-advanced-renal-cell-car-nct05931393/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05931393.jpg</video:thumbnail_loc>
      <video:title>Cabozantinib 80 MG trial for RCC (NCT05931393): short film</video:title>
      <video:description>Cabozantinib 80 MG trial for RCC (NCT05931393). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05931393.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05931393.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:57:01.728Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/sfolfoxiri-in-advanced-gastroesophageal-cancer-sage-nct05332002/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05332002.jpg</video:thumbnail_loc>
      <video:title>Four week alternating FOLFOX and… trial for Gastro-Intestinal Cancer (NCT05332002): short film</video:title>
      <video:description>Four week alternating FOLFOX and FOLFIRI (sFOLFOXIRI) trial for Gastro-Intestinal Cancer (NCT05332002). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05332002.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05332002.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:03:47.034Z</video:publication_date>
      <video:duration>87</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/short-course-adt-for-high-risk-low-intermediate-risk-artera-pros-nct07801664/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07801664.jpg</video:thumbnail_loc>
      <video:title>Androgen Deprivation Therapy (ADT) trial for Prostate Cancer (NCT07801664): short film</video:title>
      <video:description>Androgen Deprivation Therapy (ADT) trial for Prostate Cancer (NCT07801664). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07801664.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07801664.mp4</video:content_loc>
      <video:publication_date>2026-10-31T19:49:01.725Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/shortening-adjuvant-photon-and-proton-irradiation-sapphire-ii-a-nct07076485/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07076485.jpg</video:thumbnail_loc>
      <video:title>Ultrahypofractionated Radiation trial for Breast Cancer (NCT07076485): short film</video:title>
      <video:description>Ultrahypofractionated Radiation trial for Breast Cancer (NCT07076485). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07076485.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07076485.mp4</video:content_loc>
      <video:publication_date>2026-10-31T19:59:01.582Z</video:publication_date>
      <video:duration>71</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/single-arm-study-of-neoadjuvant-dostarlimab-in-stage-ii-and-iii-nct05239546/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05239546.jpg</video:thumbnail_loc>
      <video:title>Dostarlimab trial for Colon Cancer (NCT05239546): short film</video:title>
      <video:description>Dostarlimab trial for Colon Cancer (NCT05239546). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05239546.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05239546.mp4</video:content_loc>
      <video:publication_date>2026-11-01T00:03:54.069Z</video:publication_date>
      <video:duration>85</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/single-fraction-interstitial-breast-brachytherapy-nct07654257/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07654257.jpg</video:thumbnail_loc>
      <video:title>Partial Breast Irradiation trial for Breast Cancer (NCT07654257): short film</video:title>
      <video:description>Partial Breast Irradiation trial for Breast Cancer (NCT07654257). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07654257.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07654257.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:53:17.559Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/smarca4-2-inhibitor-for-pou2f3-positive-sclc-nct07551635/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07551635.jpg</video:thumbnail_loc>
      <video:title>FHD-286 trial for Small Cell Lung Cancer (NCT07551635): short film</video:title>
      <video:description>FHD-286 trial for Small Cell Lung Cancer (NCT07551635). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07551635.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07551635.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:23:35.423Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/srs-compared-with-fsrs-for-treatment-of-intact-metastatic-brain-nct05222620/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05222620.jpg</video:thumbnail_loc>
      <video:title>Questionnaire Administration trial for Metastatic Malignant Neoplasm in… (NCT05222620): short film</video:title>
      <video:description>Questionnaire Administration trial for Metastatic Malignant Neoplasm in the Brain (NCT05222620). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05222620.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05222620.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:12:13.048Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/statins-in-patients-with-clonal-cytopenia-of-undetermined-signif-nct05483010/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05483010.jpg</video:thumbnail_loc>
      <video:title>Atorvastatin trial for Clonal Cytopenia of Undetermined Significance (NCT05483010): short film</video:title>
      <video:description>Atorvastatin trial for Clonal Cytopenia of Undetermined Significance (NCT05483010). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05483010.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05483010.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:16:56.984Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/stereotactic-body-radiation-therapy-plus-immediate-or-delayed-an-nct06378866/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06378866.jpg</video:thumbnail_loc>
      <video:title>Abiraterone trial for Recurrent Castration-Sensitive Prostate Carcinoma (NCT06378866): short film</video:title>
      <video:description>Abiraterone trial for Recurrent Castration-Sensitive Prostate Carcinoma (NCT06378866). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06378866.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06378866.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:29:57.474Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/stereotactic-brain-directed-radiation-with-or-without-aguix-gado-nct04899908/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04899908.jpg</video:thumbnail_loc>
      <video:title>Stereotactic Radiation trial for Brain Cancer (NCT04899908): short film</video:title>
      <video:description>Stereotactic Radiation trial for Brain Cancer (NCT04899908). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04899908.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04899908.mp4</video:content_loc>
      <video:publication_date>2026-10-31T18:20:20.522Z</video:publication_date>
      <video:duration>85</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/stereotactic-radiation-for-growing-changing-brain-metastases-wit-nct07132190/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07132190.jpg</video:thumbnail_loc>
      <video:title>Linear accelerator-based… trial for Brain Metastases, Adult (NCT07132190): short film</video:title>
      <video:description>Linear accelerator-based stereotactic radiation for brain metastases using 0mm or 1mm PTV trial for Brain Metastases, Adult (NCT07132190). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07132190.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07132190.mp4</video:content_loc>
      <video:publication_date>2026-10-31T18:32:24.512Z</video:publication_date>
      <video:duration>69</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/strategic-endocrine-therapy-and-targeted-radiotherapy-for-prosta-nct07364071/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07364071.jpg</video:thumbnail_loc>
      <video:title>Radiation therapy trial for Prostate Adenocarcinoma (NCT07364071): short film</video:title>
      <video:description>Radiation therapy trial for Prostate Adenocarcinoma (NCT07364071). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07364071.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07364071.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:26:40.983Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/study-adding-drugs-to-usual-treatment-for-large-b-cell-lymphoma-nct05890352/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05890352.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Grade 3b Follicular Lymphoma (NCT05890352): short film</video:title>
      <video:description>Biospecimen Collection trial for Grade 3b Follicular Lymphoma (NCT05890352). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05890352.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05890352.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:29:23.943Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/study-evaluating-dosimetry-randomized-dose-optimization-dose-esc-nct06549465/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06549465.jpg</video:thumbnail_loc>
      <video:title>In-111 rosopatamab tetraxetan trial for PSMA PET-Positive… (NCT06549465): short film</video:title>
      <video:description>In-111 rosopatamab tetraxetan trial for PSMA PET-Positive Castration-Resistant Prostate Cancer (NCT06549465). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06549465.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06549465.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:55:00.227Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/study-of-ar-suppression-with-carotuximab-in-metastatic-castratio-nct05534646/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05534646.jpg</video:thumbnail_loc>
      <video:title>AR Blockade trial for Castration-resistant Prostate Cancer (NCT05534646): short film</video:title>
      <video:description>AR Blockade trial for Castration-resistant Prostate Cancer (NCT05534646). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05534646.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05534646.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:39:29.780Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/study-of-belantamab-mafodotin-with-carfilzomib-pomalidomide-and-nct05789303/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05789303.jpg</video:thumbnail_loc>
      <video:title>Belantamab mafodotin trial for Multiple Myeloma (NCT05789303): short film</video:title>
      <video:description>Belantamab mafodotin trial for Multiple Myeloma (NCT05789303). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05789303.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05789303.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:02:52.046Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/study-of-bevacizumab-in-combination-with-chemoimmunotherapy-and-nct05588388/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05588388.jpg</video:thumbnail_loc>
      <video:title>Bevacizumab trial for Extensive-stage Small-cell Lung Cancer (NCT05588388): short film</video:title>
      <video:description>Bevacizumab trial for Extensive-stage Small-cell Lung Cancer (NCT05588388). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05588388.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05588388.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:47:34.652Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/study-of-carboplatin-and-mirvetuximab-soravtansine-in-first-line-nct04606914/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04606914.jpg</video:thumbnail_loc>
      <video:title>mirvetuximab soravtansine (MIRV; IMGN853) trial for Ovarian Cancer (NCT04606914): short film</video:title>
      <video:description>mirvetuximab soravtansine (MIRV; IMGN853) trial for Ovarian Cancer (NCT04606914). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04606914.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04606914.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:13:18.464Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/study-of-cryoablation-and-nirogacestat-for-desmoid-tumor-nct05949099/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05949099.jpg</video:thumbnail_loc>
      <video:title>Nirogacestat trial for Desmoid Tumor (NCT05949099): short film</video:title>
      <video:description>Nirogacestat trial for Desmoid Tumor (NCT05949099). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05949099.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05949099.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:54:17.134Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/study-of-denikitug-gs-1811-given-alone-or-with-nivolumab-or-chem-nct07546812/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07546812.jpg</video:thumbnail_loc>
      <video:title>Denikitug trial for HER2-negative (NCT07546812): short film</video:title>
      <video:description>Denikitug trial for HER2-negative (NCT07546812). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07546812.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07546812.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:24:50.616Z</video:publication_date>
      <video:duration>91</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/study-of-denikitug-gs-1811-given-alone-or-with-nivolumab-or-with-nct07527858/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07527858.jpg</video:thumbnail_loc>
      <video:title>Denikitug trial for Advanced Microsatellite Stable Colorectal Cancer (NCT07527858): short film</video:title>
      <video:description>Denikitug trial for Advanced Microsatellite Stable Colorectal Cancer (NCT07527858). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07527858.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07527858.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:02:54.878Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/study-of-ev-for-recurrent-endometrial-carcinoma-nct07139977/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07139977.jpg</video:thumbnail_loc>
      <video:title>Enfortumab Vedotin trial for Endometrial Cancer (NCT07139977): short film</video:title>
      <video:description>Enfortumab Vedotin trial for Endometrial Cancer (NCT07139977). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07139977.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07139977.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:16:39.262Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/study-of-induction-pd-1-blockade-in-subjects-with-locally-advanc-nct04165772/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04165772.jpg</video:thumbnail_loc>
      <video:title>TSR-042 or Dostarlimab trial for Rectal Adenocarcinoma (NCT04165772): short film</video:title>
      <video:description>TSR-042 or Dostarlimab trial for Rectal Adenocarcinoma (NCT04165772). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04165772.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04165772.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:00:46.375Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/study-of-kte-x19-in-minimal-residual-disease-mrd-positive-b-cell-nct06144606/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06144606.jpg</video:thumbnail_loc>
      <video:title>Tecartus trial for B-Cell Lymphoblastic Leukemia (NCT06144606): short film</video:title>
      <video:description>Tecartus trial for B-Cell Lymphoblastic Leukemia (NCT06144606). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06144606.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06144606.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:35:43.091Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/study-of-nalirifox-in-advanced-unresectable-small-bowel-tumors-nct06835387/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06835387.jpg</video:thumbnail_loc>
      <video:title>Nanoliposomal irinotecan trial for Small Bowel Adenocarcinoma (NCT06835387): short film</video:title>
      <video:description>Nanoliposomal irinotecan trial for Small Bowel Adenocarcinoma (NCT06835387). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06835387.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06835387.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:02:59.764Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/study-of-olutasidenib-and-temozolomide-in-hgg-nct06161974/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06161974.jpg</video:thumbnail_loc>
      <video:title>Olutasidenib + TMZ trial for High Grade Glioma (NCT06161974): short film</video:title>
      <video:description>Olutasidenib + TMZ trial for High Grade Glioma (NCT06161974). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06161974.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06161974.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:05:32.174Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/study-of-onc206-jzp3507-in-advanced-pheochromocytoma-and-paragan-nct07282587/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07282587.jpg</video:thumbnail_loc>
      <video:title>ONC206 trial for Advanced Pheochromocytoma and Paraganglioma (NCT07282587): short film</video:title>
      <video:description>ONC206 trial for Advanced Pheochromocytoma and Paraganglioma (NCT07282587). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07282587.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07282587.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:24:51.559Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/study-of-oral-mrt-2359-with-apalutamide-in-prostate-cancer-nct07745361/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07745361.jpg</video:thumbnail_loc>
      <video:title>Oral MRT-2359 trial for Castration-Resistant Prostate Cancer (CRPC) (NCT07745361): short film</video:title>
      <video:description>Oral MRT-2359 trial for Castration-Resistant Prostate Cancer (CRPC) (NCT07745361). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07745361.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07745361.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:04:17.420Z</video:publication_date>
      <video:duration>81</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/study-of-patritumab-deruxtecan-plus-pembrolizumab-with-other-ant-nct06797635/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06797635.jpg</video:thumbnail_loc>
      <video:title>Patritumab deruxtecan trial for Breast Neoplasms (NCT06797635): short film</video:title>
      <video:description>Patritumab deruxtecan trial for Breast Neoplasms (NCT06797635). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06797635.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06797635.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:30:10.301Z</video:publication_date>
      <video:duration>88</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/study-of-pembrolizumab-carboplatin-paclitaxel-and-radiation-for-nct06493019/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06493019.jpg</video:thumbnail_loc>
      <video:title>Pembrolizumab trial for Anal Cancer (NCT06493019): short film</video:title>
      <video:description>Pembrolizumab trial for Anal Cancer (NCT06493019). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06493019.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06493019.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:57:25.417Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/study-of-ruxolitinib-in-relapsed-or-refractory-t-or-nk-cell-lymp-nct02974647/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02974647.jpg</video:thumbnail_loc>
      <video:title>Ruxolitinib trial for Lymphoma (NCT02974647): short film</video:title>
      <video:description>Ruxolitinib trial for Lymphoma (NCT02974647). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT02974647.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02974647.mp4</video:content_loc>
      <video:publication_date>2026-10-31T23:03:56.774Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/study-of-silevertinib-with-temozolomide-for-the-treatment-of-new-nct07326566/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07326566.jpg</video:thumbnail_loc>
      <video:title>silevertinib in combination with temozolomide trial for Glioblastoma (GBM) (NCT07326566): short film</video:title>
      <video:description>silevertinib in combination with temozolomide trial for Glioblastoma (GBM) (NCT07326566). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07326566.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07326566.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:54:07.491Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/study-of-the-efficacy-of-intratumoral-l19il2-or-l19tnf-or-l19il2-nct06284590/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06284590.jpg</video:thumbnail_loc>
      <video:title>L19IL2 trial for Melanoma Stage III (NCT06284590): short film</video:title>
      <video:description>L19IL2 trial for Melanoma Stage III (NCT06284590). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06284590.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06284590.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:00:11.102Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/study-to-assess-the-efficacy-and-safety-of-rina-s-in-participant-nct07288177/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07288177.jpg</video:thumbnail_loc>
      <video:title>Rina-S trial for Non-small Cell Lung Cancer (NSCLC) (NCT07288177): short film</video:title>
      <video:description>Rina-S trial for Non-small Cell Lung Cancer (NSCLC) (NCT07288177). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07288177.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07288177.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:55:12.144Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/study-to-determine-the-efficacy-and-safety-of-asciminib-in-pedia-nct07354074/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07354074.jpg</video:thumbnail_loc>
      <video:title>Asciminib single agent trial for Chronic Myelogenous Leukemia (NCT07354074): short film</video:title>
      <video:description>Asciminib single agent trial for Chronic Myelogenous Leukemia (NCT07354074). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07354074.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07354074.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:40:44.939Z</video:publication_date>
      <video:duration>81</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/study-to-evaluate-sutetinib-maleate-capsule-in-locally-advanced-nct05168566/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05168566.jpg</video:thumbnail_loc>
      <video:title>Sutetinib Maleate Capsule trial for Non-small Cell Lung Cancer (NCT05168566): short film</video:title>
      <video:description>Sutetinib Maleate Capsule trial for Non-small Cell Lung Cancer (NCT05168566). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05168566.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05168566.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:35:56.335Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/study-to-evaluate-the-safety-and-tolerability-of-camizestrant-in-nct07427394/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07427394.jpg</video:thumbnail_loc>
      <video:title>Camizestrant trial for Advanced Breast Cancer (NCT07427394): short film</video:title>
      <video:description>Camizestrant trial for Advanced Breast Cancer (NCT07427394). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07427394.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07427394.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:37:11.721Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/subcutaneous-talquetamab-in-elderly-patients-with-multiple-myelo-nct06827860/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06827860.jpg</video:thumbnail_loc>
      <video:title>Talquetamab trial for Multiple Myeloma in Relapse (NCT06827860): short film</video:title>
      <video:description>Talquetamab trial for Multiple Myeloma in Relapse (NCT06827860). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06827860.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06827860.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:50:49.097Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/substudy-01i-a-study-of-investigational-agents-in-participants-w-nct06780098/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06780098.jpg</video:thumbnail_loc>
      <video:title>R-DXD trial for Lung Neoplasm (NCT06780098): short film</video:title>
      <video:description>R-DXD trial for Lung Neoplasm (NCT06780098). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06780098.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06780098.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:55:37.991Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/suprachoroidal-administration-in-subjects-with-metastases-to-the-nct06643884/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06643884.jpg</video:thumbnail_loc>
      <video:title>AU-011 trial for Eye Cancer (NCT06643884): short film</video:title>
      <video:description>AU-011 trial for Eye Cancer (NCT06643884). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06643884.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06643884.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:08:03.842Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/supraphysiological-androgen-to-enhance-treatment-activity-in-met-nct06039371/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06039371.jpg</video:thumbnail_loc>
      <video:title>Biopsy Procedure trial for Castration-Resistant Prostate Carcinoma (NCT06039371): short film</video:title>
      <video:description>Biopsy Procedure trial for Castration-Resistant Prostate Carcinoma (NCT06039371). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06039371.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06039371.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:27:10.620Z</video:publication_date>
      <video:duration>94</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/surovatamig-azd0486-as-monotherapy-in-participants-with-relapsed-nct06526793/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06526793.jpg</video:thumbnail_loc>
      <video:title>Surovatamig trial for B-cell Non-Hodgkin Lymphoma (NCT06526793): short film</video:title>
      <video:description>Surovatamig trial for B-cell Non-Hodgkin Lymphoma (NCT06526793). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06526793.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06526793.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:16:52.763Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/sx-682-and-atezolizumab-for-the-treatment-of-advanced-or-metasta-nct07322341/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07322341.jpg</video:thumbnail_loc>
      <video:title>Atezolizumab trial for Advanced Lung Non-Small Cell Carcinoma (NCT07322341): short film</video:title>
      <video:description>Atezolizumab trial for Advanced Lung Non-Small Cell Carcinoma (NCT07322341). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07322341.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07322341.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:23:47.663Z</video:publication_date>
      <video:duration>91</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/sx-682-with-pembrolizumab-for-the-treatment-of-metastatic-or-rec-nct05570825/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05570825.jpg</video:thumbnail_loc>
      <video:title>Biopsy trial for Metastatic Lung Non-Small Cell Carcinoma (NCT05570825): short film</video:title>
      <video:description>Biopsy trial for Metastatic Lung Non-Small Cell Carcinoma (NCT05570825). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05570825.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05570825.mp4</video:content_loc>
      <video:publication_date>2026-10-31T23:55:19.013Z</video:publication_date>
      <video:duration>90</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/t-cell-receptor-immunotherapy-for-patients-with-metastatic-non-s-nct02133196/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02133196.jpg</video:thumbnail_loc>
      <video:title>Aldesleukin trial for Advanced Non-Small Cell Lung Cancer (NCT02133196): short film</video:title>
      <video:description>Aldesleukin trial for Advanced Non-Small Cell Lung Cancer (NCT02133196). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT02133196.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02133196.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:07:59.034Z</video:publication_date>
      <video:duration>71</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/tafasitamab-and-rituximab-for-the-treatment-of-newly-diagnosed-f-nct07731789/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07731789.jpg</video:thumbnail_loc>
      <video:title>Rituximab trial for Classic Follicular Lymphoma (NCT07731789): short film</video:title>
      <video:description>Rituximab trial for Classic Follicular Lymphoma (NCT07731789). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07731789.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07731789.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:26:49.574Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/tagraxofusp-and-azacitidine-with-venetoclax-in-newly-diagnosed-s-nct05442216/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05442216.jpg</video:thumbnail_loc>
      <video:title>Tagraxofusp trial for Acute Myeloid Leukemia (NCT05442216): short film</video:title>
      <video:description>Tagraxofusp trial for Acute Myeloid Leukemia (NCT05442216). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05442216.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05442216.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:21:17.344Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/tapur-testing-the-use-of-food-and-drug-administration-fda-approv-nct02693535/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02693535.jpg</video:thumbnail_loc>
      <video:title>Sunitinib (CLOSED TO ENROLLMENT) trial for Lymphoma, Non-Hodgkin (NCT02693535): short film</video:title>
      <video:description>Sunitinib (CLOSED TO ENROLLMENT) trial for Lymphoma, Non-Hodgkin (NCT02693535). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT02693535.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02693535.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:06:25.839Z</video:publication_date>
      <video:duration>87</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/targeted-treatment-for-advanced-non-small-cell-lung-cancer-that-nct06116682/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06116682.jpg</video:thumbnail_loc>
      <video:title>Amivantamab trial for Lung Non-Small Cell Carcinoma (NCT06116682): short film</video:title>
      <video:description>Amivantamab trial for Lung Non-Small Cell Carcinoma (NCT06116682). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06116682.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06116682.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:37:29.540Z</video:publication_date>
      <video:duration>85</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/tarlatamab-for-the-treatment-of-extensive-stage-small-cell-lung-nct07423585/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07423585.jpg</video:thumbnail_loc>
      <video:title>Biopsy Procedure trial for Extensive Stage Lung Small Cell Carcinoma (NCT07423585): short film</video:title>
      <video:description>Biopsy Procedure trial for Extensive Stage Lung Small Cell Carcinoma (NCT07423585). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07423585.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07423585.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:25:25.942Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/tebentafusp-in-hla-a-0201-positive-previously-untreated-metastat-nct06070012/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06070012.jpg</video:thumbnail_loc>
      <video:title>Tebentafusp trial for Uveal Melanoma (NCT06070012): short film</video:title>
      <video:description>Tebentafusp trial for Uveal Melanoma (NCT06070012). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06070012.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06070012.mp4</video:content_loc>
      <video:publication_date>2026-10-31T18:04:33.572Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/testing-an-experimental-approach-to-treat-patients-with-plasma-c-nct07605416/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07605416.jpg</video:thumbnail_loc>
      <video:title>Autologous Hematopoietic Stem… trial for Plasma Cell Leukemia (NCT07605416): short film</video:title>
      <video:description>Autologous Hematopoietic Stem Cell Transplantation trial for Plasma Cell Leukemia (NCT07605416). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07605416.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07605416.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:32:34.261Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/testing-atezolizumab-with-selinexor-in-people-12-years-old-with-nct05333458/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05333458.jpg</video:thumbnail_loc>
      <video:title>Atezolizumab trial for Advanced Alveolar Soft Part Sarcoma (NCT05333458): short film</video:title>
      <video:description>Atezolizumab trial for Advanced Alveolar Soft Part Sarcoma (NCT05333458). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05333458.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05333458.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:59:42.212Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/testing-drug-treatments-after-car-t-cell-therapy-in-patients-wit-nct05633615/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05633615.jpg</video:thumbnail_loc>
      <video:title>Axicabtagene Ciloleucel trial for Diffuse Large B-Cell Lymphoma (NCT05633615): short film</video:title>
      <video:description>Axicabtagene Ciloleucel trial for Diffuse Large B-Cell Lymphoma (NCT05633615). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05633615.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05633615.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:22:45.932Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/testing-new-therapies-for-patients-with-acute-myeloid-leukemia-w-nct05554406/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05554406.jpg</video:thumbnail_loc>
      <video:title>Azacitidine trial for Acute Myeloid Leukemia (NCT05554406): short film</video:title>
      <video:description>Azacitidine trial for Acute Myeloid Leukemia (NCT05554406). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05554406.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05554406.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:19:49.471Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/testing-nivolumab-with-or-without-ipilimumab-in-deficient-mismat-nct05112601/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05112601.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Endometrial Adenocarcinoma (NCT05112601): short film</video:title>
      <video:description>Biospecimen Collection trial for Endometrial Adenocarcinoma (NCT05112601). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05112601.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05112601.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:20:38.218Z</video:publication_date>
      <video:duration>76</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/testing-of-bevacizumab-erlotinib-and-atezolizumab-in-combination-nct04981509/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04981509.jpg</video:thumbnail_loc>
      <video:title>Atezolizumab trial for Hereditary Leiomyomatosis and Renal Cell Carcinoma (NCT04981509): short film</video:title>
      <video:description>Atezolizumab trial for Hereditary Leiomyomatosis and Renal Cell Carcinoma (NCT04981509). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04981509.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04981509.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:30:59.603Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/testing-osimertinib-as-a-treatment-for-lung-cancers-with-an-egfr-nct03191149/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03191149.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Advanced Lung Non-Small Cell Carcinoma (NCT03191149): short film</video:title>
      <video:description>Biospecimen Collection trial for Advanced Lung Non-Small Cell Carcinoma (NCT03191149). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03191149.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03191149.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:42:03.393Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/testing-the-addition-of-an-anti-cancer-drug-cabozantinib-to-the-nct06900595/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06900595.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Locally Advanced Adrenal Cortical… (NCT06900595): short film</video:title>
      <video:description>Biospecimen Collection trial for Locally Advanced Adrenal Cortical Carcinoma (NCT06900595). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06900595.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06900595.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:27:07.549Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/testing-the-addition-of-an-idh2-inhibitor-enasidenib-to-usual-tr-nct06577441/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06577441.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Myelodysplastic Syndrome (NCT06577441): short film</video:title>
      <video:description>Biospecimen Collection trial for Myelodysplastic Syndrome (NCT06577441). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06577441.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06577441.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:17:18.597Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/testing-the-addition-of-an-individualized-vaccine-to-durvalumab-nct03606967/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03606967.jpg</video:thumbnail_loc>
      <video:title>Biopsy Procedure trial for Anatomic Stage IV Breast Cancer AJCC v8 (NCT03606967): short film</video:title>
      <video:description>Biopsy Procedure trial for Anatomic Stage IV Breast Cancer AJCC v8 (NCT03606967). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03606967.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03606967.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:18:56.109Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/testing-the-addition-of-bms-986016-relatlimab-to-the-usual-immun-nct06029270/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06029270.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Metastatic Nasopharyngeal Carcinoma (NCT06029270): short film</video:title>
      <video:description>Biospecimen Collection trial for Metastatic Nasopharyngeal Carcinoma (NCT06029270). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06029270.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06029270.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:30:50.698Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/testing-the-addition-of-cemiplimab-regn2810-to-chemotherapy-trea-nct07281417/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07281417.jpg</video:thumbnail_loc>
      <video:title>Biopsy Procedure trial for Sinonasal Squamous Cell Carcinoma (NCT07281417): short film</video:title>
      <video:description>Biopsy Procedure trial for Sinonasal Squamous Cell Carcinoma (NCT07281417). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07281417.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07281417.mp4</video:content_loc>
      <video:publication_date>2026-10-31T07:25:29.947Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/testing-the-addition-of-chemotherapy-or-chemo-immunotherapy-to-t-nct07195734/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07195734.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Clinical Stage II HPV-Mediated… (NCT07195734): short film</video:title>
      <video:description>Biospecimen Collection trial for Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (NCT07195734). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07195734.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07195734.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:25:57.972Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/testing-the-addition-of-immunotherapy-before-surgery-for-patient-nct05647265/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05647265.jpg</video:thumbnail_loc>
      <video:title>Nivolumab trial for Pleural Biphasic Mesothelioma (NCT05647265): short film</video:title>
      <video:description>Nivolumab trial for Pleural Biphasic Mesothelioma (NCT05647265). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05647265.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05647265.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:24:50.012Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/testing-the-addition-of-stereotactic-radiation-therapy-with-immu-nct05327686/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05327686.jpg</video:thumbnail_loc>
      <video:title>Avelumab trial for Metastatic Renal Cell Carcinoma (NCT05327686): short film</video:title>
      <video:description>Avelumab trial for Metastatic Renal Cell Carcinoma (NCT05327686). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05327686.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05327686.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:58:30.477Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/testing-the-addition-of-the-anti-cancer-drug-venetoclax-and-or-t-nct06317662/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06317662.jpg</video:thumbnail_loc>
      <video:title>Asparaginase Erwinia chrysanthemi trial for Acute Leukemia of Ambiguous… (NCT06317662): short film</video:title>
      <video:description>Asparaginase Erwinia chrysanthemi trial for Acute Leukemia of Ambiguous Lineage (NCT06317662). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06317662.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06317662.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:35:31.384Z</video:publication_date>
      <video:duration>88</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/testing-the-addition-of-the-immunotherapy-drug-pembrolizumab-to-nct06770582/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06770582.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Non-Muscle Invasive Bladder Urothelial… (NCT06770582): short film</video:title>
      <video:description>Biospecimen Collection trial for Non-Muscle Invasive Bladder Urothelial Carcinoma (NCT06770582). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06770582.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06770582.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:13:41.476Z</video:publication_date>
      <video:duration>85</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/testing-the-addition-of-venetoclax-or-gemtuzumab-ozogamicin-go-t-nct06917911/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06917911.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Core Binding Factor Acute Myeloid… (NCT06917911): short film</video:title>
      <video:description>Biospecimen Collection trial for Core Binding Factor Acute Myeloid Leukemia (NCT06917911). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06917911.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06917911.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:26:01.275Z</video:publication_date>
      <video:duration>94</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/testing-the-anti-cancer-drug-glofitamab-in-patients-with-mantle-nct07003295/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07003295.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Recurrent Mantle Cell Lymphoma (NCT07003295): short film</video:title>
      <video:description>Biospecimen Collection trial for Recurrent Mantle Cell Lymphoma (NCT07003295). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07003295.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07003295.mp4</video:content_loc>
      <video:publication_date>2026-10-31T17:35:32.682Z</video:publication_date>
      <video:duration>91</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/testing-the-combination-of-anti-cancer-drugs-botensilimab-agen11-nct07551596/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07551596.jpg</video:thumbnail_loc>
      <video:title>Balstilimab trial for Colorectal Adenocarcinoma (NCT07551596): short film</video:title>
      <video:description>Balstilimab trial for Colorectal Adenocarcinoma (NCT07551596). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07551596.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07551596.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:05:58.151Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/testing-the-combination-of-venetoclax-and-rituximab-in-compariso-nct04840602/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04840602.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Lymphoplasmacytic Lymphoma (NCT04840602): short film</video:title>
      <video:description>Biospecimen Collection trial for Lymphoplasmacytic Lymphoma (NCT04840602). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04840602.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04840602.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:13:33.195Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/testing-the-effectiveness-of-a-combination-targeted-therapy-vipo-nct06649812/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06649812.jpg</video:thumbnail_loc>
      <video:title>Biopsy Procedure trial for High Grade B-Cell Lymphoma With MYC and BCL6… (NCT06649812): short film</video:title>
      <video:description>Biopsy Procedure trial for High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements (NCT06649812). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06649812.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06649812.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:44:41.729Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/testing-the-effectiveness-of-the-anti-cancer-drug-mirdametinib-i-nct07061951/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07061951.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Recurrent Chronic Lymphocytic Leukemia (NCT07061951): short film</video:title>
      <video:description>Biospecimen Collection trial for Recurrent Chronic Lymphocytic Leukemia (NCT07061951). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07061951.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07061951.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:44:54.421Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/testing-the-effectiveness-of-two-immunotherapy-drugs-nivolumab-a-nct03866382/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03866382.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Bladder Adenocarcinoma (NCT03866382): short film</video:title>
      <video:description>Biospecimen Collection trial for Bladder Adenocarcinoma (NCT03866382). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03866382.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03866382.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:31:20.717Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/testing-the-investigational-agent-combination-of-daratumumab-bor-nct07085728/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07085728.jpg</video:thumbnail_loc>
      <video:title>Cyclophosphamide trial for Myeloma Multiple (NCT07085728): short film</video:title>
      <video:description>Cyclophosphamide trial for Myeloma Multiple (NCT07085728). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07085728.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07085728.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:46:54.209Z</video:publication_date>
      <video:duration>87</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/testing-the-investigational-medication-combination-of-daratumuma-nct06948084/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06948084.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Recurrent Multiple Myeloma (NCT06948084): short film</video:title>
      <video:description>Biospecimen Collection trial for Recurrent Multiple Myeloma (NCT06948084). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06948084.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06948084.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:28:14.628Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/testing-the-safety-and-effectiveness-of-radiation-based-treatmen-nct05691465/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05691465.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Metastatic Prostate Adenocarcinoma With… (NCT05691465): short film</video:title>
      <video:description>Biospecimen Collection trial for Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation (NCT05691465). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05691465.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05691465.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:11:46.360Z</video:publication_date>
      <video:duration>87</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/testing-the-safety-and-feasibility-of-immunotherapy-drugs-botens-nct07516366/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07516366.jpg</video:thumbnail_loc>
      <video:title>Balstilimab trial for Clear Cell Renal Cell Carcinoma (NCT07516366): short film</video:title>
      <video:description>Balstilimab trial for Clear Cell Renal Cell Carcinoma (NCT07516366). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07516366.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07516366.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:13:47.896Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/testing-the-use-of-ado-trastuzumab-emtansine-compared-to-the-usu-nct05408845/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05408845.jpg</video:thumbnail_loc>
      <video:title>Biopsy Procedure trial for Metastatic Salivary Gland Carcinoma (NCT05408845): short film</video:title>
      <video:description>Biopsy Procedure trial for Metastatic Salivary Gland Carcinoma (NCT05408845). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05408845.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05408845.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:57:27.403Z</video:publication_date>
      <video:duration>90</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/testing-the-use-of-neratinib-or-the-combination-of-neratinib-and-nct06126276/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06126276.jpg</video:thumbnail_loc>
      <video:title>Biopsy Procedure trial for Malignant Female Reproductive System Neoplasm (NCT06126276): short film</video:title>
      <video:description>Biopsy Procedure trial for Malignant Female Reproductive System Neoplasm (NCT06126276). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06126276.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06126276.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:26:46.739Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/testing-what-happens-when-an-immunotherapy-drug-pembrolizumab-is-nct04671667/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04671667.jpg</video:thumbnail_loc>
      <video:title>Carboplatin trial for Recurrent Head and Neck Squamous Cell Carcinoma (NCT04671667): short film</video:title>
      <video:description>Carboplatin trial for Recurrent Head and Neck Squamous Cell Carcinoma (NCT04671667). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04671667.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04671667.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:17:59.650Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/testing-whether-cemiplimab-regn2810-plus-cdx-1140-given-prior-to-nct06980038/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06980038.jpg</video:thumbnail_loc>
      <video:title>Anti-CD40 Agonist Monoclonal… trial for Head and Neck Squamous Cell… (NCT06980038): short film</video:title>
      <video:description>Anti-CD40 Agonist Monoclonal Antibody CDX-1140 trial for Head and Neck Squamous Cell Carcinoma (NCT06980038). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06980038.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06980038.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:20:20.975Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/the-cosmyc-trial-combined-suppression-of-myc-nct06922318/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06922318.jpg</video:thumbnail_loc>
      <video:title>ZEN-3694 trial for Metastatic Castration-resistant Prostate Cancer (NCT06922318): short film</video:title>
      <video:description>ZEN-3694 trial for Metastatic Castration-resistant Prostate Cancer (NCT06922318). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06922318.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06922318.mp4</video:content_loc>
      <video:publication_date>2026-10-31T23:52:07.805Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/the-miami-empire-trial-eradication-of-metastatic-pancreatic-canc-nct06843551/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06843551.jpg</video:thumbnail_loc>
      <video:title>Stereotactic Body Radiation… trial for Metastatic Pancreatic… (NCT06843551): short film</video:title>
      <video:description>Stereotactic Body Radiation Therapy trial for Metastatic Pancreatic Ductal Adenocarcinoma (NCT06843551). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06843551.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06843551.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:45:53.685Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/the-minimalist-trial-2-nct06702033/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06702033.jpg</video:thumbnail_loc>
      <video:title>Radiation therapy trial for HPV-Related Oropharynx Squamous Cell Carcinoma (NCT06702033): short film</video:title>
      <video:description>Radiation therapy trial for HPV-Related Oropharynx Squamous Cell Carcinoma (NCT06702033). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06702033.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06702033.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:10:53.399Z</video:publication_date>
      <video:duration>86</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/the-sappho-study-sequential-therapy-with-curative-intent-in-de-n-nct06439693/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06439693.jpg</video:thumbnail_loc>
      <video:title>Nab-Paclitaxel trial for Breast Cancer Female (NCT06439693): short film</video:title>
      <video:description>Nab-Paclitaxel trial for Breast Cancer Female (NCT06439693). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06439693.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06439693.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:17:27.539Z</video:publication_date>
      <video:duration>91</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/the-study-of-atezolizumab-bevacizumab-and-memantine-in-patients-nct06789757/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06789757.jpg</video:thumbnail_loc>
      <video:title>Memantine Hydrochloride trial for Hepatocellular Carcinoma (NCT06789757): short film</video:title>
      <video:description>Memantine Hydrochloride trial for Hepatocellular Carcinoma (NCT06789757). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06789757.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06789757.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:32:47.515Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/the-sugar-study-sbrt-and-relugolix-for-prostate-cancer-nct06111781/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06111781.jpg</video:thumbnail_loc>
      <video:title>Relugolix 120 MG [Orgovyx] trial for Prostate Cancer (NCT06111781): short film</video:title>
      <video:description>Relugolix 120 MG [Orgovyx] trial for Prostate Cancer (NCT06111781). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06111781.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06111781.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:54:03.404Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/therapy-for-newly-diagnosed-patients-with-b-cell-precursor-acute-nct06533748/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06533748.jpg</video:thumbnail_loc>
      <video:title>Dexamethasone trial for Acute Lymphoblastic Leukemia (NCT06533748): short film</video:title>
      <video:description>Dexamethasone trial for Acute Lymphoblastic Leukemia (NCT06533748). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06533748.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06533748.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:41:17.788Z</video:publication_date>
      <video:duration>85</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/three-schedules-of-cue-101-administered-before-surgery-or-defini-nct04852328/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04852328.jpg</video:thumbnail_loc>
      <video:title>CUE-101 trial for Oropharyngeal Squamous Cell Carcinoma (NCT04852328): short film</video:title>
      <video:description>CUE-101 trial for Oropharyngeal Squamous Cell Carcinoma (NCT04852328). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04852328.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04852328.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:32:40.590Z</video:publication_date>
      <video:duration>94</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/to-study-the-effect-of-inavolisib-in-combination-with-fulvestran-nct07368998/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07368998.jpg</video:thumbnail_loc>
      <video:title>Inavolisib trial for Breast Cancer (NCT07368998): short film</video:title>
      <video:description>Inavolisib trial for Breast Cancer (NCT07368998). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07368998.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07368998.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:43:35.724Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/top-2301-neoadjuvant-chemo-for-nsclc-nct06385262/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06385262.jpg</video:thumbnail_loc>
      <video:title>Alirocumab trial for Non Small Cell Lung Cancer (NCT06385262): short film</video:title>
      <video:description>Alirocumab trial for Non Small Cell Lung Cancer (NCT06385262). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06385262.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06385262.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:22:23.135Z</video:publication_date>
      <video:duration>81</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/total-marrow-and-lymphoid-irradiation-in-combination-with-fludar-nct07582172/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07582172.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Acute Myeloid Leukemia With Complex… (NCT07582172): short film</video:title>
      <video:description>Biospecimen Collection trial for Acute Myeloid Leukemia With Complex Karyotype (NCT07582172). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07582172.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07582172.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:41:29.776Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/total-neoadjuvant-therapy-with-mfolfox-and-short-course-radiatio-nct04643366/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04643366.jpg</video:thumbnail_loc>
      <video:title>Chemotherapy trial for Rectal Cancer (NCT04643366): short film</video:title>
      <video:description>Chemotherapy trial for Rectal Cancer (NCT04643366). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04643366.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04643366.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:34:40.175Z</video:publication_date>
      <video:duration>92</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/transoral-surgical-resection-followed-by-de-escalated-adjuvant-i-nct05388773/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05388773.jpg</video:thumbnail_loc>
      <video:title>therapeutic conventional surgery trial for Oropharynx Cancer (NCT05388773): short film</video:title>
      <video:description>therapeutic conventional surgery trial for Oropharynx Cancer (NCT05388773). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05388773.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05388773.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:26:20.435Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/treatment-for-advanced-non-small-cell-lung-cancer-with-actionabl-nct07393555/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07393555.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Recurrent Lung Non-Small Cell Carcinoma (NCT07393555): short film</video:title>
      <video:description>Biospecimen Collection trial for Recurrent Lung Non-Small Cell Carcinoma (NCT07393555). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07393555.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07393555.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:22:10.163Z</video:publication_date>
      <video:duration>98</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/treatment-of-adc-refractory-breast-cancer-with-dato-dxd-or-t-dxd-nct06533826/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06533826.jpg</video:thumbnail_loc>
      <video:title>Trastuzumab Deruxtecan trial for Breast Cancer (NCT06533826): short film</video:title>
      <video:description>Trastuzumab Deruxtecan trial for Breast Cancer (NCT06533826). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06533826.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06533826.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:09:50.060Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/triage-of-advanced-cervical-cancer-through-immunotherapy-inducti-nct05475171/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05475171.jpg</video:thumbnail_loc>
      <video:title>Lorigerlimab trial for Metastatic Cancer (NCT05475171): short film</video:title>
      <video:description>Lorigerlimab trial for Metastatic Cancer (NCT05475171). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05475171.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05475171.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:31:34.547Z</video:publication_date>
      <video:duration>75</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/trial-comparing-lattice-radiotherapy-vs-moderately-dose-escalate-nct07594431/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07594431.jpg</video:thumbnail_loc>
      <video:title>LATTICE Radiotherapy trial for Metastases (NCT07594431): short film</video:title>
      <video:description>LATTICE Radiotherapy trial for Metastases (NCT07594431). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07594431.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07594431.mp4</video:content_loc>
      <video:publication_date>2026-10-31T17:21:17.517Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/trial-investigating-visugromab-and-nivolumab-with-or-without-doc-nct07246863/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07246863.jpg</video:thumbnail_loc>
      <video:title>Visugromab RDE (recommended dose… trial for Metastatic Non-Squamous… (NCT07246863): short film</video:title>
      <video:description>Visugromab RDE (recommended dose for expansion) trial for Metastatic Non-Squamous Non-Small Cell Lung Cancer (NCT07246863). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07246863.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07246863.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:19:35.078Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/trial-investigating-visugromab-in-combination-with-immunochemoth-nct07098988/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07098988.jpg</video:thumbnail_loc>
      <video:title>Visugromab trial for Metastatic Non-Squamous Non-Small Cell Lung Cancer (NCT07098988): short film</video:title>
      <video:description>Visugromab trial for Metastatic Non-Squamous Non-Small Cell Lung Cancer (NCT07098988). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07098988.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07098988.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:11:20.710Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/trial-of-2-step-atg-for-acute-gvhd-prevention-post-myeloablative-nct06315309/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06315309.jpg</video:thumbnail_loc>
      <video:title>ATG Combined with Tacrolimus and Mini Methotrexate trial for GVHD,Acute (NCT06315309): short film</video:title>
      <video:description>ATG Combined with Tacrolimus and Mini Methotrexate trial for GVHD,Acute (NCT06315309). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06315309.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06315309.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:40:25.806Z</video:publication_date>
      <video:duration>86</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/trial-of-amb-05x-for-patients-with-ctdna-colorectal-cancer-after-nct06617858/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06617858.jpg</video:thumbnail_loc>
      <video:title>AMB-05X trial for Colorectal Cancer (NCT06617858): short film</video:title>
      <video:description>AMB-05X trial for Colorectal Cancer (NCT06617858). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06617858.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06617858.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:39:04.603Z</video:publication_date>
      <video:duration>72</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/trial-of-an-alternative-cabozantinib-dosing-schedule-in-metastat-nct05263050/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05263050.jpg</video:thumbnail_loc>
      <video:title>Cabozantinib trial for Metastatic Renal Cell Carcinoma (NCT05263050): short film</video:title>
      <video:description>Cabozantinib trial for Metastatic Renal Cell Carcinoma (NCT05263050). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05263050.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05263050.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:00:33.087Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/trial-of-orca-t-following-reduced-intensity-or-nonmyeloablative-nct07216443/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07216443.jpg</video:thumbnail_loc>
      <video:title>Orca-T trial for Leukemia, Myeloid, Acute (NCT07216443): short film</video:title>
      <video:description>Orca-T trial for Leukemia, Myeloid, Acute (NCT07216443). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07216443.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07216443.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:23:03.418Z</video:publication_date>
      <video:duration>87</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/trial-of-therapies-with-it-cdc1s-combined-w-it-trastuzamab-for-h-nct07694986/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07694986.jpg</video:thumbnail_loc>
      <video:title>cDC1 Vaccine trial for Breast Cancer (NCT07694986): short film</video:title>
      <video:description>cDC1 Vaccine trial for Breast Cancer (NCT07694986). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07694986.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07694986.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:17:56.510Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/trial-of-trastuzumab-deruxtecan-in-previously-treated-her2-nct06750484/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06750484.jpg</video:thumbnail_loc>
      <video:title>Trastuzumab Deruxtecan trial for Breast Cancer Metastatic (NCT06750484): short film</video:title>
      <video:description>Trastuzumab Deruxtecan trial for Breast Cancer Metastatic (NCT06750484). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06750484.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06750484.mp4</video:content_loc>
      <video:publication_date>2026-10-31T19:55:12.640Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/trial-to-study-anti-hcmv-therapy-in-breast-cancer-patients-with-nct07383649/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07383649.jpg</video:thumbnail_loc>
      <video:title>Valganciclovir trial for Brain Cancer Metastatic (NCT07383649): short film</video:title>
      <video:description>Valganciclovir trial for Brain Cancer Metastatic (NCT07383649). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07383649.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07383649.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:06:52.883Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/trial-utilizing-metronidazole-to-optimize-the-microbiome-of-rect-nct06569368/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06569368.jpg</video:thumbnail_loc>
      <video:title>Metronidazole trial for Rectal Adenocarcinoma (NCT06569368): short film</video:title>
      <video:description>Metronidazole trial for Rectal Adenocarcinoma (NCT06569368). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06569368.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06569368.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:38:35.895Z</video:publication_date>
      <video:duration>70</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/turkey-tail-mushroom-for-treating-post-menopausal-women-with-her-nct06450873/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06450873.jpg</video:thumbnail_loc>
      <video:title>Coriolus Versicolor Extract trial for Estrogen Receptor-Positive Breast… (NCT06450873): short film</video:title>
      <video:description>Coriolus Versicolor Extract trial for Estrogen Receptor-Positive Breast Carcinoma (NCT06450873). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06450873.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06450873.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:34:07.285Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/ucsd-image-guided-cognitive-sparing-radiosurgery-for-intracrania-nct04343157/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04343157.jpg</video:thumbnail_loc>
      <video:title>Cognitive Sparing Brain… trial for Brain Metastases, Adult (NCT04343157): short film</video:title>
      <video:description>Cognitive Sparing Brain Stereotactic Radiosurgery (SRS) trial for Brain Metastases, Adult (NCT04343157). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04343157.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04343157.mp4</video:content_loc>
      <video:publication_date>2026-10-31T18:46:30.047Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/ultra-hypo-fractionated-adjuvant-whole-breast-radiation-therapy-nct06902311/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06902311.jpg</video:thumbnail_loc>
      <video:title>Breast Radiotherapy trial for Breast Cancer (NCT06902311): short film</video:title>
      <video:description>Breast Radiotherapy trial for Breast Cancer (NCT06902311). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06902311.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06902311.mp4</video:content_loc>
      <video:publication_date>2026-10-31T19:52:10.746Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/upfront-chemotherapy-with-radiation-therapy-crt-followed-by-chem-nct07603375/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07603375.jpg</video:thumbnail_loc>
      <video:title>FOLFOX (5-fluorouracil,… trial for Esophageal Adenocarcinoma (NCT07603375): short film</video:title>
      <video:description>FOLFOX (5-fluorouracil, Leucovorin, Oxaliplatin) trial for Esophageal Adenocarcinoma (NCT07603375). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07603375.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07603375.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:59:03.186Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/use-of-isatuximab-dexamethasone-and-lenalidomide-in-a-go-slow-fa-nct06517017/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06517017.jpg</video:thumbnail_loc>
      <video:title>Isatuximab trial for Multiple Myeloma (NCT06517017): short film</video:title>
      <video:description>Isatuximab trial for Multiple Myeloma (NCT06517017). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06517017.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06517017.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:55:53.296Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/using-circulating-tumor-dna-to-risk-adapt-post-operative-therapy-nct06445114/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06445114.jpg</video:thumbnail_loc>
      <video:title>Cisplatin trial for Oropharyngeal Cancer (NCT06445114): short film</video:title>
      <video:description>Cisplatin trial for Oropharyngeal Cancer (NCT06445114). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06445114.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06445114.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:20:33.095Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/venetoclax-and-hma-treatment-of-older-and-unfit-adults-with-flt3-nct06317649/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06317649.jpg</video:thumbnail_loc>
      <video:title>Azacitidine trial for Acute Myeloid Leukemia (NCT06317649): short film</video:title>
      <video:description>Azacitidine trial for Acute Myeloid Leukemia (NCT06317649). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06317649.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06317649.mp4</video:content_loc>
      <video:publication_date>2026-10-31T05:28:38.104Z</video:publication_date>
      <video:duration>86</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/venetoclax-cladribine-low-dose-cytarabine-and-azacitidine-in-tre-nct03586609/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03586609.jpg</video:thumbnail_loc>
      <video:title>Azacitidine trial for Acute Myeloid Leukemia (NCT03586609): short film</video:title>
      <video:description>Azacitidine trial for Acute Myeloid Leukemia (NCT03586609). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03586609.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03586609.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:47:15.482Z</video:publication_date>
      <video:duration>95</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/venetoclax-in-combination-with-cladribine-and-cytarabine-alterna-nct06504459/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06504459.jpg</video:thumbnail_loc>
      <video:title>Azacitidine trial for Acute Monocytic Leukemia (NCT06504459): short film</video:title>
      <video:description>Azacitidine trial for Acute Monocytic Leukemia (NCT06504459). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06504459.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06504459.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:33:38.588Z</video:publication_date>
      <video:duration>83</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/venetoclax-plus-zanubrutinib-for-the-treatment-of-chronic-lympho-nct07734038/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07734038.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Chronic Lymphocytic Leukemia (NCT07734038): short film</video:title>
      <video:description>Biospecimen Collection trial for Chronic Lymphocytic Leukemia (NCT07734038). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07734038.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07734038.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:16:07.369Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/venetoclax-sl-401-and-chemotherapy-for-the-treatment-of-blastic-nct04216524/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04216524.jpg</video:thumbnail_loc>
      <video:title>Cyclophosphamide trial for Blastic Plasmacytoid Dendritic Cell Neoplasm (NCT04216524): short film</video:title>
      <video:description>Cyclophosphamide trial for Blastic Plasmacytoid Dendritic Cell Neoplasm (NCT04216524). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04216524.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04216524.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:47:40.127Z</video:publication_date>
      <video:duration>81</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/vismodegib-combined-with-atezolizumab-in-platinum-resistant-ovar-nct05538091/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05538091.jpg</video:thumbnail_loc>
      <video:title>Vismodegib trial for Platinum-Resistant Fallopian Tube Carcinoma (NCT05538091): short film</video:title>
      <video:description>Vismodegib trial for Platinum-Resistant Fallopian Tube Carcinoma (NCT05538091). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05538091.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05538091.mp4</video:content_loc>
      <video:publication_date>2026-10-31T23:52:21.109Z</video:publication_date>
      <video:duration>78</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/vismodegib-fak-inhibitor-gsk2256098-capivasertib-and-abemaciclib-nct02523014/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02523014.jpg</video:thumbnail_loc>
      <video:title>Vismodegib trial for Intracranial Meningioma (NCT02523014): short film</video:title>
      <video:description>Vismodegib trial for Intracranial Meningioma (NCT02523014). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT02523014.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02523014.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:15:20.471Z</video:publication_date>
      <video:duration>95</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/vista-valproic-acid-irinotecan-and-simvastatin-for-recurrent-gli-nct07831369/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07831369.jpg</video:thumbnail_loc>
      <video:title>Valproic Acid (VPA) trial for Glioblastoma (NCT07831369): short film</video:title>
      <video:description>Valproic Acid (VPA) trial for Glioblastoma (NCT07831369). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07831369.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07831369.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:07:40.381Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/vorasidenib-study-in-pediatric-participants-with-grade-2-astrocy-nct07286292/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07286292.jpg</video:thumbnail_loc>
      <video:title>Vorasidenib trial for Grade 2 Astrocytoma or Oligodendroglioma With an… (NCT07286292): short film</video:title>
      <video:description>Vorasidenib trial for Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation (NCT07286292). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07286292.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07286292.mp4</video:content_loc>
      <video:publication_date>2026-10-31T18:25:48.071Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/wp1066-and-radiation-therapy-in-treating-patients-with-newly-dia-nct05879250/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05879250.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Glioblastoma, IDH-Wildtype (NCT05879250): short film</video:title>
      <video:description>Biospecimen Collection trial for Glioblastoma, IDH-Wildtype (NCT05879250). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05879250.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05879250.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:19:52.229Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/xl092-for-the-treatment-of-locally-advanced-or-metastatic-radioi-nct06959641/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06959641.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Locally Advanced Differentiated Thyroid… (NCT06959641): short film</video:title>
      <video:description>Biospecimen Collection trial for Locally Advanced Differentiated Thyroid Gland Carcinoma (NCT06959641). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06959641.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06959641.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:47:58.429Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/xl092-in-patients-with-metastatic-castration-resistant-prostate-nct06568562/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06568562.jpg</video:thumbnail_loc>
      <video:title>XL092 trial for Metastatic Castration-resistant Prostate Cancer (NCT06568562): short film</video:title>
      <video:description>XL092 trial for Metastatic Castration-resistant Prostate Cancer (NCT06568562). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06568562.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06568562.mp4</video:content_loc>
      <video:publication_date>2026-10-31T22:40:16.558Z</video:publication_date>
      <video:duration>92</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/xl092-zanzalintinib-for-the-treatment-of-patients-with-metastati-nct06571734/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06571734.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Metastatic Leiomyosarcoma (NCT06571734): short film</video:title>
      <video:description>Biospecimen Collection trial for Metastatic Leiomyosarcoma (NCT06571734). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06571734.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06571734.mp4</video:content_loc>
      <video:publication_date>2026-10-31T06:55:48.284Z</video:publication_date>
      <video:duration>77</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/y-90-capecitabine-and-atezolizumab-for-oligometastatic-crc-nct06555133/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06555133.jpg</video:thumbnail_loc>
      <video:title>yttrium-90 radioembolization trial for Colorectal Carcinoma Metastatic… (NCT06555133): short film</video:title>
      <video:description>yttrium-90 radioembolization trial for Colorectal Carcinoma Metastatic in the Liver (NCT06555133). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06555133.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06555133.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:47:39.823Z</video:publication_date>
      <video:duration>73</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/zanubrutinib-bendamustine-rituximab-prev-untreated-wm-nct06561347/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06561347.jpg</video:thumbnail_loc>
      <video:title>Zanubrutinib trial for Waldenstrom Macroglobulinemia (NCT06561347): short film</video:title>
      <video:description>Zanubrutinib trial for Waldenstrom Macroglobulinemia (NCT06561347). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06561347.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06561347.mp4</video:content_loc>
      <video:publication_date>2026-10-31T20:04:45.633Z</video:publication_date>
      <video:duration>85</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/zanubrutinib-obinutuzumab-sonrotoclax-boson-or-bgb-16673-obinutu-nct06849713/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06849713.jpg</video:thumbnail_loc>
      <video:title>Zanubrutinib trial for Chronic Lymphocytic Leukemia (NCT06849713): short film</video:title>
      <video:description>Zanubrutinib trial for Chronic Lymphocytic Leukemia (NCT06849713). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06849713.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06849713.mp4</video:content_loc>
      <video:publication_date>2026-10-31T17:02:56.982Z</video:publication_date>
      <video:duration>82</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/zanzalintinib-for-metastatic-clear-cell-renal-cell-carcinoma-wit-nct07043608/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07043608.jpg</video:thumbnail_loc>
      <video:title>Zanzalintinib trial for Clear Cell Renal Cell Cancer (ccRCC) (NCT07043608): short film</video:title>
      <video:description>Zanzalintinib trial for Clear Cell Renal Cell Cancer (ccRCC) (NCT07043608). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07043608.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07043608.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:03:10.056Z</video:publication_date>
      <video:duration>79</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/zanzalintinib-for-the-treatment-of-advanced-thyroid-cancer-befor-nct06959511/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06959511.jpg</video:thumbnail_loc>
      <video:title>Zanzalintinib trial for Neoadjuvant Treatment (NCT06959511): short film</video:title>
      <video:description>Zanzalintinib trial for Neoadjuvant Treatment (NCT06959511). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06959511.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06959511.mp4</video:content_loc>
      <video:publication_date>2026-10-31T19:14:07.606Z</video:publication_date>
      <video:duration>80</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/zanzalintinib-in-men-with-aggressive-variant-prostate-cancer-nct07218666/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07218666.jpg</video:thumbnail_loc>
      <video:title>Zanzalintinib trial for Aggressive Variant Prostate Carcinoma (NCT07218666): short film</video:title>
      <video:description>Zanzalintinib trial for Aggressive Variant Prostate Carcinoma (NCT07218666). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07218666.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07218666.mp4</video:content_loc>
      <video:publication_date>2026-10-31T15:57:57.138Z</video:publication_date>
      <video:duration>85</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/zanzalintinib-maintenance-in-patients-with-high-grade-neuroendoc-nct06926634/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06926634.jpg</video:thumbnail_loc>
      <video:title>Zanzalintinib trial for High Grade Neuroendocrine Neoplasms (NCT06926634): short film</video:title>
      <video:description>Zanzalintinib trial for High Grade Neuroendocrine Neoplasms (NCT06926634). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06926634.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06926634.mp4</video:content_loc>
      <video:publication_date>2026-10-31T21:24:14.332Z</video:publication_date>
      <video:duration>84</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/zen003694-combined-with-talazoparib-in-patients-with-recurrent-o-nct05071937/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05071937.jpg</video:thumbnail_loc>
      <video:title>ZEN003694 trial for Ovarian Cancer (NCT05071937): short film</video:title>
      <video:description>ZEN003694 trial for Ovarian Cancer (NCT05071937). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05071937.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05071937.mp4</video:content_loc>
      <video:publication_date>2026-10-31T23:54:24.369Z</video:publication_date>
      <video:duration>89</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
  <url>
    <loc>https://www.trianglehealth.com/phase-2/ziftomenib-for-the-treatment-of-patients-with-npm1-mutated-or-km-nct06930352/video</loc>
    <video:video>
      <video:thumbnail_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06930352.jpg</video:thumbnail_loc>
      <video:title>Biospecimen Collection trial for Acute Myeloid Leukemia (NCT06930352): short film</video:title>
      <video:description>Biospecimen Collection trial for Acute Myeloid Leukemia (NCT06930352). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06930352.</video:description>
      <video:content_loc>https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06930352.mp4</video:content_loc>
      <video:publication_date>2026-10-31T16:47:50.593Z</video:publication_date>
      <video:duration>74</video:duration>
      <video:family_friendly>yes</video:family_friendly>
      <video:live>no</video:live>
    </video:video>
  </url>
</urlset>
